STUDYID|DOMAIN|USUBJID|CESEQ|CETERM|CEDECOD|CESEV|TAETORD|EPOCH|CEDTC|CESTDTC|CEENDTC|CEDY|CESTDY|CEENDY|CESTRTPT|CESTTPT|CEENRTPT|CEENTPT
Study ID|CE|d713606e-c808-49d6-878b-242fa5423a99|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-05-08|2021-10-18|2022-06-13|219|17|255|COINCIDENT|2022-02-07|BEFORE|2022-03-06
Study ID|CE|d713606e-c808-49d6-878b-242fa5423a99|2|[?]|[?]|MODERATE|2|TREATMENT|2022-05-29|2022-03-12|2022-07-19|240|162|291|UNKNOWN|2022-01-13|BEFORE|2022-01-19
Study ID|CE|19276962-2753-41ca-93c0-b62eebf73043|1|[?]|[?]|SEVERE|4|TREATMENT|2022-04-14|2022-03-08|2022-05-19|174|137|209|UNKNOWN|2022-04-25|ONGOING|2022-05-15
Study ID|CE|19276962-2753-41ca-93c0-b62eebf73043|2|[?]|[?]|MILD|6|TREATMENT|2022-05-18|2022-05-04|2022-06-04|208|194|225|BEFORE|2021-11-05|COINCIDENT|2021-11-06
Study ID|CE|fba486eb-0c9f-4093-83ec-7b3a3119e949|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-06-03|2022-03-01|2022-06-05|287|193|289|COINCIDENT|2021-09-02|ONGOING|2021-09-04
Study ID|CE|fba486eb-0c9f-4093-83ec-7b3a3119e949|2|[?]|[?]|MODERATE|3|WASHOUT|2021-11-08|2021-10-14|2022-04-25|80|55|248|BEFORE|2021-09-13|AFTER|2021-09-14
Study ID|CE|9b1d13e0-4298-471e-b0f4-e66662712e84|1|[?]|[?]|SEVERE|1|SCREENING|2022-04-27|2021-10-31|2022-07-10|180|2|254|UNKNOWN|2021-11-11|ONGOING|2021-11-12
Study ID|CE|9b1d13e0-4298-471e-b0f4-e66662712e84|2|[?]|[?]|MODERATE|6|TREATMENT|2021-11-09|2021-11-04|2022-07-13|11|6|257|AFTER|2021-11-24|ONGOING|2021-12-25
Study ID|CE|e7827662-389f-439b-bd52-bcc90880dae5|1|[?]|[?]|MILD|1|SCREENING|2021-10-08|2021-09-17|2022-03-22|31|10|196|COINCIDENT|2021-11-14|BEFORE|2021-12-12
Study ID|CE|e7827662-389f-439b-bd52-bcc90880dae5|2|[?]|[?]|MODERATE|4|TREATMENT|2022-05-28|2021-10-16|2022-05-30|263|39|265|AFTER|2021-09-16|BEFORE|2021-09-22
Study ID|CE|a1870039-6e2b-4170-8c6b-bd813a0f62f2|1|[?]|[?]|MILD|3|WASHOUT|2022-03-09|2022-01-18|2022-03-30|147|97|168|UNKNOWN|2022-04-11|COINCIDENT|2022-04-18
Study ID|CE|a1870039-6e2b-4170-8c6b-bd813a0f62f2|2|[?]|[?]|MODERATE|3|WASHOUT|2022-02-14|2021-12-10|2022-05-14|124|58|213|UNKNOWN|2022-03-11|AFTER|2022-03-18
Study ID|CE|42b8617e-b2c0-4f9d-af9c-4c9618d9676b|1|[?]|[?]|MODERATE|1|SCREENING|2022-02-09|2021-12-28|2022-05-23|114|71|217|UNKNOWN|2021-12-20|COINCIDENT|2021-12-31
Study ID|CE|42b8617e-b2c0-4f9d-af9c-4c9618d9676b|2|[?]|[?]|MILD|5|WASHOUT|2022-03-05|2021-10-21|2022-07-21|138|3|276|AFTER|2021-10-29|ONGOING|2021-11-15
Study ID|CE|ab5335fb-bc0d-460f-abe5-5d613b1b6afb|1|[?]|[?]|SEVERE|5|WASHOUT|2022-04-26|2021-10-27|2022-05-08|208|27|220|COINCIDENT|2021-12-14|AFTER|2022-01-08
Study ID|CE|ab5335fb-bc0d-460f-abe5-5d613b1b6afb|2|[?]|[?]|MILD|2|TREATMENT|2022-03-25|2021-12-04|2022-06-18|176|65|261|BEFORE|2022-01-20|BEFORE|2022-01-21
Study ID|CE|f975203f-2a45-4166-b937-afb03fb17d1e|1|[?]|[?]|MILD|4|TREATMENT|2022-06-26|2022-01-30|2022-07-17|268|121|289|AFTER|2022-01-19|COINCIDENT|2022-01-21
Study ID|CE|f975203f-2a45-4166-b937-afb03fb17d1e|2|[?]|[?]|MODERATE|2|TREATMENT|2022-06-06|2022-01-04|2022-07-12|248|95|284|BEFORE|2022-06-22|BEFORE|2022-06-28
Study ID|CE|8faca3ae-52d5-4e2a-896d-9a5b86ea1a1a|1|[?]|[?]|MILD|6|TREATMENT|2021-09-29|2021-09-25|2021-12-25|45|41|132|AFTER|2021-10-03|BEFORE|2021-11-14
Study ID|CE|8faca3ae-52d5-4e2a-896d-9a5b86ea1a1a|2|[?]|[?]|MILD|1|SCREENING|2022-02-22|2021-11-29|2022-05-14|191|106|272|COINCIDENT|2021-12-28|BEFORE|2021-12-29
Study ID|CE|b3a504cf-317b-429e-bb1b-39c4b1568a5f|1|[?]|[?]|MILD|4|TREATMENT|2022-06-10|2022-05-31|2022-06-16|292|282|298|AFTER|2021-12-20|ONGOING|2021-12-22
Study ID|CE|b3a504cf-317b-429e-bb1b-39c4b1568a5f|2|[?]|[?]|MILD|6|TREATMENT|2022-04-23|2021-08-24|2022-05-07|244|2|258|COINCIDENT|2022-04-21|BEFORE|2022-05-07
Study ID|CE|bc1b5635-3292-4053-8401-e257c00b5db2|1|[?]|[?]|SEVERE|4|TREATMENT|2021-12-18|2021-11-14|2022-05-03|110|76|246|BEFORE|2022-01-29|AFTER|2022-01-30
Study ID|CE|bc1b5635-3292-4053-8401-e257c00b5db2|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-05-06|2022-03-18|2022-06-23|249|200|297|BEFORE|2021-12-13|AFTER|2021-12-18
Study ID|CE|2deec466-9b3f-4b48-ac64-56beeb018888|1|[?]|[?]|SEVERE|2|TREATMENT|2021-10-21|2021-10-10|2022-05-03|29|18|223|AFTER|2022-07-10|BEFORE|2022-07-11
Study ID|CE|2deec466-9b3f-4b48-ac64-56beeb018888|2|[?]|[?]|MODERATE|1|SCREENING|2022-01-19|2021-12-08|2022-06-08|119|77|259|COINCIDENT|2022-06-25|AFTER|2022-06-26
Study ID|CE|d5eff634-c07e-4933-9551-0f596a0a6aa3|1|[?]|[?]|MODERATE|6|TREATMENT|2021-10-14|2021-09-22|2021-12-22|62|40|131|UNKNOWN|2021-09-07|COINCIDENT|2021-09-08
Study ID|CE|d5eff634-c07e-4933-9551-0f596a0a6aa3|2|[?]|[?]|SEVERE|2|TREATMENT|2022-04-05|2021-08-17|2022-05-16|235|4|276|UNKNOWN|2022-02-24|COINCIDENT|2022-02-25
Study ID|CE|b831f8dd-ec31-4fae-9e3d-1c64e6fcacb1|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-07-31|2022-07-16|2022-08-05|294|279|299|COINCIDENT|2021-11-29|BEFORE|2022-01-26
Study ID|CE|b831f8dd-ec31-4fae-9e3d-1c64e6fcacb1|2|[?]|[?]|SEVERE|3|WASHOUT|2022-01-03|2021-11-08|2022-05-19|85|29|221|AFTER|2022-03-14|COINCIDENT|2022-04-14
Study ID|CE|47665624-a6d0-4756-8af7-b3643cf402fc|1|[?]|[?]|SEVERE|2|TREATMENT|2022-05-03|2022-04-30|2022-05-21|215|212|233|UNKNOWN|2021-11-22|BEFORE|2021-12-12
Study ID|CE|47665624-a6d0-4756-8af7-b3643cf402fc|2|[?]|[?]|MILD|4|TREATMENT|2021-10-10|2021-10-04|2022-01-07|10|4|99|UNKNOWN|2021-11-19|BEFORE|2021-12-26
Study ID|CE|80a01467-5aa8-45f7-919a-0e1e0046d252|1|[?]|[?]|MODERATE|3|WASHOUT|2021-12-13|2021-12-08|2022-06-24|92|87|285|UNKNOWN|2022-04-01|BEFORE|2022-04-07
Study ID|CE|80a01467-5aa8-45f7-919a-0e1e0046d252|2|[?]|[?]|MODERATE|1|SCREENING|2021-10-22|2021-09-24|2022-01-14|40|12|124|UNKNOWN|2022-02-07|COINCIDENT|2022-02-17
Study ID|CE|5b2e3107-b84c-43dc-a5fc-43f02e7def1c|1|[?]|[?]|MILD|1|SCREENING|2022-05-15|2022-04-06|2022-07-19|201|162|266|BEFORE|2022-04-17|ONGOING|2022-04-21
Study ID|CE|5b2e3107-b84c-43dc-a5fc-43f02e7def1c|2|[?]|[?]|MILD|6|TREATMENT|2022-03-24|2022-01-08|2022-06-02|149|74|219|AFTER|2021-12-15|COINCIDENT|2021-12-17
Study ID|CE|848bf545-6441-48fa-80cc-b97aba0d77c3|1|[?]|[?]|MILD|3|WASHOUT|2022-05-26|2021-11-22|2022-06-30|230|45|265|AFTER|2022-02-13|AFTER|2022-02-15
Study ID|CE|848bf545-6441-48fa-80cc-b97aba0d77c3|2|[?]|[?]|MODERATE|1|SCREENING|2022-05-21|2022-03-22|2022-07-27|225|165|292|UNKNOWN|2022-03-11|ONGOING|2022-04-24
Study ID|CE|4c476a2e-71de-47b8-845d-73d5963ebf61|1|[?]|[?]|MILD|1|SCREENING|2022-04-26|2022-02-27|2022-07-20|187|129|272|UNKNOWN|2022-07-25|AFTER|2022-07-26
Study ID|CE|4c476a2e-71de-47b8-845d-73d5963ebf61|2|[?]|[?]|SEVERE|5|WASHOUT|2022-02-14|2022-02-08|2022-07-26|116|110|278|AFTER|2022-03-02|AFTER|2022-03-07
Study ID|CE|fd8e4cff-6799-40e2-84ee-a222b5d564ad|1|[?]|[?]|MODERATE|6|TREATMENT|2022-06-01|2021-12-14|2022-06-21|242|73|262|AFTER|2022-04-21|AFTER|2022-04-29
Study ID|CE|fd8e4cff-6799-40e2-84ee-a222b5d564ad|2|[?]|[?]|MODERATE|4|TREATMENT|2022-05-13|2021-12-12|2022-06-09|223|71|250|BEFORE|2021-12-09|AFTER|2022-01-21
Study ID|CE|afc20884-6463-4dd3-a61c-c73566fde2d2|1|[?]|[?]|MILD|5|WASHOUT|2022-06-05|2022-03-18|2022-06-17|234|155|246|COINCIDENT|2021-11-04|ONGOING|2021-11-05
Study ID|CE|afc20884-6463-4dd3-a61c-c73566fde2d2|2|[?]|[?]|SEVERE|5|WASHOUT|2022-08-05|2021-11-08|2022-08-07|295|25|297|COINCIDENT|2021-12-22|COINCIDENT|2022-01-02
Study ID|CE|cafdfd6a-907b-4504-893d-b2353295e18c|1|[?]|[?]|MILD|6|TREATMENT|2021-12-28|2021-12-04|2022-01-30|100|76|133|UNKNOWN|2021-12-01|COINCIDENT|2021-12-02
Study ID|CE|cafdfd6a-907b-4504-893d-b2353295e18c|2|[?]|[?]|SEVERE|2|TREATMENT|2021-11-23|2021-10-10|2022-03-13|65|21|175|UNKNOWN|2022-01-13|COINCIDENT|2022-01-14
Study ID|CE|6be30d43-dc8c-4406-b5b2-6461039ac501|1|[?]|[?]|MODERATE|4|TREATMENT|2022-05-08|2021-12-16|2022-07-19|203|60|275|COINCIDENT|2022-05-19|ONGOING|2022-06-06
Study ID|CE|6be30d43-dc8c-4406-b5b2-6461039ac501|2|[?]|[?]|MODERATE|5|WASHOUT|2022-01-10|2022-01-08|2022-01-15|85|83|90|AFTER|2021-12-29|AFTER|2021-12-30
Study ID|CE|2fa374c2-4d57-4de3-a86b-a3a374e6ab68|1|[?]|[?]|MILD|4|TREATMENT|2021-11-13|2021-10-24|2022-04-29|57|37|224|UNKNOWN|2021-12-01|COINCIDENT|2021-12-09
Study ID|CE|2fa374c2-4d57-4de3-a86b-a3a374e6ab68|2|[?]|[?]|SEVERE|4|TREATMENT|2022-04-30|2021-11-13|2022-05-30|225|57|255|COINCIDENT|2022-04-19|COINCIDENT|2022-04-21
Study ID|CE|22adef60-8485-404f-99a6-70b3983d9d63|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-03-20|2022-02-20|2022-06-03|160|132|235|AFTER|2022-05-15|ONGOING|2022-05-24
Study ID|CE|22adef60-8485-404f-99a6-70b3983d9d63|2|[?]|[?]|SEVERE|1|SCREENING|2021-11-27|2021-10-19|2022-04-13|47|8|184|COINCIDENT|2022-05-07|COINCIDENT|2022-05-09
Study ID|CE|88be6386-17bc-4005-93f7-547e970c0162|1|[?]|[?]|MILD|6|TREATMENT|2022-06-15|2021-10-01|2022-06-27|282|25|294|AFTER|2022-02-21|BEFORE|2022-03-06
Study ID|CE|88be6386-17bc-4005-93f7-547e970c0162|2|[?]|[?]|MODERATE|1|SCREENING|2022-07-01|2022-05-24|2022-07-02|298|260|299|UNKNOWN|2022-03-28|BEFORE|2022-04-06
Study ID|CE|3ae36993-0a7f-4299-9f2b-0af624d27fb4|1|[?]|[?]|MODERATE|4|TREATMENT|2022-03-25|2022-01-09|2022-07-15|187|112|299|AFTER|2022-03-24|ONGOING|2022-06-07
Study ID|CE|3ae36993-0a7f-4299-9f2b-0af624d27fb4|2|[?]|[?]|MILD|5|WASHOUT|2022-03-17|2021-11-05|2022-04-09|179|47|202|COINCIDENT|2021-12-01|AFTER|2021-12-03
Study ID|CE|67f55a16-dc5c-4ff7-b9e0-453bd287538e|1|[?]|[?]|MILD|2|TREATMENT|2021-12-13|2021-12-06|2022-04-23|67|60|198|UNKNOWN|2022-03-05|ONGOING|2022-03-15
Study ID|CE|67f55a16-dc5c-4ff7-b9e0-453bd287538e|2|[?]|[?]|MODERATE|2|TREATMENT|2022-01-29|2021-10-25|2022-02-22|114|18|138|AFTER|2022-04-08|COINCIDENT|2022-04-23
Study ID|CE|b6a9a102-8ce6-48c6-ae0f-59c6a078f608|1|[?]|[?]|MODERATE|4|TREATMENT|2021-12-09|2021-10-14|2022-01-06|123|67|151|COINCIDENT|2021-11-29|COINCIDENT|2021-11-30
Study ID|CE|b6a9a102-8ce6-48c6-ae0f-59c6a078f608|2|[?]|[?]|SEVERE|1|SCREENING|2021-09-28|2021-08-25|2022-03-20|51|17|224|UNKNOWN|2021-08-30|BEFORE|2021-08-31
Study ID|CE|15a62d52-47e5-41a0-a12a-a88965957b79|1|[?]|[?]|SEVERE|4|TREATMENT|2022-05-04|2022-04-02|2022-06-10|222|190|259|COINCIDENT|2022-05-20|AFTER|2022-07-05
Study ID|CE|15a62d52-47e5-41a0-a12a-a88965957b79|2|[?]|[?]|MODERATE|6|TREATMENT|2022-06-14|2022-03-25|2022-06-16|263|182|265|AFTER|2022-03-11|ONGOING|2022-03-25
Study ID|CE|eb675e48-769a-46e2-be7a-41aa1f53046a|1|[?]|[?]|MILD|1|SCREENING|2022-06-01|2022-03-21|2022-06-05|237|165|241|AFTER|2022-02-26|COINCIDENT|2022-03-14
Study ID|CE|eb675e48-769a-46e2-be7a-41aa1f53046a|2|[?]|[?]|SEVERE|2|TREATMENT|2022-07-01|2021-11-01|2022-07-06|267|25|272|COINCIDENT|2022-01-11|ONGOING|2022-02-26
Study ID|CE|2eafa16a-62cc-4f6c-b84c-e9fb97d7b423|1|[?]|[?]|SEVERE|1|SCREENING|2022-01-24|2022-01-20|2022-03-17|87|83|139|UNKNOWN|2022-02-17|COINCIDENT|2022-04-08
Study ID|CE|2eafa16a-62cc-4f6c-b84c-e9fb97d7b423|2|[?]|[?]|MILD|2|TREATMENT|2022-01-10|2021-11-18|2022-04-29|73|20|182|AFTER|2022-01-18|AFTER|2022-01-20
Study ID|CE|f3614c5a-73d1-4268-b164-2eff0b860d10|1|[?]|[?]|SEVERE|4|TREATMENT|2021-11-06|2021-10-01|2022-04-22|82|46|249|BEFORE|2021-08-19|BEFORE|2021-08-19
Study ID|CE|f3614c5a-73d1-4268-b164-2eff0b860d10|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-01-03|2021-08-23|2022-04-10|140|7|237|BEFORE|2022-01-25|BEFORE|2022-01-26
Study ID|CE|4ee388d9-9a78-4a48-aee5-eee7065d8a24|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-12-31|2021-09-17|2022-01-18|122|17|140|BEFORE|2021-09-17|BEFORE|2021-09-19
Study ID|CE|4ee388d9-9a78-4a48-aee5-eee7065d8a24|2|[?]|[?]|SEVERE|5|WASHOUT|2021-10-08|2021-09-22|2021-10-09|38|22|39|BEFORE|2021-09-30|BEFORE|2021-10-05
Study ID|CE|2ac651d5-c732-44e4-8f9e-7fbe3078bced|1|[?]|[?]|MODERATE|4|TREATMENT|2022-06-11|2022-05-20|2022-06-18|280|258|287|COINCIDENT|2021-09-10|ONGOING|2021-09-11
Study ID|CE|2ac651d5-c732-44e4-8f9e-7fbe3078bced|2|[?]|[?]|SEVERE|1|SCREENING|2022-05-09|2021-12-31|2022-06-04|247|118|273|AFTER|2022-03-23|AFTER|2022-03-26
Study ID|CE|19c4b5d7-3f8e-4d71-91a5-1c54ef1e6363|1|[?]|[?]|MILD|4|TREATMENT|2022-01-30|2021-11-01|2022-07-11|106|16|268|AFTER|2022-01-15|COINCIDENT|2022-01-22
Study ID|CE|19c4b5d7-3f8e-4d71-91a5-1c54ef1e6363|2|[?]|[?]|MILD|1|SCREENING|2021-11-11|2021-10-26|2022-04-17|26|10|183|AFTER|2021-12-28|ONGOING|2022-02-08
Study ID|CE|a6419434-b962-48b4-b026-86a708cdf45f|1|[?]|[?]|MODERATE|5|WASHOUT|2022-07-21|2021-12-13|2022-07-27|288|68|294|BEFORE|2022-05-06|BEFORE|2022-05-08
Study ID|CE|a6419434-b962-48b4-b026-86a708cdf45f|2|[?]|[?]|MODERATE|1|SCREENING|2022-07-25|2022-01-22|2022-07-30|292|108|297|UNKNOWN|2022-04-13|BEFORE|2022-04-27
Study ID|CE|43b05d09-d9d8-4c7e-86ef-02a98a379637|1|[?]|[?]|MILD|5|WASHOUT|2022-03-14|2021-12-01|2022-06-27|152|49|257|BEFORE|2022-02-05|BEFORE|2022-03-04
Study ID|CE|43b05d09-d9d8-4c7e-86ef-02a98a379637|2|[?]|[?]|MODERATE|5|WASHOUT|2022-04-12|2022-03-02|2022-05-23|181|140|222|BEFORE|2022-03-05|COINCIDENT|2022-07-01
Study ID|CE|617f2f04-58b4-4709-a5be-1b1fbd267629|1|[?]|[?]|SEVERE|3|WASHOUT|2022-03-29|2021-09-13|2022-04-04|199|2|205|UNKNOWN|2021-10-07|AFTER|2021-12-22
Study ID|CE|617f2f04-58b4-4709-a5be-1b1fbd267629|2|[?]|[?]|MODERATE|2|TREATMENT|2021-12-31|2021-11-30|2022-04-24|111|80|225|UNKNOWN|2022-06-09|AFTER|2022-06-23
Study ID|CE|8df00fbb-03af-45c1-8059-728b4e005ccc|1|[?]|[?]|MILD|3|WASHOUT|2022-07-02|2021-12-29|2022-07-06|295|110|299|AFTER|2022-03-05|COINCIDENT|2022-03-07
Study ID|CE|8df00fbb-03af-45c1-8059-728b4e005ccc|2|[?]|[?]|MODERATE|6|TREATMENT|2021-09-19|2021-09-14|2022-01-30|9|4|142|COINCIDENT|2022-03-19|BEFORE|2022-03-21
Study ID|CE|a3dacbc1-5539-4c71-bb6d-5f76f67a6ac0|1|[?]|[?]|MODERATE|6|TREATMENT|2022-03-23|2021-11-17|2022-05-19|147|21|204|COINCIDENT|2021-12-27|BEFORE|2022-01-06
Study ID|CE|a3dacbc1-5539-4c71-bb6d-5f76f67a6ac0|2|[?]|[?]|MILD|1|SCREENING|2022-07-14|2022-02-16|2022-08-05|260|112|282|BEFORE|2021-10-31|COINCIDENT|2021-10-31
Study ID|CE|9c2bc89e-2ac0-412d-8a6b-f2e0b8dd2ca3|1|[?]|[?]|MODERATE|2|TREATMENT|2021-09-11|2021-09-09|2022-06-21|4|2|287|BEFORE|2022-01-22|AFTER|2022-01-23
Study ID|CE|9c2bc89e-2ac0-412d-8a6b-f2e0b8dd2ca3|2|[?]|[?]|MILD|2|TREATMENT|2021-09-11|2021-09-10|2022-03-06|4|3|180|AFTER|2022-02-05|COINCIDENT|2022-02-19
Study ID|CE|31f9ea80-527d-4eb4-ad98-6688f6347d39|1|[?]|[?]|MODERATE|3|WASHOUT|2022-03-21|2021-09-13|2022-04-19|211|22|240|BEFORE|2021-09-18|AFTER|2021-09-21
Study ID|CE|31f9ea80-527d-4eb4-ad98-6688f6347d39|2|[?]|[?]|MODERATE|3|WASHOUT|2021-12-08|2021-11-27|2022-05-03|108|97|254|AFTER|2022-01-31|BEFORE|2022-02-03
Study ID|CE|5e138a4b-9752-4d7c-8e14-5287394d5e66|1|[?]|[?]|MODERATE|4|TREATMENT|2021-10-15|2021-10-12|2022-01-11|7|4|95|AFTER|2022-04-23|BEFORE|2022-04-24
Study ID|CE|5e138a4b-9752-4d7c-8e14-5287394d5e66|2|[?]|[?]|SEVERE|3|WASHOUT|2022-05-05|2022-04-09|2022-06-30|209|183|265|UNKNOWN|2022-03-24|AFTER|2022-03-29
Study ID|CE|fff8406a-d54f-42c4-84df-3dc1c8a00753|1|[?]|[?]|MODERATE|2|TREATMENT|2022-01-26|2021-09-10|2022-05-04|172|34|270|UNKNOWN|2022-02-03|AFTER|2022-03-08
Study ID|CE|fff8406a-d54f-42c4-84df-3dc1c8a00753|2|[?]|[?]|MODERATE|4|TREATMENT|2022-04-11|2022-01-03|2022-04-24|247|149|260|AFTER|2022-01-01|COINCIDENT|2022-02-05
Study ID|CE|22095a9b-6771-4df2-aa8f-1830ecffbbb2|1|[?]|[?]|MILD|2|TREATMENT|2022-01-15|2022-01-09|2022-05-07|137|131|249|BEFORE|2021-10-04|BEFORE|2021-10-12
Study ID|CE|22095a9b-6771-4df2-aa8f-1830ecffbbb2|2|[?]|[?]|SEVERE|5|WASHOUT|2021-11-11|2021-09-06|2021-12-14|72|6|105|BEFORE|2021-09-15|AFTER|2021-09-16
Study ID|CE|626e1e91-37a9-4d83-999c-e073773869f5|1|[?]|[?]|SEVERE|4|TREATMENT|2022-02-19|2021-12-28|2022-05-02|182|129|254|AFTER|2021-12-18|AFTER|2021-12-20
Study ID|CE|626e1e91-37a9-4d83-999c-e073773869f5|2|[?]|[?]|MODERATE|1|SCREENING|2022-03-25|2022-01-20|2022-04-28|216|152|250|BEFORE|2021-11-02|BEFORE|2021-12-07
Study ID|CE|0303e1ae-d354-4808-9f64-f02c8ac612b3|1|[?]|[?]|SEVERE|2|TREATMENT|2022-05-26|2022-04-10|2022-06-13|280|234|298|COINCIDENT|2021-12-21|BEFORE|2022-01-06
Study ID|CE|0303e1ae-d354-4808-9f64-f02c8ac612b3|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-04-07|2022-01-11|2022-04-23|231|145|247|UNKNOWN|2021-11-28|AFTER|2021-12-12
Study ID|CE|1281079e-bc3d-48c8-b66d-a5ac44b50c84|1|[?]|[?]|MILD|3|WASHOUT|2022-07-01|2022-02-10|2022-07-17|265|124|281|AFTER|2021-12-07|COINCIDENT|2022-01-29
Study ID|CE|1281079e-bc3d-48c8-b66d-a5ac44b50c84|2|[?]|[?]|MODERATE|5|WASHOUT|2021-11-11|2021-10-25|2022-06-24|33|16|258|UNKNOWN|2022-06-20|BEFORE|2022-06-21
Study ID|CE|75a8da56-f2e9-4b0c-aa93-848992cff6f5|1|[?]|[?]|SEVERE|3|WASHOUT|2022-01-24|2022-01-18|2022-04-21|88|82|175|UNKNOWN|2022-04-08|ONGOING|2022-06-25
Study ID|CE|75a8da56-f2e9-4b0c-aa93-848992cff6f5|2|[?]|[?]|MILD|1|SCREENING|2022-06-13|2021-12-24|2022-07-07|228|57|252|COINCIDENT|2022-05-05|ONGOING|2022-05-06
Study ID|CE|28957af8-b000-4d8f-8557-8580445d7f2f|1|[?]|[?]|SEVERE|3|WASHOUT|2021-09-28|2021-09-27|2022-04-27|34|33|245|UNKNOWN|2021-09-15|COINCIDENT|2021-09-18
Study ID|CE|28957af8-b000-4d8f-8557-8580445d7f2f|2|[?]|[?]|MILD|4|TREATMENT|2022-03-31|2021-09-12|2022-04-11|218|18|229|AFTER|2021-10-04|COINCIDENT|2021-10-06
Study ID|CE|61a0979d-56bb-41c0-9b78-6d99b39f776f|1|[?]|[?]|MILD|6|TREATMENT|2021-10-07|2021-09-12|2022-04-08|41|16|224|UNKNOWN|2021-10-17|ONGOING|2021-10-26
Study ID|CE|61a0979d-56bb-41c0-9b78-6d99b39f776f|2|[?]|[?]|MILD|1|SCREENING|2022-06-20|2021-09-14|2022-06-22|297|18|299|AFTER|2022-01-04|BEFORE|2022-03-04
Study ID|CE|6aaeef9d-a806-4440-8b57-98a81398d67d|1|[?]|[?]|MILD|2|TREATMENT|2021-09-30|2021-09-16|2022-03-21|32|18|204|BEFORE|2021-09-01|ONGOING|2021-09-01
Study ID|CE|6aaeef9d-a806-4440-8b57-98a81398d67d|2|[?]|[?]|SEVERE|5|WASHOUT|2022-04-15|2022-04-03|2022-06-21|229|217|296|BEFORE|2021-10-03|BEFORE|2021-10-04
Study ID|CE|65b0ce2c-b9c5-4c7f-a8aa-4bd6d555304b|1|[?]|[?]|SEVERE|6|TREATMENT|2021-12-09|2021-11-08|2022-02-13|65|34|131|UNKNOWN|2022-02-19|COINCIDENT|2022-03-26
Study ID|CE|65b0ce2c-b9c5-4c7f-a8aa-4bd6d555304b|2|[?]|[?]|SEVERE|3|WASHOUT|2022-05-10|2022-04-28|2022-05-21|217|205|228|COINCIDENT|2022-02-08|COINCIDENT|2022-02-22
Study ID|CE|d3acc9bf-719d-4f9f-9ee8-542bb9778058|1|[?]|[?]|MODERATE|5|WASHOUT|2022-02-19|2021-12-05|2022-08-06|119|43|287|BEFORE|2022-03-01|ONGOING|2022-03-02
Study ID|CE|d3acc9bf-719d-4f9f-9ee8-542bb9778058|2|[?]|[?]|MODERATE|6|TREATMENT|2021-10-26|2021-10-25|2022-06-14|3|2|234|UNKNOWN|2022-02-02|AFTER|2022-02-23
Study ID|CE|9a35b233-5288-4376-9c63-5b86f8f6672d|1|[?]|[?]|MILD|3|WASHOUT|2022-07-05|2022-03-15|2022-07-28|253|141|276|UNKNOWN|2021-10-30|ONGOING|2021-11-03
Study ID|CE|9a35b233-5288-4376-9c63-5b86f8f6672d|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-06-30|2022-01-06|2022-08-10|248|73|289|UNKNOWN|2022-04-11|COINCIDENT|2022-04-30
Study ID|CE|e3d54bd1-a96e-4415-8c47-3476c9c7236b|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-11-25|2021-10-27|2021-12-01|32|3|38|UNKNOWN|2021-11-30|ONGOING|2022-03-21
Study ID|CE|e3d54bd1-a96e-4415-8c47-3476c9c7236b|2|[?]|[?]|MODERATE|3|WASHOUT|2022-03-16|2021-12-10|2022-04-05|143|47|163|AFTER|2022-02-19|ONGOING|2022-02-20
Study ID|CE|abaea736-f6c5-4354-b783-5931177c9c7b|1|[?]|[?]|SEVERE|6|TREATMENT|2021-10-25|2021-10-22|2022-02-15|16|13|129|BEFORE|2022-03-12|BEFORE|2022-03-17
Study ID|CE|abaea736-f6c5-4354-b783-5931177c9c7b|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-04-08|2022-03-05|2022-06-14|181|147|248|BEFORE|2021-10-22|COINCIDENT|2021-10-24
Study ID|CE|7d60d223-5bcf-4607-96a8-602c2de91f32|1|[?]|[?]|MODERATE|2|TREATMENT|2022-01-29|2021-12-22|2022-05-08|167|129|266|AFTER|2021-09-07|AFTER|2021-11-07
Study ID|CE|7d60d223-5bcf-4607-96a8-602c2de91f32|2|[?]|[?]|MODERATE|5|WASHOUT|2021-09-24|2021-09-03|2022-02-01|40|19|170|UNKNOWN|2021-09-13|BEFORE|2021-10-01
Study ID|CE|8a49d289-4d0d-45a6-aafd-79d3a1469c30|1|[?]|[?]|MODERATE|6|TREATMENT|2022-03-14|2022-03-10|2022-03-19|143|139|148|AFTER|2022-01-26|BEFORE|2022-03-23
Study ID|CE|8a49d289-4d0d-45a6-aafd-79d3a1469c30|2|[?]|[?]|SEVERE|2|TREATMENT|2021-11-21|2021-11-15|2022-06-25|30|24|246|COINCIDENT|2021-12-16|ONGOING|2022-01-21
Study ID|CE|38fc7d5f-a83a-41e0-9cc2-00962bb1e016|1|[?]|[?]|MODERATE|6|TREATMENT|2022-02-24|2021-10-15|2022-04-03|185|53|223|BEFORE|2021-11-01|ONGOING|2021-11-11
Study ID|CE|38fc7d5f-a83a-41e0-9cc2-00962bb1e016|2|[?]|[?]|SEVERE|4|TREATMENT|2021-11-02|2021-09-10|2022-05-25|71|18|275|COINCIDENT|2021-11-06|BEFORE|2021-11-13
Study ID|CE|8cb8b17b-558f-4b2f-b773-38119cbeed97|1|[?]|[?]|MODERATE|1|SCREENING|2022-02-25|2022-02-02|2022-04-11|189|166|234|UNKNOWN|2022-05-08|ONGOING|2022-05-13
Study ID|CE|8cb8b17b-558f-4b2f-b773-38119cbeed97|2|[?]|[?]|MILD|1|SCREENING|2021-10-24|2021-09-20|2022-04-30|65|31|253|BEFORE|2022-01-14|AFTER|2022-03-17
Study ID|CE|326bc136-7ef2-48a6-bf25-72481da70ba6|1|[?]|[?]|MODERATE|1|SCREENING|2021-10-29|2021-08-28|2021-12-15|66|4|113|UNKNOWN|2021-09-16|COINCIDENT|2021-10-03
Study ID|CE|326bc136-7ef2-48a6-bf25-72481da70ba6|2|[?]|[?]|MODERATE|6|TREATMENT|2022-03-17|2021-10-02|2022-04-15|205|39|234|AFTER|2021-09-04|COINCIDENT|2021-09-08
Study ID|CE|31859576-209e-409e-b331-46285e48e2b4|1|[?]|[?]|MODERATE|1|SCREENING|2022-03-26|2022-02-13|2022-03-27|172|131|173|BEFORE|2021-10-07|BEFORE|2021-10-07
Study ID|CE|31859576-209e-409e-b331-46285e48e2b4|2|[?]|[?]|MODERATE|5|WASHOUT|2021-11-30|2021-10-19|2021-12-08|56|14|64|COINCIDENT|2021-11-25|AFTER|2021-11-26
Study ID|CE|3432d463-0704-492c-aab8-f47f1eefdf0f|1|[?]|[?]|MODERATE|5|WASHOUT|2021-10-14|2021-09-16|2022-06-09|40|12|278|AFTER|2021-10-30|AFTER|2021-11-02
Study ID|CE|3432d463-0704-492c-aab8-f47f1eefdf0f|2|[?]|[?]|MODERATE|1|SCREENING|2022-01-29|2021-11-23|2022-06-24|147|80|293|UNKNOWN|2021-11-22|COINCIDENT|2021-12-13
Study ID|CE|e5cf09f7-8ebb-4b96-bb18-a6e0281d8e4f|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-07-07|2022-02-13|2022-07-12|270|126|275|UNKNOWN|2021-11-29|COINCIDENT|2022-01-23
Study ID|CE|e5cf09f7-8ebb-4b96-bb18-a6e0281d8e4f|2|[?]|[?]|MODERATE|4|TREATMENT|2021-11-06|2021-10-14|2022-06-10|27|4|243|COINCIDENT|2022-06-04|BEFORE|2022-07-08
Study ID|CE|4ec49792-4081-4e07-a478-009f715fe92f|1|[?]|[?]|MILD|5|WASHOUT|2021-09-30|2021-09-08|2021-12-18|35|13|114|COINCIDENT|2022-02-23|BEFORE|2022-03-09
Study ID|CE|4ec49792-4081-4e07-a478-009f715fe92f|2|[?]|[?]|MODERATE|4|TREATMENT|2021-11-25|2021-10-10|2022-04-18|91|45|235|BEFORE|2022-01-10|ONGOING|2022-01-11
Study ID|CE|395bc1a2-3aa9-4efa-b468-899beabd1001|1|[?]|[?]|MILD|6|TREATMENT|2022-02-02|2021-11-02|2022-03-14|168|76|208|UNKNOWN|2021-11-24|ONGOING|2021-12-02
Study ID|CE|395bc1a2-3aa9-4efa-b468-899beabd1001|2|[?]|[?]|SEVERE|5|WASHOUT|2021-10-05|2021-09-18|2022-02-15|48|31|181|BEFORE|2021-11-07|BEFORE|2021-11-10
Study ID|CE|1c47e5f6-4e35-409c-a891-ab52f28a0400|1|[?]|[?]|MODERATE|1|SCREENING|2022-01-20|2021-11-15|2022-04-05|101|35|176|BEFORE|2021-11-07|ONGOING|2022-06-01
Study ID|CE|1c47e5f6-4e35-409c-a891-ab52f28a0400|2|[?]|[?]|MODERATE|6|TREATMENT|2022-05-26|2021-10-16|2022-06-22|227|5|254|BEFORE|2022-02-28|BEFORE|2022-03-27
Study ID|CE|f102dfe2-cca3-4f55-a66b-858ca672663f|1|[?]|[?]|SEVERE|5|WASHOUT|2022-03-08|2022-01-21|2022-06-22|141|95|247|COINCIDENT|2021-10-25|BEFORE|2021-10-26
Study ID|CE|f102dfe2-cca3-4f55-a66b-858ca672663f|2|[?]|[?]|SEVERE|6|TREATMENT|2022-03-21|2021-12-08|2022-08-13|154|51|299|AFTER|2021-11-26|ONGOING|2022-03-02
Study ID|CE|a306acbd-a329-497f-9d5d-2787ea6700be|1|[?]|[?]|SEVERE|2|TREATMENT|2021-09-04|2021-08-25|2022-04-20|15|5|243|COINCIDENT|2022-02-01|AFTER|2022-03-05
Study ID|CE|a306acbd-a329-497f-9d5d-2787ea6700be|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-04-07|2021-09-11|2022-05-07|230|22|260|BEFORE|2021-09-06|BEFORE|2021-09-20
Study ID|CE|ee62f692-ae79-49c2-9495-a50194feba65|1|[?]|[?]|SEVERE|2|TREATMENT|2022-05-26|2022-04-06|2022-08-01|229|179|296|COINCIDENT|2021-11-12|BEFORE|2021-11-20
Study ID|CE|ee62f692-ae79-49c2-9495-a50194feba65|2|[?]|[?]|MILD|3|WASHOUT|2022-02-04|2022-01-03|2022-05-01|118|86|204|COINCIDENT|2022-02-26|COINCIDENT|2022-03-05
Study ID|CE|6848c047-d167-4a31-b2dc-0175ab0e9fb5|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-11-09|2021-11-01|2022-05-15|17|9|204|COINCIDENT|2022-03-13|COINCIDENT|2022-05-04
Study ID|CE|6848c047-d167-4a31-b2dc-0175ab0e9fb5|2|[?]|[?]|MODERATE|3|WASHOUT|2022-08-06|2022-06-14|2022-08-07|287|234|288|BEFORE|2022-05-16|COINCIDENT|2022-05-17
Study ID|CE|3634f8d0-a8c2-476a-a10f-be394a45de2f|1|[?]|[?]|SEVERE|4|TREATMENT|2022-05-15|2022-01-19|2022-06-05|241|125|262|AFTER|2022-04-04|AFTER|2022-04-07
Study ID|CE|3634f8d0-a8c2-476a-a10f-be394a45de2f|2|[?]|[?]|MODERATE|1|SCREENING|2022-03-28|2022-02-25|2022-05-06|193|162|232|AFTER|2022-03-06|AFTER|2022-04-13
Study ID|CE|8406f0e0-f958-4cbf-b2f8-209bdc55cec5|1|[?]|[?]|MILD|6|TREATMENT|2022-02-12|2021-12-09|2022-05-28|153|88|258|BEFORE|2022-02-12|COINCIDENT|2022-02-17
Study ID|CE|8406f0e0-f958-4cbf-b2f8-209bdc55cec5|2|[?]|[?]|SEVERE|3|WASHOUT|2021-10-10|2021-09-28|2022-05-13|28|16|243|BEFORE|2022-03-10|BEFORE|2022-03-24
Study ID|CE|a625107a-976d-4442-9bcd-06fb6630e271|1|[?]|[?]|MILD|5|WASHOUT|2022-02-16|2022-01-11|2022-07-21|142|106|297|UNKNOWN|2022-06-01|ONGOING|2022-06-03
Study ID|CE|a625107a-976d-4442-9bcd-06fb6630e271|2|[?]|[?]|SEVERE|1|SCREENING|2022-02-25|2022-01-11|2022-07-08|151|106|284|AFTER|2022-02-02|COINCIDENT|2022-02-03
Study ID|CE|4de184be-ccc0-4545-8c9b-138a71194fcc|1|[?]|[?]|MILD|7|FOLLOW-UP|2021-11-28|2021-11-24|2022-02-26|90|86|180|AFTER|2022-01-07|BEFORE|2022-01-11
Study ID|CE|4de184be-ccc0-4545-8c9b-138a71194fcc|2|[?]|[?]|MILD|6|TREATMENT|2022-05-17|2022-05-09|2022-06-19|260|252|293|COINCIDENT|2021-10-22|COINCIDENT|2021-11-17
Study ID|CE|2b3bad9f-1020-4540-8fb5-a28b1834a028|1|[?]|[?]|MODERATE|3|WASHOUT|2022-06-20|2022-04-05|2022-07-01|257|181|268|COINCIDENT|2021-12-25|COINCIDENT|2021-12-30
Study ID|CE|2b3bad9f-1020-4540-8fb5-a28b1834a028|2|[?]|[?]|SEVERE|4|TREATMENT|2022-05-05|2022-04-11|2022-06-08|211|187|245|AFTER|2021-11-20|ONGOING|2021-11-21
Study ID|CE|6f06fdd7-9b4c-475a-9a2f-fa63b6880f6b|1|[?]|[?]|MILD|5|WASHOUT|2021-12-25|2021-12-18|2022-02-17|105|98|159|AFTER|2022-04-04|COINCIDENT|2022-04-05
Study ID|CE|6f06fdd7-9b4c-475a-9a2f-fa63b6880f6b|2|[?]|[?]|MODERATE|5|WASHOUT|2021-11-04|2021-10-18|2021-12-01|54|37|81|AFTER|2022-05-01|BEFORE|2022-05-02
Study ID|CE|34327bcd-ee05-4828-a302-a9edc20e9e42|1|[?]|[?]|MILD|3|WASHOUT|2021-11-20|2021-10-16|2022-03-07|104|69|211|BEFORE|2022-02-12|ONGOING|2022-02-20
Study ID|CE|34327bcd-ee05-4828-a302-a9edc20e9e42|2|[?]|[?]|SEVERE|2|TREATMENT|2021-11-19|2021-09-11|2022-02-03|103|34|179|AFTER|2021-12-27|AFTER|2022-01-19
Study ID|CE|528a5210-4439-40ce-a1e7-0597f7aa9350|1|[?]|[?]|SEVERE|6|TREATMENT|2021-10-15|2021-10-04|2022-04-21|22|11|210|UNKNOWN|2021-10-27|AFTER|2021-11-25
Study ID|CE|528a5210-4439-40ce-a1e7-0597f7aa9350|2|[?]|[?]|MILD|1|SCREENING|2022-06-19|2021-10-31|2022-07-04|269|38|284|AFTER|2022-02-22|ONGOING|2022-02-23
Study ID|CE|a15a4209-7a42-4c07-b6fe-4a49bf5357c6|1|[?]|[?]|MODERATE|6|TREATMENT|2021-11-30|2021-11-10|2021-12-22|99|79|121|AFTER|2022-01-21|BEFORE|2022-03-03
Study ID|CE|a15a4209-7a42-4c07-b6fe-4a49bf5357c6|2|[?]|[?]|MILD|4|TREATMENT|2022-02-28|2022-01-21|2022-03-17|189|151|206|UNKNOWN|2021-12-10|BEFORE|2022-01-04
Study ID|CE|caf6881d-791f-42f0-afd7-885216350fd9|1|[?]|[?]|MODERATE|5|WASHOUT|2022-05-19|2021-10-14|2022-06-08|270|53|290|COINCIDENT|2021-11-15|ONGOING|2021-11-21
Study ID|CE|caf6881d-791f-42f0-afd7-885216350fd9|2|[?]|[?]|MILD|5|WASHOUT|2021-09-03|2021-09-01|2021-12-24|12|10|124|UNKNOWN|2021-09-14|AFTER|2021-09-17
Study ID|CE|49d7b534-90c3-4790-8ed3-4bed04676ece|1|[?]|[?]|MILD|5|WASHOUT|2021-11-07|2021-09-06|2022-06-12|68|6|285|AFTER|2021-10-21|AFTER|2021-10-31
Study ID|CE|49d7b534-90c3-4790-8ed3-4bed04676ece|2|[?]|[?]|SEVERE|5|WASHOUT|2021-11-30|2021-09-17|2022-04-07|91|17|219|COINCIDENT|2021-11-07|BEFORE|2021-11-08
Study ID|CE|9d1a0f42-d590-4b1f-9368-22ee3a5e8403|1|[?]|[?]|MILD|3|WASHOUT|2022-02-24|2022-01-31|2022-05-16|184|160|265|AFTER|2021-11-02|ONGOING|2021-11-25
Study ID|CE|9d1a0f42-d590-4b1f-9368-22ee3a5e8403|2|[?]|[?]|MODERATE|4|TREATMENT|2022-03-21|2022-01-26|2022-05-09|209|155|258|BEFORE|2021-10-23|BEFORE|2021-10-26
Study ID|CE|38b834d2-d543-40b8-b25e-cec32309b253|1|[?]|[?]|SEVERE|2|TREATMENT|2022-05-18|2022-03-12|2022-06-01|233|166|247|AFTER|2022-02-15|ONGOING|2022-05-29
Study ID|CE|38b834d2-d543-40b8-b25e-cec32309b253|2|[?]|[?]|SEVERE|5|WASHOUT|2021-12-03|2021-10-19|2022-06-25|67|22|271|COINCIDENT|2021-11-05|AFTER|2021-11-12
Study ID|CE|80c7f221-8a14-44aa-b7aa-cf75bb6348b1|1|[?]|[?]|SEVERE|5|WASHOUT|2022-05-18|2022-01-08|2022-08-11|214|84|299|COINCIDENT|2022-04-02|AFTER|2022-04-12
Study ID|CE|80c7f221-8a14-44aa-b7aa-cf75bb6348b1|2|[?]|[?]|MILD|4|TREATMENT|2022-02-23|2021-11-12|2022-06-26|130|27|253|AFTER|2022-03-13|ONGOING|2022-04-26
Study ID|CE|76f7cfaf-118f-4158-bcd1-99a21bb06da2|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-03-16|2021-11-19|2022-03-20|165|48|169|COINCIDENT|2022-01-04|ONGOING|2022-05-29
Study ID|CE|76f7cfaf-118f-4158-bcd1-99a21bb06da2|2|[?]|[?]|SEVERE|1|SCREENING|2022-03-11|2022-03-08|2022-05-18|160|157|228|BEFORE|2022-03-28|ONGOING|2022-05-26
Study ID|CE|aeedb489-9c1e-480b-9baf-7e723060cd28|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-03-30|2021-10-02|2022-05-05|224|45|260|COINCIDENT|2021-10-20|ONGOING|2021-11-23
Study ID|CE|aeedb489-9c1e-480b-9baf-7e723060cd28|2|[?]|[?]|MILD|7|FOLLOW-UP|2021-11-01|2021-09-23|2021-11-30|75|36|104|BEFORE|2021-09-06|ONGOING|2021-09-07
Study ID|CE|7d1d8119-224d-4ca8-94d9-d78a917ae454|1|[?]|[?]|SEVERE|4|TREATMENT|2022-04-13|2022-01-19|2022-05-07|239|155|263|UNKNOWN|2021-10-31|BEFORE|2021-11-09
Study ID|CE|7d1d8119-224d-4ca8-94d9-d78a917ae454|2|[?]|[?]|MILD|2|TREATMENT|2022-02-28|2021-12-02|2022-05-14|195|107|270|BEFORE|2021-12-19|BEFORE|2021-12-26
Study ID|CE|f15ef6ad-be4b-4dca-8862-feb841db6887|1|[?]|[?]|MODERATE|4|TREATMENT|2022-06-27|2022-06-03|2022-06-28|294|270|295|AFTER|2022-04-02|BEFORE|2022-04-03
Study ID|CE|f15ef6ad-be4b-4dca-8862-feb841db6887|2|[?]|[?]|SEVERE|4|TREATMENT|2021-11-21|2021-11-17|2022-02-24|76|72|171|COINCIDENT|2021-09-27|AFTER|2021-10-09
Study ID|CE|967139c3-a1f7-4745-bc11-41e641e8bcfd|1|[?]|[?]|MILD|4|TREATMENT|2022-04-18|2022-04-04|2022-04-20|255|241|257|COINCIDENT|2021-09-26|BEFORE|2021-10-09
Study ID|CE|967139c3-a1f7-4745-bc11-41e641e8bcfd|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-04-27|2021-11-01|2022-05-28|264|87|295|AFTER|2021-12-07|BEFORE|2021-12-21
Study ID|CE|467a1f4e-ae0d-4f87-ba06-e60d270111d1|1|[?]|[?]|SEVERE|5|WASHOUT|2022-06-26|2022-06-09|2022-08-04|241|224|280|AFTER|2021-11-11|BEFORE|2021-11-13
Study ID|CE|467a1f4e-ae0d-4f87-ba06-e60d270111d1|2|[?]|[?]|MILD|5|WASHOUT|2022-01-03|2021-11-17|2022-03-14|67|20|137|AFTER|2021-11-04|ONGOING|2021-11-06
Study ID|CE|bec02309-a085-460f-be3d-cc290c5c3266|1|[?]|[?]|SEVERE|1|SCREENING|2022-06-30|2022-02-01|2022-08-20|247|98|298|COINCIDENT|2022-04-09|AFTER|2022-06-13
Study ID|CE|bec02309-a085-460f-be3d-cc290c5c3266|2|[?]|[?]|MILD|4|TREATMENT|2022-05-18|2021-11-02|2022-07-06|204|7|253|UNKNOWN|2022-01-08|COINCIDENT|2022-02-07
Study ID|CE|2151a119-37d1-4532-a75d-6e4945ad235c|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-12-01|2021-10-08|2022-05-26|108|54|284|AFTER|2022-04-08|AFTER|2022-04-09
Study ID|CE|2151a119-37d1-4532-a75d-6e4945ad235c|2|[?]|[?]|MILD|3|WASHOUT|2022-04-08|2021-09-19|2022-05-06|236|35|264|COINCIDENT|2021-11-08|ONGOING|2021-12-13
Study ID|CE|76925097-8b5d-4db0-a753-80df265aa961|1|[?]|[?]|MODERATE|2|TREATMENT|2021-10-15|2021-10-15|2022-05-11|2|2|210|UNKNOWN|2021-11-27|AFTER|2021-11-28
Study ID|CE|76925097-8b5d-4db0-a753-80df265aa961|2|[?]|[?]|MILD|1|SCREENING|2022-05-23|2021-11-23|2022-07-23|222|41|283|AFTER|2021-12-28|AFTER|2022-01-23
Study ID|CE|a15b3809-05c6-497d-baa3-575910ca6be0|1|[?]|[?]|MILD|6|TREATMENT|2022-05-16|2022-03-22|2022-07-05|223|168|273|COINCIDENT|2022-05-13|AFTER|2022-05-16
Study ID|CE|a15b3809-05c6-497d-baa3-575910ca6be0|2|[?]|[?]|MILD|4|TREATMENT|2022-05-22|2021-11-28|2022-07-13|229|54|281|AFTER|2021-11-12|ONGOING|2021-11-14
Study ID|CE|be96372a-43f4-4186-ba38-af187089e655|1|[?]|[?]|MILD|6|TREATMENT|2022-02-08|2021-11-26|2022-05-25|184|110|290|COINCIDENT|2022-04-15|COINCIDENT|2022-04-20
Study ID|CE|be96372a-43f4-4186-ba38-af187089e655|2|[?]|[?]|MILD|1|SCREENING|2022-01-04|2021-12-08|2022-04-09|149|122|244|AFTER|2022-02-05|COINCIDENT|2022-03-11
Study ID|CE|c5e627be-f1e3-495b-81f6-13b445cdca13|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-11|2021-12-12|2022-07-01|245|64|265|AFTER|2021-11-08|COINCIDENT|2021-11-30
Study ID|CE|c5e627be-f1e3-495b-81f6-13b445cdca13|2|[?]|[?]|MODERATE|6|TREATMENT|2022-06-07|2022-04-10|2022-08-02|241|183|297|UNKNOWN|2021-10-13|COINCIDENT|2021-10-14
Study ID|CE|99b8c1a3-deb5-432e-8589-679a52b0861e|1|[?]|[?]|MODERATE|5|WASHOUT|2021-12-15|2021-12-07|2022-02-08|101|93|156|BEFORE|2021-11-30|BEFORE|2021-12-03
Study ID|CE|99b8c1a3-deb5-432e-8589-679a52b0861e|2|[?]|[?]|MODERATE|3|WASHOUT|2021-12-23|2021-09-15|2022-06-20|109|10|288|UNKNOWN|2021-09-10|BEFORE|2021-09-13
Study ID|CE|2392bd8f-d606-464b-abf0-f66f06c8613a|1|[?]|[?]|MODERATE|2|TREATMENT|2021-10-19|2021-10-14|2021-11-15|32|27|59|UNKNOWN|2022-02-21|BEFORE|2022-03-03
Study ID|CE|2392bd8f-d606-464b-abf0-f66f06c8613a|2|[?]|[?]|MILD|1|SCREENING|2022-01-19|2021-12-07|2022-06-19|124|81|275|UNKNOWN|2021-10-21|ONGOING|2021-11-21
Study ID|CE|84bda3cd-0134-47c0-b64f-97b25fc0fa04|1|[?]|[?]|SEVERE|4|TREATMENT|2021-11-19|2021-09-11|2022-04-27|92|23|251|COINCIDENT|2021-09-15|AFTER|2021-10-02
Study ID|CE|84bda3cd-0134-47c0-b64f-97b25fc0fa04|2|[?]|[?]|SEVERE|5|WASHOUT|2022-05-24|2022-03-01|2022-06-08|278|194|293|AFTER|2022-02-04|AFTER|2022-02-05
Study ID|CE|3ed72845-5bef-446c-974d-2b7521c3eecf|1|[?]|[?]|MODERATE|2|TREATMENT|2022-03-06|2021-12-12|2022-06-09|176|92|271|UNKNOWN|2021-12-22|ONGOING|2022-01-07
Study ID|CE|3ed72845-5bef-446c-974d-2b7521c3eecf|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-12-21|2021-12-11|2022-02-18|101|91|160|UNKNOWN|2021-12-11|AFTER|2021-12-18
Study ID|CE|b135e6c7-dd3e-47cc-9859-19398f2f6be0|1|[?]|[?]|MODERATE|5|WASHOUT|2021-09-26|2021-09-11|2021-12-27|17|2|109|UNKNOWN|2022-02-09|COINCIDENT|2022-02-15
Study ID|CE|b135e6c7-dd3e-47cc-9859-19398f2f6be0|2|[?]|[?]|MILD|3|WASHOUT|2021-11-30|2021-09-14|2022-02-07|82|5|151|COINCIDENT|2021-11-18|COINCIDENT|2022-03-10
Study ID|CE|4fdaf1de-23fd-4cfe-b96f-d0e8ed253a6b|1|[?]|[?]|MODERATE|6|TREATMENT|2021-10-18|2021-10-07|2022-06-03|14|3|242|COINCIDENT|2022-01-06|AFTER|2022-01-10
Study ID|CE|4fdaf1de-23fd-4cfe-b96f-d0e8ed253a6b|2|[?]|[?]|MILD|3|WASHOUT|2022-02-07|2021-11-17|2022-07-30|126|44|299|UNKNOWN|2022-04-23|ONGOING|2022-04-24
Study ID|CE|614ca6ee-fba6-431f-8036-5c576b03c829|1|[?]|[?]|MILD|2|TREATMENT|2022-07-06|2021-12-01|2022-08-18|256|39|299|AFTER|2022-02-13|AFTER|2022-03-23
Study ID|CE|614ca6ee-fba6-431f-8036-5c576b03c829|2|[?]|[?]|MILD|7|FOLLOW-UP|2021-12-01|2021-10-26|2022-02-26|39|3|126|AFTER|2022-08-11|COINCIDENT|2022-08-14
Study ID|CE|9ffc41b2-93bb-4a00-99e8-51f41ad10f1f|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-12-15|2021-12-01|2022-05-16|103|89|255|AFTER|2021-12-19|COINCIDENT|2021-12-24
Study ID|CE|9ffc41b2-93bb-4a00-99e8-51f41ad10f1f|2|[?]|[?]|SEVERE|4|TREATMENT|2021-10-16|2021-10-12|2022-02-15|43|39|165|AFTER|2022-01-16|AFTER|2022-02-05
Study ID|CE|eb0c4506-7c3a-45c7-8a21-226a052ff830|1|[?]|[?]|MILD|3|WASHOUT|2022-07-05|2021-09-23|2022-07-09|294|9|298|BEFORE|2021-10-22|AFTER|2021-11-10
Study ID|CE|eb0c4506-7c3a-45c7-8a21-226a052ff830|2|[?]|[?]|MILD|6|TREATMENT|2022-02-22|2022-01-24|2022-04-19|161|132|217|UNKNOWN|2022-03-24|AFTER|2022-03-25
Study ID|CE|0fb43761-7a6d-436f-8bcf-cf2d3ace4f9d|1|[?]|[?]|MODERATE|4|TREATMENT|2022-04-01|2021-11-03|2022-04-28|231|82|258|COINCIDENT|2021-08-18|COINCIDENT|2021-08-19
Study ID|CE|0fb43761-7a6d-436f-8bcf-cf2d3ace4f9d|2|[?]|[?]|MODERATE|1|SCREENING|2022-05-21|2021-10-23|2022-05-29|281|71|289|AFTER|2022-03-23|ONGOING|2022-03-24
Study ID|CE|9e31425e-d439-40d6-a518-c76b9d0c221b|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-01-02|2021-12-15|2022-05-31|99|81|248|BEFORE|2021-10-20|COINCIDENT|2021-10-27
Study ID|CE|9e31425e-d439-40d6-a518-c76b9d0c221b|2|[?]|[?]|SEVERE|3|WASHOUT|2021-10-04|2021-09-29|2022-01-10|9|4|107|UNKNOWN|2022-01-02|AFTER|2022-03-09
Study ID|CE|0b28391a-5735-42c9-8c0f-fe2f499180ad|1|[?]|[?]|SEVERE|2|TREATMENT|2022-01-20|2021-10-24|2022-02-19|100|12|130|AFTER|2022-06-27|BEFORE|2022-06-28
Study ID|CE|0b28391a-5735-42c9-8c0f-fe2f499180ad|2|[?]|[?]|MILD|4|TREATMENT|2021-12-15|2021-12-13|2022-04-25|64|62|195|COINCIDENT|2021-11-04|BEFORE|2021-11-05
Study ID|CE|d4bdfcb0-f9b0-40b4-8a2b-ee14ecc4a788|1|[?]|[?]|SEVERE|2|TREATMENT|2022-06-06|2021-12-10|2022-07-12|263|85|299|COINCIDENT|2021-10-27|COINCIDENT|2021-11-04
Study ID|CE|d4bdfcb0-f9b0-40b4-8a2b-ee14ecc4a788|2|[?]|[?]|SEVERE|3|WASHOUT|2022-04-20|2022-01-30|2022-06-10|216|136|267|COINCIDENT|2022-01-04|ONGOING|2022-02-18
Study ID|CE|072bccd8-4efe-4b27-b304-52dad87c879d|1|[?]|[?]|MODERATE|3|WASHOUT|2022-05-09|2022-01-26|2022-06-16|256|153|294|AFTER|2021-10-03|AFTER|2021-10-04
Study ID|CE|072bccd8-4efe-4b27-b304-52dad87c879d|2|[?]|[?]|SEVERE|1|SCREENING|2021-11-29|2021-08-29|2022-01-31|95|3|158|BEFORE|2021-10-22|AFTER|2021-10-28
Study ID|CE|1d852bb3-1772-4eb1-85a6-79cbb41f2f29|1|[?]|[?]|SEVERE|2|TREATMENT|2021-11-09|2021-10-22|2022-04-19|25|7|186|COINCIDENT|2022-01-27|COINCIDENT|2022-02-03
Study ID|CE|1d852bb3-1772-4eb1-85a6-79cbb41f2f29|2|[?]|[?]|MODERATE|4|TREATMENT|2022-08-03|2022-08-02|2022-08-08|292|291|297|AFTER|2022-07-01|BEFORE|2022-07-02
Study ID|CE|a7a714e9-49e2-4e73-ad90-0fecf0d35cf5|1|[?]|[?]|MODERATE|2|TREATMENT|2021-11-29|2021-11-27|2022-06-17|75|73|275|AFTER|2021-11-07|ONGOING|2021-11-12
Study ID|CE|a7a714e9-49e2-4e73-ad90-0fecf0d35cf5|2|[?]|[?]|MODERATE|2|TREATMENT|2022-02-15|2022-02-09|2022-07-07|153|147|295|BEFORE|2021-12-21|ONGOING|2022-01-18
Study ID|CE|948c63c5-3146-42c3-b999-794f4f7eb5ac|1|[?]|[?]|MODERATE|1|SCREENING|2022-04-21|2021-12-28|2022-05-08|251|137|268|COINCIDENT|2021-11-18|COINCIDENT|2021-11-20
Study ID|CE|948c63c5-3146-42c3-b999-794f4f7eb5ac|2|[?]|[?]|SEVERE|3|WASHOUT|2021-11-18|2021-09-12|2022-03-26|97|30|225|UNKNOWN|2021-09-01|COINCIDENT|2021-09-05
Study ID|CE|b5eaeff7-2cda-4196-a352-bb42cf321606|1|[?]|[?]|MILD|4|TREATMENT|2022-04-04|2021-10-11|2022-04-22|213|38|231|COINCIDENT|2021-09-24|BEFORE|2021-10-02
Study ID|CE|b5eaeff7-2cda-4196-a352-bb42cf321606|2|[?]|[?]|MILD|1|SCREENING|2022-03-12|2022-02-18|2022-06-23|190|168|293|COINCIDENT|2021-11-22|COINCIDENT|2021-12-12
Study ID|CE|41c087e5-1dfb-4285-96a3-fd59076e5717|1|[?]|[?]|MILD|2|TREATMENT|2022-03-17|2021-12-18|2022-03-21|175|86|179|COINCIDENT|2022-03-08|BEFORE|2022-03-19
Study ID|CE|41c087e5-1dfb-4285-96a3-fd59076e5717|2|[?]|[?]|SEVERE|1|SCREENING|2021-10-14|2021-10-05|2022-07-10|21|12|290|UNKNOWN|2022-06-01|AFTER|2022-06-03
Study ID|CE|1ff7c459-01b3-4598-838c-7f3f9eacc752|1|[?]|[?]|SEVERE|6|TREATMENT|2022-02-27|2021-11-30|2022-05-18|190|101|270|BEFORE|2021-09-04|COINCIDENT|2021-09-05
Study ID|CE|1ff7c459-01b3-4598-838c-7f3f9eacc752|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-09-23|2021-09-05|2022-03-29|33|15|220|COINCIDENT|2021-10-12|AFTER|2021-10-16
Study ID|CE|f30f326c-bba6-4e50-98c4-2654c1cbea4d|1|[?]|[?]|MODERATE|1|SCREENING|2022-07-09|2022-01-25|2022-07-14|262|97|267|COINCIDENT|2022-01-20|COINCIDENT|2022-02-08
Study ID|CE|f30f326c-bba6-4e50-98c4-2654c1cbea4d|2|[?]|[?]|MODERATE|1|SCREENING|2022-06-12|2022-03-10|2022-07-01|235|141|254|COINCIDENT|2021-11-13|BEFORE|2021-11-14
Study ID|CE|88f49917-6cc4-4bfc-bbcc-d0ef408649f2|1|[?]|[?]|MODERATE|3|WASHOUT|2022-04-07|2022-01-04|2022-06-27|216|123|297|AFTER|2021-12-23|BEFORE|2021-12-31
Study ID|CE|88f49917-6cc4-4bfc-bbcc-d0ef408649f2|2|[?]|[?]|MODERATE|6|TREATMENT|2022-01-13|2021-12-03|2022-04-25|132|91|234|AFTER|2021-09-28|COINCIDENT|2021-10-03
Study ID|CE|38d60c2e-c043-47cf-9ef7-5e1346d65d5d|1|[?]|[?]|MODERATE|3|WASHOUT|2022-04-30|2021-12-23|2022-06-03|259|131|293|BEFORE|2021-08-30|COINCIDENT|2022-01-31
Study ID|CE|38d60c2e-c043-47cf-9ef7-5e1346d65d5d|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-11-12|2021-09-19|2022-05-21|90|36|280|UNKNOWN|2021-09-09|AFTER|2021-09-16
Study ID|CE|5dc6b4b8-9cce-42ce-8186-5d9515e52929|1|[?]|[?]|MODERATE|4|TREATMENT|2022-03-04|2022-01-21|2022-03-25|131|89|152|UNKNOWN|2022-04-06|ONGOING|2022-04-08
Study ID|CE|5dc6b4b8-9cce-42ce-8186-5d9515e52929|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-06-24|2022-01-26|2022-07-06|243|94|255|AFTER|2021-12-26|COINCIDENT|2022-01-24
Study ID|CE|a756e1c5-dd35-47cf-b3e2-610b6595dc15|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-01-21|2021-12-22|2022-04-30|91|61|190|COINCIDENT|2021-12-22|AFTER|2021-12-23
Study ID|CE|a756e1c5-dd35-47cf-b3e2-610b6595dc15|2|[?]|[?]|MILD|4|TREATMENT|2022-01-01|2021-12-08|2022-04-02|71|47|162|COINCIDENT|2021-12-29|ONGOING|2022-01-04
Study ID|CE|4f75fe33-11e7-4c44-8a39-6391188b1db5|1|[?]|[?]|MILD|5|WASHOUT|2022-05-17|2022-05-04|2022-05-29|266|253|278|COINCIDENT|2022-01-03|COINCIDENT|2022-01-12
Study ID|CE|4f75fe33-11e7-4c44-8a39-6391188b1db5|2|[?]|[?]|MILD|5|WASHOUT|2021-11-05|2021-09-04|2022-03-21|73|11|209|AFTER|2022-01-12|COINCIDENT|2022-01-22
Study ID|CE|d1bd1be2-7172-44b3-b1d5-32a3d377b4d6|1|[?]|[?]|MILD|1|SCREENING|2022-01-25|2021-10-06|2022-05-09|144|33|248|UNKNOWN|2021-09-28|COINCIDENT|2021-09-30
Study ID|CE|d1bd1be2-7172-44b3-b1d5-32a3d377b4d6|2|[?]|[?]|MILD|2|TREATMENT|2022-06-25|2022-01-01|2022-06-27|295|120|297|BEFORE|2022-04-09|BEFORE|2022-04-10
Study ID|CE|053425cd-706f-4d2e-847c-5a779ae9b2ab|1|[?]|[?]|MODERATE|5|WASHOUT|2022-05-15|2022-01-11|2022-08-14|205|81|296|BEFORE|2021-11-15|AFTER|2022-03-30
Study ID|CE|053425cd-706f-4d2e-847c-5a779ae9b2ab|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-07-03|2022-06-10|2022-07-05|254|231|256|BEFORE|2021-10-25|COINCIDENT|2021-10-25
Study ID|CE|4bd332b3-6cd8-4e28-94ef-0b1a0be0a002|1|[?]|[?]|MILD|6|TREATMENT|2021-08-17|2021-08-16|2022-05-24|4|3|284|BEFORE|2021-12-05|ONGOING|2022-02-03
Study ID|CE|4bd332b3-6cd8-4e28-94ef-0b1a0be0a002|2|[?]|[?]|SEVERE|2|TREATMENT|2022-01-30|2021-11-25|2022-05-11|170|104|271|UNKNOWN|2021-10-23|BEFORE|2021-11-08
Study ID|CE|e01de567-61df-4da1-8dcd-7190d1b9d889|1|[?]|[?]|MILD|6|TREATMENT|2021-11-23|2021-11-07|2022-06-19|28|12|236|AFTER|2022-03-02|COINCIDENT|2022-04-21
Study ID|CE|e01de567-61df-4da1-8dcd-7190d1b9d889|2|[?]|[?]|MILD|6|TREATMENT|2021-11-15|2021-11-08|2022-03-07|20|13|132|BEFORE|2021-11-19|AFTER|2021-11-29
Study ID|CE|7569cb98-81bf-4117-b076-8e27f6a12eee|1|[?]|[?]|MILD|4|TREATMENT|2021-11-07|2021-10-07|2021-12-04|67|36|94|COINCIDENT|2022-04-25|ONGOING|2022-06-15
Study ID|CE|7569cb98-81bf-4117-b076-8e27f6a12eee|2|[?]|[?]|SEVERE|4|TREATMENT|2022-01-09|2021-12-29|2022-06-18|130|119|290|COINCIDENT|2021-10-11|BEFORE|2021-10-12
Study ID|CE|ffc9571a-170d-44d9-be33-4e602e45fb1f|1|[?]|[?]|MODERATE|6|TREATMENT|2022-02-17|2021-09-17|2022-04-16|177|24|235|BEFORE|2021-12-23|BEFORE|2022-05-09
Study ID|CE|ffc9571a-170d-44d9-be33-4e602e45fb1f|2|[?]|[?]|MILD|1|SCREENING|2021-10-13|2021-10-08|2022-01-10|50|45|139|UNKNOWN|2021-10-30|AFTER|2022-02-10
Study ID|CE|1a307872-c540-43e0-b6cf-6c7abd48bd34|1|[?]|[?]|MODERATE|2|TREATMENT|2022-06-18|2021-11-13|2022-07-11|250|33|273|UNKNOWN|2021-12-02|COINCIDENT|2022-07-24
Study ID|CE|1a307872-c540-43e0-b6cf-6c7abd48bd34|2|[?]|[?]|MILD|6|TREATMENT|2021-12-19|2021-12-10|2022-07-31|69|60|293|AFTER|2021-11-13|AFTER|2021-11-15
Study ID|CE|ae0d4887-73ee-47ff-98df-69e53708973a|1|[?]|[?]|MODERATE|1|SCREENING|2022-06-01|2022-04-17|2022-06-24|260|215|283|BEFORE|2022-05-21|ONGOING|2022-05-23
Study ID|CE|ae0d4887-73ee-47ff-98df-69e53708973a|2|[?]|[?]|MILD|3|WASHOUT|2022-01-04|2021-11-16|2022-03-16|112|63|183|AFTER|2022-02-26|ONGOING|2022-05-04
Study ID|CE|a9d0cb3a-b2bf-442c-a297-b01e8e701c6b|1|[?]|[?]|SEVERE|3|WASHOUT|2022-01-30|2021-10-03|2022-04-28|139|20|227|COINCIDENT|2021-10-02|AFTER|2021-10-09
Study ID|CE|a9d0cb3a-b2bf-442c-a297-b01e8e701c6b|2|[?]|[?]|MODERATE|5|WASHOUT|2022-01-15|2021-09-22|2022-03-22|124|9|190|AFTER|2021-12-29|COINCIDENT|2022-01-31
Study ID|CE|5988e1e7-9658-4677-be9d-c61a0cb2cc95|1|[?]|[?]|SEVERE|4|TREATMENT|2021-09-18|2021-09-14|2022-06-08|23|19|286|UNKNOWN|2021-11-08|ONGOING|2021-11-09
Study ID|CE|5988e1e7-9658-4677-be9d-c61a0cb2cc95|2|[?]|[?]|SEVERE|5|WASHOUT|2022-04-10|2021-09-10|2022-04-28|227|15|245|UNKNOWN|2021-11-23|BEFORE|2021-11-25
Study ID|CE|fc101382-4916-4ee4-bf00-6398e8aece08|1|[?]|[?]|SEVERE|5|WASHOUT|2022-05-24|2021-10-29|2022-06-16|224|17|247|UNKNOWN|2022-05-07|BEFORE|2022-07-05
Study ID|CE|fc101382-4916-4ee4-bf00-6398e8aece08|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-05-24|2022-02-08|2022-08-07|224|119|299|COINCIDENT|2021-10-24|ONGOING|2021-10-24
Study ID|CE|93dc1418-6279-4db0-b55b-a26645a9b30c|1|[?]|[?]|MILD|5|WASHOUT|2022-03-14|2021-10-25|2022-06-20|159|19|257|BEFORE|2021-12-09|COINCIDENT|2021-12-21
Study ID|CE|93dc1418-6279-4db0-b55b-a26645a9b30c|2|[?]|[?]|MODERATE|6|TREATMENT|2022-03-19|2021-11-14|2022-06-13|164|39|250|AFTER|2022-03-31|ONGOING|2022-04-04
Study ID|CE|166f2758-b6c5-4439-9201-22007ca181c7|1|[?]|[?]|MODERATE|5|WASHOUT|2022-05-29|2021-10-07|2022-06-26|261|27|289|UNKNOWN|2022-06-23|AFTER|2022-06-24
Study ID|CE|166f2758-b6c5-4439-9201-22007ca181c7|2|[?]|[?]|MILD|1|SCREENING|2022-05-21|2022-05-01|2022-07-02|253|233|295|BEFORE|2022-02-23|AFTER|2022-03-11
Study ID|CE|dfe799ef-40f8-4293-ae08-fefc54ae3bd1|1|[?]|[?]|MILD|4|TREATMENT|2021-12-31|2021-11-07|2022-06-20|110|56|281|AFTER|2021-12-24|ONGOING|2022-02-03
Study ID|CE|dfe799ef-40f8-4293-ae08-fefc54ae3bd1|2|[?]|[?]|MILD|4|TREATMENT|2021-10-19|2021-10-10|2022-04-10|37|28|210|AFTER|2022-04-05|ONGOING|2022-05-13
Study ID|CE|a385105b-f0f8-4f28-9f0d-83590bdbb515|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-01-20|2021-12-16|2022-07-13|106|71|280|COINCIDENT|2022-05-23|AFTER|2022-05-24
Study ID|CE|a385105b-f0f8-4f28-9f0d-83590bdbb515|2|[?]|[?]|MODERATE|2|TREATMENT|2022-02-25|2021-11-28|2022-03-24|142|53|169|AFTER|2022-01-14|BEFORE|2022-01-21
Study ID|CE|808520d3-3b76-49bc-b3af-bc2fe89292ce|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-14|2022-02-24|2022-06-15|293|183|294|UNKNOWN|2022-03-12|BEFORE|2022-04-21
Study ID|CE|808520d3-3b76-49bc-b3af-bc2fe89292ce|2|[?]|[?]|MODERATE|4|TREATMENT|2022-04-28|2021-09-28|2022-05-17|246|34|265|COINCIDENT|2021-09-16|ONGOING|2021-09-20
Study ID|CE|7a0b128e-56a8-4dc2-9fff-5da61f895cc7|1|[?]|[?]|MODERATE|6|TREATMENT|2022-01-15|2021-12-03|2022-07-10|89|46|265|BEFORE|2022-06-12|BEFORE|2022-07-16
Study ID|CE|7a0b128e-56a8-4dc2-9fff-5da61f895cc7|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-01-21|2022-01-03|2022-06-29|95|77|254|AFTER|2022-07-11|BEFORE|2022-07-18
Study ID|CE|958d143a-5381-49c5-8bd4-57e1369c3c83|1|[?]|[?]|MODERATE|6|TREATMENT|2021-12-20|2021-12-08|2022-07-07|91|79|290|AFTER|2022-01-21|AFTER|2022-05-24
Study ID|CE|958d143a-5381-49c5-8bd4-57e1369c3c83|2|[?]|[?]|SEVERE|4|TREATMENT|2022-01-23|2021-11-21|2022-03-30|125|62|191|COINCIDENT|2021-10-27|BEFORE|2021-10-29
Study ID|CE|1b08fa0e-c785-4e2b-ade6-764dc0199b46|1|[?]|[?]|MODERATE|5|WASHOUT|2022-06-11|2022-01-07|2022-06-19|281|126|289|COINCIDENT|2021-10-06|ONGOING|2021-10-12
Study ID|CE|1b08fa0e-c785-4e2b-ade6-764dc0199b46|2|[?]|[?]|MODERATE|1|SCREENING|2021-12-13|2021-09-13|2022-04-19|101|10|228|BEFORE|2021-09-13|BEFORE|2021-09-14
Study ID|CE|9e430cf4-27f1-4fd8-abbb-1971b7f6698b|1|[?]|[?]|SEVERE|1|SCREENING|2022-07-11|2022-04-24|2022-07-24|283|205|296|UNKNOWN|2022-01-28|BEFORE|2022-02-01
Study ID|CE|9e430cf4-27f1-4fd8-abbb-1971b7f6698b|2|[?]|[?]|MODERATE|2|TREATMENT|2022-04-23|2021-12-19|2022-06-10|204|79|252|COINCIDENT|2021-10-15|ONGOING|2021-10-28
Study ID|CE|fc84f14d-27bf-4f2e-beb1-af50ddf975b8|1|[?]|[?]|MODERATE|1|SCREENING|2022-07-30|2022-05-10|2022-08-14|283|202|298|COINCIDENT|2022-01-17|ONGOING|2022-01-17
Study ID|CE|fc84f14d-27bf-4f2e-beb1-af50ddf975b8|2|[?]|[?]|MILD|2|TREATMENT|2021-11-06|2021-10-24|2022-05-14|17|4|206|UNKNOWN|2021-10-27|COINCIDENT|2021-10-28
Study ID|CE|e2242eef-d92e-40e2-a481-3da17eef3d9f|1|[?]|[?]|SEVERE|6|TREATMENT|2022-02-23|2021-11-30|2022-04-12|185|100|233|AFTER|2021-12-19|COINCIDENT|2021-12-20
Study ID|CE|e2242eef-d92e-40e2-a481-3da17eef3d9f|2|[?]|[?]|MILD|6|TREATMENT|2021-11-22|2021-11-01|2022-04-16|92|71|237|AFTER|2022-05-05|COINCIDENT|2022-05-19
Study ID|CE|fb8e4e6b-79e5-4a38-bb3b-8b9dea8d70b0|1|[?]|[?]|SEVERE|2|TREATMENT|2022-04-02|2022-01-09|2022-05-22|220|137|270|AFTER|2021-10-11|AFTER|2021-10-23
Study ID|CE|fb8e4e6b-79e5-4a38-bb3b-8b9dea8d70b0|2|[?]|[?]|MODERATE|4|TREATMENT|2021-12-25|2021-09-07|2022-03-08|122|13|195|AFTER|2022-04-13|BEFORE|2022-04-18
Study ID|CE|c416dd33-f0c5-4097-8be0-a8baef1f41ab|1|[?]|[?]|SEVERE|5|WASHOUT|2021-11-06|2021-10-31|2022-03-15|66|60|195|COINCIDENT|2021-12-24|ONGOING|2022-01-11
Study ID|CE|c416dd33-f0c5-4097-8be0-a8baef1f41ab|2|[?]|[?]|MODERATE|6|TREATMENT|2022-05-12|2022-01-20|2022-05-26|253|141|267|BEFORE|2021-11-03|ONGOING|2022-04-07
Study ID|CE|33606058-1c76-4b31-bb71-b25bc019dacc|1|[?]|[?]|SEVERE|4|TREATMENT|2022-03-23|2022-01-18|2022-06-12|146|82|227|COINCIDENT|2021-12-26|BEFORE|2022-01-07
Study ID|CE|33606058-1c76-4b31-bb71-b25bc019dacc|2|[?]|[?]|MODERATE|6|TREATMENT|2022-07-02|2022-04-14|2022-07-19|247|168|264|AFTER|2022-05-22|COINCIDENT|2022-06-19
Study ID|CE|b3117024-d79c-4ba6-bc57-cd5e32352abb|1|[?]|[?]|SEVERE|6|TREATMENT|2022-06-15|2021-10-26|2022-06-19|260|28|264|COINCIDENT|2022-04-28|BEFORE|2022-05-07
Study ID|CE|b3117024-d79c-4ba6-bc57-cd5e32352abb|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-10-29|2021-10-13|2022-01-23|31|15|117|COINCIDENT|2021-11-22|AFTER|2021-11-25
Study ID|CE|5f681c2a-5efd-4774-bfb8-d031fbdd917d|1|[?]|[?]|SEVERE|1|SCREENING|2022-01-22|2022-01-20|2022-04-29|120|118|217|BEFORE|2022-01-20|COINCIDENT|2022-01-22
Study ID|CE|5f681c2a-5efd-4774-bfb8-d031fbdd917d|2|[?]|[?]|MILD|1|SCREENING|2022-06-30|2022-03-04|2022-07-14|279|161|293|UNKNOWN|2021-10-29|COINCIDENT|2021-10-30
Study ID|CE|a9e04609-9af3-4587-8ac0-a8d62854939a|1|[?]|[?]|MODERATE|3|WASHOUT|2022-05-19|2022-01-17|2022-07-15|203|81|260|BEFORE|2021-12-20|AFTER|2021-12-26
Study ID|CE|a9e04609-9af3-4587-8ac0-a8d62854939a|2|[?]|[?]|MILD|4|TREATMENT|2022-03-23|2021-10-31|2022-08-17|146|3|293|BEFORE|2021-11-08|ONGOING|2021-11-09
Study ID|CE|0913ad12-1f57-4c53-953c-53b2c77d6916|1|[?]|[?]|MODERATE|5|WASHOUT|2022-03-18|2022-01-09|2022-07-16|159|91|279|UNKNOWN|2022-04-08|BEFORE|2022-06-07
Study ID|CE|0913ad12-1f57-4c53-953c-53b2c77d6916|2|[?]|[?]|MODERATE|5|WASHOUT|2022-05-29|2022-02-18|2022-08-03|231|131|297|AFTER|2022-02-06|ONGOING|2022-04-02
Study ID|CE|5621f735-4c04-4865-ae76-417f931fc416|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-12-17|2021-10-19|2022-08-03|66|7|295|BEFORE|2021-12-12|AFTER|2021-12-15
Study ID|CE|5621f735-4c04-4865-ae76-417f931fc416|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-02-01|2021-10-19|2022-06-19|112|7|250|COINCIDENT|2022-03-25|BEFORE|2022-03-25
Study ID|CE|d2815dac-314a-4b51-a2a8-7c34342d8762|1|[?]|[?]|MILD|2|TREATMENT|2021-10-21|2021-10-19|2022-06-26|4|2|252|COINCIDENT|2022-01-08|COINCIDENT|2022-01-08
Study ID|CE|d2815dac-314a-4b51-a2a8-7c34342d8762|2|[?]|[?]|MODERATE|6|TREATMENT|2022-03-20|2022-03-06|2022-07-17|154|140|273|BEFORE|2021-12-21|BEFORE|2021-12-29
Study ID|CE|1e4a58b7-6c40-49c2-8366-ab18bde326ba|1|[?]|[?]|MODERATE|6|TREATMENT|2022-03-30|2021-10-29|2022-05-21|191|39|243|COINCIDENT|2022-02-24|COINCIDENT|2022-03-14
Study ID|CE|1e4a58b7-6c40-49c2-8366-ab18bde326ba|2|[?]|[?]|MODERATE|2|TREATMENT|2021-10-11|2021-09-22|2022-04-20|21|2|212|AFTER|2022-01-16|AFTER|2022-02-20
Study ID|CE|6142ec67-5b3f-4b25-ab15-4b89681287aa|1|[?]|[?]|MILD|5|WASHOUT|2021-10-25|2021-10-17|2021-11-08|62|54|76|UNKNOWN|2021-09-04|COINCIDENT|2021-11-12
Study ID|CE|6142ec67-5b3f-4b25-ab15-4b89681287aa|2|[?]|[?]|SEVERE|3|WASHOUT|2021-10-25|2021-09-04|2022-01-24|62|11|153|BEFORE|2021-12-26|AFTER|2022-02-22
Study ID|CE|f3d1a010-45e4-4136-985b-2c267cc61bc0|1|[?]|[?]|MILD|3|WASHOUT|2022-05-28|2022-01-01|2022-05-30|285|138|287|AFTER|2022-01-12|BEFORE|2022-01-21
Study ID|CE|f3d1a010-45e4-4136-985b-2c267cc61bc0|2|[?]|[?]|SEVERE|5|WASHOUT|2022-04-30|2021-11-11|2022-05-21|257|87|278|COINCIDENT|2021-08-23|AFTER|2021-08-27
Study ID|CE|02731faf-c909-4245-bde8-9ed89623636c|1|[?]|[?]|MILD|6|TREATMENT|2022-01-11|2021-12-11|2022-03-17|119|88|184|BEFORE|2022-01-26|BEFORE|2022-03-07
Study ID|CE|02731faf-c909-4245-bde8-9ed89623636c|2|[?]|[?]|SEVERE|1|SCREENING|2022-05-29|2022-04-06|2022-06-27|257|204|286|UNKNOWN|2021-10-29|BEFORE|2021-10-31
Study ID|CE|f41c7623-dc71-40b6-af05-cb27bcc5bc0d|1|[?]|[?]|MILD|2|TREATMENT|2021-11-25|2021-11-04|2022-08-16|35|14|299|COINCIDENT|2022-08-07|ONGOING|2022-08-09
Study ID|CE|f41c7623-dc71-40b6-af05-cb27bcc5bc0d|2|[?]|[?]|SEVERE|5|WASHOUT|2022-01-23|2021-11-26|2022-04-29|94|36|190|COINCIDENT|2021-10-26|BEFORE|2021-10-26
Study ID|CE|3ca6f491-6adb-461e-8c77-6964298881b8|1|[?]|[?]|MILD|4|TREATMENT|2021-09-06|2021-09-05|2022-03-16|4|3|195|AFTER|2021-11-12|AFTER|2021-11-24
Study ID|CE|3ca6f491-6adb-461e-8c77-6964298881b8|2|[?]|[?]|SEVERE|2|TREATMENT|2021-10-20|2021-09-14|2022-04-23|48|12|233|BEFORE|2022-02-20|BEFORE|2022-02-21
Study ID|CE|348c5733-3f80-4958-aed9-788cae022359|1|[?]|[?]|MILD|3|WASHOUT|2021-09-30|2021-09-27|2021-11-28|6|3|65|BEFORE|2022-05-21|COINCIDENT|2022-05-27
Study ID|CE|348c5733-3f80-4958-aed9-788cae022359|2|[?]|[?]|MODERATE|1|SCREENING|2021-10-20|2021-10-03|2022-06-05|26|9|254|BEFORE|2022-03-13|BEFORE|2022-04-03
Study ID|CE|25afbbe4-4844-47b1-a1f2-719a1d539a7e|1|[?]|[?]|MODERATE|6|TREATMENT|2022-03-09|2022-03-07|2022-04-15|201|199|238|AFTER|2021-10-22|COINCIDENT|2021-10-26
Study ID|CE|25afbbe4-4844-47b1-a1f2-719a1d539a7e|2|[?]|[?]|MODERATE|6|TREATMENT|2021-09-20|2021-09-15|2022-04-21|31|26|244|AFTER|2021-08-31|ONGOING|2021-10-12
Study ID|CE|ebdeac60-a9e0-40b5-a156-2e65c3d34ece|1|[?]|[?]|MILD|3|WASHOUT|2021-12-05|2021-11-23|2022-07-30|49|37|286|BEFORE|2021-12-07|COINCIDENT|2021-12-10
Study ID|CE|ebdeac60-a9e0-40b5-a156-2e65c3d34ece|2|[?]|[?]|MILD|4|TREATMENT|2022-06-04|2022-05-15|2022-06-07|230|210|233|COINCIDENT|2021-12-29|COINCIDENT|2022-03-19
Study ID|CE|0a056ab2-3769-4bb4-ab9f-581f1f302e5e|1|[?]|[?]|MODERATE|2|TREATMENT|2021-12-16|2021-11-01|2022-01-25|107|62|147|COINCIDENT|2021-09-11|ONGOING|2021-09-13
Study ID|CE|0a056ab2-3769-4bb4-ab9f-581f1f302e5e|2|[?]|[?]|SEVERE|3|WASHOUT|2021-09-06|2021-09-05|2022-03-07|6|5|188|AFTER|2022-01-11|AFTER|2022-02-11
Study ID|CE|0dc6f54f-28d3-4e98-9202-ecde1228feba|1|[?]|[?]|MODERATE|6|TREATMENT|2022-02-08|2021-11-13|2022-03-01|174|87|195|COINCIDENT|2021-09-11|AFTER|2021-09-18
Study ID|CE|0dc6f54f-28d3-4e98-9202-ecde1228feba|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-10-14|2021-09-04|2021-11-16|57|17|90|UNKNOWN|2021-10-15|ONGOING|2021-10-29
Study ID|CE|a918255d-29fb-4e33-b0b7-df6fc4790307|1|[?]|[?]|MILD|3|WASHOUT|2022-05-18|2022-02-03|2022-07-18|232|128|293|BEFORE|2022-03-09|ONGOING|2022-06-11
Study ID|CE|a918255d-29fb-4e33-b0b7-df6fc4790307|2|[?]|[?]|SEVERE|1|SCREENING|2021-11-16|2021-10-19|2022-06-15|49|21|260|COINCIDENT|2021-12-16|COINCIDENT|2022-01-07
Study ID|CE|cca42372-642c-4914-89be-334f5e371202|1|[?]|[?]|MILD|4|TREATMENT|2022-03-28|2022-03-24|2022-06-02|200|196|266|COINCIDENT|2022-04-24|COINCIDENT|2022-05-29
Study ID|CE|cca42372-642c-4914-89be-334f5e371202|2|[?]|[?]|MODERATE|6|TREATMENT|2022-01-08|2022-01-05|2022-06-14|121|118|278|BEFORE|2021-12-28|AFTER|2022-01-22
Study ID|CE|ef11d251-ad64-4ee8-8924-97229080b97f|1|[?]|[?]|MILD|5|WASHOUT|2021-12-14|2021-10-06|2022-06-22|72|3|262|COINCIDENT|2021-12-24|COINCIDENT|2022-01-30
Study ID|CE|ef11d251-ad64-4ee8-8924-97229080b97f|2|[?]|[?]|SEVERE|2|TREATMENT|2021-11-23|2021-10-11|2021-12-04|51|8|62|BEFORE|2021-10-15|ONGOING|2021-10-16
Study ID|CE|c81be2c6-6a71-42ed-821c-2539d90f9da6|1|[?]|[?]|MILD|5|WASHOUT|2022-06-22|2022-06-13|2022-06-27|281|272|286|COINCIDENT|2021-09-25|AFTER|2021-11-12
Study ID|CE|c81be2c6-6a71-42ed-821c-2539d90f9da6|2|[?]|[?]|MODERATE|5|WASHOUT|2022-05-12|2022-01-05|2022-06-28|240|113|287|AFTER|2021-12-21|BEFORE|2021-12-26
Study ID|CE|195e00af-25ec-43b2-98a0-b7dbb0918556|1|[?]|[?]|MILD|4|TREATMENT|2022-05-08|2022-04-19|2022-05-29|260|241|281|COINCIDENT|2021-09-07|AFTER|2021-09-08
Study ID|CE|195e00af-25ec-43b2-98a0-b7dbb0918556|2|[?]|[?]|MODERATE|2|TREATMENT|2022-03-15|2021-10-13|2022-04-20|206|53|242|UNKNOWN|2021-09-08|ONGOING|2021-09-09
Study ID|CE|166f2644-d223-48de-a053-7a7931229ea9|1|[?]|[?]|MODERATE|6|TREATMENT|2022-07-08|2022-06-22|2022-07-16|288|272|296|COINCIDENT|2022-03-13|COINCIDENT|2022-03-14
Study ID|CE|166f2644-d223-48de-a053-7a7931229ea9|2|[?]|[?]|MODERATE|2|TREATMENT|2022-04-13|2021-12-27|2022-06-20|202|95|270|AFTER|2022-03-16|ONGOING|2022-03-27
Study ID|CE|50f00565-e065-4bb5-906f-43b4994f05d9|1|[?]|[?]|MODERATE|6|TREATMENT|2022-02-06|2021-10-01|2022-05-27|168|40|278|UNKNOWN|2022-01-04|BEFORE|2022-02-08
Study ID|CE|50f00565-e065-4bb5-906f-43b4994f05d9|2|[?]|[?]|MILD|6|TREATMENT|2021-12-17|2021-12-16|2022-03-07|117|116|197|AFTER|2021-08-28|BEFORE|2021-09-01
Study ID|CE|25be6337-0010-4c3f-a40d-73f1970be014|1|[?]|[?]|MODERATE|1|SCREENING|2022-03-04|2021-10-05|2022-04-22|196|46|245|AFTER|2022-01-20|AFTER|2022-01-30
Study ID|CE|25be6337-0010-4c3f-a40d-73f1970be014|2|[?]|[?]|MODERATE|2|TREATMENT|2022-06-07|2022-03-05|2022-06-11|291|197|295|UNKNOWN|2021-11-16|BEFORE|2021-11-24
Study ID|CE|51665699-7b2e-4584-ba77-1495e49154c8|1|[?]|[?]|SEVERE|6|TREATMENT|2021-11-27|2021-11-12|2022-06-10|55|40|250|COINCIDENT|2021-12-22|COINCIDENT|2021-12-25
Study ID|CE|51665699-7b2e-4584-ba77-1495e49154c8|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-07-18|2021-11-28|2022-07-22|288|56|292|COINCIDENT|2022-05-15|BEFORE|2022-06-02
Study ID|CE|677139a9-de5a-46e8-9b01-78b89bb5721c|1|[?]|[?]|SEVERE|3|WASHOUT|2022-04-08|2022-03-17|2022-06-29|191|169|273|UNKNOWN|2022-02-13|BEFORE|2022-02-27
Study ID|CE|677139a9-de5a-46e8-9b01-78b89bb5721c|2|[?]|[?]|MILD|4|TREATMENT|2022-04-20|2022-01-06|2022-06-04|203|99|248|BEFORE|2021-10-30|ONGOING|2021-11-13
Study ID|CE|875a63c3-b499-4a5a-8b56-ca6d10bf9c26|1|[?]|[?]|MILD|2|TREATMENT|2021-10-08|2021-10-03|2021-11-06|60|55|89|BEFORE|2021-08-19|COINCIDENT|2021-08-20
Study ID|CE|875a63c3-b499-4a5a-8b56-ca6d10bf9c26|2|[?]|[?]|MODERATE|2|TREATMENT|2022-05-17|2021-11-08|2022-06-03|281|91|298|BEFORE|2021-10-28|ONGOING|2021-10-29
Study ID|CE|07f84376-6ab5-43a9-8ee5-51f2f8046eb2|1|[?]|[?]|MODERATE|4|TREATMENT|2022-05-29|2022-02-04|2022-06-11|282|168|295|UNKNOWN|2021-10-20|ONGOING|2021-10-23
Study ID|CE|07f84376-6ab5-43a9-8ee5-51f2f8046eb2|2|[?]|[?]|MODERATE|2|TREATMENT|2021-10-08|2021-09-09|2021-12-31|49|20|133|BEFORE|2021-09-21|BEFORE|2021-09-23
Study ID|CE|b179358d-b542-479f-8a24-8cd656f8b29c|1|[?]|[?]|MODERATE|1|SCREENING|2022-07-11|2022-01-25|2022-07-21|256|89|266|AFTER|2021-12-03|AFTER|2021-12-08
Study ID|CE|b179358d-b542-479f-8a24-8cd656f8b29c|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-04-20|2022-02-20|2022-06-04|174|115|219|AFTER|2021-12-19|BEFORE|2021-12-20
Study ID|CE|f2b14285-7731-41ba-803d-a13079c8d7e2|1|[?]|[?]|MILD|1|SCREENING|2021-10-20|2021-10-15|2022-01-27|21|16|120|BEFORE|2021-10-10|AFTER|2021-12-04
Study ID|CE|f2b14285-7731-41ba-803d-a13079c8d7e2|2|[?]|[?]|MODERATE|2|TREATMENT|2022-02-22|2022-02-21|2022-06-17|146|145|261|UNKNOWN|2022-02-28|COINCIDENT|2022-03-04
Study ID|CE|01dab730-8fa8-48b8-9db4-549d17fe9364|1|[?]|[?]|MODERATE|6|TREATMENT|2022-05-17|2022-03-30|2022-06-12|256|208|282|AFTER|2022-02-03|COINCIDENT|2022-03-06
Study ID|CE|01dab730-8fa8-48b8-9db4-549d17fe9364|2|[?]|[?]|MILD|6|TREATMENT|2021-10-12|2021-09-11|2022-04-19|39|8|228|COINCIDENT|2022-03-02|BEFORE|2022-04-02
Study ID|CE|91824814-dbc7-42f2-933a-843c745307f0|1|[?]|[?]|MODERATE|2|TREATMENT|2021-11-19|2021-10-02|2022-05-18|67|19|247|UNKNOWN|2022-02-04|ONGOING|2022-03-06
Study ID|CE|91824814-dbc7-42f2-933a-843c745307f0|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-04-02|2022-03-11|2022-06-16|201|179|276|BEFORE|2022-04-24|ONGOING|2022-05-29
Study ID|CE|0a8847a0-ad08-43f0-8f7c-09194197ded3|1|[?]|[?]|MODERATE|1|SCREENING|2022-07-03|2022-01-07|2022-07-30|262|85|289|UNKNOWN|2022-03-08|AFTER|2022-04-08
Study ID|CE|0a8847a0-ad08-43f0-8f7c-09194197ded3|2|[?]|[?]|MILD|5|WASHOUT|2022-02-16|2021-11-05|2022-02-26|125|22|135|AFTER|2022-03-03|BEFORE|2022-03-11
Study ID|CE|3ef841f6-b1d8-41c0-a708-ed1a2866d92b|1|[?]|[?]|MODERATE|6|TREATMENT|2022-05-11|2021-12-17|2022-06-11|253|108|284|BEFORE|2021-11-10|COINCIDENT|2021-12-10
Study ID|CE|3ef841f6-b1d8-41c0-a708-ed1a2866d92b|2|[?]|[?]|MILD|5|WASHOUT|2022-01-30|2021-11-07|2022-05-26|152|68|268|UNKNOWN|2021-09-25|AFTER|2021-09-27
Study ID|CE|ec732f35-e389-42ea-b5c1-5795312935ac|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-11-14|2021-10-03|2022-01-31|75|33|153|AFTER|2021-09-24|COINCIDENT|2021-10-29
Study ID|CE|ec732f35-e389-42ea-b5c1-5795312935ac|2|[?]|[?]|SEVERE|2|TREATMENT|2022-01-01|2021-12-18|2022-02-21|123|109|174|BEFORE|2022-03-03|COINCIDENT|2022-03-09
Study ID|CE|ae055ad4-6e9a-47f9-8914-6bab08f739fc|1|[?]|[?]|SEVERE|1|SCREENING|2021-12-07|2021-10-01|2022-04-20|92|25|226|BEFORE|2022-03-15|COINCIDENT|2022-03-20
Study ID|CE|ae055ad4-6e9a-47f9-8914-6bab08f739fc|2|[?]|[?]|MODERATE|2|TREATMENT|2021-09-17|2021-09-13|2022-05-16|11|7|252|UNKNOWN|2021-10-21|ONGOING|2022-01-09
Study ID|CE|7d95af47-fe69-49d0-b3c2-0b4b011bdf97|1|[?]|[?]|MILD|7|FOLLOW-UP|2021-12-03|2021-10-26|2022-03-25|91|53|203|AFTER|2022-05-07|ONGOING|2022-05-26
Study ID|CE|7d95af47-fe69-49d0-b3c2-0b4b011bdf97|2|[?]|[?]|MILD|2|TREATMENT|2021-10-24|2021-10-01|2022-01-13|51|28|132|COINCIDENT|2021-10-20|ONGOING|2022-01-05
Study ID|CE|ba667dad-f75a-4736-b891-0bf204438374|1|[?]|[?]|MODERATE|5|WASHOUT|2022-05-10|2021-11-03|2022-05-25|271|83|286|AFTER|2021-09-12|COINCIDENT|2021-09-13
Study ID|CE|ba667dad-f75a-4736-b891-0bf204438374|2|[?]|[?]|SEVERE|3|WASHOUT|2022-05-04|2022-01-20|2022-05-17|265|161|278|UNKNOWN|2021-09-19|AFTER|2021-09-21
Study ID|CE|86bf2d3a-e791-4eec-8ef8-6aa975a23d46|1|[?]|[?]|SEVERE|5|WASHOUT|2022-06-08|2022-05-08|2022-07-24|232|201|278|COINCIDENT|2022-02-10|AFTER|2022-02-16
Study ID|CE|86bf2d3a-e791-4eec-8ef8-6aa975a23d46|2|[?]|[?]|MODERATE|3|WASHOUT|2022-05-13|2022-03-28|2022-05-25|206|160|218|AFTER|2022-03-12|COINCIDENT|2022-04-01
Study ID|CE|e223e6f1-4f84-4ae8-9621-67d13737279a|1|[?]|[?]|SEVERE|3|WASHOUT|2022-01-15|2022-01-03|2022-07-06|84|72|256|UNKNOWN|2021-11-30|AFTER|2021-12-11
Study ID|CE|e223e6f1-4f84-4ae8-9621-67d13737279a|2|[?]|[?]|SEVERE|6|TREATMENT|2022-04-01|2022-01-21|2022-04-03|160|90|162|BEFORE|2021-12-26|AFTER|2022-04-05
Study ID|CE|6b71d31d-4466-4699-a4d8-38998456913a|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-12-10|2021-12-04|2022-07-09|54|48|265|AFTER|2022-01-02|AFTER|2022-03-31
Study ID|CE|6b71d31d-4466-4699-a4d8-38998456913a|2|[?]|[?]|MILD|4|TREATMENT|2022-06-10|2021-12-06|2022-08-12|236|50|299|BEFORE|2022-03-29|AFTER|2022-04-04
Study ID|CE|6a8b54cc-5569-4c3a-8f25-d0a357c23c1b|1|[?]|[?]|SEVERE|6|TREATMENT|2022-05-24|2021-08-26|2022-06-02|275|4|284|AFTER|2022-03-17|BEFORE|2022-03-30
Study ID|CE|6a8b54cc-5569-4c3a-8f25-d0a357c23c1b|2|[?]|[?]|MODERATE|2|TREATMENT|2022-03-20|2021-10-01|2022-05-30|210|40|281|UNKNOWN|2021-12-03|AFTER|2021-12-05
Study ID|CE|d7453b4b-c700-4116-88e0-5ec07255fcc1|1|[?]|[?]|MODERATE|2|TREATMENT|2022-01-26|2021-11-02|2022-06-11|148|63|284|BEFORE|2022-01-12|BEFORE|2022-01-29
Study ID|CE|d7453b4b-c700-4116-88e0-5ec07255fcc1|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-03-08|2022-03-05|2022-06-14|189|186|287|COINCIDENT|2022-02-06|BEFORE|2022-02-28
Study ID|CE|97846c4a-bc01-4a2b-9d5a-15f44d085c04|1|[?]|[?]|MILD|3|WASHOUT|2022-06-09|2021-10-29|2022-06-30|256|33|277|BEFORE|2022-02-02|COINCIDENT|2022-02-04
Study ID|CE|97846c4a-bc01-4a2b-9d5a-15f44d085c04|2|[?]|[?]|MODERATE|4|TREATMENT|2021-11-30|2021-11-20|2022-03-23|65|55|178|UNKNOWN|2022-02-04|BEFORE|2022-02-05
Study ID|CE|6ac67159-7286-4911-9ffa-136fbe29e4f3|1|[?]|[?]|MODERATE|1|SCREENING|2022-07-17|2022-02-27|2022-07-29|272|132|284|BEFORE|2022-02-09|BEFORE|2022-06-05
Study ID|CE|6ac67159-7286-4911-9ffa-136fbe29e4f3|2|[?]|[?]|SEVERE|3|WASHOUT|2022-08-04|2022-08-02|2022-08-07|290|288|293|AFTER|2021-11-03|AFTER|2021-11-09
Study ID|CE|71bb085e-762e-4807-bf68-38c734740c69|1|[?]|[?]|MILD|3|WASHOUT|2022-04-16|2022-02-02|2022-06-12|239|166|296|COINCIDENT|2021-08-22|COINCIDENT|2021-08-22
Study ID|CE|71bb085e-762e-4807-bf68-38c734740c69|2|[?]|[?]|MODERATE|1|SCREENING|2022-01-27|2021-10-22|2022-03-22|160|63|214|UNKNOWN|2022-02-06|BEFORE|2022-02-12
Study ID|CE|c44e84f0-4142-417a-b150-0f869ba0b626|1|[?]|[?]|MODERATE|4|TREATMENT|2022-07-19|2022-01-06|2022-07-28|271|77|280|UNKNOWN|2021-11-17|COINCIDENT|2021-11-24
Study ID|CE|c44e84f0-4142-417a-b150-0f869ba0b626|2|[?]|[?]|MODERATE|1|SCREENING|2022-06-21|2022-06-11|2022-07-12|243|233|264|COINCIDENT|2021-12-05|COINCIDENT|2021-12-06
Study ID|CE|beafde56-2984-4fbf-ae59-57666400ec13|1|[?]|[?]|MODERATE|5|WASHOUT|2022-04-23|2022-04-12|2022-06-03|256|245|297|AFTER|2022-01-12|COINCIDENT|2022-01-15
Study ID|CE|beafde56-2984-4fbf-ae59-57666400ec13|2|[?]|[?]|MODERATE|4|TREATMENT|2022-01-04|2021-08-28|2022-03-17|147|18|219|AFTER|2021-09-18|ONGOING|2021-09-26
Study ID|CE|1bd533cc-d6ad-4b46-b65f-22521af557c5|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-11-24|2021-11-05|2022-03-26|29|10|151|AFTER|2022-01-29|BEFORE|2022-03-24
Study ID|CE|1bd533cc-d6ad-4b46-b65f-22521af557c5|2|[?]|[?]|MODERATE|6|TREATMENT|2022-02-26|2022-01-22|2022-07-25|123|88|272|BEFORE|2021-11-19|BEFORE|2021-11-25
Study ID|CE|ea38ac51-e63c-4105-a611-7f82e602e40d|1|[?]|[?]|SEVERE|3|WASHOUT|2021-12-21|2021-11-13|2022-01-25|121|83|156|AFTER|2021-09-03|BEFORE|2021-09-05
Study ID|CE|ea38ac51-e63c-4105-a611-7f82e602e40d|2|[?]|[?]|MILD|2|TREATMENT|2022-04-16|2021-09-20|2022-06-15|237|29|297|BEFORE|2021-12-19|AFTER|2021-12-21
Study ID|CE|d0ffcc8c-51e8-4e39-bff1-70ee52985b9e|1|[?]|[?]|SEVERE|6|TREATMENT|2021-09-23|2021-09-21|2022-05-15|4|2|238|UNKNOWN|2022-04-17|ONGOING|2022-06-12
Study ID|CE|d0ffcc8c-51e8-4e39-bff1-70ee52985b9e|2|[?]|[?]|SEVERE|1|SCREENING|2021-10-22|2021-10-05|2022-05-12|33|16|235|AFTER|2022-05-27|AFTER|2022-06-09
Study ID|CE|1d54d4f1-bde4-4686-96bf-d1d78ab25874|1|[?]|[?]|MILD|1|SCREENING|2021-10-03|2021-09-17|2021-11-13|25|9|66|AFTER|2021-10-29|AFTER|2021-11-15
Study ID|CE|1d54d4f1-bde4-4686-96bf-d1d78ab25874|2|[?]|[?]|SEVERE|2|TREATMENT|2022-01-12|2021-11-01|2022-07-01|126|54|296|COINCIDENT|2022-03-11|BEFORE|2022-03-22
Study ID|CE|d0902968-a6cd-4b8d-bcf8-4da11b088679|1|[?]|[?]|MILD|5|WASHOUT|2022-03-15|2022-02-22|2022-04-02|186|165|204|AFTER|2021-11-14|BEFORE|2021-11-16
Study ID|CE|d0902968-a6cd-4b8d-bcf8-4da11b088679|2|[?]|[?]|MODERATE|6|TREATMENT|2022-06-16|2022-01-06|2022-07-01|279|118|294|UNKNOWN|2021-09-16|AFTER|2021-09-24
Study ID|CE|dc30ce6d-7caf-4baa-a7ef-368c1213ba44|1|[?]|[?]|MILD|2|TREATMENT|2022-06-09|2021-12-14|2022-06-16|267|90|274|UNKNOWN|2021-09-22|COINCIDENT|2021-09-28
Study ID|CE|dc30ce6d-7caf-4baa-a7ef-368c1213ba44|2|[?]|[?]|MODERATE|2|TREATMENT|2021-12-12|2021-11-20|2022-03-08|88|66|174|BEFORE|2022-02-11|BEFORE|2022-04-15
Study ID|CE|72574893-e8f5-44d2-8e9b-ef6b0d1f5f7b|1|[?]|[?]|MILD|4|TREATMENT|2021-11-05|2021-09-23|2022-05-31|51|8|258|COINCIDENT|2022-03-17|AFTER|2022-04-24
Study ID|CE|72574893-e8f5-44d2-8e9b-ef6b0d1f5f7b|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-06-22|2021-12-16|2022-07-03|280|92|291|COINCIDENT|2021-11-06|BEFORE|2021-11-07
Study ID|CE|e246564a-8c28-4bba-b70d-12cc38919ed9|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-11-22|2021-11-01|2022-04-11|68|47|208|UNKNOWN|2022-04-03|AFTER|2022-04-07
Study ID|CE|e246564a-8c28-4bba-b70d-12cc38919ed9|2|[?]|[?]|MILD|4|TREATMENT|2022-01-04|2021-11-27|2022-01-18|111|73|125|BEFORE|2022-02-12|ONGOING|2022-02-14
Study ID|CE|c04a3991-7665-487f-916f-f695b3a91afa|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-03-29|2021-08-19|2022-04-03|230|8|235|UNKNOWN|2021-10-11|BEFORE|2021-10-21
Study ID|CE|c04a3991-7665-487f-916f-f695b3a91afa|2|[?]|[?]|MILD|5|WASHOUT|2022-02-03|2021-09-22|2022-03-24|176|42|225|BEFORE|2022-02-25|BEFORE|2022-03-21
Study ID|CE|808e1ec0-c263-4209-a16c-28d78a445acd|1|[?]|[?]|MILD|5|WASHOUT|2022-03-25|2021-12-23|2022-06-21|175|83|263|COINCIDENT|2021-12-01|BEFORE|2022-04-05
Study ID|CE|808e1ec0-c263-4209-a16c-28d78a445acd|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-12-29|2021-12-16|2022-03-22|89|76|172|COINCIDENT|2022-02-21|ONGOING|2022-04-19
Study ID|CE|9725ad20-8ca3-48e7-824e-7dba1da8abdd|1|[?]|[?]|MILD|4|TREATMENT|2022-01-29|2022-01-27|2022-03-31|168|166|229|COINCIDENT|2022-01-19|COINCIDENT|2022-04-08
Study ID|CE|9725ad20-8ca3-48e7-824e-7dba1da8abdd|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-02-25|2021-08-29|2022-03-22|195|15|220|UNKNOWN|2021-08-22|BEFORE|2021-08-23
Study ID|CE|12fe384b-bcd1-4b63-855a-0c5e220b6caa|1|[?]|[?]|MODERATE|1|SCREENING|2022-05-24|2022-02-21|2022-08-13|215|123|296|AFTER|2021-12-26|ONGOING|2021-12-27
Study ID|CE|12fe384b-bcd1-4b63-855a-0c5e220b6caa|2|[?]|[?]|MILD|3|WASHOUT|2022-02-27|2021-10-24|2022-03-14|129|3|144|UNKNOWN|2022-01-27|BEFORE|2022-02-11
Study ID|CE|42351b79-f2f3-4c6f-9d70-2fab11eca35a|1|[?]|[?]|MODERATE|4|TREATMENT|2022-06-03|2022-02-18|2022-06-15|237|132|249|AFTER|2021-10-14|AFTER|2022-01-04
Study ID|CE|42351b79-f2f3-4c6f-9d70-2fab11eca35a|2|[?]|[?]|MILD|2|TREATMENT|2022-04-12|2021-11-02|2022-07-27|185|24|291|COINCIDENT|2021-12-09|BEFORE|2021-12-10
Study ID|CE|1850f6e3-d8dd-48a2-a4c1-7676bb1fafd5|1|[?]|[?]|SEVERE|3|WASHOUT|2022-01-15|2021-10-01|2022-02-14|156|50|186|BEFORE|2021-09-09|COINCIDENT|2021-09-10
Study ID|CE|1850f6e3-d8dd-48a2-a4c1-7676bb1fafd5|2|[?]|[?]|SEVERE|2|TREATMENT|2022-03-29|2021-08-28|2022-05-22|229|16|283|BEFORE|2021-10-18|COINCIDENT|2021-10-25
Study ID|CE|cdf46a68-d9ca-4645-a48a-93ffb1cab1b7|1|[?]|[?]|MODERATE|1|SCREENING|2022-03-14|2022-01-20|2022-05-31|159|106|237|AFTER|2022-02-06|ONGOING|2022-05-13
Study ID|CE|cdf46a68-d9ca-4645-a48a-93ffb1cab1b7|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-01|2022-05-31|2022-08-01|238|237|299|COINCIDENT|2022-01-15|ONGOING|2022-01-26
Study ID|CE|8ca35852-d560-4920-a83c-0ce950d886ec|1|[?]|[?]|MILD|1|SCREENING|2022-02-15|2022-02-03|2022-06-14|154|142|273|UNKNOWN|2021-11-08|ONGOING|2021-11-26
Study ID|CE|8ca35852-d560-4920-a83c-0ce950d886ec|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-02-01|2022-01-16|2022-06-23|140|124|282|BEFORE|2021-09-21|COINCIDENT|2021-09-22
Study ID|CE|b1c9bc78-2257-44c2-8b8b-6426cf6d3e7c|1|[?]|[?]|MILD|6|TREATMENT|2021-11-11|2021-10-19|2022-03-26|95|72|230|AFTER|2021-11-05|ONGOING|2022-02-25
Study ID|CE|b1c9bc78-2257-44c2-8b8b-6426cf6d3e7c|2|[?]|[?]|MODERATE|6|TREATMENT|2022-04-27|2022-02-25|2022-05-31|262|201|296|COINCIDENT|2021-10-13|AFTER|2021-10-18
Study ID|CE|3f85e60b-02d4-49f7-b18e-165a3111bea7|1|[?]|[?]|MODERATE|1|SCREENING|2022-05-14|2021-10-20|2022-07-09|223|17|279|BEFORE|2022-02-09|COINCIDENT|2022-04-29
Study ID|CE|3f85e60b-02d4-49f7-b18e-165a3111bea7|2|[?]|[?]|MILD|2|TREATMENT|2022-06-01|2022-01-14|2022-07-01|241|103|271|UNKNOWN|2022-04-12|BEFORE|2022-04-13
Study ID|CE|cde9f3d9-ddee-4509-8eb7-a564be85aaff|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-11-24|2021-11-15|2022-01-25|35|26|97|AFTER|2021-12-14|COINCIDENT|2021-12-15
Study ID|CE|cde9f3d9-ddee-4509-8eb7-a564be85aaff|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-08-04|2022-04-13|2022-08-12|288|175|296|AFTER|2022-08-04|ONGOING|2022-08-10
Study ID|CE|3107c700-6a04-4e10-ad7c-cd8a0311386d|1|[?]|[?]|MODERATE|2|TREATMENT|2022-04-22|2022-02-11|2022-06-09|236|166|284|BEFORE|2022-04-06|BEFORE|2022-04-17
Study ID|CE|3107c700-6a04-4e10-ad7c-cd8a0311386d|2|[?]|[?]|SEVERE|1|SCREENING|2021-10-03|2021-09-26|2022-06-18|35|28|293|BEFORE|2022-01-10|COINCIDENT|2022-04-11
Study ID|CE|ff8ce288-b923-44e6-ae07-5dac29048b6d|1|[?]|[?]|MILD|1|SCREENING|2022-07-21|2021-11-04|2022-07-25|277|18|281|UNKNOWN|2022-03-02|BEFORE|2022-03-03
Study ID|CE|ff8ce288-b923-44e6-ae07-5dac29048b6d|2|[?]|[?]|SEVERE|2|TREATMENT|2022-03-17|2021-12-03|2022-08-06|151|47|293|BEFORE|2022-03-23|AFTER|2022-03-24
Study ID|CE|83270fc0-01ac-4d5a-807d-bb4a7bde1c7f|1|[?]|[?]|MILD|5|WASHOUT|2021-12-02|2021-10-24|2022-02-17|60|21|137|BEFORE|2021-11-27|ONGOING|2022-01-04
Study ID|CE|83270fc0-01ac-4d5a-807d-bb4a7bde1c7f|2|[?]|[?]|MILD|4|TREATMENT|2021-10-29|2021-10-11|2021-11-11|26|8|39|UNKNOWN|2022-02-17|ONGOING|2022-06-10
Study ID|CE|764b8b95-3ff5-4ed7-992b-0eddc8f2f042|1|[?]|[?]|SEVERE|1|SCREENING|2021-10-06|2021-10-01|2021-11-24|7|2|56|BEFORE|2022-05-29|ONGOING|2022-05-30
Study ID|CE|764b8b95-3ff5-4ed7-992b-0eddc8f2f042|2|[?]|[?]|MODERATE|2|TREATMENT|2022-01-24|2021-10-31|2022-06-13|117|32|257|BEFORE|2022-03-11|ONGOING|2022-05-26
Study ID|CE|9c54af9a-3b79-4bc6-807e-71b15c34adf8|1|[?]|[?]|MILD|5|WASHOUT|2022-06-09|2022-01-28|2022-06-26|241|109|258|AFTER|2022-04-01|COINCIDENT|2022-04-02
Study ID|CE|9c54af9a-3b79-4bc6-807e-71b15c34adf8|2|[?]|[?]|MODERATE|6|TREATMENT|2021-10-30|2021-10-28|2022-01-08|19|17|89|COINCIDENT|2022-03-11|AFTER|2022-03-21
Study ID|CE|a8c7879f-9b99-4eef-8bae-5f2045165742|1|[?]|[?]|MODERATE|5|WASHOUT|2021-12-23|2021-11-09|2022-02-25|57|13|121|BEFORE|2021-11-27|AFTER|2021-12-28
Study ID|CE|a8c7879f-9b99-4eef-8bae-5f2045165742|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-02-10|2021-11-02|2022-06-19|106|6|235|COINCIDENT|2022-05-08|ONGOING|2022-05-09
Study ID|CE|3335ac20-54bb-4eab-a1a3-bad43caa109b|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-10-31|2021-10-15|2022-01-29|22|6|112|COINCIDENT|2021-10-14|BEFORE|2021-10-15
Study ID|CE|3335ac20-54bb-4eab-a1a3-bad43caa109b|2|[?]|[?]|SEVERE|1|SCREENING|2021-10-15|2021-10-14|2022-01-08|6|5|91|UNKNOWN|2021-12-18|AFTER|2022-01-07
Study ID|CE|d756c97e-423f-4dd4-b738-c969a1b08461|1|[?]|[?]|MILD|1|SCREENING|2021-08-23|2021-08-18|2022-05-18|8|3|276|COINCIDENT|2021-10-08|COINCIDENT|2021-10-10
Study ID|CE|d756c97e-423f-4dd4-b738-c969a1b08461|2|[?]|[?]|MILD|5|WASHOUT|2022-02-14|2021-10-15|2022-05-23|183|61|281|UNKNOWN|2021-09-03|BEFORE|2021-09-04
Study ID|CE|94d170c2-fc3e-45f0-869b-471e4f0c613a|1|[?]|[?]|MODERATE|1|SCREENING|2022-02-24|2021-12-10|2022-02-27|176|100|179|BEFORE|2022-03-11|AFTER|2022-05-15
Study ID|CE|94d170c2-fc3e-45f0-869b-471e4f0c613a|2|[?]|[?]|SEVERE|6|TREATMENT|2022-01-12|2021-12-28|2022-06-01|133|118|273|BEFORE|2022-02-21|AFTER|2022-02-22
Study ID|CE|9a166b73-8cb2-43fa-aeab-7d2ef06fe7e7|1|[?]|[?]|SEVERE|5|WASHOUT|2022-04-15|2021-09-05|2022-04-23|236|14|244|UNKNOWN|2022-05-09|AFTER|2022-06-11
Study ID|CE|9a166b73-8cb2-43fa-aeab-7d2ef06fe7e7|2|[?]|[?]|MODERATE|6|TREATMENT|2022-03-02|2021-12-09|2022-05-16|192|109|267|AFTER|2021-09-28|AFTER|2021-10-16
Study ID|CE|a04b7049-49aa-4c99-8705-4962cad4040a|1|[?]|[?]|SEVERE|5|WASHOUT|2022-04-11|2022-01-27|2022-05-01|236|162|256|COINCIDENT|2021-12-13|BEFORE|2021-12-15
Study ID|CE|a04b7049-49aa-4c99-8705-4962cad4040a|2|[?]|[?]|SEVERE|2|TREATMENT|2021-11-28|2021-09-27|2022-05-13|102|40|268|BEFORE|2021-10-19|ONGOING|2021-10-24
Study ID|CE|3cf1a0ae-c84b-47be-a432-b5e4293bfc26|1|[?]|[?]|MILD|3|WASHOUT|2021-11-22|2021-10-21|2022-04-21|44|12|194|UNKNOWN|2021-12-20|AFTER|2021-12-29
Study ID|CE|3cf1a0ae-c84b-47be-a432-b5e4293bfc26|2|[?]|[?]|MODERATE|5|WASHOUT|2022-01-14|2021-12-25|2022-04-28|97|77|201|AFTER|2021-12-25|BEFORE|2022-02-09
Study ID|CE|9819ea3f-0f7d-4e01-8c85-c9aa2db89060|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-10|2022-02-20|2022-07-03|264|154|287|COINCIDENT|2022-03-03|ONGOING|2022-03-08
Study ID|CE|9819ea3f-0f7d-4e01-8c85-c9aa2db89060|2|[?]|[?]|MILD|1|SCREENING|2021-11-20|2021-10-21|2022-03-04|62|32|166|COINCIDENT|2022-06-30|AFTER|2022-07-01
Study ID|CE|31705791-d8b5-4b87-9a86-b3e24475463d|1|[?]|[?]|SEVERE|3|WASHOUT|2022-02-22|2021-09-17|2022-06-09|172|14|279|UNKNOWN|2022-03-01|ONGOING|2022-03-16
Study ID|CE|31705791-d8b5-4b87-9a86-b3e24475463d|2|[?]|[?]|SEVERE|5|WASHOUT|2022-04-16|2021-11-30|2022-04-18|225|88|227|BEFORE|2021-11-21|ONGOING|2021-11-29
Study ID|CE|aafbdfe9-c0bf-4729-98b5-6d4a48cd0100|1|[?]|[?]|MODERATE|4|TREATMENT|2022-05-07|2022-04-14|2022-05-29|192|169|214|UNKNOWN|2022-04-02|BEFORE|2022-04-20
Study ID|CE|aafbdfe9-c0bf-4729-98b5-6d4a48cd0100|2|[?]|[?]|SEVERE|1|SCREENING|2021-10-31|2021-10-29|2022-05-24|4|2|209|AFTER|2022-01-26|ONGOING|2022-02-04
Study ID|CE|52373cda-1ccf-427a-baea-1fa13a0a431c|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-01-17|2021-11-27|2022-05-02|141|90|246|BEFORE|2022-03-05|AFTER|2022-03-08
Study ID|CE|52373cda-1ccf-427a-baea-1fa13a0a431c|2|[?]|[?]|MODERATE|6|TREATMENT|2022-01-09|2021-09-04|2022-04-16|133|6|230|BEFORE|2022-05-29|AFTER|2022-05-30
Study ID|CE|609f31d1-1a82-4f98-acb3-4d6674d56ada|1|[?]|[?]|MILD|2|TREATMENT|2021-09-30|2021-09-29|2022-07-17|9|8|299|BEFORE|2022-05-01|COINCIDENT|2022-05-02
Study ID|CE|609f31d1-1a82-4f98-acb3-4d6674d56ada|2|[?]|[?]|MILD|3|WASHOUT|2022-04-19|2022-03-24|2022-06-07|210|184|259|COINCIDENT|2021-11-28|COINCIDENT|2021-12-04
Study ID|CE|8fcf9829-8812-434a-a31d-123cbbacbdf5|1|[?]|[?]|MILD|3|WASHOUT|2022-03-24|2021-10-28|2022-08-02|159|12|290|BEFORE|2021-11-27|BEFORE|2021-12-01
Study ID|CE|8fcf9829-8812-434a-a31d-123cbbacbdf5|2|[?]|[?]|MILD|3|WASHOUT|2021-12-13|2021-11-05|2022-01-31|58|20|107|BEFORE|2022-01-07|ONGOING|2022-01-11
Study ID|CE|a259b1eb-481b-4ef5-8509-c110c0aec4f9|1|[?]|[?]|MODERATE|3|WASHOUT|2022-02-14|2021-10-06|2022-04-11|142|11|198|BEFORE|2022-06-11|COINCIDENT|2022-06-17
Study ID|CE|a259b1eb-481b-4ef5-8509-c110c0aec4f9|2|[?]|[?]|MODERATE|1|SCREENING|2022-04-04|2021-11-30|2022-07-06|191|66|284|COINCIDENT|2022-03-29|AFTER|2022-04-04
Study ID|CE|1cf3ce30-295f-4ff8-8556-2fe8cb8b0bc7|1|[?]|[?]|SEVERE|5|WASHOUT|2021-10-02|2021-09-28|2022-05-30|25|21|265|UNKNOWN|2021-12-25|AFTER|2021-12-26
Study ID|CE|1cf3ce30-295f-4ff8-8556-2fe8cb8b0bc7|2|[?]|[?]|MODERATE|1|SCREENING|2021-12-26|2021-10-20|2022-01-03|110|43|118|COINCIDENT|2022-05-02|AFTER|2022-06-11
Study ID|CE|28e37863-8010-4475-a326-ca687a0b1c77|1|[?]|[?]|MODERATE|1|SCREENING|2021-10-24|2021-10-04|2022-05-20|22|2|230|BEFORE|2022-03-04|COINCIDENT|2022-03-17
Study ID|CE|28e37863-8010-4475-a326-ca687a0b1c77|2|[?]|[?]|MILD|5|WASHOUT|2022-07-01|2022-05-06|2022-07-04|272|216|275|UNKNOWN|2022-04-21|ONGOING|2022-04-26
Study ID|CE|e59eba09-9366-4808-b6df-5d6974f6ff34|1|[?]|[?]|SEVERE|2|TREATMENT|2022-01-31|2022-01-05|2022-06-04|171|145|295|COINCIDENT|2021-08-24|AFTER|2021-08-28
Study ID|CE|e59eba09-9366-4808-b6df-5d6974f6ff34|2|[?]|[?]|MILD|1|SCREENING|2022-01-14|2021-10-11|2022-05-09|154|59|269|BEFORE|2021-12-23|BEFORE|2021-12-29
Study ID|CE|61d5efed-8673-4e45-8d71-455182e69f36|1|[?]|[?]|MODERATE|4|TREATMENT|2022-02-01|2021-12-01|2022-06-09|132|70|260|COINCIDENT|2022-04-12|BEFORE|2022-04-14
Study ID|CE|61d5efed-8673-4e45-8d71-455182e69f36|2|[?]|[?]|MODERATE|5|WASHOUT|2022-04-23|2022-04-10|2022-04-28|213|200|218|COINCIDENT|2022-01-14|COINCIDENT|2022-01-15
Study ID|CE|93cb4676-6d85-47d2-8abe-9e2894c1988e|1|[?]|[?]|MILD|2|TREATMENT|2022-06-07|2021-10-30|2022-07-09|263|43|295|AFTER|2022-04-20|ONGOING|2022-04-24
Study ID|CE|93cb4676-6d85-47d2-8abe-9e2894c1988e|2|[?]|[?]|MILD|6|TREATMENT|2022-03-19|2021-12-08|2022-04-22|183|82|217|UNKNOWN|2022-01-31|COINCIDENT|2022-02-09
Study ID|CE|0230d010-e393-4a25-9d74-1f04f04a62f4|1|[?]|[?]|MILD|6|TREATMENT|2022-04-06|2022-01-03|2022-05-28|220|127|272|COINCIDENT|2021-12-24|COINCIDENT|2021-12-25
Study ID|CE|0230d010-e393-4a25-9d74-1f04f04a62f4|2|[?]|[?]|MODERATE|1|SCREENING|2022-04-07|2021-10-03|2022-04-25|221|35|239|BEFORE|2021-11-02|ONGOING|2021-11-09
Study ID|CE|98dc4659-5b52-461c-b74a-a9475a5a5d6a|1|[?]|[?]|MILD|5|WASHOUT|2021-10-28|2021-10-18|2022-04-01|69|59|224|COINCIDENT|2022-01-08|ONGOING|2022-01-12
Study ID|CE|98dc4659-5b52-461c-b74a-a9475a5a5d6a|2|[?]|[?]|MILD|6|TREATMENT|2022-06-11|2021-11-05|2022-06-12|295|77|296|UNKNOWN|2021-11-06|AFTER|2021-12-21
Study ID|CE|36277ed8-38e6-4056-b51d-928ec80926e7|1|[?]|[?]|MODERATE|5|WASHOUT|2022-03-01|2021-12-28|2022-03-08|195|132|202|BEFORE|2022-03-07|AFTER|2022-03-30
Study ID|CE|36277ed8-38e6-4056-b51d-928ec80926e7|2|[?]|[?]|MODERATE|1|SCREENING|2021-08-27|2021-08-22|2021-11-05|9|4|79|BEFORE|2021-10-01|AFTER|2021-10-29
Study ID|CE|0d0321a6-ccd7-468b-963d-27c9faef7f5e|1|[?]|[?]|SEVERE|5|WASHOUT|2022-02-21|2021-10-15|2022-05-10|155|26|233|UNKNOWN|2021-11-05|COINCIDENT|2021-11-06
Study ID|CE|0d0321a6-ccd7-468b-963d-27c9faef7f5e|2|[?]|[?]|MILD|2|TREATMENT|2022-03-15|2022-02-21|2022-04-03|177|155|196|AFTER|2022-01-05|COINCIDENT|2022-01-27
Study ID|CE|73c43d89-0f5f-41fc-8b2f-123abce98d5f|1|[?]|[?]|SEVERE|6|TREATMENT|2022-07-08|2022-05-05|2022-07-30|259|195|281|COINCIDENT|2022-04-17|BEFORE|2022-04-18
Study ID|CE|73c43d89-0f5f-41fc-8b2f-123abce98d5f|2|[?]|[?]|MILD|3|WASHOUT|2022-07-03|2022-04-23|2022-07-10|254|183|261|UNKNOWN|2021-12-12|COINCIDENT|2022-04-20
Study ID|CE|6f8b89c1-09b9-45a1-ad04-191a1d7b31d9|1|[?]|[?]|SEVERE|3|WASHOUT|2021-09-01|2021-08-10|2022-02-16|26|4|194|BEFORE|2021-11-26|ONGOING|2022-01-20
Study ID|CE|6f8b89c1-09b9-45a1-ad04-191a1d7b31d9|2|[?]|[?]|SEVERE|4|TREATMENT|2021-11-02|2021-10-30|2021-12-31|88|85|147|BEFORE|2022-02-22|AFTER|2022-03-30
Study ID|CE|380a12da-1c9d-436f-920e-574406d171fe|1|[?]|[?]|MILD|3|WASHOUT|2021-09-28|2021-09-15|2021-11-27|20|7|80|COINCIDENT|2021-10-07|BEFORE|2021-10-09
Study ID|CE|380a12da-1c9d-436f-920e-574406d171fe|2|[?]|[?]|MODERATE|2|TREATMENT|2022-02-25|2022-01-17|2022-03-03|170|131|176|BEFORE|2022-03-10|AFTER|2022-03-30
Study ID|CE|a9d6d2e3-38a5-47ca-bbb9-c0e41e8432b7|1|[?]|[?]|MILD|3|WASHOUT|2022-05-01|2021-12-01|2022-05-13|241|90|253|BEFORE|2022-01-31|COINCIDENT|2022-02-03
Study ID|CE|a9d6d2e3-38a5-47ca-bbb9-c0e41e8432b7|2|[?]|[?]|MILD|5|WASHOUT|2022-01-09|2021-10-31|2022-01-22|129|59|142|AFTER|2022-03-01|BEFORE|2022-03-09
Study ID|CE|c9483c30-fed5-45b9-85cf-299559cd97b7|1|[?]|[?]|MODERATE|4|TREATMENT|2021-11-14|2021-09-08|2022-04-02|94|27|233|AFTER|2022-04-30|BEFORE|2022-05-02
Study ID|CE|c9483c30-fed5-45b9-85cf-299559cd97b7|2|[?]|[?]|MODERATE|1|SCREENING|2021-12-28|2021-12-02|2022-01-12|138|112|153|AFTER|2021-08-21|COINCIDENT|2021-08-24
Study ID|CE|70b6a549-03e7-415f-9af2-ab9183c1a78f|1|[?]|[?]|SEVERE|5|WASHOUT|2022-05-03|2021-11-24|2022-06-04|225|65|257|BEFORE|2021-10-26|ONGOING|2021-10-30
Study ID|CE|70b6a549-03e7-415f-9af2-ab9183c1a78f|2|[?]|[?]|MILD|1|SCREENING|2021-11-10|2021-10-03|2022-04-09|51|13|201|AFTER|2022-02-04|BEFORE|2022-02-06
Study ID|CE|f3c55f64-987f-4ab7-bb31-821dc6fc0d96|1|[?]|[?]|SEVERE|4|TREATMENT|2022-02-18|2021-12-05|2022-03-19|126|51|155|AFTER|2021-11-08|ONGOING|2021-11-12
Study ID|CE|f3c55f64-987f-4ab7-bb31-821dc6fc0d96|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-05-08|2022-01-18|2022-08-02|205|95|291|AFTER|2021-12-12|ONGOING|2022-02-04
Study ID|CE|ecc23866-885e-403c-bf01-5cce2a7c010f|1|[?]|[?]|SEVERE|4|TREATMENT|2021-10-24|2021-10-24|2022-07-01|2|2|252|BEFORE|2021-11-17|ONGOING|2022-03-03
Study ID|CE|ecc23866-885e-403c-bf01-5cce2a7c010f|2|[?]|[?]|SEVERE|4|TREATMENT|2022-02-04|2022-01-28|2022-05-01|105|98|191|UNKNOWN|2022-05-29|BEFORE|2022-06-27
Study ID|CE|665c979c-d076-44e0-9f76-4869bc22b09e|1|[?]|[?]|MILD|4|TREATMENT|2021-12-28|2021-11-13|2022-05-19|101|56|243|UNKNOWN|2022-02-19|COINCIDENT|2022-03-07
Study ID|CE|665c979c-d076-44e0-9f76-4869bc22b09e|2|[?]|[?]|SEVERE|2|TREATMENT|2021-12-24|2021-11-10|2022-01-02|97|53|106|BEFORE|2022-02-02|BEFORE|2022-02-03
Study ID|CE|1533f51f-0564-49ad-bf8c-472538fa03a4|1|[?]|[?]|SEVERE|2|TREATMENT|2021-12-22|2021-11-23|2022-05-15|95|66|239|BEFORE|2021-12-15|ONGOING|2022-01-18
Study ID|CE|1533f51f-0564-49ad-bf8c-472538fa03a4|2|[?]|[?]|MODERATE|2|TREATMENT|2022-02-07|2021-11-28|2022-04-09|142|71|203|UNKNOWN|2021-11-21|AFTER|2021-11-22
Study ID|CE|d15001d4-14c3-440c-bac4-6fb4414fb410|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-04-04|2021-12-13|2022-07-19|169|57|275|BEFORE|2022-03-27|AFTER|2022-04-03
Study ID|CE|d15001d4-14c3-440c-bac4-6fb4414fb410|2|[?]|[?]|MODERATE|5|WASHOUT|2022-07-07|2022-06-03|2022-07-28|263|229|284|COINCIDENT|2022-03-03|ONGOING|2022-03-16
Study ID|CE|9b8601b3-75d2-47ad-8256-b10ee9e99123|1|[?]|[?]|MILD|6|TREATMENT|2021-12-31|2021-12-19|2022-06-16|81|69|248|UNKNOWN|2021-12-02|AFTER|2021-12-24
Study ID|CE|9b8601b3-75d2-47ad-8256-b10ee9e99123|2|[?]|[?]|MILD|4|TREATMENT|2021-10-23|2021-10-19|2022-04-22|12|8|193|BEFORE|2021-11-03|COINCIDENT|2021-11-21
Study ID|CE|dc90d8f8-a9d3-4869-8b00-9a75bcc1e302|1|[?]|[?]|SEVERE|1|SCREENING|2022-02-06|2021-12-18|2022-04-26|167|117|246|COINCIDENT|2022-01-23|BEFORE|2022-01-27
Study ID|CE|dc90d8f8-a9d3-4869-8b00-9a75bcc1e302|2|[?]|[?]|MODERATE|2|TREATMENT|2022-04-16|2022-03-27|2022-06-16|236|216|297|COINCIDENT|2022-01-15|COINCIDENT|2022-03-23
Study ID|CE|1f338414-9f49-4dec-bcc2-a20311ab653a|1|[?]|[?]|SEVERE|2|TREATMENT|2022-02-23|2021-12-10|2022-07-16|153|78|296|AFTER|2022-01-09|COINCIDENT|2022-01-10
Study ID|CE|1f338414-9f49-4dec-bcc2-a20311ab653a|2|[?]|[?]|SEVERE|2|TREATMENT|2022-06-06|2021-09-29|2022-07-14|256|6|294|COINCIDENT|2022-01-22|COINCIDENT|2022-01-24
Study ID|CE|12728dc0-3f6a-4d2c-b396-b6bcdb2927d1|1|[?]|[?]|MILD|3|WASHOUT|2022-01-06|2021-09-13|2022-04-07|133|18|224|BEFORE|2022-03-22|BEFORE|2022-04-04
Study ID|CE|12728dc0-3f6a-4d2c-b396-b6bcdb2927d1|2|[?]|[?]|MILD|3|WASHOUT|2022-02-04|2021-10-11|2022-02-15|162|46|173|COINCIDENT|2022-01-05|COINCIDENT|2022-04-25
Study ID|CE|24a85a44-fd7a-45d8-bcb5-cf65e095b4e5|1|[?]|[?]|MODERATE|5|WASHOUT|2022-08-06|2022-07-04|2022-08-07|296|263|297|UNKNOWN|2021-11-15|COINCIDENT|2021-11-18
Study ID|CE|24a85a44-fd7a-45d8-bcb5-cf65e095b4e5|2|[?]|[?]|SEVERE|2|TREATMENT|2022-02-09|2022-01-17|2022-06-22|118|95|251|UNKNOWN|2021-11-19|COINCIDENT|2021-12-07
Study ID|CE|7dcec4d6-6b65-4340-8f44-54730c0671f4|1|[?]|[?]|MODERATE|3|WASHOUT|2021-12-17|2021-11-06|2022-03-28|92|51|193|AFTER|2021-11-17|COINCIDENT|2021-12-14
Study ID|CE|7dcec4d6-6b65-4340-8f44-54730c0671f4|2|[?]|[?]|MODERATE|6|TREATMENT|2022-05-15|2022-04-28|2022-06-24|241|224|281|UNKNOWN|2022-05-08|ONGOING|2022-05-16
Study ID|CE|129a67f2-3c33-4322-9257-08f9b1b2adb5|1|[?]|[?]|SEVERE|1|SCREENING|2021-10-18|2021-09-27|2022-06-24|41|20|290|AFTER|2021-12-10|COINCIDENT|2021-12-11
Study ID|CE|129a67f2-3c33-4322-9257-08f9b1b2adb5|2|[?]|[?]|MILD|5|WASHOUT|2022-06-06|2022-04-28|2022-06-07|272|233|273|AFTER|2021-10-22|AFTER|2022-02-14
Study ID|CE|24cab1dd-d866-4de2-ab08-4d9242db328a|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-10-17|2021-10-14|2021-12-02|8|5|54|COINCIDENT|2022-03-31|AFTER|2022-06-19
Study ID|CE|24cab1dd-d866-4de2-ab08-4d9242db328a|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-06-26|2021-12-09|2022-07-01|260|61|265|AFTER|2022-02-24|AFTER|2022-02-25
Study ID|CE|bbbc30c5-fb5f-4424-90ce-32f90a80ea4a|1|[?]|[?]|SEVERE|1|SCREENING|2021-10-22|2021-08-30|2021-12-27|73|20|139|AFTER|2021-08-25|COINCIDENT|2021-08-27
Study ID|CE|bbbc30c5-fb5f-4424-90ce-32f90a80ea4a|2|[?]|[?]|MILD|6|TREATMENT|2021-10-18|2021-10-01|2022-01-27|69|52|170|BEFORE|2022-04-03|BEFORE|2022-04-06
Study ID|CE|1ca6d30a-3042-4e3b-85bf-d07738068c8d|1|[?]|[?]|SEVERE|4|TREATMENT|2022-02-16|2021-10-06|2022-06-28|137|4|269|AFTER|2022-03-05|ONGOING|2022-03-08
Study ID|CE|1ca6d30a-3042-4e3b-85bf-d07738068c8d|2|[?]|[?]|MODERATE|2|TREATMENT|2021-12-10|2021-10-21|2022-06-16|69|19|257|AFTER|2022-03-31|COINCIDENT|2022-04-03
Study ID|CE|0ab2aea5-1905-4e6d-abfd-c1cfd6c3c6e0|1|[?]|[?]|MILD|5|WASHOUT|2022-06-17|2022-02-18|2022-08-15|232|113|291|UNKNOWN|2022-03-28|ONGOING|2022-05-24
Study ID|CE|0ab2aea5-1905-4e6d-abfd-c1cfd6c3c6e0|2|[?]|[?]|MODERATE|4|TREATMENT|2022-01-03|2021-11-15|2022-05-19|67|18|203|BEFORE|2022-02-18|AFTER|2022-04-03
Study ID|CE|d5e867a2-5911-4645-bbd0-df9f0d79d8bc|1|[?]|[?]|MODERATE|1|SCREENING|2022-07-11|2022-05-29|2022-07-14|294|251|297|BEFORE|2022-05-26|ONGOING|2022-06-14
Study ID|CE|d5e867a2-5911-4645-bbd0-df9f0d79d8bc|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-12-11|2021-11-22|2022-03-10|82|63|171|BEFORE|2022-03-03|AFTER|2022-03-21
Study ID|CE|7f7be32a-b13e-4866-a1c2-00da92af3f92|1|[?]|[?]|MILD|1|SCREENING|2021-12-07|2021-10-27|2022-02-28|51|10|134|UNKNOWN|2022-01-03|ONGOING|2022-01-04
Study ID|CE|7f7be32a-b13e-4866-a1c2-00da92af3f92|2|[?]|[?]|SEVERE|6|TREATMENT|2022-01-22|2021-12-03|2022-06-08|97|47|234|AFTER|2022-01-06|COINCIDENT|2022-01-26
Study ID|CE|8824d842-e09b-4dc2-96bd-080b228c8a6c|1|[?]|[?]|MODERATE|6|TREATMENT|2022-06-02|2022-01-06|2022-06-17|272|125|287|BEFORE|2021-10-20|ONGOING|2021-10-28
Study ID|CE|8824d842-e09b-4dc2-96bd-080b228c8a6c|2|[?]|[?]|MODERATE|2|TREATMENT|2022-01-23|2021-11-29|2022-04-23|142|87|232|UNKNOWN|2022-05-07|AFTER|2022-05-11
Study ID|CE|6f6d16b9-f088-4b48-a9d7-5620b38212f4|1|[?]|[?]|MODERATE|2|TREATMENT|2022-07-23|2022-05-04|2022-07-30|284|204|291|UNKNOWN|2022-01-12|ONGOING|2022-01-13
Study ID|CE|6f6d16b9-f088-4b48-a9d7-5620b38212f4|2|[?]|[?]|MODERATE|6|TREATMENT|2022-06-06|2022-04-13|2022-07-25|237|183|286|BEFORE|2021-11-30|BEFORE|2022-01-22
Study ID|CE|f5e4e708-55f2-4281-a8ed-b42ef27f6671|1|[?]|[?]|SEVERE|4|TREATMENT|2022-03-04|2022-01-21|2022-05-22|139|97|218|BEFORE|2022-03-05|COINCIDENT|2022-05-04
Study ID|CE|f5e4e708-55f2-4281-a8ed-b42ef27f6671|2|[?]|[?]|MILD|1|SCREENING|2021-11-01|2021-10-24|2022-06-18|16|8|245|UNKNOWN|2021-11-09|BEFORE|2021-11-13
Study ID|CE|2bc210d1-2103-45a9-912d-c3b940211dec|1|[?]|[?]|MILD|2|TREATMENT|2022-05-25|2022-05-01|2022-06-06|238|214|250|AFTER|2022-01-26|ONGOING|2022-01-29
Study ID|CE|2bc210d1-2103-45a9-912d-c3b940211dec|2|[?]|[?]|MILD|6|TREATMENT|2021-12-27|2021-12-15|2022-02-12|89|77|136|COINCIDENT|2021-11-29|ONGOING|2021-12-10
Study ID|CE|0f8419dd-1497-4496-8cd5-77cc5af2a2bb|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-04-16|2021-11-24|2022-05-09|225|82|248|BEFORE|2021-09-20|ONGOING|2021-09-21
Study ID|CE|0f8419dd-1497-4496-8cd5-77cc5af2a2bb|2|[?]|[?]|MILD|7|FOLLOW-UP|2021-09-25|2021-09-19|2021-12-29|22|16|117|AFTER|2021-12-13|COINCIDENT|2021-12-20
Study ID|CE|94ba310d-113e-45d2-a7f2-3bb52a0f83e6|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-01-30|2022-01-16|2022-02-16|152|138|169|UNKNOWN|2021-09-09|ONGOING|2021-10-07
Study ID|CE|94ba310d-113e-45d2-a7f2-3bb52a0f83e6|2|[?]|[?]|SEVERE|6|TREATMENT|2022-04-25|2022-03-22|2022-05-21|237|203|263|AFTER|2022-04-19|COINCIDENT|2022-04-20
Study ID|CE|cacf3cf3-3c48-423c-9b15-1563573b9e00|1|[?]|[?]|MODERATE|6|TREATMENT|2022-07-01|2022-04-11|2022-07-31|251|170|281|COINCIDENT|2022-05-06|ONGOING|2022-05-09
Study ID|CE|cacf3cf3-3c48-423c-9b15-1563573b9e00|2|[?]|[?]|SEVERE|6|TREATMENT|2022-05-30|2022-05-11|2022-07-30|219|200|280|UNKNOWN|2021-12-06|COINCIDENT|2021-12-07
Study ID|CE|98603ea2-3f67-4f4b-87f5-5b5705b3538d|1|[?]|[?]|MODERATE|6|TREATMENT|2022-07-14|2022-03-08|2022-07-17|286|158|289|UNKNOWN|2022-02-26|BEFORE|2022-02-27
Study ID|CE|98603ea2-3f67-4f4b-87f5-5b5705b3538d|2|[?]|[?]|MILD|2|TREATMENT|2021-10-20|2021-10-18|2021-11-07|19|17|37|UNKNOWN|2022-06-28|COINCIDENT|2022-06-29
Study ID|CE|bd3d322d-1da9-41ad-865e-f25599f98687|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-01-07|2021-12-31|2022-03-06|109|102|167|COINCIDENT|2022-06-18|AFTER|2022-06-21
Study ID|CE|bd3d322d-1da9-41ad-865e-f25599f98687|2|[?]|[?]|MODERATE|5|WASHOUT|2021-09-27|2021-09-24|2022-01-21|7|4|123|AFTER|2021-11-09|COINCIDENT|2021-11-14
Study ID|CE|eafb6349-037c-413d-a4d1-13d105700f04|1|[?]|[?]|MILD|2|TREATMENT|2022-03-04|2021-10-19|2022-06-16|185|49|289|BEFORE|2022-01-19|ONGOING|2022-01-26
Study ID|CE|eafb6349-037c-413d-a4d1-13d105700f04|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-03-25|2021-10-12|2022-06-21|206|42|294|AFTER|2021-10-19|BEFORE|2021-11-09
Study ID|CE|040ec88f-f136-4e8c-ab55-70d2f1d87728|1|[?]|[?]|MILD|2|TREATMENT|2021-11-05|2021-10-31|2021-12-03|60|55|88|AFTER|2021-11-25|BEFORE|2021-11-28
Study ID|CE|040ec88f-f136-4e8c-ab55-70d2f1d87728|2|[?]|[?]|SEVERE|5|WASHOUT|2022-03-07|2021-12-29|2022-03-09|182|114|184|UNKNOWN|2021-11-21|COINCIDENT|2021-11-30
Study ID|CE|3d2eaf49-98cb-450e-a0f4-8e188a3e9743|1|[?]|[?]|MODERATE|5|WASHOUT|2022-07-01|2021-11-25|2022-07-14|283|65|296|BEFORE|2021-12-04|COINCIDENT|2021-12-05
Study ID|CE|3d2eaf49-98cb-450e-a0f4-8e188a3e9743|2|[?]|[?]|SEVERE|2|TREATMENT|2022-02-01|2021-12-06|2022-03-15|133|76|175|COINCIDENT|2022-03-09|BEFORE|2022-04-03
Study ID|CE|9222e497-21a6-488c-b8a0-11f0fb12eaf3|1|[?]|[?]|MILD|7|FOLLOW-UP|2021-12-06|2021-10-26|2022-01-07|44|3|76|AFTER|2022-06-14|BEFORE|2022-07-07
Study ID|CE|9222e497-21a6-488c-b8a0-11f0fb12eaf3|2|[?]|[?]|MODERATE|2|TREATMENT|2022-08-05|2022-01-26|2022-08-14|286|95|295|COINCIDENT|2022-01-03|BEFORE|2022-01-09
Study ID|CE|573ab644-6f30-4f50-a499-22968a99d3db|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-02-08|2021-09-15|2022-06-04|168|22|284|COINCIDENT|2022-04-09|AFTER|2022-04-12
Study ID|CE|573ab644-6f30-4f50-a499-22968a99d3db|2|[?]|[?]|SEVERE|2|TREATMENT|2021-11-20|2021-10-22|2022-02-03|88|59|163|BEFORE|2021-10-01|AFTER|2021-10-08
Study ID|CE|9f896e27-284d-437c-9e61-a7b9b1e1dcc9|1|[?]|[?]|MODERATE|1|SCREENING|2022-07-14|2022-02-09|2022-08-08|271|116|296|UNKNOWN|2022-01-10|AFTER|2022-03-06
Study ID|CE|9f896e27-284d-437c-9e61-a7b9b1e1dcc9|2|[?]|[?]|MILD|3|WASHOUT|2021-10-18|2021-10-18|2022-01-21|2|2|97|BEFORE|2021-11-12|AFTER|2022-02-06
Study ID|CE|ac59aed4-fda2-4cf1-bb80-8075cb35b853|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-03-01|2021-10-05|2022-03-28|180|33|207|AFTER|2022-05-08|BEFORE|2022-05-10
Study ID|CE|ac59aed4-fda2-4cf1-bb80-8075cb35b853|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-06-01|2022-02-21|2022-06-07|272|172|278|AFTER|2021-12-20|COINCIDENT|2022-01-15
Study ID|CE|09a644bd-a8cd-45a1-bde7-2711c8f7be76|1|[?]|[?]|SEVERE|4|TREATMENT|2021-10-09|2021-09-16|2022-05-02|44|21|249|UNKNOWN|2021-09-13|AFTER|2021-09-15
Study ID|CE|09a644bd-a8cd-45a1-bde7-2711c8f7be76|2|[?]|[?]|MODERATE|1|SCREENING|2022-06-05|2021-09-16|2022-06-06|283|21|284|UNKNOWN|2022-05-04|BEFORE|2022-05-13
Study ID|CE|fb28d99b-b4af-4d3e-9b66-25f3a7ba0b60|1|[?]|[?]|MILD|6|TREATMENT|2022-01-11|2022-01-08|2022-04-30|87|84|196|AFTER|2021-12-06|COINCIDENT|2021-12-08
Study ID|CE|fb28d99b-b4af-4d3e-9b66-25f3a7ba0b60|2|[?]|[?]|MODERATE|4|TREATMENT|2021-11-22|2021-11-21|2021-12-06|37|36|51|BEFORE|2021-11-19|COINCIDENT|2022-01-12
Study ID|CE|953c03ac-2ac5-4419-80d4-8dfaa9d764ed|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-02-17|2021-10-07|2022-06-16|166|33|285|AFTER|2021-10-16|AFTER|2021-11-16
Study ID|CE|953c03ac-2ac5-4419-80d4-8dfaa9d764ed|2|[?]|[?]|SEVERE|3|WASHOUT|2021-09-19|2021-09-06|2021-10-28|15|2|54|BEFORE|2021-09-23|AFTER|2021-09-28
Study ID|CE|35dc4735-9b9c-4dc3-bbd6-c500edecd2e2|1|[?]|[?]|MILD|4|TREATMENT|2021-11-06|2021-09-18|2022-01-10|53|4|118|UNKNOWN|2022-06-16|COINCIDENT|2022-06-17
Study ID|CE|35dc4735-9b9c-4dc3-bbd6-c500edecd2e2|2|[?]|[?]|MODERATE|4|TREATMENT|2021-09-27|2021-09-21|2022-01-09|13|7|117|AFTER|2021-12-25|ONGOING|2022-01-07
Study ID|CE|68a9c486-1ea0-4faf-b116-0d99639f5ac0|1|[?]|[?]|MODERATE|5|WASHOUT|2021-12-16|2021-10-25|2022-01-28|60|8|103|AFTER|2022-04-29|BEFORE|2022-05-09
Study ID|CE|68a9c486-1ea0-4faf-b116-0d99639f5ac0|2|[?]|[?]|MILD|4|TREATMENT|2021-11-22|2021-11-21|2022-02-17|36|35|123|AFTER|2021-11-11|COINCIDENT|2021-11-12
Study ID|CE|0fef3c1c-47d7-420c-9130-7e4daf02e4a5|1|[?]|[?]|SEVERE|3|WASHOUT|2021-11-21|2021-10-11|2022-05-06|44|3|210|BEFORE|2021-12-15|AFTER|2022-01-10
Study ID|CE|0fef3c1c-47d7-420c-9130-7e4daf02e4a5|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-06-06|2022-05-27|2022-07-19|241|231|284|BEFORE|2022-05-27|COINCIDENT|2022-06-19
Study ID|CE|cb2a7cd4-3814-458f-8d9f-1d9d501a5493|1|[?]|[?]|SEVERE|1|SCREENING|2022-06-26|2021-12-06|2022-06-28|292|90|294|BEFORE|2021-12-27|ONGOING|2021-12-28
Study ID|CE|cb2a7cd4-3814-458f-8d9f-1d9d501a5493|2|[?]|[?]|MILD|6|TREATMENT|2022-03-29|2022-03-07|2022-04-29|203|181|234|AFTER|2022-01-12|AFTER|2022-03-28
Study ID|CE|fe5681d0-ae8f-4138-a471-b3987b3ecef2|1|[?]|[?]|MILD|2|TREATMENT|2022-08-14|2022-03-07|2022-08-15|299|139|300|COINCIDENT|2022-06-08|BEFORE|2022-06-22
Study ID|CE|fe5681d0-ae8f-4138-a471-b3987b3ecef2|2|[?]|[?]|MODERATE|3|WASHOUT|2021-11-08|2021-11-07|2022-04-13|20|19|176|COINCIDENT|2022-04-03|ONGOING|2022-06-24
Study ID|CE|78099927-98e6-481e-975c-6db28590527d|1|[?]|[?]|SEVERE|5|WASHOUT|2021-10-22|2021-08-17|2021-12-29|73|7|141|AFTER|2021-08-16|AFTER|2021-08-19
Study ID|CE|78099927-98e6-481e-975c-6db28590527d|2|[?]|[?]|SEVERE|2|TREATMENT|2022-02-25|2021-10-10|2022-03-01|199|61|203|UNKNOWN|2021-11-10|COINCIDENT|2021-11-20
Study ID|CE|63867bf1-8945-43c8-9889-45315844a1ba|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-11-16|2021-10-07|2021-12-16|77|37|107|COINCIDENT|2022-02-17|AFTER|2022-02-18
Study ID|CE|63867bf1-8945-43c8-9889-45315844a1ba|2|[?]|[?]|MILD|7|FOLLOW-UP|2021-10-17|2021-10-08|2022-02-09|47|38|162|COINCIDENT|2022-06-15|ONGOING|2022-06-18
Study ID|CE|746358fc-dc62-47e8-840d-c41f56096bf1|1|[?]|[?]|SEVERE|3|WASHOUT|2022-02-13|2021-10-26|2022-05-28|147|37|251|AFTER|2022-04-12|BEFORE|2022-04-18
Study ID|CE|746358fc-dc62-47e8-840d-c41f56096bf1|2|[?]|[?]|MILD|1|SCREENING|2021-12-06|2021-11-15|2021-12-24|78|57|96|BEFORE|2021-10-16|AFTER|2022-01-02
Study ID|CE|bba7936a-2e13-460c-b5d6-4e05d61ff34e|1|[?]|[?]|MODERATE|1|SCREENING|2022-02-07|2021-10-08|2022-06-04|179|57|296|BEFORE|2022-02-13|BEFORE|2022-02-14
Study ID|CE|bba7936a-2e13-460c-b5d6-4e05d61ff34e|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-03-14|2022-01-17|2022-04-19|214|158|250|UNKNOWN|2021-08-19|COINCIDENT|2021-08-19
Study ID|CE|4913facb-a897-4a54-bf00-03e8de26dea9|1|[?]|[?]|SEVERE|6|TREATMENT|2022-01-05|2021-12-08|2022-07-30|87|59|293|AFTER|2021-11-05|COINCIDENT|2021-11-06
Study ID|CE|4913facb-a897-4a54-bf00-03e8de26dea9|2|[?]|[?]|MODERATE|5|WASHOUT|2022-04-17|2022-02-26|2022-04-27|189|139|199|COINCIDENT|2021-10-27|AFTER|2021-10-29
Study ID|CE|b9fc69bf-5074-43b3-bb5b-ef5a9274bb9f|1|[?]|[?]|MILD|6|TREATMENT|2021-11-06|2021-11-01|2022-05-28|17|12|220|AFTER|2021-11-02|ONGOING|2021-11-03
Study ID|CE|b9fc69bf-5074-43b3-bb5b-ef5a9274bb9f|2|[?]|[?]|MILD|2|TREATMENT|2022-02-04|2022-01-25|2022-05-07|107|97|199|UNKNOWN|2021-11-16|BEFORE|2021-11-20
Study ID|CE|18d9c429-a7fa-484d-8ad1-aff9c485ccd5|1|[?]|[?]|MODERATE|4|TREATMENT|2022-01-10|2021-12-10|2022-04-13|109|78|202|AFTER|2021-11-05|ONGOING|2021-11-19
Study ID|CE|18d9c429-a7fa-484d-8ad1-aff9c485ccd5|2|[?]|[?]|SEVERE|5|WASHOUT|2022-03-18|2022-01-09|2022-06-15|176|108|265|BEFORE|2021-10-19|ONGOING|2021-11-01
Study ID|CE|f96f2f97-2dde-4b49-92d6-e2318b5b8dd6|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-08-26|2021-08-19|2021-09-21|20|13|46|COINCIDENT|2021-12-21|ONGOING|2021-12-30
Study ID|CE|f96f2f97-2dde-4b49-92d6-e2318b5b8dd6|2|[?]|[?]|MODERATE|3|WASHOUT|2021-10-15|2021-10-11|2022-05-15|70|66|282|UNKNOWN|2021-08-24|BEFORE|2021-09-04
Study ID|CE|9aa605b0-f301-4a30-a77f-b8ea80c5404e|1|[?]|[?]|MILD|1|SCREENING|2022-01-10|2021-11-10|2022-08-18|75|14|295|COINCIDENT|2021-12-15|ONGOING|2022-03-11
Study ID|CE|9aa605b0-f301-4a30-a77f-b8ea80c5404e|2|[?]|[?]|SEVERE|2|TREATMENT|2022-03-07|2021-11-04|2022-04-07|131|8|162|BEFORE|2022-05-05|BEFORE|2022-05-05
Study ID|CE|7d3a3c79-4678-477a-a2e4-006e877825e9|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-03-13|2021-11-27|2022-05-18|149|43|215|BEFORE|2022-02-14|BEFORE|2022-03-22
Study ID|CE|7d3a3c79-4678-477a-a2e4-006e877825e9|2|[?]|[?]|MODERATE|1|SCREENING|2022-04-20|2021-12-14|2022-07-09|187|60|267|BEFORE|2022-06-05|COINCIDENT|2022-06-06
Study ID|CE|c1890918-1c35-4e9c-91c4-3eda13542117|1|[?]|[?]|MODERATE|2|TREATMENT|2021-12-13|2021-10-09|2022-07-07|83|18|289|UNKNOWN|2021-11-14|BEFORE|2021-11-17
Study ID|CE|c1890918-1c35-4e9c-91c4-3eda13542117|2|[?]|[?]|MODERATE|3|WASHOUT|2021-10-29|2021-09-24|2022-06-05|38|3|257|BEFORE|2022-01-16|ONGOING|2022-01-22
Study ID|CE|0c945d4a-80ce-4068-861c-44af5f738490|1|[?]|[?]|MILD|3|WASHOUT|2022-07-12|2022-04-09|2022-07-13|294|200|295|BEFORE|2022-06-01|BEFORE|2022-06-02
Study ID|CE|0c945d4a-80ce-4068-861c-44af5f738490|2|[?]|[?]|MODERATE|3|WASHOUT|2022-02-11|2021-12-28|2022-06-23|143|98|275|AFTER|2022-03-06|BEFORE|2022-04-04
Study ID|CE|e79af959-1fd9-4849-9443-43591b71e62a|1|[?]|[?]|MILD|2|TREATMENT|2022-03-27|2022-03-05|2022-06-14|162|140|241|COINCIDENT|2022-03-10|ONGOING|2022-03-21
Study ID|CE|e79af959-1fd9-4849-9443-43591b71e62a|2|[?]|[?]|SEVERE|4|TREATMENT|2022-01-16|2021-12-04|2022-06-16|92|49|243|UNKNOWN|2022-02-22|AFTER|2022-03-04
Study ID|CE|4d43d548-e243-4110-952f-14ada154970c|1|[?]|[?]|SEVERE|6|TREATMENT|2022-01-22|2021-11-17|2022-01-25|110|44|113|UNKNOWN|2022-01-26|ONGOING|2022-01-27
Study ID|CE|4d43d548-e243-4110-952f-14ada154970c|2|[?]|[?]|SEVERE|2|TREATMENT|2022-04-30|2022-03-03|2022-05-29|208|150|237|AFTER|2022-01-07|COINCIDENT|2022-01-30
Study ID|CE|30320185-e97c-4242-ae4d-cb24611b7750|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-09-25|2021-08-30|2022-04-02|34|8|223|BEFORE|2021-11-13|BEFORE|2021-11-17
Study ID|CE|30320185-e97c-4242-ae4d-cb24611b7750|2|[?]|[?]|MILD|7|FOLLOW-UP|2021-12-07|2021-10-30|2021-12-09|107|69|109|BEFORE|2022-01-12|BEFORE|2022-04-20
Study ID|CE|5d0127ff-c151-45eb-b3b7-926bfe449838|1|[?]|[?]|SEVERE|2|TREATMENT|2021-10-10|2021-09-26|2022-01-18|28|14|128|COINCIDENT|2022-02-05|COINCIDENT|2022-02-09
Study ID|CE|5d0127ff-c151-45eb-b3b7-926bfe449838|2|[?]|[?]|MILD|3|WASHOUT|2021-10-31|2021-10-24|2022-01-05|49|42|115|COINCIDENT|2022-04-23|ONGOING|2022-04-24
Study ID|CE|25c04c0b-c392-474c-a3d5-82711041ca1e|1|[?]|[?]|MILD|3|WASHOUT|2022-03-11|2022-01-29|2022-03-30|135|94|154|COINCIDENT|2022-02-25|BEFORE|2022-03-30
Study ID|CE|25c04c0b-c392-474c-a3d5-82711041ca1e|2|[?]|[?]|MODERATE|1|SCREENING|2021-11-22|2021-11-12|2022-08-08|26|16|285|UNKNOWN|2022-04-13|BEFORE|2022-06-06
Study ID|CE|bcceaae7-1012-4528-be14-489633f52157|1|[?]|[?]|MODERATE|6|TREATMENT|2022-04-07|2021-11-17|2022-05-15|224|83|262|BEFORE|2021-09-08|COINCIDENT|2021-09-09
Study ID|CE|bcceaae7-1012-4528-be14-489633f52157|2|[?]|[?]|MILD|5|WASHOUT|2022-03-25|2022-01-17|2022-05-01|211|144|248|AFTER|2022-05-13|BEFORE|2022-05-24
Study ID|CE|8c6ca613-79a4-447f-89e4-ea0774da639c|1|[?]|[?]|SEVERE|1|SCREENING|2022-04-03|2022-02-20|2022-05-28|216|174|271|AFTER|2021-09-08|COINCIDENT|2021-09-09
Study ID|CE|8c6ca613-79a4-447f-89e4-ea0774da639c|2|[?]|[?]|MODERATE|1|SCREENING|2022-02-04|2021-12-16|2022-05-22|158|108|265|BEFORE|2022-04-21|COINCIDENT|2022-04-24
Study ID|CE|cec457ac-fa41-4b67-9fd8-f0754d6c23a1|1|[?]|[?]|MILD|5|WASHOUT|2022-06-13|2022-01-18|2022-06-15|291|145|293|COINCIDENT|2022-05-16|ONGOING|2022-06-01
Study ID|CE|cec457ac-fa41-4b67-9fd8-f0754d6c23a1|2|[?]|[?]|SEVERE|2|TREATMENT|2022-02-12|2022-01-20|2022-05-03|170|147|250|AFTER|2021-11-07|ONGOING|2021-11-08
Study ID|CE|b162843c-5086-4bd5-ae65-072fb1dc8140|1|[?]|[?]|SEVERE|1|SCREENING|2022-04-25|2021-09-13|2022-06-09|239|15|284|BEFORE|2021-11-14|BEFORE|2021-11-22
Study ID|CE|b162843c-5086-4bd5-ae65-072fb1dc8140|2|[?]|[?]|MODERATE|2|TREATMENT|2022-06-13|2021-11-05|2022-06-23|288|68|298|COINCIDENT|2021-11-16|ONGOING|2021-11-28
Study ID|CE|eb87675c-9d36-455b-b08d-3ff38da1bdcf|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-06-09|2022-03-05|2022-07-11|227|131|259|COINCIDENT|2022-03-01|BEFORE|2022-03-03
Study ID|CE|eb87675c-9d36-455b-b08d-3ff38da1bdcf|2|[?]|[?]|MODERATE|5|WASHOUT|2022-07-29|2021-12-30|2022-08-03|277|66|282|COINCIDENT|2022-02-08|AFTER|2022-02-26
Study ID|CE|db09cf52-bd36-44dd-ae61-446ebfe27d96|1|[?]|[?]|MILD|5|WASHOUT|2021-11-07|2021-10-14|2021-12-01|55|31|79|UNKNOWN|2022-04-28|COINCIDENT|2022-04-30
Study ID|CE|db09cf52-bd36-44dd-ae61-446ebfe27d96|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-05-11|2022-01-21|2022-05-16|240|130|245|COINCIDENT|2021-12-11|COINCIDENT|2021-12-15
Study ID|CE|81ac7f9e-c4d4-46e2-8539-0ad8ad46df96|1|[?]|[?]|MILD|3|WASHOUT|2022-01-28|2021-12-14|2022-06-21|142|97|286|UNKNOWN|2021-09-20|COINCIDENT|2021-09-21
Study ID|CE|81ac7f9e-c4d4-46e2-8539-0ad8ad46df96|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-12-05|2021-10-21|2022-02-21|88|43|166|COINCIDENT|2022-01-21|ONGOING|2022-03-12
Study ID|CE|c7bcaf1a-6382-4247-ba8f-1b2eab6a072f|1|[?]|[?]|MILD|6|TREATMENT|2022-03-28|2021-11-20|2022-04-15|159|31|177|COINCIDENT|2022-03-21|ONGOING|2022-04-01
Study ID|CE|c7bcaf1a-6382-4247-ba8f-1b2eab6a072f|2|[?]|[?]|SEVERE|3|WASHOUT|2022-03-10|2022-02-16|2022-05-18|141|119|210|COINCIDENT|2021-10-28|COINCIDENT|2021-10-29
Study ID|CE|05997ac8-3c85-45ab-aae5-2fa752d4dcbb|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-09-25|2021-09-02|2021-12-08|47|24|121|BEFORE|2021-09-22|BEFORE|2021-11-13
Study ID|CE|05997ac8-3c85-45ab-aae5-2fa752d4dcbb|2|[?]|[?]|MILD|4|TREATMENT|2022-02-06|2021-09-24|2022-05-30|181|46|294|BEFORE|2022-02-10|ONGOING|2022-04-04
Study ID|CE|615e5774-576d-4bf2-bf4a-d037187fc9dc|1|[?]|[?]|MILD|1|SCREENING|2022-05-11|2022-04-15|2022-06-12|259|233|291|AFTER|2022-04-24|ONGOING|2022-04-25
Study ID|CE|615e5774-576d-4bf2-bf4a-d037187fc9dc|2|[?]|[?]|SEVERE|4|TREATMENT|2022-04-23|2021-10-04|2022-06-17|241|40|296|BEFORE|2021-10-28|ONGOING|2021-10-30
Study ID|CE|4b45ad63-686b-48d9-a170-e68e3986e094|1|[?]|[?]|MILD|6|TREATMENT|2022-04-22|2022-02-23|2022-06-07|197|139|243|BEFORE|2021-11-22|BEFORE|2021-11-23
Study ID|CE|4b45ad63-686b-48d9-a170-e68e3986e094|2|[?]|[?]|MODERATE|1|SCREENING|2022-03-12|2022-01-03|2022-05-10|156|88|215|COINCIDENT|2022-02-15|ONGOING|2022-02-19
Study ID|CE|de28132b-7820-42e2-b6ed-73122f687503|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-04-29|2022-02-26|2022-06-11|204|142|247|UNKNOWN|2021-12-18|COINCIDENT|2021-12-19
Study ID|CE|de28132b-7820-42e2-b6ed-73122f687503|2|[?]|[?]|SEVERE|2|TREATMENT|2022-03-05|2021-11-08|2022-04-24|149|32|199|AFTER|2022-01-11|BEFORE|2022-02-03
Study ID|CE|ddf32ab2-063e-4e0c-a39b-1b62fafcd9c0|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-01-31|2021-09-26|2022-04-23|141|14|223|AFTER|2022-04-24|AFTER|2022-05-05
Study ID|CE|ddf32ab2-063e-4e0c-a39b-1b62fafcd9c0|2|[?]|[?]|MILD|4|TREATMENT|2021-11-10|2021-11-02|2022-02-05|59|51|146|BEFORE|2022-05-01|COINCIDENT|2022-05-09
Study ID|CE|1012002b-2a83-4649-97a1-7abae8449749|1|[?]|[?]|MILD|1|SCREENING|2022-05-09|2021-10-09|2022-06-14|260|48|296|AFTER|2022-03-06|COINCIDENT|2022-03-22
Study ID|CE|1012002b-2a83-4649-97a1-7abae8449749|2|[?]|[?]|MODERATE|5|WASHOUT|2021-11-20|2021-10-02|2022-05-11|90|41|262|COINCIDENT|2022-04-04|ONGOING|2022-04-11
Study ID|CE|4f2dee02-6b3f-488e-aab1-9ae321997823|1|[?]|[?]|MILD|6|TREATMENT|2022-05-09|2022-02-24|2022-06-05|253|179|280|AFTER|2022-03-23|COINCIDENT|2022-04-01
Study ID|CE|4f2dee02-6b3f-488e-aab1-9ae321997823|2|[?]|[?]|MODERATE|4|TREATMENT|2022-02-07|2021-10-11|2022-03-23|162|43|206|UNKNOWN|2021-09-11|COINCIDENT|2021-09-12
Study ID|CE|b30d18a1-37bc-4b36-800a-dc7fef2b9121|1|[?]|[?]|MODERATE|3|WASHOUT|2022-02-22|2021-11-21|2022-06-29|168|75|295|BEFORE|2022-01-05|BEFORE|2022-01-18
Study ID|CE|b30d18a1-37bc-4b36-800a-dc7fef2b9121|2|[?]|[?]|MILD|6|TREATMENT|2022-06-28|2021-12-28|2022-07-02|294|112|298|AFTER|2022-04-13|BEFORE|2022-04-19
Study ID|CE|d1e3fd18-c1ac-471c-95fd-210c5f45c90f|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-06-11|2021-10-17|2022-06-30|271|34|290|COINCIDENT|2021-10-14|COINCIDENT|2021-10-17
Study ID|CE|d1e3fd18-c1ac-471c-95fd-210c5f45c90f|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-03-08|2021-10-03|2022-05-13|176|20|242|BEFORE|2022-01-08|BEFORE|2022-01-14
Study ID|CE|460242c7-6626-4d89-95d7-122a274cacbc|1|[?]|[?]|MODERATE|4|TREATMENT|2021-10-27|2021-10-16|2021-12-20|57|46|111|UNKNOWN|2021-12-08|COINCIDENT|2021-12-26
Study ID|CE|460242c7-6626-4d89-95d7-122a274cacbc|2|[?]|[?]|SEVERE|5|WASHOUT|2022-03-21|2022-01-04|2022-05-10|202|126|252|UNKNOWN|2021-11-28|AFTER|2021-12-03
Study ID|CE|80564fe6-89a7-48ca-970c-8fd6cfb2faa9|1|[?]|[?]|MODERATE|5|WASHOUT|2022-04-08|2021-12-18|2022-05-26|233|122|281|UNKNOWN|2021-10-19|ONGOING|2021-10-21
Study ID|CE|80564fe6-89a7-48ca-970c-8fd6cfb2faa9|2|[?]|[?]|SEVERE|1|SCREENING|2022-02-13|2022-01-22|2022-04-29|179|157|254|UNKNOWN|2021-11-10|AFTER|2021-11-22
Study ID|CE|a0290e05-7c42-4d9b-a5eb-c8ad65bcfd2b|1|[?]|[?]|MODERATE|3|WASHOUT|2022-01-22|2021-09-30|2022-04-05|140|26|213|COINCIDENT|2021-10-29|COINCIDENT|2021-11-16
Study ID|CE|a0290e05-7c42-4d9b-a5eb-c8ad65bcfd2b|2|[?]|[?]|MILD|2|TREATMENT|2022-06-05|2022-03-07|2022-06-29|274|184|298|COINCIDENT|2022-04-02|AFTER|2022-04-11
Study ID|CE|5a5ac5e2-564e-4cde-b25b-bf9a69399310|1|[?]|[?]|MODERATE|2|TREATMENT|2022-04-03|2021-12-21|2022-08-17|161|58|297|UNKNOWN|2021-11-16|BEFORE|2022-02-05
Study ID|CE|5a5ac5e2-564e-4cde-b25b-bf9a69399310|2|[?]|[?]|MODERATE|1|SCREENING|2021-11-05|2021-11-02|2022-04-09|12|9|167|COINCIDENT|2022-06-04|BEFORE|2022-06-06
Study ID|CE|bf7ab21f-d573-471a-9b64-2c0b952994dd|1|[?]|[?]|SEVERE|3|WASHOUT|2022-06-13|2021-10-02|2022-06-15|263|9|265|BEFORE|2022-06-06|COINCIDENT|2022-06-09
Study ID|CE|bf7ab21f-d573-471a-9b64-2c0b952994dd|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-06-10|2022-04-14|2022-07-12|260|203|292|BEFORE|2021-11-21|AFTER|2021-11-22
Study ID|CE|f7cfadf0-f78d-4548-ad04-8d37e6d031f1|1|[?]|[?]|MILD|2|TREATMENT|2022-02-16|2021-09-26|2022-04-25|160|17|228|UNKNOWN|2021-10-15|ONGOING|2021-10-30
Study ID|CE|f7cfadf0-f78d-4548-ad04-8d37e6d031f1|2|[?]|[?]|MILD|6|TREATMENT|2021-10-07|2021-09-24|2021-12-12|28|15|94|COINCIDENT|2021-11-23|AFTER|2021-11-24
Study ID|CE|e2a9612c-3b14-4b8c-ac88-39ac9de31c2f|1|[?]|[?]|SEVERE|3|WASHOUT|2021-12-03|2021-10-09|2022-05-23|99|44|270|AFTER|2021-10-12|ONGOING|2021-10-22
Study ID|CE|e2a9612c-3b14-4b8c-ac88-39ac9de31c2f|2|[?]|[?]|MODERATE|1|SCREENING|2021-10-20|2021-09-28|2021-12-13|55|33|109|AFTER|2021-09-19|ONGOING|2021-10-24
Study ID|CE|ef8e1969-22b2-4191-bb95-209af30b5096|1|[?]|[?]|SEVERE|4|TREATMENT|2022-02-02|2022-01-01|2022-05-14|134|102|235|UNKNOWN|2021-10-30|COINCIDENT|2021-11-23
Study ID|CE|ef8e1969-22b2-4191-bb95-209af30b5096|2|[?]|[?]|SEVERE|4|TREATMENT|2021-10-10|2021-09-25|2022-04-30|19|4|221|BEFORE|2022-03-20|AFTER|2022-04-02
Study ID|CE|aaab833d-2546-4606-a806-4fbed4c00eeb|1|[?]|[?]|MILD|6|TREATMENT|2022-07-09|2021-12-10|2022-07-16|261|50|268|UNKNOWN|2021-10-29|COINCIDENT|2021-10-30
Study ID|CE|aaab833d-2546-4606-a806-4fbed4c00eeb|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-07-26|2022-01-05|2022-08-14|278|76|297|COINCIDENT|2022-07-02|AFTER|2022-07-20
Study ID|CE|ceebe624-3386-406a-a055-e7d4952cd37e|1|[?]|[?]|MILD|4|TREATMENT|2021-11-01|2021-10-31|2021-11-19|5|4|23|AFTER|2022-07-12|BEFORE|2022-07-29
Study ID|CE|ceebe624-3386-406a-a055-e7d4952cd37e|2|[?]|[?]|MILD|6|TREATMENT|2022-01-21|2021-11-10|2022-02-13|86|14|109|UNKNOWN|2022-07-25|COINCIDENT|2022-08-03
Study ID|CE|131a7b87-c5fb-4176-841a-b4d1af976105|1|[?]|[?]|MILD|6|TREATMENT|2022-04-21|2021-12-15|2022-05-02|239|112|250|COINCIDENT|2021-12-28|BEFORE|2022-01-08
Study ID|CE|131a7b87-c5fb-4176-841a-b4d1af976105|2|[?]|[?]|MILD|1|SCREENING|2022-01-19|2021-11-10|2022-03-11|147|77|198|BEFORE|2022-04-27|ONGOING|2022-04-30
Study ID|CE|1ce2e510-e54a-46a7-8bed-d9c786d428de|1|[?]|[?]|SEVERE|5|WASHOUT|2022-04-29|2022-04-06|2022-05-18|265|242|284|AFTER|2022-02-12|ONGOING|2022-04-04
Study ID|CE|1ce2e510-e54a-46a7-8bed-d9c786d428de|2|[?]|[?]|SEVERE|2|TREATMENT|2022-05-21|2022-01-11|2022-06-02|287|157|299|BEFORE|2021-11-21|BEFORE|2021-12-05
Study ID|CE|c7c28c4a-e559-497a-8181-fe015050b12f|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-11-14|2021-09-25|2022-06-29|71|21|298|COINCIDENT|2021-11-16|AFTER|2021-12-01
Study ID|CE|c7c28c4a-e559-497a-8181-fe015050b12f|2|[?]|[?]|SEVERE|4|TREATMENT|2021-09-26|2021-09-16|2021-12-12|22|12|99|COINCIDENT|2021-12-17|COINCIDENT|2021-12-18
Study ID|CE|79564b04-8e29-4939-8810-6c637d1d4504|1|[?]|[?]|MILD|1|SCREENING|2022-06-12|2022-06-07|2022-07-17|246|241|281|BEFORE|2021-10-16|BEFORE|2021-10-19
Study ID|CE|79564b04-8e29-4939-8810-6c637d1d4504|2|[?]|[?]|SEVERE|1|SCREENING|2022-03-05|2022-01-23|2022-07-31|147|106|295|UNKNOWN|2022-03-18|AFTER|2022-04-18
Study ID|CE|f9cf9898-ea99-474b-a173-15b8e0068065|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-02-12|2021-12-07|2022-06-26|106|39|240|UNKNOWN|2021-11-10|BEFORE|2021-11-13
Study ID|CE|f9cf9898-ea99-474b-a173-15b8e0068065|2|[?]|[?]|MODERATE|6|TREATMENT|2022-01-25|2021-11-10|2022-08-05|88|12|280|BEFORE|2022-05-09|COINCIDENT|2022-06-14
Study ID|CE|c7990059-5e9d-41da-8832-f19ebf5ce11a|1|[?]|[?]|MILD|2|TREATMENT|2022-06-03|2021-12-19|2022-08-05|236|70|299|AFTER|2021-10-17|BEFORE|2021-10-25
Study ID|CE|c7990059-5e9d-41da-8832-f19ebf5ce11a|2|[?]|[?]|MILD|5|WASHOUT|2022-01-16|2021-11-10|2022-07-08|98|31|271|COINCIDENT|2022-05-03|COINCIDENT|2022-05-20
Study ID|CE|b1f6503d-502b-47b3-9266-ba6cfa45c138|1|[?]|[?]|MILD|6|TREATMENT|2022-05-22|2021-12-10|2022-07-03|226|63|268|BEFORE|2022-02-25|COINCIDENT|2022-02-28
Study ID|CE|b1f6503d-502b-47b3-9266-ba6cfa45c138|2|[?]|[?]|SEVERE|4|TREATMENT|2022-02-15|2021-11-15|2022-03-22|130|38|165|UNKNOWN|2021-11-29|COINCIDENT|2021-12-09
Study ID|CE|1f200d28-91a8-43dd-acdc-76276cc05e00|1|[?]|[?]|MODERATE|3|WASHOUT|2022-07-08|2021-11-12|2022-07-14|291|53|297|COINCIDENT|2021-11-18|AFTER|2021-11-22
Study ID|CE|1f200d28-91a8-43dd-acdc-76276cc05e00|2|[?]|[?]|SEVERE|4|TREATMENT|2021-11-06|2021-10-30|2022-01-23|47|40|125|COINCIDENT|2021-11-03|AFTER|2022-01-05
Study ID|CE|9ed5969e-2bab-4e80-96e2-5200f770ba03|1|[?]|[?]|SEVERE|1|SCREENING|2022-07-08|2022-06-05|2022-07-16|279|246|287|UNKNOWN|2021-11-03|AFTER|2021-11-04
Study ID|CE|9ed5969e-2bab-4e80-96e2-5200f770ba03|2|[?]|[?]|MODERATE|1|SCREENING|2021-11-26|2021-11-05|2022-06-26|55|34|267|AFTER|2021-11-30|AFTER|2021-12-15
Study ID|CE|0c4ce5af-6958-46b5-9475-1b3a4fc0d33f|1|[?]|[?]|SEVERE|2|TREATMENT|2021-11-27|2021-10-15|2022-01-14|102|59|150|UNKNOWN|2021-12-12|AFTER|2021-12-21
Study ID|CE|0c4ce5af-6958-46b5-9475-1b3a4fc0d33f|2|[?]|[?]|MODERATE|1|SCREENING|2021-08-31|2021-08-24|2021-09-08|14|7|22|BEFORE|2021-09-14|ONGOING|2021-10-10
Study ID|CE|69c9c9dd-3ab0-4a43-94c8-9c40b580b4f2|1|[?]|[?]|SEVERE|4|TREATMENT|2022-06-30|2022-05-17|2022-07-05|279|235|284|AFTER|2022-04-02|ONGOING|2022-04-03
Study ID|CE|69c9c9dd-3ab0-4a43-94c8-9c40b580b4f2|2|[?]|[?]|MODERATE|4|TREATMENT|2022-03-30|2022-02-22|2022-06-25|187|151|274|UNKNOWN|2021-10-01|COINCIDENT|2021-10-02
Study ID|CE|54911800-8507-499a-a7a0-7f2d2fb091d3|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-02-24|2021-12-30|2022-04-12|192|136|239|COINCIDENT|2021-12-16|ONGOING|2022-03-20
Study ID|CE|54911800-8507-499a-a7a0-7f2d2fb091d3|2|[?]|[?]|MODERATE|2|TREATMENT|2022-04-02|2022-01-01|2022-04-30|229|138|257|UNKNOWN|2022-02-19|BEFORE|2022-02-20
Study ID|CE|62d81c3b-7e47-4ca1-9b1b-5ae8ba53e4d5|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-05-16|2022-04-14|2022-06-16|215|183|246|AFTER|2022-05-15|AFTER|2022-06-21
Study ID|CE|62d81c3b-7e47-4ca1-9b1b-5ae8ba53e4d5|2|[?]|[?]|MODERATE|4|TREATMENT|2021-11-18|2021-10-19|2022-01-05|36|6|84|BEFORE|2022-07-16|AFTER|2022-07-30
Study ID|CE|5c3a10c5-ff6d-4848-8fba-89ed56deebcd|1|[?]|[?]|SEVERE|4|TREATMENT|2022-01-03|2021-11-11|2022-08-04|75|22|288|COINCIDENT|2022-03-28|AFTER|2022-04-01
Study ID|CE|5c3a10c5-ff6d-4848-8fba-89ed56deebcd|2|[?]|[?]|MODERATE|2|TREATMENT|2022-06-21|2022-01-28|2022-07-05|244|100|258|BEFORE|2022-04-03|BEFORE|2022-04-10
Study ID|CE|100085d7-f49a-468d-a92d-0304e65f71b6|1|[?]|[?]|MODERATE|4|TREATMENT|2021-09-08|2021-08-30|2022-02-20|18|9|183|BEFORE|2021-10-20|ONGOING|2021-12-05
Study ID|CE|100085d7-f49a-468d-a92d-0304e65f71b6|2|[?]|[?]|SEVERE|3|WASHOUT|2021-11-06|2021-10-24|2022-03-27|77|64|218|COINCIDENT|2021-11-23|COINCIDENT|2021-11-28
Study ID|CE|9cbde452-5eb2-4af6-b986-456a7d96594a|1|[?]|[?]|SEVERE|3|WASHOUT|2022-02-05|2022-01-13|2022-03-03|169|146|195|COINCIDENT|2022-01-06|COINCIDENT|2022-01-06
Study ID|CE|9cbde452-5eb2-4af6-b986-456a7d96594a|2|[?]|[?]|MILD|2|TREATMENT|2022-02-07|2021-10-15|2022-03-29|171|56|221|AFTER|2021-10-07|ONGOING|2021-10-09
Study ID|CE|8e171a3f-46df-4df0-9a45-ef1577574095|1|[?]|[?]|MILD|7|FOLLOW-UP|2021-12-24|2021-09-23|2022-03-16|100|8|182|BEFORE|2022-05-09|COINCIDENT|2022-05-14
Study ID|CE|8e171a3f-46df-4df0-9a45-ef1577574095|2|[?]|[?]|MODERATE|5|WASHOUT|2022-04-26|2022-01-11|2022-04-30|223|118|227|COINCIDENT|2021-12-21|ONGOING|2022-01-31
Study ID|CE|099b7ac3-d3ae-4370-a687-a9829c374dd3|1|[?]|[?]|MODERATE|4|TREATMENT|2022-01-10|2021-10-30|2022-03-08|80|8|137|BEFORE|2022-01-21|BEFORE|2022-02-02
Study ID|CE|099b7ac3-d3ae-4370-a687-a9829c374dd3|2|[?]|[?]|MODERATE|4|TREATMENT|2022-02-06|2021-12-09|2022-02-12|107|48|113|BEFORE|2022-03-05|ONGOING|2022-03-19
Study ID|CE|7d023693-f052-4b93-8706-1cfc6754f05b|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-05-07|2022-04-19|2022-06-17|252|234|293|BEFORE|2021-10-08|ONGOING|2021-10-10
Study ID|CE|7d023693-f052-4b93-8706-1cfc6754f05b|2|[?]|[?]|SEVERE|3|WASHOUT|2021-10-28|2021-09-26|2022-01-03|61|29|128|UNKNOWN|2021-12-09|BEFORE|2022-01-21
Study ID|CE|975abcca-91ce-4b91-b607-3967668b0432|1|[?]|[?]|SEVERE|1|SCREENING|2022-07-14|2022-03-26|2022-08-08|270|160|295|UNKNOWN|2022-03-17|AFTER|2022-04-25
Study ID|CE|975abcca-91ce-4b91-b607-3967668b0432|2|[?]|[?]|MODERATE|2|TREATMENT|2022-06-01|2022-03-30|2022-07-02|227|164|258|UNKNOWN|2022-04-06|BEFORE|2022-04-25
Study ID|CE|3831851f-30ba-47d0-8ce2-565af7ed3055|1|[?]|[?]|MODERATE|4|TREATMENT|2022-02-18|2021-09-17|2022-05-27|184|30|282|BEFORE|2022-01-23|ONGOING|2022-01-26
Study ID|CE|3831851f-30ba-47d0-8ce2-565af7ed3055|2|[?]|[?]|MILD|2|TREATMENT|2021-09-17|2021-09-04|2021-12-19|30|17|123|BEFORE|2022-01-26|BEFORE|2022-01-27
Study ID|CE|e691e72d-cc4a-4256-913c-9889f5282c2b|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-01-05|2022-01-01|2022-01-19|71|67|85|BEFORE|2021-11-22|COINCIDENT|2021-11-29
Study ID|CE|e691e72d-cc4a-4256-913c-9889f5282c2b|2|[?]|[?]|MODERATE|2|TREATMENT|2022-04-16|2022-01-27|2022-05-06|172|93|192|AFTER|2022-04-23|COINCIDENT|2022-05-12
Study ID|CE|eff0d0b0-90a4-49be-8963-0e1e14b65c99|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-01|2022-05-17|2022-07-19|238|223|286|UNKNOWN|2021-12-14|ONGOING|2022-02-23
Study ID|CE|eff0d0b0-90a4-49be-8963-0e1e14b65c99|2|[?]|[?]|MODERATE|1|SCREENING|2022-04-24|2021-12-17|2022-05-13|200|72|219|COINCIDENT|2021-12-14|BEFORE|2021-12-24
Study ID|CE|923bf4b4-2489-4fb8-bde3-b5747b98a128|1|[?]|[?]|MODERATE|4|TREATMENT|2021-10-26|2021-09-01|2022-03-15|62|7|202|COINCIDENT|2021-12-23|COINCIDENT|2021-12-30
Study ID|CE|923bf4b4-2489-4fb8-bde3-b5747b98a128|2|[?]|[?]|MILD|4|TREATMENT|2022-02-17|2021-12-08|2022-03-26|176|105|213|UNKNOWN|2021-12-10|BEFORE|2022-04-05
Study ID|CE|754a5564-4735-449b-b57c-8909371e4ea1|1|[?]|[?]|SEVERE|4|TREATMENT|2022-06-19|2022-05-23|2022-07-16|245|218|272|UNKNOWN|2022-04-02|AFTER|2022-04-05
Study ID|CE|754a5564-4735-449b-b57c-8909371e4ea1|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-07-04|2022-06-09|2022-08-01|260|235|288|AFTER|2022-01-24|AFTER|2022-01-30
Study ID|CE|a2f1f1f7-ee92-4e60-97a7-6b506252b2dd|1|[?]|[?]|MILD|2|TREATMENT|2022-03-24|2021-12-22|2022-06-03|177|85|248|BEFORE|2021-11-05|AFTER|2021-11-22
Study ID|CE|a2f1f1f7-ee92-4e60-97a7-6b506252b2dd|2|[?]|[?]|SEVERE|2|TREATMENT|2021-11-16|2021-11-15|2022-03-25|49|48|178|UNKNOWN|2021-12-07|COINCIDENT|2021-12-08
Study ID|CE|12e2e175-84e0-48bf-8a02-1cbdb8b7a646|1|[?]|[?]|MODERATE|4|TREATMENT|2022-03-14|2022-01-14|2022-05-09|143|84|199|BEFORE|2022-03-15|ONGOING|2022-03-16
Study ID|CE|12e2e175-84e0-48bf-8a02-1cbdb8b7a646|2|[?]|[?]|MODERATE|3|WASHOUT|2022-01-21|2021-11-04|2022-02-02|91|13|103|UNKNOWN|2021-11-18|ONGOING|2021-11-19
Study ID|CE|1f46fe9b-33e4-4555-9195-7acaf5d149be|1|[?]|[?]|MILD|2|TREATMENT|2022-02-01|2022-01-02|2022-06-11|153|123|283|AFTER|2021-12-14|COINCIDENT|2021-12-23
Study ID|CE|1f46fe9b-33e4-4555-9195-7acaf5d149be|2|[?]|[?]|MODERATE|4|TREATMENT|2021-12-13|2021-11-20|2022-04-07|103|80|218|BEFORE|2022-03-29|AFTER|2022-05-18
Study ID|CE|caf416eb-7ca0-45be-bbff-f39131db02ef|1|[?]|[?]|MODERATE|4|TREATMENT|2022-05-27|2021-12-01|2022-06-17|249|72|270|BEFORE|2022-04-09|AFTER|2022-04-14
Study ID|CE|caf416eb-7ca0-45be-bbff-f39131db02ef|2|[?]|[?]|SEVERE|2|TREATMENT|2022-01-14|2021-11-18|2022-03-12|116|59|173|COINCIDENT|2022-04-01|BEFORE|2022-04-11
Study ID|CE|1d94fa8d-4e72-4d3b-8d50-b5a276fdbdf9|1|[?]|[?]|MODERATE|2|TREATMENT|2022-04-06|2022-03-12|2022-06-13|159|134|227|UNKNOWN|2022-04-08|COINCIDENT|2022-05-02
Study ID|CE|1d94fa8d-4e72-4d3b-8d50-b5a276fdbdf9|2|[?]|[?]|MILD|5|WASHOUT|2022-06-02|2022-02-04|2022-08-05|216|98|280|BEFORE|2022-05-13|AFTER|2022-06-17
Study ID|CE|00ae1afd-197f-472e-b400-614a5c0859e8|1|[?]|[?]|SEVERE|5|WASHOUT|2021-12-04|2021-10-08|2022-01-22|98|41|147|BEFORE|2021-09-28|COINCIDENT|2021-10-02
Study ID|CE|00ae1afd-197f-472e-b400-614a5c0859e8|2|[?]|[?]|SEVERE|2|TREATMENT|2022-01-14|2021-12-15|2022-03-27|139|109|211|COINCIDENT|2022-01-27|BEFORE|2022-03-13
Study ID|CE|ccd0534d-432b-4bbf-82d2-075fad3a74b7|1|[?]|[?]|SEVERE|3|WASHOUT|2022-07-17|2022-04-06|2022-07-20|285|183|288|UNKNOWN|2021-12-20|BEFORE|2021-12-21
Study ID|CE|ccd0534d-432b-4bbf-82d2-075fad3a74b7|2|[?]|[?]|MILD|6|TREATMENT|2022-01-19|2021-12-03|2022-06-22|106|59|260|AFTER|2022-03-06|COINCIDENT|2022-04-11
Study ID|CE|0d66f896-f5ed-4f9d-8568-47d4708f5348|1|[?]|[?]|MILD|5|WASHOUT|2022-04-23|2021-12-03|2022-05-12|217|76|236|BEFORE|2021-11-29|ONGOING|2021-12-06
Study ID|CE|0d66f896-f5ed-4f9d-8568-47d4708f5348|2|[?]|[?]|SEVERE|6|TREATMENT|2021-11-14|2021-10-11|2022-04-20|57|23|214|BEFORE|2022-02-24|AFTER|2022-05-22
Study ID|CE|2f83788c-5f95-47c0-91aa-a8577b6864ae|1|[?]|[?]|SEVERE|6|TREATMENT|2021-11-24|2021-10-03|2022-04-04|58|6|189|UNKNOWN|2021-11-09|ONGOING|2021-11-13
Study ID|CE|2f83788c-5f95-47c0-91aa-a8577b6864ae|2|[?]|[?]|MODERATE|1|SCREENING|2021-10-10|2021-10-02|2022-06-26|13|5|272|AFTER|2022-05-14|BEFORE|2022-05-16
Study ID|CE|67ea82d1-7c31-47dd-a86d-735cb8959645|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-05-11|2022-03-06|2022-05-21|199|133|209|AFTER|2022-04-13|BEFORE|2022-04-18
Study ID|CE|67ea82d1-7c31-47dd-a86d-735cb8959645|2|[?]|[?]|SEVERE|1|SCREENING|2022-03-11|2021-12-04|2022-06-23|138|41|242|COINCIDENT|2022-01-13|AFTER|2022-01-14
Study ID|CE|a120fa16-f4c5-44cc-b4b7-d48d3e6ea808|1|[?]|[?]|MODERATE|3|WASHOUT|2022-03-24|2021-10-05|2022-04-19|190|20|216|COINCIDENT|2022-04-28|COINCIDENT|2022-06-01
Study ID|CE|a120fa16-f4c5-44cc-b4b7-d48d3e6ea808|2|[?]|[?]|SEVERE|4|TREATMENT|2022-02-22|2022-02-19|2022-06-27|160|157|285|BEFORE|2021-11-14|BEFORE|2022-01-08
Study ID|CE|da347bd5-04a6-4702-9bdf-d423296bd37a|1|[?]|[?]|MILD|1|SCREENING|2022-06-03|2021-12-11|2022-06-14|287|113|298|UNKNOWN|2021-12-17|BEFORE|2022-01-31
Study ID|CE|da347bd5-04a6-4702-9bdf-d423296bd37a|2|[?]|[?]|SEVERE|5|WASHOUT|2022-04-16|2022-02-08|2022-05-20|239|172|273|AFTER|2022-02-23|COINCIDENT|2022-02-26
Study ID|CE|c6935776-c0dc-45a8-b6ef-4f0b0df78049|1|[?]|[?]|MODERATE|4|TREATMENT|2022-06-14|2022-05-19|2022-07-07|268|242|291|UNKNOWN|2022-02-27|ONGOING|2022-03-21
Study ID|CE|c6935776-c0dc-45a8-b6ef-4f0b0df78049|2|[?]|[?]|SEVERE|1|SCREENING|2021-10-31|2021-10-05|2022-07-08|42|16|292|AFTER|2022-01-08|COINCIDENT|2022-01-09
Study ID|CE|e078c95e-c244-42b3-a2df-de4a04c44045|1|[?]|[?]|MILD|3|WASHOUT|2021-11-09|2021-10-01|2022-01-20|44|5|116|COINCIDENT|2021-10-08|BEFORE|2021-10-13
Study ID|CE|e078c95e-c244-42b3-a2df-de4a04c44045|2|[?]|[?]|SEVERE|1|SCREENING|2022-05-27|2022-04-04|2022-07-07|243|190|284|COINCIDENT|2022-07-10|ONGOING|2022-07-13
Study ID|CE|9741b905-8565-460d-8dca-06ccf0ce4e46|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-03-17|2021-10-07|2022-06-08|192|31|275|BEFORE|2021-10-19|ONGOING|2021-11-05
Study ID|CE|9741b905-8565-460d-8dca-06ccf0ce4e46|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-04-19|2021-11-02|2022-06-19|225|57|286|UNKNOWN|2021-11-13|BEFORE|2021-11-13
Study ID|CE|a1d554e2-e153-4703-ac09-a261b054d818|1|[?]|[?]|SEVERE|5|WASHOUT|2021-11-23|2021-09-21|2022-01-27|84|21|149|COINCIDENT|2022-01-28|BEFORE|2022-02-24
Study ID|CE|a1d554e2-e153-4703-ac09-a261b054d818|2|[?]|[?]|MODERATE|4|TREATMENT|2022-06-23|2022-06-06|2022-06-26|296|279|299|BEFORE|2021-12-22|AFTER|2021-12-27
Study ID|CE|2bfaca0e-7432-4006-82f9-df89cd638dec|1|[?]|[?]|MILD|5|WASHOUT|2022-03-09|2021-10-23|2022-07-06|147|10|266|BEFORE|2022-01-21|AFTER|2022-03-11
Study ID|CE|2bfaca0e-7432-4006-82f9-df89cd638dec|2|[?]|[?]|MILD|1|SCREENING|2022-07-25|2021-11-06|2022-07-30|285|24|290|AFTER|2022-06-26|BEFORE|2022-06-27
Study ID|CE|73e211f4-249d-4736-b234-bfbc04721709|1|[?]|[?]|MILD|5|WASHOUT|2022-02-01|2021-11-12|2022-03-09|167|86|203|BEFORE|2021-09-05|AFTER|2021-09-19
Study ID|CE|73e211f4-249d-4736-b234-bfbc04721709|2|[?]|[?]|MODERATE|6|TREATMENT|2022-06-10|2021-09-23|2022-06-13|296|36|299|AFTER|2021-10-27|BEFORE|2021-11-15
Study ID|CE|8d0d1112-a65d-4ad9-bce5-7f5c11bec70d|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-08-05|2021-11-19|2022-08-06|297|38|298|COINCIDENT|2021-10-16|AFTER|2021-10-17
Study ID|CE|8d0d1112-a65d-4ad9-bce5-7f5c11bec70d|2|[?]|[?]|SEVERE|5|WASHOUT|2021-11-04|2021-10-19|2022-06-01|23|7|232|UNKNOWN|2021-10-14|COINCIDENT|2021-10-14
Study ID|CE|50303234-a96f-4a05-a979-d5f199e465c6|1|[?]|[?]|MILD|3|WASHOUT|2022-04-11|2022-01-19|2022-08-12|176|94|299|UNKNOWN|2022-02-11|ONGOING|2022-03-01
Study ID|CE|50303234-a96f-4a05-a979-d5f199e465c6|2|[?]|[?]|MILD|1|SCREENING|2022-08-02|2022-04-22|2022-08-04|289|187|291|BEFORE|2022-01-06|BEFORE|2022-05-10
Study ID|CE|1ed4eb06-a61b-4ee8-a2ee-3e8ddcc09a16|1|[?]|[?]|MODERATE|6|TREATMENT|2022-05-09|2022-04-28|2022-05-25|257|246|273|AFTER|2021-12-16|BEFORE|2022-02-04
Study ID|CE|1ed4eb06-a61b-4ee8-a2ee-3e8ddcc09a16|2|[?]|[?]|SEVERE|1|SCREENING|2022-03-19|2021-09-28|2022-04-28|206|34|246|AFTER|2021-10-14|ONGOING|2021-10-15
Study ID|CE|4386650d-d299-4d8d-a657-58c847fb8c00|1|[?]|[?]|MILD|5|WASHOUT|2022-02-04|2021-11-30|2022-03-17|109|43|150|AFTER|2022-06-11|ONGOING|2022-06-21
Study ID|CE|4386650d-d299-4d8d-a657-58c847fb8c00|2|[?]|[?]|MODERATE|3|WASHOUT|2022-07-14|2021-11-27|2022-07-17|269|40|272|AFTER|2022-04-02|BEFORE|2022-04-08
Study ID|CE|363b577d-5a9b-4cd5-a353-5ac7547e0b69|1|[?]|[?]|MODERATE|2|TREATMENT|2022-01-05|2021-11-28|2022-06-05|120|82|271|AFTER|2022-01-06|COINCIDENT|2022-03-20
Study ID|CE|363b577d-5a9b-4cd5-a353-5ac7547e0b69|2|[?]|[?]|SEVERE|2|TREATMENT|2022-06-10|2022-03-12|2022-06-18|276|186|284|COINCIDENT|2021-12-05|COINCIDENT|2021-12-26
Study ID|CE|0dae606b-1594-45a8-a22b-f01abc193c6f|1|[?]|[?]|SEVERE|1|SCREENING|2022-02-16|2021-10-13|2022-04-16|133|7|192|AFTER|2022-02-26|BEFORE|2022-03-07
Study ID|CE|0dae606b-1594-45a8-a22b-f01abc193c6f|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-02-01|2021-12-17|2022-07-03|118|72|270|AFTER|2022-02-28|AFTER|2022-03-14
Study ID|CE|29b7909c-0caf-4a3d-98dd-f1dc96294bcf|1|[?]|[?]|SEVERE|3|WASHOUT|2022-03-24|2022-01-24|2022-05-15|206|147|258|BEFORE|2021-09-26|AFTER|2021-09-28
Study ID|CE|29b7909c-0caf-4a3d-98dd-f1dc96294bcf|2|[?]|[?]|MODERATE|5|WASHOUT|2022-05-15|2021-09-22|2022-06-17|258|23|291|UNKNOWN|2021-11-21|COINCIDENT|2021-11-22
Study ID|CE|caa5f408-9834-4b2e-b07a-acc62f7e6606|1|[?]|[?]|SEVERE|2|TREATMENT|2021-11-01|2021-10-30|2022-02-08|4|2|103|BEFORE|2022-02-06|ONGOING|2022-02-07
Study ID|CE|caa5f408-9834-4b2e-b07a-acc62f7e6606|2|[?]|[?]|MILD|4|TREATMENT|2021-12-27|2021-12-23|2022-02-04|60|56|99|BEFORE|2022-03-13|COINCIDENT|2022-05-08
Study ID|CE|04820ebc-945e-4625-a6e3-b40c32e374f8|1|[?]|[?]|SEVERE|6|TREATMENT|2022-04-05|2022-01-11|2022-04-29|184|100|208|BEFORE|2022-03-13|COINCIDENT|2022-03-17
Study ID|CE|04820ebc-945e-4625-a6e3-b40c32e374f8|2|[?]|[?]|SEVERE|6|TREATMENT|2021-11-07|2021-10-12|2022-05-11|35|9|220|COINCIDENT|2021-11-19|BEFORE|2021-11-20
Study ID|CE|cf5c476b-1fa3-443b-b692-e1749ec1a311|1|[?]|[?]|MODERATE|3|WASHOUT|2022-05-09|2021-10-25|2022-05-25|243|47|259|BEFORE|2021-12-12|ONGOING|2021-12-14
Study ID|CE|cf5c476b-1fa3-443b-b692-e1749ec1a311|2|[?]|[?]|MILD|5|WASHOUT|2022-05-08|2021-11-27|2022-06-22|242|80|287|COINCIDENT|2021-09-13|COINCIDENT|2021-09-14
Study ID|CE|c472e3b9-65a2-4eff-a2f8-2795a8dcb69a|1|[?]|[?]|MILD|5|WASHOUT|2022-03-08|2022-02-25|2022-05-12|154|143|219|BEFORE|2022-01-14|ONGOING|2022-01-17
Study ID|CE|c472e3b9-65a2-4eff-a2f8-2795a8dcb69a|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-01-13|2021-12-17|2022-02-07|100|73|125|BEFORE|2022-07-10|AFTER|2022-07-12
Study ID|CE|318c96b9-51b5-46c7-ac4d-6bebe6060498|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-02-03|2021-11-18|2022-07-23|111|34|281|AFTER|2021-12-15|ONGOING|2022-03-11
Study ID|CE|318c96b9-51b5-46c7-ac4d-6bebe6060498|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-01-09|2021-10-21|2022-04-07|86|6|174|BEFORE|2022-04-12|AFTER|2022-06-24
Study ID|CE|7741ac05-c3df-49b6-bce4-593b34a9dd72|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-02-22|2021-12-29|2022-03-27|143|88|176|COINCIDENT|2022-01-09|ONGOING|2022-01-11
Study ID|CE|7741ac05-c3df-49b6-bce4-593b34a9dd72|2|[?]|[?]|SEVERE|3|WASHOUT|2022-03-29|2021-12-10|2022-06-17|178|69|258|AFTER|2021-12-06|AFTER|2021-12-15
Study ID|CE|17381173-41bd-4620-83dc-ab51611d807e|1|[?]|[?]|MODERATE|2|TREATMENT|2022-02-03|2022-01-14|2022-04-08|143|123|207|UNKNOWN|2021-10-22|COINCIDENT|2021-10-23
Study ID|CE|17381173-41bd-4620-83dc-ab51611d807e|2|[?]|[?]|MODERATE|6|TREATMENT|2022-06-27|2021-12-29|2022-06-28|287|107|288|BEFORE|2022-05-11|AFTER|2022-05-18
Study ID|CE|99233170-3f1d-4cea-acca-6a9df5e53fb9|1|[?]|[?]|MILD|5|WASHOUT|2022-05-08|2021-12-15|2022-05-18|265|121|275|BEFORE|2021-10-27|AFTER|2021-10-29
Study ID|CE|99233170-3f1d-4cea-acca-6a9df5e53fb9|2|[?]|[?]|SEVERE|3|WASHOUT|2021-12-19|2021-11-10|2022-03-15|125|86|211|BEFORE|2022-05-17|ONGOING|2022-05-18
Study ID|CE|e25f381b-35ad-4e0e-b68f-5064f975797c|1|[?]|[?]|MILD|6|TREATMENT|2022-06-23|2022-02-10|2022-07-03|279|146|289|UNKNOWN|2021-09-25|BEFORE|2021-09-29
Study ID|CE|e25f381b-35ad-4e0e-b68f-5064f975797c|2|[?]|[?]|SEVERE|2|TREATMENT|2021-10-11|2021-10-01|2021-10-17|24|14|30|BEFORE|2021-12-28|ONGOING|2021-12-29
Study ID|CE|c01e42ba-3c20-4dc8-8275-973b23c7d24e|1|[?]|[?]|SEVERE|1|SCREENING|2021-12-30|2021-12-12|2022-05-25|105|87|251|COINCIDENT|2022-01-13|ONGOING|2022-01-20
Study ID|CE|c01e42ba-3c20-4dc8-8275-973b23c7d24e|2|[?]|[?]|SEVERE|3|WASHOUT|2022-02-17|2021-09-21|2022-04-02|154|5|198|BEFORE|2022-04-28|BEFORE|2022-04-28
Study ID|CE|1e88658b-be76-4197-a4ba-5e9e6ecf9510|1|[?]|[?]|MILD|6|TREATMENT|2022-05-21|2022-03-18|2022-07-03|234|170|277|AFTER|2021-11-22|AFTER|2021-11-24
Study ID|CE|1e88658b-be76-4197-a4ba-5e9e6ecf9510|2|[?]|[?]|MILD|4|TREATMENT|2021-12-12|2021-10-31|2022-01-24|74|32|117|BEFORE|2022-06-28|AFTER|2022-07-09
Study ID|CE|8f7bdef5-9a74-42d8-b249-33b99356ce97|1|[?]|[?]|SEVERE|1|SCREENING|2022-06-12|2022-01-16|2022-06-20|289|142|297|COINCIDENT|2022-02-08|ONGOING|2022-02-18
Study ID|CE|8f7bdef5-9a74-42d8-b249-33b99356ce97|2|[?]|[?]|SEVERE|4|TREATMENT|2022-02-12|2021-10-23|2022-06-18|169|57|295|COINCIDENT|2022-01-04|AFTER|2022-01-10
Study ID|CE|ff8bdf28-42ca-4c5b-ad57-231fb9e9eab8|1|[?]|[?]|SEVERE|3|WASHOUT|2022-01-18|2021-12-29|2022-05-21|115|95|238|COINCIDENT|2022-07-14|AFTER|2022-07-16
Study ID|CE|ff8bdf28-42ca-4c5b-ad57-231fb9e9eab8|2|[?]|[?]|MODERATE|6|TREATMENT|2022-02-16|2021-10-28|2022-07-15|144|33|293|BEFORE|2021-12-25|BEFORE|2021-12-26
Study ID|CE|2b7f19fd-2b74-43af-96e6-d3277f9bfb16|1|[?]|[?]|MODERATE|5|WASHOUT|2021-11-19|2021-10-21|2022-01-10|78|49|130|COINCIDENT|2022-02-14|ONGOING|2022-03-02
Study ID|CE|2b7f19fd-2b74-43af-96e6-d3277f9bfb16|2|[?]|[?]|MODERATE|3|WASHOUT|2022-04-14|2022-02-25|2022-04-29|224|176|239|UNKNOWN|2021-11-14|BEFORE|2021-11-17
Study ID|CE|e8c495d0-b9c2-48a0-9846-f0cd24df8675|1|[?]|[?]|MODERATE|5|WASHOUT|2022-05-19|2021-11-11|2022-07-26|229|40|297|AFTER|2022-03-30|AFTER|2022-05-01
Study ID|CE|e8c495d0-b9c2-48a0-9846-f0cd24df8675|2|[?]|[?]|MODERATE|2|TREATMENT|2022-01-20|2021-11-18|2022-07-25|110|47|296|COINCIDENT|2021-11-19|ONGOING|2021-11-20
Study ID|CE|102375bf-0d0d-4b6d-ad07-e82886eebd33|1|[?]|[?]|SEVERE|6|TREATMENT|2022-04-25|2022-04-24|2022-05-29|260|259|294|UNKNOWN|2021-09-15|AFTER|2021-09-18
Study ID|CE|102375bf-0d0d-4b6d-ad07-e82886eebd33|2|[?]|[?]|MILD|1|SCREENING|2021-09-14|2021-08-27|2022-04-14|37|19|249|AFTER|2022-01-28|AFTER|2022-02-22
Study ID|CE|2cbee9a8-b1ff-45d7-95e7-444c53088ec6|1|[?]|[?]|MILD|4|TREATMENT|2021-12-27|2021-11-05|2022-06-06|125|73|286|UNKNOWN|2022-05-18|ONGOING|2022-05-22
Study ID|CE|2cbee9a8-b1ff-45d7-95e7-444c53088ec6|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-08-30|2021-08-28|2021-12-19|6|4|117|BEFORE|2022-05-30|COINCIDENT|2022-06-11
Study ID|CE|d8fa5a4c-28f1-48ba-a463-83a0f2149944|1|[?]|[?]|MODERATE|4|TREATMENT|2021-10-23|2021-10-18|2021-12-29|50|45|117|AFTER|2021-10-17|BEFORE|2021-10-26
Study ID|CE|d8fa5a4c-28f1-48ba-a463-83a0f2149944|2|[?]|[?]|MILD|5|WASHOUT|2022-01-17|2021-11-29|2022-02-17|136|87|167|BEFORE|2021-09-19|AFTER|2021-10-31
Study ID|CE|7a8957a1-9945-4a8b-84be-4f5c7b3f2f2d|1|[?]|[?]|MODERATE|3|WASHOUT|2021-12-18|2021-11-02|2022-03-16|66|20|154|UNKNOWN|2021-10-16|COINCIDENT|2021-10-17
Study ID|CE|7a8957a1-9945-4a8b-84be-4f5c7b3f2f2d|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-04-13|2022-01-03|2022-06-19|182|82|249|COINCIDENT|2022-05-19|ONGOING|2022-05-24
Study ID|CE|5df59b18-8e89-4f71-aa42-e67131bcca74|1|[?]|[?]|SEVERE|6|TREATMENT|2021-09-21|2021-09-04|2022-05-09|28|11|258|BEFORE|2021-10-12|BEFORE|2021-10-30
Study ID|CE|5df59b18-8e89-4f71-aa42-e67131bcca74|2|[?]|[?]|SEVERE|5|WASHOUT|2022-05-04|2021-12-02|2022-06-13|253|100|293|COINCIDENT|2021-09-02|ONGOING|2021-09-03
Study ID|CE|33bc825d-2eef-4f45-92ad-9fa4a1041abc|1|[?]|[?]|MODERATE|1|SCREENING|2021-09-18|2021-08-21|2022-03-30|35|7|228|AFTER|2021-10-06|BEFORE|2021-10-09
Study ID|CE|33bc825d-2eef-4f45-92ad-9fa4a1041abc|2|[?]|[?]|MILD|1|SCREENING|2022-04-14|2022-02-13|2022-05-22|243|183|281|COINCIDENT|2022-06-03|COINCIDENT|2022-06-05
Study ID|CE|79aa6da6-c48b-465d-a8e3-8a70cc7fe0a0|1|[?]|[?]|MODERATE|4|TREATMENT|2022-02-24|2021-12-16|2022-04-07|181|111|223|UNKNOWN|2021-12-06|ONGOING|2022-04-15
Study ID|CE|79aa6da6-c48b-465d-a8e3-8a70cc7fe0a0|2|[?]|[?]|MILD|2|TREATMENT|2022-01-06|2022-01-04|2022-01-27|132|130|153|COINCIDENT|2022-04-28|BEFORE|2022-05-21
Study ID|CE|25a0f0de-927e-42b6-8806-8694ba57fdbe|1|[?]|[?]|MODERATE|2|TREATMENT|2022-04-16|2022-02-26|2022-05-11|221|172|246|UNKNOWN|2021-11-27|COINCIDENT|2021-12-01
Study ID|CE|25a0f0de-927e-42b6-8806-8694ba57fdbe|2|[?]|[?]|SEVERE|6|TREATMENT|2022-04-22|2022-01-03|2022-06-06|227|118|272|UNKNOWN|2022-03-27|COINCIDENT|2022-06-08
Study ID|CE|6a1315aa-839b-4b9e-b531-04697602c150|1|[?]|[?]|MILD|4|TREATMENT|2021-09-21|2021-08-24|2021-11-30|35|7|105|UNKNOWN|2021-12-22|BEFORE|2022-01-24
Study ID|CE|6a1315aa-839b-4b9e-b531-04697602c150|2|[?]|[?]|MILD|1|SCREENING|2022-01-24|2021-11-30|2022-06-01|160|105|288|COINCIDENT|2022-04-25|AFTER|2022-05-17
Study ID|CE|0424f6df-1e7e-4656-8d05-94b93de045f0|1|[?]|[?]|SEVERE|6|TREATMENT|2021-11-25|2021-11-18|2021-12-10|58|51|73|COINCIDENT|2021-12-18|AFTER|2021-12-19
Study ID|CE|0424f6df-1e7e-4656-8d05-94b93de045f0|2|[?]|[?]|MILD|6|TREATMENT|2022-03-02|2022-02-24|2022-06-16|155|149|261|BEFORE|2021-11-14|BEFORE|2021-12-25
Study ID|CE|edc797eb-dcac-465a-90b3-7200364e4115|1|[?]|[?]|MILD|7|FOLLOW-UP|2021-12-09|2021-11-17|2022-06-10|92|70|275|AFTER|2022-06-23|AFTER|2022-06-26
Study ID|CE|edc797eb-dcac-465a-90b3-7200364e4115|2|[?]|[?]|SEVERE|4|TREATMENT|2022-06-22|2022-05-12|2022-06-24|287|246|289|AFTER|2021-12-13|BEFORE|2022-03-21
Study ID|CE|d3c66bad-a6a4-4ab2-8ab9-16c6062f4e37|1|[?]|[?]|SEVERE|2|TREATMENT|2022-05-22|2021-11-13|2022-06-30|245|55|284|BEFORE|2021-10-01|COINCIDENT|2021-10-09
Study ID|CE|d3c66bad-a6a4-4ab2-8ab9-16c6062f4e37|2|[?]|[?]|MODERATE|4|TREATMENT|2022-01-23|2021-11-09|2022-06-04|126|51|258|BEFORE|2021-10-19|BEFORE|2021-10-20
Study ID|CE|ed11b631-0d04-44fe-8581-179d81848148|1|[?]|[?]|SEVERE|1|SCREENING|2022-07-18|2022-06-19|2022-07-19|281|252|282|AFTER|2022-03-21|BEFORE|2022-03-30
Study ID|CE|ed11b631-0d04-44fe-8581-179d81848148|2|[?]|[?]|SEVERE|3|WASHOUT|2021-10-16|2021-10-12|2022-01-06|6|2|88|BEFORE|2021-11-24|ONGOING|2021-11-25
Study ID|CE|5f46adb9-5194-4421-ba70-2f276b9e82c5|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-10-10|2021-09-11|2022-05-31|57|28|290|UNKNOWN|2021-09-23|AFTER|2021-10-08
Study ID|CE|5f46adb9-5194-4421-ba70-2f276b9e82c5|2|[?]|[?]|SEVERE|1|SCREENING|2022-01-29|2021-12-07|2022-05-26|168|115|285|UNKNOWN|2022-01-13|BEFORE|2022-02-14
Study ID|CE|02ce4273-a033-40ac-b8a0-aae023732aa9|1|[?]|[?]|MODERATE|2|TREATMENT|2022-06-14|2022-01-16|2022-06-27|286|137|299|AFTER|2022-06-04|COINCIDENT|2022-06-07
Study ID|CE|02ce4273-a033-40ac-b8a0-aae023732aa9|2|[?]|[?]|MODERATE|4|TREATMENT|2021-12-31|2021-10-17|2022-04-08|121|46|219|AFTER|2021-11-11|AFTER|2021-11-20
Study ID|CE|2725ff54-6e0c-4857-8749-13096a80eedb|1|[?]|[?]|MODERATE|2|TREATMENT|2022-04-13|2021-11-07|2022-06-30|209|52|287|UNKNOWN|2022-05-07|COINCIDENT|2022-05-22
Study ID|CE|2725ff54-6e0c-4857-8749-13096a80eedb|2|[?]|[?]|MODERATE|3|WASHOUT|2022-03-13|2022-02-07|2022-04-30|178|144|226|BEFORE|2021-12-20|COINCIDENT|2021-12-22
Study ID|CE|0b84fe7d-fea2-4025-a6e5-30d14d9669c2|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-09-18|2021-09-06|2022-04-02|14|2|210|COINCIDENT|2021-11-04|BEFORE|2021-11-07
Study ID|CE|0b84fe7d-fea2-4025-a6e5-30d14d9669c2|2|[?]|[?]|MILD|1|SCREENING|2021-11-03|2021-09-13|2021-12-29|60|9|116|AFTER|2021-10-14|ONGOING|2021-11-05
Study ID|CE|8d66f913-08d2-4c0e-b662-91e2ce0a7d1e|1|[?]|[?]|SEVERE|2|TREATMENT|2022-05-25|2021-12-18|2022-07-20|230|72|286|UNKNOWN|2021-10-19|ONGOING|2021-10-20
Study ID|CE|8d66f913-08d2-4c0e-b662-91e2ce0a7d1e|2|[?]|[?]|MILD|2|TREATMENT|2022-06-14|2022-06-10|2022-06-16|250|246|252|BEFORE|2021-10-11|BEFORE|2021-10-11
Study ID|CE|2baf42c1-e2c2-46e7-b559-a4f27dde2a62|1|[?]|[?]|MILD|3|WASHOUT|2021-10-11|2021-09-29|2022-06-25|33|21|290|AFTER|2021-10-14|ONGOING|2021-11-17
Study ID|CE|2baf42c1-e2c2-46e7-b559-a4f27dde2a62|2|[?]|[?]|MODERATE|1|SCREENING|2021-10-22|2021-09-13|2022-01-08|44|5|122|AFTER|2022-05-05|ONGOING|2022-05-19
Study ID|CE|3b938a08-d41a-4b13-8fca-02fdcea7459f|1|[?]|[?]|MODERATE|1|SCREENING|2021-10-31|2021-08-28|2022-02-19|78|14|189|UNKNOWN|2022-05-27|COINCIDENT|2022-05-31
Study ID|CE|3b938a08-d41a-4b13-8fca-02fdcea7459f|2|[?]|[?]|MILD|1|SCREENING|2022-06-03|2021-10-08|2022-06-04|293|55|294|UNKNOWN|2022-01-27|AFTER|2022-03-31
Study ID|CE|24c2989c-3b77-401f-a162-b1dcfb9ba02a|1|[?]|[?]|SEVERE|6|TREATMENT|2022-04-25|2022-02-27|2022-05-22|228|171|255|UNKNOWN|2022-03-04|BEFORE|2022-03-05
Study ID|CE|24c2989c-3b77-401f-a162-b1dcfb9ba02a|2|[?]|[?]|MODERATE|2|TREATMENT|2022-06-22|2021-09-12|2022-06-23|286|3|287|AFTER|2021-11-05|COINCIDENT|2021-11-29
Study ID|CE|5b5dc815-e7bd-40d1-bf51-8c1f383eaac3|1|[?]|[?]|MODERATE|5|WASHOUT|2022-03-20|2021-12-04|2022-04-20|152|46|183|UNKNOWN|2022-02-03|ONGOING|2022-02-26
Study ID|CE|5b5dc815-e7bd-40d1-bf51-8c1f383eaac3|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-29|2022-05-11|2022-07-12|253|204|266|UNKNOWN|2021-12-24|ONGOING|2022-01-03
Study ID|CE|3a612fb3-b197-437b-b1e2-2205114ebbe9|1|[?]|[?]|MODERATE|6|TREATMENT|2022-06-18|2021-12-10|2022-07-29|250|60|291|COINCIDENT|2021-12-07|ONGOING|2021-12-08
Study ID|CE|3a612fb3-b197-437b-b1e2-2205114ebbe9|2|[?]|[?]|MILD|6|TREATMENT|2022-03-30|2021-11-07|2022-06-15|170|27|247|BEFORE|2022-05-11|COINCIDENT|2022-05-22
Study ID|CE|0cfe074e-2d3d-4985-8187-30ccbf1327f7|1|[?]|[?]|SEVERE|3|WASHOUT|2022-04-12|2022-04-08|2022-06-14|205|201|268|COINCIDENT|2021-10-31|BEFORE|2021-11-04
Study ID|CE|0cfe074e-2d3d-4985-8187-30ccbf1327f7|2|[?]|[?]|SEVERE|5|WASHOUT|2021-12-11|2021-11-05|2022-03-28|83|47|190|BEFORE|2021-11-05|COINCIDENT|2021-12-16
Study ID|CE|fd90b54e-45f0-4c57-8be7-ea03b4ba72bd|1|[?]|[?]|MILD|5|WASHOUT|2022-02-23|2021-11-25|2022-05-02|201|111|269|COINCIDENT|2022-01-26|BEFORE|2022-03-18
Study ID|CE|fd90b54e-45f0-4c57-8be7-ea03b4ba72bd|2|[?]|[?]|MILD|4|TREATMENT|2021-09-22|2021-09-08|2021-09-26|47|33|51|AFTER|2021-08-21|AFTER|2021-08-27
Study ID|CE|d2ee9a68-accc-410b-afcd-465f50b2549e|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-03-03|2021-11-11|2022-06-21|152|40|262|BEFORE|2021-10-11|ONGOING|2021-10-20
Study ID|CE|d2ee9a68-accc-410b-afcd-465f50b2549e|2|[?]|[?]|MILD|2|TREATMENT|2021-10-13|2021-10-05|2022-02-27|11|3|148|COINCIDENT|2021-11-04|AFTER|2022-01-01
Study ID|CE|6115f166-0c52-4e50-bcd7-5077eb324052|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-03-13|2021-09-17|2022-06-25|195|18|299|COINCIDENT|2021-09-02|AFTER|2021-10-06
Study ID|CE|6115f166-0c52-4e50-bcd7-5077eb324052|2|[?]|[?]|SEVERE|5|WASHOUT|2022-05-07|2022-04-23|2022-06-16|250|236|290|AFTER|2021-09-22|COINCIDENT|2021-09-24
Study ID|CE|33cc84d6-d563-4122-9e12-2f5f4d108d3d|1|[?]|[?]|MILD|4|TREATMENT|2022-06-01|2022-03-23|2022-08-10|219|149|289|BEFORE|2021-12-16|AFTER|2022-01-14
Study ID|CE|33cc84d6-d563-4122-9e12-2f5f4d108d3d|2|[?]|[?]|MODERATE|6|TREATMENT|2022-05-12|2021-11-11|2022-07-14|199|17|262|UNKNOWN|2022-04-24|BEFORE|2022-06-11
Study ID|CE|a8e4d91e-ec8e-43b7-b6ae-6d6531a5d183|1|[?]|[?]|MILD|5|WASHOUT|2022-01-10|2021-12-09|2022-02-04|140|108|165|UNKNOWN|2021-09-30|COINCIDENT|2021-12-13
Study ID|CE|a8e4d91e-ec8e-43b7-b6ae-6d6531a5d183|2|[?]|[?]|MODERATE|6|TREATMENT|2021-11-14|2021-11-07|2022-04-16|83|76|236|COINCIDENT|2021-09-24|COINCIDENT|2021-09-28
Study ID|CE|39005f68-0383-4062-a43a-73af8fc6ed79|1|[?]|[?]|MILD|2|TREATMENT|2021-12-11|2021-10-29|2022-01-17|99|56|136|UNKNOWN|2021-11-05|COINCIDENT|2022-02-10
Study ID|CE|39005f68-0383-4062-a43a-73af8fc6ed79|2|[?]|[?]|MODERATE|3|WASHOUT|2021-10-04|2021-09-05|2022-05-22|31|2|261|UNKNOWN|2021-12-17|ONGOING|2022-02-06
Study ID|CE|07ad428b-af9a-4329-9020-edfc3510efb7|1|[?]|[?]|SEVERE|1|SCREENING|2022-02-12|2022-01-04|2022-04-13|174|135|234|UNKNOWN|2022-03-26|ONGOING|2022-04-03
Study ID|CE|07ad428b-af9a-4329-9020-edfc3510efb7|2|[?]|[?]|SEVERE|5|WASHOUT|2022-01-18|2021-11-17|2022-04-07|149|87|228|BEFORE|2021-09-05|COINCIDENT|2021-09-07
Study ID|CE|6afbc143-c718-434e-b2c9-90fb94d15e5f|1|[?]|[?]|MILD|3|WASHOUT|2022-04-15|2022-02-23|2022-04-22|194|143|201|AFTER|2022-02-26|BEFORE|2022-03-13
Study ID|CE|6afbc143-c718-434e-b2c9-90fb94d15e5f|2|[?]|[?]|MILD|2|TREATMENT|2022-03-03|2021-11-10|2022-07-06|151|38|276|AFTER|2022-03-16|COINCIDENT|2022-03-21
Study ID|CE|9a2bf45c-ff6b-42d1-b37b-1d9227a57adb|1|[?]|[?]|MILD|1|SCREENING|2022-01-21|2021-11-06|2022-04-10|106|30|185|BEFORE|2021-10-12|BEFORE|2021-10-12
Study ID|CE|9a2bf45c-ff6b-42d1-b37b-1d9227a57adb|2|[?]|[?]|SEVERE|4|TREATMENT|2022-04-21|2022-02-05|2022-04-29|196|121|204|UNKNOWN|2021-12-02|BEFORE|2021-12-21
Study ID|CE|fc67788f-0782-4e37-ab27-87ed60178271|1|[?]|[?]|SEVERE|4|TREATMENT|2021-11-16|2021-09-30|2022-02-19|57|10|152|COINCIDENT|2022-05-29|COINCIDENT|2022-07-06
Study ID|CE|fc67788f-0782-4e37-ab27-87ed60178271|2|[?]|[?]|MILD|7|FOLLOW-UP|2021-11-17|2021-10-05|2022-06-27|58|15|280|COINCIDENT|2022-01-04|AFTER|2022-01-07
Study ID|CE|934efb57-d68c-40b6-9677-2bf5af0f5afe|1|[?]|[?]|MILD|1|SCREENING|2022-03-31|2021-11-08|2022-07-03|166|23|260|BEFORE|2021-11-13|AFTER|2021-11-18
Study ID|CE|934efb57-d68c-40b6-9677-2bf5af0f5afe|2|[?]|[?]|SEVERE|2|TREATMENT|2021-12-24|2021-11-01|2022-02-17|69|16|124|UNKNOWN|2021-10-31|ONGOING|2021-11-05
Study ID|CE|3fb1940f-49e7-4d22-89c2-49fa8ba12b8e|1|[?]|[?]|MILD|2|TREATMENT|2022-05-15|2022-03-30|2022-05-18|264|218|267|UNKNOWN|2022-01-21|COINCIDENT|2022-01-30
Study ID|CE|3fb1940f-49e7-4d22-89c2-49fa8ba12b8e|2|[?]|[?]|MODERATE|2|TREATMENT|2022-03-15|2021-10-07|2022-06-06|203|44|286|AFTER|2022-01-08|BEFORE|2022-01-10
Study ID|CE|434b2cb0-e767-4f5d-97fb-c71c8624cb48|1|[?]|[?]|MODERATE|2|TREATMENT|2021-08-13|2021-08-10|2021-12-21|5|2|135|UNKNOWN|2021-08-26|BEFORE|2021-08-27
Study ID|CE|434b2cb0-e767-4f5d-97fb-c71c8624cb48|2|[?]|[?]|SEVERE|3|WASHOUT|2022-04-04|2021-08-21|2022-04-28|239|13|263|AFTER|2022-01-08|ONGOING|2022-01-27
Study ID|CE|bac51837-53f4-4785-98bd-a7fdeb04e309|1|[?]|[?]|MILD|3|WASHOUT|2022-06-10|2021-11-27|2022-06-25|277|82|292|UNKNOWN|2022-02-04|AFTER|2022-03-11
Study ID|CE|bac51837-53f4-4785-98bd-a7fdeb04e309|2|[?]|[?]|MODERATE|1|SCREENING|2021-11-28|2021-10-26|2022-01-03|83|50|119|AFTER|2021-10-03|BEFORE|2021-10-04
Study ID|CE|7978ecc6-c84e-4c79-bcec-9034523ed0ec|1|[?]|[?]|MILD|6|TREATMENT|2022-03-02|2021-12-14|2022-05-19|162|84|240|AFTER|2021-11-18|ONGOING|2021-11-30
Study ID|CE|7978ecc6-c84e-4c79-bcec-9034523ed0ec|2|[?]|[?]|SEVERE|1|SCREENING|2021-10-14|2021-09-29|2022-01-22|23|8|123|UNKNOWN|2022-01-18|ONGOING|2022-01-18
Study ID|CE|41baa737-5c54-4341-97a5-39eba1110af5|1|[?]|[?]|MODERATE|2|TREATMENT|2022-04-29|2022-03-20|2022-05-27|233|193|261|UNKNOWN|2021-09-25|COINCIDENT|2021-09-25
Study ID|CE|41baa737-5c54-4341-97a5-39eba1110af5|2|[?]|[?]|MILD|6|TREATMENT|2022-05-18|2022-04-20|2022-06-02|252|224|267|COINCIDENT|2021-11-05|AFTER|2021-11-21
Study ID|CE|1639ffae-9892-4db3-bcf1-8ec410d02017|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-05-13|2021-10-13|2022-07-14|220|8|282|UNKNOWN|2021-11-11|ONGOING|2021-11-17
Study ID|CE|1639ffae-9892-4db3-bcf1-8ec410d02017|2|[?]|[?]|MODERATE|1|SCREENING|2022-05-22|2022-04-05|2022-07-09|229|182|277|UNKNOWN|2021-12-09|AFTER|2021-12-15
Study ID|CE|9fba0a8e-3fe2-4f06-b4cf-7aa401e971a7|1|[?]|[?]|SEVERE|6|TREATMENT|2022-04-28|2022-02-16|2022-06-11|211|140|255|UNKNOWN|2022-04-19|ONGOING|2022-04-26
Study ID|CE|9fba0a8e-3fe2-4f06-b4cf-7aa401e971a7|2|[?]|[?]|SEVERE|4|TREATMENT|2022-03-14|2021-10-18|2022-06-24|166|19|268|BEFORE|2022-04-03|COINCIDENT|2022-04-04
Study ID|CE|1e40f81b-3d74-4582-9c8d-bd0f9c7a044d|1|[?]|[?]|SEVERE|1|SCREENING|2022-02-23|2022-01-29|2022-04-21|128|103|185|UNKNOWN|2022-03-29|ONGOING|2022-03-30
Study ID|CE|1e40f81b-3d74-4582-9c8d-bd0f9c7a044d|2|[?]|[?]|SEVERE|6|TREATMENT|2022-01-17|2021-10-29|2022-05-30|91|11|224|UNKNOWN|2022-02-07|AFTER|2022-02-17
Study ID|CE|eb393899-029c-4066-b337-87c4543b422d|1|[?]|[?]|SEVERE|2|TREATMENT|2021-11-10|2021-09-25|2022-02-10|94|48|186|COINCIDENT|2021-11-27|COINCIDENT|2021-12-27
Study ID|CE|eb393899-029c-4066-b337-87c4543b422d|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-01-10|2021-12-18|2022-05-07|155|132|272|BEFORE|2021-09-08|ONGOING|2021-11-09
Study ID|CE|2176468c-0dba-4e31-9fb0-2d8c58f0a96a|1|[?]|[?]|MODERATE|4|TREATMENT|2022-01-26|2021-12-26|2022-04-04|169|138|237|UNKNOWN|2021-12-19|BEFORE|2021-12-20
Study ID|CE|2176468c-0dba-4e31-9fb0-2d8c58f0a96a|2|[?]|[?]|MILD|5|WASHOUT|2022-03-19|2022-01-28|2022-04-26|221|171|259|BEFORE|2022-03-02|COINCIDENT|2022-03-12
Study ID|CE|dfd17f44-0437-45de-9c6e-7cf4559269eb|1|[?]|[?]|MILD|4|TREATMENT|2022-05-25|2022-02-23|2022-06-13|235|144|254|COINCIDENT|2021-11-26|AFTER|2021-12-11
Study ID|CE|dfd17f44-0437-45de-9c6e-7cf4559269eb|2|[?]|[?]|MODERATE|6|TREATMENT|2021-11-14|2021-10-04|2022-05-28|43|2|238|BEFORE|2021-11-09|AFTER|2021-11-10
Study ID|CE|b115ac47-1e2b-485b-8d75-936280817c9c|1|[?]|[?]|MILD|4|TREATMENT|2022-02-23|2022-01-15|2022-05-11|148|109|225|UNKNOWN|2021-11-28|BEFORE|2021-12-07
Study ID|CE|b115ac47-1e2b-485b-8d75-936280817c9c|2|[?]|[?]|MILD|6|TREATMENT|2022-02-16|2021-09-30|2022-07-06|141|2|281|COINCIDENT|2021-12-15|COINCIDENT|2021-12-30
Study ID|CE|f2e017c3-9709-44a0-9fc9-6fb67695b97d|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-03-02|2021-11-06|2022-03-28|145|29|171|BEFORE|2021-11-06|BEFORE|2021-11-15
Study ID|CE|f2e017c3-9709-44a0-9fc9-6fb67695b97d|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-07-27|2021-12-25|2022-07-30|292|78|295|BEFORE|2022-06-02|COINCIDENT|2022-06-05
Study ID|CE|322efb1f-10c2-41cf-8b4a-d84ae00b9faa|1|[?]|[?]|MODERATE|4|TREATMENT|2022-03-23|2021-10-31|2022-03-28|147|4|152|AFTER|2021-12-21|ONGOING|2021-12-23
Study ID|CE|322efb1f-10c2-41cf-8b4a-d84ae00b9faa|2|[?]|[?]|MODERATE|4|TREATMENT|2022-03-18|2022-02-14|2022-08-21|142|110|298|BEFORE|2021-11-03|COINCIDENT|2021-11-04
Study ID|CE|8c7d810e-4a9c-4df2-b1bd-585e3e0c29ee|1|[?]|[?]|MILD|2|TREATMENT|2022-02-28|2021-12-25|2022-07-10|140|75|272|UNKNOWN|2022-06-10|COINCIDENT|2022-06-11
Study ID|CE|8c7d810e-4a9c-4df2-b1bd-585e3e0c29ee|2|[?]|[?]|MILD|4|TREATMENT|2022-08-02|2022-02-25|2022-08-06|295|137|299|COINCIDENT|2022-05-03|ONGOING|2022-05-13
Study ID|CE|6ea38426-aa83-4704-ab5d-2874505f731a|1|[?]|[?]|MODERATE|4|TREATMENT|2021-09-27|2021-09-20|2022-04-22|34|27|241|AFTER|2021-12-28|COINCIDENT|2022-01-04
Study ID|CE|6ea38426-aa83-4704-ab5d-2874505f731a|2|[?]|[?]|MODERATE|5|WASHOUT|2022-05-22|2022-03-11|2022-05-30|271|199|279|UNKNOWN|2021-11-30|ONGOING|2021-12-02
Study ID|CE|37741997-556e-4bb0-9a8b-dcba68aad5ef|1|[?]|[?]|MILD|3|WASHOUT|2022-06-14|2021-12-22|2022-07-04|279|105|299|AFTER|2021-11-25|BEFORE|2021-12-27
Study ID|CE|37741997-556e-4bb0-9a8b-dcba68aad5ef|2|[?]|[?]|MODERATE|5|WASHOUT|2022-01-23|2021-09-17|2022-03-31|137|9|204|UNKNOWN|2021-12-22|BEFORE|2022-01-12
Study ID|CE|3cc095a9-7201-4ee1-9d97-935fe761fb61|1|[?]|[?]|SEVERE|1|SCREENING|2022-05-07|2022-04-16|2022-06-04|268|247|296|COINCIDENT|2021-09-24|ONGOING|2021-11-05
Study ID|CE|3cc095a9-7201-4ee1-9d97-935fe761fb61|2|[?]|[?]|MILD|4|TREATMENT|2021-10-14|2021-09-26|2021-11-04|63|45|84|COINCIDENT|2022-02-18|ONGOING|2022-03-09
Study ID|CE|badb6da6-bea2-41f0-98fc-93ac3b8aed7c|1|[?]|[?]|MODERATE|6|TREATMENT|2022-07-22|2022-05-13|2022-08-10|273|203|292|UNKNOWN|2021-12-29|ONGOING|2021-12-29
Study ID|CE|badb6da6-bea2-41f0-98fc-93ac3b8aed7c|2|[?]|[?]|MILD|4|TREATMENT|2022-07-25|2021-11-30|2022-08-01|276|39|283|AFTER|2022-07-08|BEFORE|2022-07-09
Study ID|CE|ea87a2bd-903c-423d-ad46-3c53656bf49c|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-06-20|2022-02-25|2022-08-06|238|123|285|BEFORE|2022-06-17|AFTER|2022-07-09
Study ID|CE|ea87a2bd-903c-423d-ad46-3c53656bf49c|2|[?]|[?]|SEVERE|4|TREATMENT|2021-11-17|2021-11-16|2021-12-10|23|22|46|COINCIDENT|2022-04-16|ONGOING|2022-05-24
Study ID|CE|5f1ef0c5-2c53-43c1-8231-d68e65462800|1|[?]|[?]|MODERATE|5|WASHOUT|2021-09-14|2021-09-08|2022-03-17|32|26|216|BEFORE|2021-11-19|ONGOING|2021-11-20
Study ID|CE|5f1ef0c5-2c53-43c1-8231-d68e65462800|2|[?]|[?]|SEVERE|5|WASHOUT|2021-09-01|2021-08-16|2022-05-03|19|3|263|AFTER|2021-09-03|ONGOING|2021-09-04
Study ID|CE|39e8e130-6965-4eac-8eba-3e4af7aeea6b|1|[?]|[?]|MODERATE|5|WASHOUT|2021-11-11|2021-10-25|2022-06-20|68|51|289|UNKNOWN|2022-04-15|COINCIDENT|2022-04-16
Study ID|CE|39e8e130-6965-4eac-8eba-3e4af7aeea6b|2|[?]|[?]|MODERATE|4|TREATMENT|2022-02-16|2021-10-20|2022-04-23|165|46|231|BEFORE|2022-03-17|ONGOING|2022-03-31
Study ID|CE|b05aafad-12da-4c19-85aa-845cf6f6819b|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-03-01|2022-01-30|2022-03-08|159|129|166|COINCIDENT|2022-02-22|COINCIDENT|2022-03-22
Study ID|CE|b05aafad-12da-4c19-85aa-845cf6f6819b|2|[?]|[?]|MILD|2|TREATMENT|2021-11-20|2021-10-16|2022-05-08|58|23|227|AFTER|2021-09-28|COINCIDENT|2021-10-15
Study ID|CE|0c7eb347-7a5a-4be1-804e-9a51d1690b28|1|[?]|[?]|SEVERE|1|SCREENING|2022-03-19|2022-02-12|2022-04-02|196|161|210|UNKNOWN|2021-11-03|AFTER|2022-02-21
Study ID|CE|0c7eb347-7a5a-4be1-804e-9a51d1690b28|2|[?]|[?]|MILD|2|TREATMENT|2022-03-29|2021-10-05|2022-04-07|206|31|215|COINCIDENT|2022-01-30|BEFORE|2022-01-30
Study ID|CE|f4eae613-6019-4f7f-b1db-223290b90a34|1|[?]|[?]|MILD|3|WASHOUT|2021-09-16|2021-09-11|2022-03-01|8|3|174|COINCIDENT|2021-10-26|COINCIDENT|2021-10-28
Study ID|CE|f4eae613-6019-4f7f-b1db-223290b90a34|2|[?]|[?]|MODERATE|3|WASHOUT|2022-04-26|2021-11-18|2022-05-26|230|71|260|UNKNOWN|2021-11-17|COINCIDENT|2021-11-20
Study ID|CE|fd9d14f6-9c92-45db-b709-633924577209|1|[?]|[?]|SEVERE|2|TREATMENT|2021-09-18|2021-09-07|2022-06-18|20|9|293|COINCIDENT|2022-03-09|ONGOING|2022-03-15
Study ID|CE|fd9d14f6-9c92-45db-b709-633924577209|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-10-02|2021-09-16|2021-12-24|34|18|117|AFTER|2021-09-03|COINCIDENT|2021-09-04
Study ID|CE|3489f7bf-ab6e-4f96-a65b-f1748be4c4b8|1|[?]|[?]|SEVERE|2|TREATMENT|2022-02-27|2021-09-21|2022-04-03|164|5|199|UNKNOWN|2021-11-09|COINCIDENT|2021-11-14
Study ID|CE|3489f7bf-ab6e-4f96-a65b-f1748be4c4b8|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-10-03|2021-09-21|2021-10-13|17|5|27|BEFORE|2022-02-28|COINCIDENT|2022-03-18
Study ID|CE|11c7db3b-f41f-49c7-9b23-abc30f90bfad|1|[?]|[?]|MODERATE|3|WASHOUT|2022-03-12|2021-11-02|2022-04-14|214|84|247|COINCIDENT|2021-08-15|BEFORE|2021-08-15
Study ID|CE|11c7db3b-f41f-49c7-9b23-abc30f90bfad|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-05-16|2022-02-05|2022-05-24|279|179|287|COINCIDENT|2021-12-06|COINCIDENT|2022-01-27
Study ID|CE|b7a8e338-2d22-4b6d-b659-bb404a4501e0|1|[?]|[?]|MILD|7|FOLLOW-UP|2021-11-09|2021-10-31|2022-04-25|18|9|185|UNKNOWN|2022-03-06|AFTER|2022-03-07
Study ID|CE|b7a8e338-2d22-4b6d-b659-bb404a4501e0|2|[?]|[?]|MODERATE|4|TREATMENT|2022-07-08|2022-05-08|2022-07-15|259|198|266|COINCIDENT|2022-04-30|ONGOING|2022-05-17
Study ID|CE|8fe35032-c39c-4344-8f02-b9fd301a42bb|1|[?]|[?]|SEVERE|6|TREATMENT|2022-04-15|2022-03-23|2022-07-29|174|151|279|UNKNOWN|2022-03-29|ONGOING|2022-04-23
Study ID|CE|8fe35032-c39c-4344-8f02-b9fd301a42bb|2|[?]|[?]|SEVERE|2|TREATMENT|2022-03-05|2022-02-14|2022-06-13|133|114|233|BEFORE|2022-03-22|AFTER|2022-04-19
Study ID|CE|326c0467-89b9-4ca9-9869-45d895d9c833|1|[?]|[?]|MODERATE|1|SCREENING|2022-05-14|2022-02-12|2022-07-11|236|145|294|UNKNOWN|2022-04-09|ONGOING|2022-04-12
Study ID|CE|326c0467-89b9-4ca9-9869-45d895d9c833|2|[?]|[?]|MILD|2|TREATMENT|2022-06-07|2021-09-23|2022-06-18|260|3|271|COINCIDENT|2021-12-17|BEFORE|2021-12-19
Study ID|CE|1891448d-dbbd-4154-a793-0f7498187060|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-03-26|2022-02-27|2022-07-08|184|157|288|BEFORE|2022-01-20|AFTER|2022-02-02
Study ID|CE|1891448d-dbbd-4154-a793-0f7498187060|2|[?]|[?]|SEVERE|4|TREATMENT|2021-11-29|2021-10-03|2022-03-15|67|10|173|UNKNOWN|2022-01-10|BEFORE|2022-01-12
Study ID|CE|9eba0bdd-c6cb-4a39-b1c6-43af7281d383|1|[?]|[?]|MILD|4|TREATMENT|2022-07-21|2022-06-19|2022-08-04|269|237|283|UNKNOWN|2022-03-18|COINCIDENT|2022-03-20
Study ID|CE|9eba0bdd-c6cb-4a39-b1c6-43af7281d383|2|[?]|[?]|SEVERE|6|TREATMENT|2022-07-12|2022-04-23|2022-07-31|260|180|279|UNKNOWN|2022-01-19|AFTER|2022-02-07
Study ID|CE|018e26b8-610c-4ffc-ab50-d2abddadfbd3|1|[?]|[?]|SEVERE|3|WASHOUT|2022-07-24|2022-02-22|2022-07-25|271|119|272|COINCIDENT|2022-04-29|AFTER|2022-05-09
Study ID|CE|018e26b8-610c-4ffc-ab50-d2abddadfbd3|2|[?]|[?]|MODERATE|4|TREATMENT|2022-02-08|2021-11-26|2022-04-29|105|31|185|BEFORE|2022-08-06|ONGOING|2022-08-14
Study ID|CE|d697be0b-c117-4262-8431-859e7641370b|1|[?]|[?]|MODERATE|6|TREATMENT|2022-04-03|2021-10-20|2022-06-10|212|47|280|BEFORE|2022-02-05|COINCIDENT|2022-02-08
Study ID|CE|d697be0b-c117-4262-8431-859e7641370b|2|[?]|[?]|SEVERE|1|SCREENING|2022-05-30|2022-05-17|2022-06-28|269|256|298|AFTER|2021-10-19|ONGOING|2021-10-22
Study ID|CE|1325428d-d272-4950-9588-27dac0f58b2d|1|[?]|[?]|MODERATE|1|SCREENING|2022-05-09|2022-03-07|2022-06-19|193|130|234|COINCIDENT|2022-06-11|BEFORE|2022-06-16
Study ID|CE|1325428d-d272-4950-9588-27dac0f58b2d|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-11-07|2021-10-30|2022-06-10|10|2|225|COINCIDENT|2022-01-16|BEFORE|2022-04-15
Study ID|CE|090de1de-e936-4be2-a746-62fe121f7da8|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-03|2022-01-28|2022-08-12|221|95|291|AFTER|2022-02-19|AFTER|2022-04-09
Study ID|CE|090de1de-e936-4be2-a746-62fe121f7da8|2|[?]|[?]|MODERATE|3|WASHOUT|2022-05-29|2021-11-15|2022-07-25|216|21|273|COINCIDENT|2021-10-30|COINCIDENT|2021-10-31
Study ID|CE|51e2b6a9-dabf-425b-8263-88ec0bc326df|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-01-30|2021-11-23|2022-02-21|126|58|148|BEFORE|2022-06-20|ONGOING|2022-06-22
Study ID|CE|51e2b6a9-dabf-425b-8263-88ec0bc326df|2|[?]|[?]|MODERATE|3|WASHOUT|2022-01-25|2021-12-11|2022-05-24|121|76|240|BEFORE|2021-10-15|ONGOING|2021-10-16
Study ID|CE|f6a7da73-f887-48fb-a8dd-dba1df8264ac|1|[?]|[?]|SEVERE|6|TREATMENT|2022-02-23|2022-01-22|2022-06-17|179|147|293|AFTER|2022-02-18|AFTER|2022-03-24
Study ID|CE|f6a7da73-f887-48fb-a8dd-dba1df8264ac|2|[?]|[?]|SEVERE|6|TREATMENT|2022-06-19|2021-12-25|2022-06-22|295|119|298|AFTER|2021-11-16|ONGOING|2021-11-27
Study ID|CE|e4d806f1-76f0-49ca-8bbb-8c23827c4cdc|1|[?]|[?]|MILD|2|TREATMENT|2022-08-08|2022-03-23|2022-08-09|299|161|300|BEFORE|2022-03-15|ONGOING|2022-03-16
Study ID|CE|e4d806f1-76f0-49ca-8bbb-8c23827c4cdc|2|[?]|[?]|MILD|2|TREATMENT|2022-02-28|2021-12-22|2022-05-26|138|70|225|BEFORE|2021-11-21|COINCIDENT|2021-11-22
Study ID|CE|448187d1-4bec-472e-8cff-b945923aeb54|1|[?]|[?]|MILD|1|SCREENING|2021-12-14|2021-10-09|2022-05-31|72|6|240|AFTER|2022-01-14|AFTER|2022-02-14
Study ID|CE|448187d1-4bec-472e-8cff-b945923aeb54|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-04-02|2022-01-08|2022-05-04|181|97|213|AFTER|2022-03-12|BEFORE|2022-04-06
Study ID|CE|6b89a0c6-7ba2-49b1-b8b4-98ee72a8d610|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-02-09|2021-11-21|2022-07-28|121|41|290|UNKNOWN|2022-02-24|BEFORE|2022-07-18
Study ID|CE|6b89a0c6-7ba2-49b1-b8b4-98ee72a8d610|2|[?]|[?]|MILD|3|WASHOUT|2021-10-13|2021-10-13|2022-03-09|2|2|149|BEFORE|2022-04-23|AFTER|2022-05-31
Study ID|CE|48bd4478-8623-48a0-be65-6f1024caf526|1|[?]|[?]|MODERATE|4|TREATMENT|2022-04-13|2021-11-06|2022-05-28|204|46|249|AFTER|2022-02-13|AFTER|2022-02-28
Study ID|CE|48bd4478-8623-48a0-be65-6f1024caf526|2|[?]|[?]|MODERATE|3|WASHOUT|2022-07-05|2022-03-16|2022-07-12|287|176|294|BEFORE|2022-05-18|AFTER|2022-05-21
Study ID|CE|4aa4833b-07b3-4f10-be23-98d8449b562c|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-04-03|2021-12-03|2022-06-12|184|63|254|BEFORE|2022-01-17|BEFORE|2022-01-18
Study ID|CE|4aa4833b-07b3-4f10-be23-98d8449b562c|2|[?]|[?]|MILD|4|TREATMENT|2021-12-03|2021-11-23|2022-06-17|63|53|259|COINCIDENT|2022-01-28|ONGOING|2022-02-07
Study ID|CE|bd0bf10f-4c49-457a-9d98-b7f007619beb|1|[?]|[?]|MODERATE|6|TREATMENT|2021-10-30|2021-10-16|2022-06-08|31|17|252|UNKNOWN|2021-12-25|AFTER|2022-01-23
Study ID|CE|bd0bf10f-4c49-457a-9d98-b7f007619beb|2|[?]|[?]|MODERATE|2|TREATMENT|2022-03-05|2022-03-03|2022-06-08|157|155|252|COINCIDENT|2021-10-15|ONGOING|2021-10-17
Study ID|CE|d0fbd021-74a2-4c6c-9a37-88b11e02e00a|1|[?]|[?]|MILD|3|WASHOUT|2021-11-28|2021-11-17|2022-04-08|30|19|161|UNKNOWN|2022-04-02|ONGOING|2022-04-11
Study ID|CE|d0fbd021-74a2-4c6c-9a37-88b11e02e00a|2|[?]|[?]|SEVERE|3|WASHOUT|2022-04-01|2021-12-18|2022-06-28|154|50|242|AFTER|2021-11-11|COINCIDENT|2021-11-12
Study ID|CE|70630273-d909-4fbf-b576-8dcb9788749e|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-01-04|2021-09-25|2022-03-22|143|42|220|BEFORE|2022-03-17|ONGOING|2022-03-19
Study ID|CE|70630273-d909-4fbf-b576-8dcb9788749e|2|[?]|[?]|MODERATE|1|SCREENING|2021-10-25|2021-08-18|2022-05-27|72|4|286|COINCIDENT|2021-08-27|ONGOING|2021-09-26
Study ID|CE|a7330018-d906-4045-863f-cdeee9d0404c|1|[?]|[?]|MILD|7|FOLLOW-UP|2021-11-07|2021-09-12|2021-12-17|82|26|122|COINCIDENT|2021-08-22|COINCIDENT|2021-08-23
Study ID|CE|a7330018-d906-4045-863f-cdeee9d0404c|2|[?]|[?]|MODERATE|4|TREATMENT|2022-04-02|2022-03-11|2022-04-21|228|206|247|UNKNOWN|2021-09-20|COINCIDENT|2021-09-23
Study ID|CE|28ef3051-2a9a-4935-8177-bb4ead0807f3|1|[?]|[?]|MILD|1|SCREENING|2021-12-14|2021-11-15|2022-06-09|113|84|290|AFTER|2021-10-28|COINCIDENT|2021-11-25
Study ID|CE|28ef3051-2a9a-4935-8177-bb4ead0807f3|2|[?]|[?]|MILD|5|WASHOUT|2022-06-12|2021-12-08|2022-06-14|293|107|295|COINCIDENT|2022-04-15|BEFORE|2022-04-29
Study ID|CE|30f1e4f7-89e3-47e9-a6bf-c456f77ae0ae|1|[?]|[?]|MODERATE|3|WASHOUT|2022-06-30|2021-12-11|2022-07-05|244|43|249|COINCIDENT|2021-11-08|AFTER|2021-11-11
Study ID|CE|30f1e4f7-89e3-47e9-a6bf-c456f77ae0ae|2|[?]|[?]|MODERATE|3|WASHOUT|2022-04-17|2022-01-16|2022-08-01|170|79|276|BEFORE|2022-06-24|ONGOING|2022-06-26
Study ID|CE|b4a535cc-d816-4c2d-96af-08b3a11fd61f|1|[?]|[?]|SEVERE|5|WASHOUT|2021-10-25|2021-10-24|2022-02-11|3|2|112|COINCIDENT|2022-02-19|BEFORE|2022-03-07
Study ID|CE|b4a535cc-d816-4c2d-96af-08b3a11fd61f|2|[?]|[?]|MILD|4|TREATMENT|2022-04-19|2022-01-04|2022-08-17|179|74|299|AFTER|2021-12-18|AFTER|2021-12-19
Study ID|CE|94ee6fa6-c06a-424c-af88-76e7d8e4cf17|1|[?]|[?]|SEVERE|1|SCREENING|2022-06-02|2022-05-10|2022-06-25|227|204|250|BEFORE|2021-11-17|COINCIDENT|2021-11-30
Study ID|CE|94ee6fa6-c06a-424c-af88-76e7d8e4cf17|2|[?]|[?]|MILD|2|TREATMENT|2021-11-10|2021-10-23|2022-07-08|23|5|263|BEFORE|2022-05-13|AFTER|2022-05-22
Study ID|CE|b38c5cd8-6c9b-4997-9657-261c705eb0f2|1|[?]|[?]|SEVERE|2|TREATMENT|2022-07-02|2021-12-25|2022-07-05|251|62|254|BEFORE|2022-02-26|ONGOING|2022-04-17
Study ID|CE|b38c5cd8-6c9b-4997-9657-261c705eb0f2|2|[?]|[?]|MILD|6|TREATMENT|2022-08-07|2022-06-08|2022-08-15|287|227|295|AFTER|2022-01-16|AFTER|2022-01-23
Study ID|CE|39def9d8-a452-486b-b1e8-12bebd4c36da|1|[?]|[?]|SEVERE|3|WASHOUT|2022-02-03|2021-09-26|2022-03-03|149|19|177|COINCIDENT|2022-01-27|COINCIDENT|2022-03-07
Study ID|CE|39def9d8-a452-486b-b1e8-12bebd4c36da|2|[?]|[?]|MODERATE|6|TREATMENT|2021-10-31|2021-10-23|2022-07-02|54|46|298|BEFORE|2021-11-18|ONGOING|2021-11-30
Study ID|CE|7d08a831-9e94-440e-828a-4ba3a85d5841|1|[?]|[?]|SEVERE|3|WASHOUT|2021-11-02|2021-10-18|2022-03-11|20|5|149|BEFORE|2022-01-29|ONGOING|2022-01-30
Study ID|CE|7d08a831-9e94-440e-828a-4ba3a85d5841|2|[?]|[?]|MODERATE|5|WASHOUT|2022-07-16|2022-05-05|2022-07-20|276|204|280|UNKNOWN|2022-01-25|BEFORE|2022-01-26
Study ID|CE|59795f52-5ee4-4a72-8b03-87e04bb0e87e|1|[?]|[?]|MILD|1|SCREENING|2021-09-18|2021-09-14|2021-11-26|28|24|97|AFTER|2022-03-14|BEFORE|2022-03-15
Study ID|CE|59795f52-5ee4-4a72-8b03-87e04bb0e87e|2|[?]|[?]|MODERATE|2|TREATMENT|2021-09-16|2021-09-02|2021-11-09|26|12|80|AFTER|2021-12-02|ONGOING|2022-01-02
Study ID|CE|b1ebda49-a95a-4140-b833-154fe8ab3401|1|[?]|[?]|MODERATE|4|TREATMENT|2022-01-17|2021-09-20|2022-02-16|159|40|189|COINCIDENT|2021-10-10|COINCIDENT|2021-10-11
Study ID|CE|b1ebda49-a95a-4140-b833-154fe8ab3401|2|[?]|[?]|MILD|2|TREATMENT|2022-04-18|2022-02-09|2022-05-26|250|182|288|AFTER|2021-09-01|COINCIDENT|2021-09-07
Study ID|CE|fa311f24-630a-411a-a48f-3c3b07e213d2|1|[?]|[?]|MILD|6|TREATMENT|2021-12-14|2021-09-20|2022-01-15|106|21|138|UNKNOWN|2021-10-17|AFTER|2022-01-16
Study ID|CE|fa311f24-630a-411a-a48f-3c3b07e213d2|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-11-27|2021-09-15|2022-05-25|89|16|268|COINCIDENT|2021-10-04|COINCIDENT|2021-10-11
Study ID|CE|f12d0bcd-16ab-420a-ab4c-a8e688285fde|1|[?]|[?]|SEVERE|6|TREATMENT|2022-08-07|2022-03-08|2022-08-09|295|143|297|UNKNOWN|2022-02-04|ONGOING|2022-02-08
Study ID|CE|f12d0bcd-16ab-420a-ab4c-a8e688285fde|2|[?]|[?]|SEVERE|4|TREATMENT|2022-07-17|2022-05-06|2022-07-28|274|202|285|BEFORE|2022-02-22|BEFORE|2022-03-21
Study ID|CE|c307f13b-c7fe-437b-a990-e00f4e1f104a|1|[?]|[?]|SEVERE|3|WASHOUT|2022-04-10|2021-08-22|2022-05-09|237|6|266|AFTER|2021-11-24|BEFORE|2021-11-28
Study ID|CE|c307f13b-c7fe-437b-a990-e00f4e1f104a|2|[?]|[?]|MODERATE|4|TREATMENT|2021-12-04|2021-10-19|2022-04-05|110|64|232|AFTER|2021-10-30|AFTER|2021-10-31
Study ID|CE|6c12bd19-7c12-411e-ba09-c9a4dce7ffd8|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-01-18|2021-10-23|2022-01-28|145|58|155|AFTER|2021-10-08|COINCIDENT|2021-11-12
Study ID|CE|6c12bd19-7c12-411e-ba09-c9a4dce7ffd8|2|[?]|[?]|MODERATE|6|TREATMENT|2022-03-04|2021-11-08|2022-05-01|190|74|248|UNKNOWN|2021-09-01|COINCIDENT|2021-09-02
Study ID|CE|eb822c77-ec30-4c17-bb12-bfb773c9d3eb|1|[?]|[?]|SEVERE|6|TREATMENT|2022-07-19|2022-05-29|2022-07-21|294|243|296|UNKNOWN|2022-02-27|AFTER|2022-04-14
Study ID|CE|eb822c77-ec30-4c17-bb12-bfb773c9d3eb|2|[?]|[?]|MILD|6|TREATMENT|2022-04-02|2021-11-25|2022-07-05|186|58|280|AFTER|2022-07-06|ONGOING|2022-07-09
Study ID|CE|c13f95cc-1a44-4b19-a007-4e6db10f9d94|1|[?]|[?]|SEVERE|5|WASHOUT|2022-04-26|2021-10-27|2022-05-09|206|25|219|AFTER|2021-10-23|COINCIDENT|2021-10-27
Study ID|CE|c13f95cc-1a44-4b19-a007-4e6db10f9d94|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-04-27|2022-03-05|2022-07-13|207|154|284|UNKNOWN|2021-12-03|BEFORE|2021-12-04
Study ID|CE|d0c75130-9899-4931-8ab5-ab5f0811f9c1|1|[?]|[?]|MODERATE|5|WASHOUT|2022-07-13|2021-10-16|2022-07-14|273|3|274|UNKNOWN|2022-05-24|AFTER|2022-05-25
Study ID|CE|d0c75130-9899-4931-8ab5-ab5f0811f9c1|2|[?]|[?]|SEVERE|1|SCREENING|2021-12-09|2021-11-20|2022-08-01|57|38|292|UNKNOWN|2022-02-22|AFTER|2022-04-10
Study ID|CE|59bb2cf4-a255-40d4-9d73-6d1114e2b8a9|1|[?]|[?]|MODERATE|2|TREATMENT|2021-11-25|2021-09-15|2022-03-10|89|18|194|COINCIDENT|2022-01-27|ONGOING|2022-02-07
Study ID|CE|59bb2cf4-a255-40d4-9d73-6d1114e2b8a9|2|[?]|[?]|MILD|1|SCREENING|2022-02-16|2021-09-09|2022-06-22|172|12|298|BEFORE|2021-09-30|COINCIDENT|2021-09-30
Study ID|CE|9aa5a461-1f6e-4dd2-bb06-e01d71ab3cce|1|[?]|[?]|MILD|1|SCREENING|2021-10-31|2021-09-04|2021-11-16|79|22|95|UNKNOWN|2022-01-18|COINCIDENT|2022-03-01
Study ID|CE|9aa5a461-1f6e-4dd2-bb06-e01d71ab3cce|2|[?]|[?]|MILD|3|WASHOUT|2022-03-27|2022-03-08|2022-04-11|226|207|241|UNKNOWN|2021-08-30|ONGOING|2021-09-01
Study ID|CE|ed9b7770-a013-48b1-bd83-3761f33c675f|1|[?]|[?]|SEVERE|6|TREATMENT|2022-06-06|2021-10-26|2022-07-06|231|8|261|BEFORE|2022-03-26|COINCIDENT|2022-04-25
Study ID|CE|ed9b7770-a013-48b1-bd83-3761f33c675f|2|[?]|[?]|MILD|2|TREATMENT|2022-06-02|2022-05-25|2022-06-26|227|219|251|BEFORE|2022-01-08|COINCIDENT|2022-01-15
Study ID|CE|30f82443-3ada-472b-b68c-281db036c5b7|1|[?]|[?]|MODERATE|4|TREATMENT|2022-06-26|2022-06-21|2022-06-30|249|244|253|UNKNOWN|2022-01-17|COINCIDENT|2022-01-21
Study ID|CE|30f82443-3ada-472b-b68c-281db036c5b7|2|[?]|[?]|SEVERE|4|TREATMENT|2021-12-05|2021-11-23|2022-06-21|46|34|244|UNKNOWN|2022-06-16|ONGOING|2022-06-17
Study ID|CE|572f79de-369d-40c4-9153-a1f25fbb7e8f|1|[?]|[?]|MILD|2|TREATMENT|2022-01-31|2021-11-13|2022-05-08|121|42|218|BEFORE|2021-11-01|COINCIDENT|2021-11-07
Study ID|CE|572f79de-369d-40c4-9153-a1f25fbb7e8f|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-10-25|2021-10-18|2022-03-28|23|16|177|BEFORE|2021-12-23|ONGOING|2022-01-27
Study ID|CE|ff46289d-51d9-4fe8-9709-39509630591a|1|[?]|[?]|MILD|4|TREATMENT|2021-10-15|2021-09-14|2022-04-05|47|16|219|COINCIDENT|2021-11-25|AFTER|2021-11-27
Study ID|CE|ff46289d-51d9-4fe8-9709-39509630591a|2|[?]|[?]|MILD|6|TREATMENT|2021-09-30|2021-09-23|2021-12-25|32|25|118|AFTER|2021-10-03|AFTER|2021-10-09
Study ID|CE|243f053d-22b2-4468-a717-af7f22b7be1a|1|[?]|[?]|SEVERE|4|TREATMENT|2022-07-21|2022-03-14|2022-07-23|288|159|290|AFTER|2022-02-02|COINCIDENT|2022-03-09
Study ID|CE|243f053d-22b2-4468-a717-af7f22b7be1a|2|[?]|[?]|MODERATE|4|TREATMENT|2021-11-29|2021-11-28|2022-06-03|54|53|240|BEFORE|2022-04-02|AFTER|2022-05-08
Study ID|CE|b93fe287-2430-4c53-a385-fabbf6ece60a|1|[?]|[?]|MODERATE|2|TREATMENT|2022-02-11|2021-09-21|2022-02-21|177|34|187|BEFORE|2021-08-28|COINCIDENT|2021-08-29
Study ID|CE|b93fe287-2430-4c53-a385-fabbf6ece60a|2|[?]|[?]|MODERATE|4|TREATMENT|2021-12-09|2021-11-19|2022-03-28|113|93|222|COINCIDENT|2021-12-01|ONGOING|2022-01-02
Study ID|CE|303cbab3-0804-43b0-8a2a-97fef0d5272d|1|[?]|[?]|SEVERE|6|TREATMENT|2021-12-18|2021-09-25|2021-12-26|120|36|128|BEFORE|2021-09-29|ONGOING|2022-03-20
Study ID|CE|303cbab3-0804-43b0-8a2a-97fef0d5272d|2|[?]|[?]|SEVERE|4|TREATMENT|2021-10-03|2021-08-31|2022-04-29|44|11|252|COINCIDENT|2021-10-05|ONGOING|2021-10-30
Study ID|CE|a2cd90d1-73b8-47f3-bf1e-6662f47b7ad8|1|[?]|[?]|SEVERE|5|WASHOUT|2022-03-10|2021-10-26|2022-05-13|175|40|239|UNKNOWN|2021-10-17|ONGOING|2021-10-20
Study ID|CE|a2cd90d1-73b8-47f3-bf1e-6662f47b7ad8|2|[?]|[?]|MODERATE|5|WASHOUT|2021-12-31|2021-12-20|2022-05-24|106|95|250|COINCIDENT|2022-04-02|AFTER|2022-04-09
Study ID|CE|9f0a9ed8-d47a-408a-9a60-ab92ee14317f|1|[?]|[?]|SEVERE|1|SCREENING|2022-06-21|2022-02-01|2022-06-23|285|145|287|BEFORE|2021-10-14|BEFORE|2021-10-28
Study ID|CE|9f0a9ed8-d47a-408a-9a60-ab92ee14317f|2|[?]|[?]|MODERATE|1|SCREENING|2022-05-13|2022-04-25|2022-05-22|246|228|255|BEFORE|2022-02-05|COINCIDENT|2022-02-27
Study ID|CE|5b922ca1-bf69-45e3-b16f-180ab68cfc8f|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-01-29|2021-10-17|2022-02-10|159|55|171|AFTER|2021-09-09|AFTER|2021-09-29
Study ID|CE|5b922ca1-bf69-45e3-b16f-180ab68cfc8f|2|[?]|[?]|MODERATE|5|WASHOUT|2022-05-13|2021-10-10|2022-05-27|263|48|277|UNKNOWN|2022-02-25|BEFORE|2022-03-03
Study ID|CE|164be186-dcce-4440-a795-1130b543f736|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-05-05|2022-02-14|2022-07-20|204|124|280|AFTER|2021-12-14|AFTER|2021-12-15
Study ID|CE|164be186-dcce-4440-a795-1130b543f736|2|[?]|[?]|MODERATE|4|TREATMENT|2021-11-25|2021-10-21|2022-03-01|43|8|139|UNKNOWN|2022-01-10|COINCIDENT|2022-01-13
Study ID|CE|655c7821-7058-486b-96bd-e0cb4e00d6ca|1|[?]|[?]|SEVERE|6|TREATMENT|2022-04-03|2022-03-20|2022-07-05|175|161|268|COINCIDENT|2021-11-03|ONGOING|2021-12-05
Study ID|CE|655c7821-7058-486b-96bd-e0cb4e00d6ca|2|[?]|[?]|MILD|5|WASHOUT|2021-12-23|2021-10-31|2022-06-25|74|21|258|BEFORE|2022-01-26|AFTER|2022-01-29
Study ID|CE|a414ce50-a635-461a-a109-591cda1040ca|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-06|2022-05-20|2022-06-15|221|204|230|AFTER|2022-06-04|COINCIDENT|2022-06-15
Study ID|CE|a414ce50-a635-461a-a109-591cda1040ca|2|[?]|[?]|MILD|4|TREATMENT|2022-05-21|2022-03-29|2022-07-08|205|152|253|AFTER|2022-01-25|AFTER|2022-02-21
Study ID|CE|e137040f-31fe-4c36-9fa2-d5917539d11d|1|[?]|[?]|MILD|2|TREATMENT|2021-12-02|2021-10-20|2022-07-14|46|3|270|BEFORE|2022-04-28|COINCIDENT|2022-05-19
Study ID|CE|e137040f-31fe-4c36-9fa2-d5917539d11d|2|[?]|[?]|SEVERE|5|WASHOUT|2021-12-24|2021-11-27|2022-04-28|68|41|193|BEFORE|2021-12-24|AFTER|2022-01-13
Study ID|CE|cb063824-7827-4ba8-860f-13ea6401bd33|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-01-11|2021-12-28|2022-04-07|103|89|189|AFTER|2021-10-14|AFTER|2021-10-16
Study ID|CE|cb063824-7827-4ba8-860f-13ea6401bd33|2|[?]|[?]|MODERATE|3|WASHOUT|2022-07-06|2022-02-28|2022-07-25|279|151|298|COINCIDENT|2022-05-18|AFTER|2022-05-22
Study ID|CE|e89dc34b-13f6-40d2-86d7-a46fef07d855|1|[?]|[?]|MODERATE|2|TREATMENT|2021-11-05|2021-09-28|2022-05-29|41|3|246|UNKNOWN|2021-10-22|AFTER|2021-10-23
Study ID|CE|e89dc34b-13f6-40d2-86d7-a46fef07d855|2|[?]|[?]|MODERATE|6|TREATMENT|2022-03-03|2021-10-03|2022-06-04|159|8|252|COINCIDENT|2021-11-24|ONGOING|2021-12-21
Study ID|CE|7737fac2-0749-41bc-8249-0388b2fd68ef|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-04|2021-08-25|2022-06-05|298|15|299|AFTER|2021-10-01|AFTER|2021-10-11
Study ID|CE|7737fac2-0749-41bc-8249-0388b2fd68ef|2|[?]|[?]|MILD|2|TREATMENT|2022-01-23|2021-12-19|2022-03-01|166|131|203|AFTER|2021-08-25|COINCIDENT|2021-08-27
Study ID|CE|ed838820-1c2a-4cb2-b2d1-a15a67a591e7|1|[?]|[?]|MILD|6|TREATMENT|2021-10-23|2021-10-05|2022-06-24|45|27|289|UNKNOWN|2021-10-05|BEFORE|2021-10-27
Study ID|CE|ed838820-1c2a-4cb2-b2d1-a15a67a591e7|2|[?]|[?]|MILD|6|TREATMENT|2022-02-28|2021-10-07|2022-03-09|173|29|182|AFTER|2022-01-17|ONGOING|2022-03-22
Study ID|CE|0c6caab4-8a56-44dd-83dd-f100286b9e74|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-12-18|2021-12-15|2022-01-06|62|59|81|BEFORE|2022-01-26|COINCIDENT|2022-02-03
Study ID|CE|0c6caab4-8a56-44dd-83dd-f100286b9e74|2|[?]|[?]|MODERATE|1|SCREENING|2022-05-19|2022-04-15|2022-08-11|214|180|298|COINCIDENT|2022-05-13|ONGOING|2022-05-17
Study ID|CE|2cace3eb-a9ed-4b42-9acf-3083596a70e0|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-05-08|2021-11-08|2022-05-19|195|14|206|UNKNOWN|2021-12-23|AFTER|2021-12-27
Study ID|CE|2cace3eb-a9ed-4b42-9acf-3083596a70e0|2|[?]|[?]|MILD|2|TREATMENT|2022-02-23|2021-11-27|2022-03-14|121|33|140|BEFORE|2022-08-15|BEFORE|2022-08-16
Study ID|CE|d3d357d9-0a5d-4ad3-8cb6-5976f71accb3|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-03-20|2022-01-17|2022-05-15|166|104|222|BEFORE|2022-01-05|BEFORE|2022-01-15
Study ID|CE|d3d357d9-0a5d-4ad3-8cb6-5976f71accb3|2|[?]|[?]|MILD|1|SCREENING|2022-05-31|2022-04-16|2022-07-18|238|193|286|AFTER|2021-10-09|COINCIDENT|2021-10-10
Study ID|CE|14e47c8e-f157-4202-b16f-563957d7c7ca|1|[?]|[?]|MILD|1|SCREENING|2021-12-18|2021-10-03|2022-06-10|87|11|261|COINCIDENT|2021-10-02|BEFORE|2021-10-03
Study ID|CE|14e47c8e-f157-4202-b16f-563957d7c7ca|2|[?]|[?]|SEVERE|5|WASHOUT|2022-04-25|2022-01-23|2022-07-04|215|123|285|AFTER|2022-06-17|AFTER|2022-06-18
Study ID|CE|cb700cc0-92f5-4a8c-b5e5-64ba84d1b22d|1|[?]|[?]|MILD|2|TREATMENT|2022-06-30|2022-03-07|2022-07-02|294|179|296|UNKNOWN|2022-02-21|AFTER|2022-02-27
Study ID|CE|cb700cc0-92f5-4a8c-b5e5-64ba84d1b22d|2|[?]|[?]|SEVERE|6|TREATMENT|2022-03-29|2022-02-21|2022-06-20|201|165|284|COINCIDENT|2021-11-11|BEFORE|2021-12-20
Study ID|CE|86d62168-ed8f-4583-9710-02d5f265e4d8|1|[?]|[?]|MODERATE|3|WASHOUT|2022-01-10|2021-12-01|2022-04-10|130|90|220|BEFORE|2021-11-21|BEFORE|2022-02-03
Study ID|CE|86d62168-ed8f-4583-9710-02d5f265e4d8|2|[?]|[?]|SEVERE|3|WASHOUT|2022-01-05|2021-09-16|2022-06-14|125|14|285|BEFORE|2021-11-11|BEFORE|2021-11-13
Study ID|CE|8833f332-3d59-42b9-98cf-814501052dfd|1|[?]|[?]|MODERATE|4|TREATMENT|2021-09-02|2021-09-01|2022-03-23|13|12|215|COINCIDENT|2021-11-09|AFTER|2021-12-04
Study ID|CE|8833f332-3d59-42b9-98cf-814501052dfd|2|[?]|[?]|MILD|1|SCREENING|2022-03-11|2021-09-22|2022-03-26|203|33|218|BEFORE|2022-03-12|BEFORE|2022-03-20
Study ID|CE|1549db45-529f-4d67-8deb-c44e5770fa42|1|[?]|[?]|MODERATE|6|TREATMENT|2021-11-12|2021-10-13|2022-06-06|42|12|248|AFTER|2022-02-02|BEFORE|2022-03-14
Study ID|CE|1549db45-529f-4d67-8deb-c44e5770fa42|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-07-19|2022-06-19|2022-07-21|291|261|293|BEFORE|2021-10-03|BEFORE|2021-10-03
Study ID|CE|7001ef0f-72be-48a3-b427-56e8e43422cf|1|[?]|[?]|SEVERE|6|TREATMENT|2022-04-13|2021-10-28|2022-04-16|236|69|239|UNKNOWN|2021-08-30|BEFORE|2021-09-04
Study ID|CE|7001ef0f-72be-48a3-b427-56e8e43422cf|2|[?]|[?]|MODERATE|1|SCREENING|2021-10-13|2021-09-24|2021-11-25|54|35|97|UNKNOWN|2021-10-29|ONGOING|2021-10-30
Study ID|CE|12c6ab37-bc49-4067-9009-1e122459c621|1|[?]|[?]|MODERATE|5|WASHOUT|2021-11-02|2021-09-20|2022-01-17|54|11|130|UNKNOWN|2022-01-01|AFTER|2022-01-31
Study ID|CE|12c6ab37-bc49-4067-9009-1e122459c621|2|[?]|[?]|MODERATE|2|TREATMENT|2022-06-28|2022-01-16|2022-07-01|292|129|295|COINCIDENT|2021-12-07|COINCIDENT|2021-12-21
Study ID|CE|a5463071-7429-40f2-9e02-337ae889669d|1|[?]|[?]|SEVERE|6|TREATMENT|2022-04-23|2021-11-14|2022-06-15|195|35|248|COINCIDENT|2022-03-23|ONGOING|2022-04-30
Study ID|CE|a5463071-7429-40f2-9e02-337ae889669d|2|[?]|[?]|MODERATE|3|WASHOUT|2021-12-25|2021-11-05|2022-06-14|76|26|247|AFTER|2022-06-08|COINCIDENT|2022-07-06
Study ID|CE|24169321-2355-409b-b819-e3a808ed24e9|1|[?]|[?]|MODERATE|5|WASHOUT|2022-02-25|2021-11-28|2022-04-13|193|104|240|AFTER|2021-11-25|AFTER|2021-11-28
Study ID|CE|24169321-2355-409b-b819-e3a808ed24e9|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-09-26|2021-09-11|2021-12-30|41|26|136|AFTER|2022-05-18|COINCIDENT|2022-05-19
Study ID|CE|cdca79f6-2e7f-462f-9c1f-ab7b06fc1843|1|[?]|[?]|MILD|5|WASHOUT|2022-03-26|2022-01-05|2022-05-08|185|105|228|COINCIDENT|2022-03-18|AFTER|2022-05-07
Study ID|CE|cdca79f6-2e7f-462f-9c1f-ab7b06fc1843|2|[?]|[?]|SEVERE|2|TREATMENT|2022-06-19|2021-11-25|2022-07-18|270|64|299|UNKNOWN|2022-01-08|BEFORE|2022-01-28
Study ID|CE|8d9c886d-707d-40e3-8588-c6910dda733a|1|[?]|[?]|MILD|1|SCREENING|2021-11-24|2021-11-10|2022-01-30|37|23|104|COINCIDENT|2022-03-22|AFTER|2022-03-23
Study ID|CE|8d9c886d-707d-40e3-8588-c6910dda733a|2|[?]|[?]|MODERATE|4|TREATMENT|2022-06-08|2022-03-04|2022-08-06|233|137|292|UNKNOWN|2021-12-15|AFTER|2021-12-18
Study ID|CE|cb2f7899-e727-42d2-804d-5a4a60216e27|1|[?]|[?]|MILD|4|TREATMENT|2022-05-19|2021-12-23|2022-06-07|226|79|245|AFTER|2022-04-04|COINCIDENT|2022-04-29
Study ID|CE|cb2f7899-e727-42d2-804d-5a4a60216e27|2|[?]|[?]|MILD|4|TREATMENT|2021-10-26|2021-10-22|2022-07-01|21|17|269|BEFORE|2021-10-25|COINCIDENT|2021-10-27
Study ID|CE|683c148f-7062-45e5-8292-a819f788d4ef|1|[?]|[?]|MODERATE|1|SCREENING|2022-03-28|2022-02-12|2022-05-18|198|154|249|UNKNOWN|2022-05-12|AFTER|2022-05-15
Study ID|CE|683c148f-7062-45e5-8292-a819f788d4ef|2|[?]|[?]|SEVERE|4|TREATMENT|2022-05-15|2022-02-28|2022-06-02|246|170|264|COINCIDENT|2021-11-05|BEFORE|2022-01-13
Study ID|CE|0854edf0-d4c4-485b-a2a6-af120559f427|1|[?]|[?]|MODERATE|3|WASHOUT|2021-11-26|2021-10-25|2022-03-07|65|33|166|AFTER|2022-03-16|BEFORE|2022-04-06
Study ID|CE|0854edf0-d4c4-485b-a2a6-af120559f427|2|[?]|[?]|MILD|5|WASHOUT|2021-11-22|2021-11-20|2022-05-30|61|59|250|BEFORE|2021-10-09|ONGOING|2021-10-10
Study ID|CE|d15128a8-f001-460b-a13d-b84c534549a5|1|[?]|[?]|MODERATE|5|WASHOUT|2022-02-06|2021-11-05|2022-04-14|149|56|216|BEFORE|2022-01-15|AFTER|2022-02-09
Study ID|CE|d15128a8-f001-460b-a13d-b84c534549a5|2|[?]|[?]|SEVERE|5|WASHOUT|2022-02-08|2021-09-16|2022-07-06|151|6|299|AFTER|2022-02-01|BEFORE|2022-02-02
Study ID|CE|6db4143d-10c0-47c1-b285-0dce306a0332|1|[?]|[?]|SEVERE|5|WASHOUT|2021-10-11|2021-09-28|2022-04-07|23|10|201|UNKNOWN|2021-10-20|COINCIDENT|2021-10-21
Study ID|CE|6db4143d-10c0-47c1-b285-0dce306a0332|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-10-28|2021-10-04|2022-07-14|40|16|299|AFTER|2021-12-11|AFTER|2022-01-12
Study ID|CE|19bc0794-e5de-41d3-b963-023119d05010|1|[?]|[?]|MILD|2|TREATMENT|2022-04-22|2022-01-01|2022-06-13|191|80|243|AFTER|2021-11-20|AFTER|2021-11-23
Study ID|CE|19bc0794-e5de-41d3-b963-023119d05010|2|[?]|[?]|SEVERE|1|SCREENING|2021-12-18|2021-12-17|2022-05-20|66|65|219|AFTER|2022-01-25|BEFORE|2022-02-16
Study ID|CE|f8391173-3563-4fd2-aecc-bb1ecd64d577|1|[?]|[?]|MODERATE|5|WASHOUT|2022-05-10|2022-02-03|2022-05-21|247|151|258|COINCIDENT|2021-12-29|ONGOING|2022-06-05
Study ID|CE|f8391173-3563-4fd2-aecc-bb1ecd64d577|2|[?]|[?]|SEVERE|1|SCREENING|2022-06-20|2022-05-20|2022-07-01|288|257|299|BEFORE|2021-12-05|ONGOING|2022-01-25
Study ID|CE|d1e5d6d9-4f78-41e1-b469-6566418bc856|1|[?]|[?]|MODERATE|5|WASHOUT|2022-08-14|2021-11-20|2022-08-15|298|31|299|UNKNOWN|2021-11-23|BEFORE|2021-11-24
Study ID|CE|d1e5d6d9-4f78-41e1-b469-6566418bc856|2|[?]|[?]|SEVERE|3|WASHOUT|2022-04-02|2022-01-01|2022-07-05|164|73|258|COINCIDENT|2022-04-16|AFTER|2022-04-25
Study ID|CE|e0cfd275-64aa-4995-995a-fbc5b5a368b2|1|[?]|[?]|MILD|2|TREATMENT|2022-06-22|2021-12-17|2022-07-05|254|67|267|BEFORE|2022-03-26|AFTER|2022-04-05
Study ID|CE|e0cfd275-64aa-4995-995a-fbc5b5a368b2|2|[?]|[?]|MILD|2|TREATMENT|2021-12-13|2021-10-21|2022-04-02|63|10|173|AFTER|2021-12-27|AFTER|2022-02-05
Study ID|CE|93a5bacb-f220-45be-9329-5c73363ed53b|1|[?]|[?]|MODERATE|5|WASHOUT|2022-01-02|2021-12-06|2022-04-01|72|45|161|BEFORE|2021-12-06|COINCIDENT|2021-12-17
Study ID|CE|93a5bacb-f220-45be-9329-5c73363ed53b|2|[?]|[?]|MODERATE|4|TREATMENT|2022-02-12|2021-10-29|2022-03-13|113|7|142|BEFORE|2022-01-01|COINCIDENT|2022-01-08
Study ID|CE|d3f324e4-1ede-4f14-94d3-ffbbef10d646|1|[?]|[?]|MODERATE|3|WASHOUT|2022-04-04|2021-10-30|2022-07-15|171|15|273|UNKNOWN|2022-05-22|COINCIDENT|2022-06-22
Study ID|CE|d3f324e4-1ede-4f14-94d3-ffbbef10d646|2|[?]|[?]|MILD|6|TREATMENT|2022-05-29|2022-03-01|2022-07-20|226|137|278|UNKNOWN|2021-12-28|BEFORE|2021-12-30
Study ID|CE|e5da9056-0005-4e1b-be83-cbc3d12764e5|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-04-04|2022-03-08|2022-06-07|208|181|272|AFTER|2021-09-22|BEFORE|2021-09-27
Study ID|CE|e5da9056-0005-4e1b-be83-cbc3d12764e5|2|[?]|[?]|MILD|1|SCREENING|2022-01-25|2021-10-28|2022-05-18|139|50|252|UNKNOWN|2021-12-31|COINCIDENT|2022-01-07
Study ID|CE|4845fb08-1d83-49e6-8ff9-653c3f3394f4|1|[?]|[?]|SEVERE|4|TREATMENT|2022-07-12|2022-01-02|2022-07-15|279|88|282|UNKNOWN|2022-07-01|BEFORE|2022-07-03
Study ID|CE|4845fb08-1d83-49e6-8ff9-653c3f3394f4|2|[?]|[?]|SEVERE|4|TREATMENT|2022-05-19|2022-03-08|2022-07-20|225|153|287|BEFORE|2022-02-13|ONGOING|2022-02-24
Study ID|CE|b355f502-2f42-4dbd-aeba-23c83cc82261|1|[?]|[?]|SEVERE|3|WASHOUT|2022-02-22|2021-09-08|2022-02-27|183|16|188|COINCIDENT|2021-09-17|ONGOING|2021-10-08
Study ID|CE|b355f502-2f42-4dbd-aeba-23c83cc82261|2|[?]|[?]|MILD|6|TREATMENT|2022-01-24|2021-08-26|2022-04-11|154|3|231|UNKNOWN|2021-10-16|AFTER|2021-11-25
Study ID|CE|dbd8c5b1-6ac0-4a31-94b9-4073da7d09a2|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-04-11|2022-01-04|2022-05-22|212|115|253|UNKNOWN|2022-01-11|AFTER|2022-02-06
Study ID|CE|dbd8c5b1-6ac0-4a31-94b9-4073da7d09a2|2|[?]|[?]|MILD|7|FOLLOW-UP|2021-09-17|2021-09-13|2022-05-10|6|2|241|COINCIDENT|2022-05-09|BEFORE|2022-05-12
Study ID|CE|a670e73c-6a53-4f32-af2a-4a951d4a8ebc|1|[?]|[?]|SEVERE|6|TREATMENT|2021-12-14|2021-09-11|2022-04-21|120|26|248|COINCIDENT|2021-10-26|AFTER|2021-12-11
Study ID|CE|a670e73c-6a53-4f32-af2a-4a951d4a8ebc|2|[?]|[?]|SEVERE|3|WASHOUT|2022-03-30|2021-10-06|2022-03-31|226|51|227|COINCIDENT|2021-11-21|COINCIDENT|2021-11-25
Study ID|CE|3f3bb1b8-f058-49be-a1c0-1599d5c6f61d|1|[?]|[?]|MILD|3|WASHOUT|2022-04-26|2022-03-06|2022-05-11|198|147|213|BEFORE|2021-10-22|BEFORE|2021-10-25
Study ID|CE|3f3bb1b8-f058-49be-a1c0-1599d5c6f61d|2|[?]|[?]|MILD|1|SCREENING|2022-02-26|2021-12-23|2022-07-25|139|74|288|AFTER|2021-12-08|ONGOING|2022-01-04
Study ID|CE|11662041-2a09-422e-bea9-2439b4ec197f|1|[?]|[?]|MILD|1|SCREENING|2022-02-14|2021-11-21|2022-06-05|181|96|292|UNKNOWN|2021-09-23|BEFORE|2021-09-24
Study ID|CE|11662041-2a09-422e-bea9-2439b4ec197f|2|[?]|[?]|SEVERE|3|WASHOUT|2022-04-21|2021-09-02|2022-05-04|247|16|260|AFTER|2021-09-15|ONGOING|2021-09-25
Study ID|CE|4844756a-975e-458c-906a-aa8810210a03|1|[?]|[?]|MODERATE|1|SCREENING|2022-04-02|2022-03-10|2022-04-23|186|163|207|BEFORE|2022-05-31|AFTER|2022-06-08
Study ID|CE|4844756a-975e-458c-906a-aa8810210a03|2|[?]|[?]|MODERATE|3|WASHOUT|2022-04-13|2022-03-17|2022-04-27|197|170|211|COINCIDENT|2022-02-12|COINCIDENT|2022-03-15
Study ID|CE|ac6bb1a4-5711-4732-ab1e-ab8c7bcad0ef|1|[?]|[?]|MILD|4|TREATMENT|2022-01-06|2021-11-25|2022-04-30|119|77|233|AFTER|2022-02-24|AFTER|2022-04-07
Study ID|CE|ac6bb1a4-5711-4732-ab1e-ab8c7bcad0ef|2|[?]|[?]|SEVERE|5|WASHOUT|2021-11-11|2021-11-03|2022-05-28|63|55|261|BEFORE|2022-01-14|ONGOING|2022-04-19
Study ID|CE|66d82444-1e96-4aa3-8a6f-213e1c91aff8|1|[?]|[?]|MILD|1|SCREENING|2022-07-12|2022-04-29|2022-07-19|288|214|295|BEFORE|2021-10-05|ONGOING|2021-10-06
Study ID|CE|66d82444-1e96-4aa3-8a6f-213e1c91aff8|2|[?]|[?]|MILD|6|TREATMENT|2021-11-29|2021-11-08|2022-03-06|63|42|160|UNKNOWN|2022-01-21|BEFORE|2022-03-17
Study ID|CE|85e322c1-c83f-4a50-a8b9-567f45aace35|1|[?]|[?]|MILD|2|TREATMENT|2022-05-23|2021-12-31|2022-06-05|272|129|285|COINCIDENT|2022-01-20|BEFORE|2022-01-27
Study ID|CE|85e322c1-c83f-4a50-a8b9-567f45aace35|2|[?]|[?]|SEVERE|3|WASHOUT|2022-05-07|2021-11-21|2022-06-11|256|89|291|UNKNOWN|2022-02-12|AFTER|2022-02-16
Study ID|CE|88f390b8-2e4a-4ec6-90c0-627fd2ea27f6|1|[?]|[?]|SEVERE|1|SCREENING|2021-09-17|2021-09-11|2022-01-13|11|5|129|UNKNOWN|2021-11-27|AFTER|2021-12-21
Study ID|CE|88f390b8-2e4a-4ec6-90c0-627fd2ea27f6|2|[?]|[?]|SEVERE|4|TREATMENT|2022-06-16|2021-10-26|2022-06-30|283|50|297|UNKNOWN|2022-01-02|ONGOING|2022-01-03
Study ID|CE|9313ccd0-1f71-479f-976b-ff5182bf3fe9|1|[?]|[?]|SEVERE|2|TREATMENT|2022-06-02|2021-09-26|2022-06-11|278|29|287|UNKNOWN|2021-10-03|AFTER|2021-10-25
Study ID|CE|9313ccd0-1f71-479f-976b-ff5182bf3fe9|2|[?]|[?]|SEVERE|6|TREATMENT|2021-10-16|2021-10-07|2021-11-09|49|40|73|BEFORE|2022-04-12|AFTER|2022-04-16
Study ID|CE|55e15a91-a192-44f5-b72f-d364eb6b8331|1|[?]|[?]|MILD|1|SCREENING|2022-05-10|2021-11-27|2022-07-27|218|54|296|AFTER|2021-11-13|ONGOING|2021-11-16
Study ID|CE|55e15a91-a192-44f5-b72f-d364eb6b8331|2|[?]|[?]|MODERATE|3|WASHOUT|2022-02-25|2021-11-25|2022-04-22|144|52|200|COINCIDENT|2022-06-30|AFTER|2022-07-01
Study ID|CE|325b6c89-ae9e-4463-8690-8a7c2a625467|1|[?]|[?]|MODERATE|5|WASHOUT|2022-02-25|2021-12-18|2022-05-05|192|123|261|COINCIDENT|2021-11-19|AFTER|2021-12-13
Study ID|CE|325b6c89-ae9e-4463-8690-8a7c2a625467|2|[?]|[?]|MILD|3|WASHOUT|2021-11-02|2021-10-05|2022-01-22|77|49|158|UNKNOWN|2022-01-12|BEFORE|2022-03-08
Study ID|CE|2e0e8646-d205-415b-8223-dd72aa5681ed|1|[?]|[?]|MODERATE|5|WASHOUT|2022-01-22|2021-11-19|2022-05-24|144|80|266|AFTER|2021-10-27|COINCIDENT|2021-10-28
Study ID|CE|2e0e8646-d205-415b-8223-dd72aa5681ed|2|[?]|[?]|SEVERE|3|WASHOUT|2021-10-26|2021-10-07|2022-03-09|56|37|190|AFTER|2021-11-18|ONGOING|2021-12-08
Study ID|CE|664740e0-4da9-43fd-af07-1ec459ac3120|1|[?]|[?]|MILD|1|SCREENING|2022-05-23|2022-03-19|2022-07-13|223|158|274|BEFORE|2022-01-23|AFTER|2022-02-05
Study ID|CE|664740e0-4da9-43fd-af07-1ec459ac3120|2|[?]|[?]|MODERATE|4|TREATMENT|2022-01-26|2021-12-23|2022-07-23|106|72|284|AFTER|2022-01-04|BEFORE|2022-01-06
Study ID|CE|e2bcd781-5145-401f-93a6-967394fa863d|1|[?]|[?]|SEVERE|2|TREATMENT|2022-01-07|2021-11-17|2022-01-29|128|77|150|BEFORE|2022-02-14|BEFORE|2022-03-05
Study ID|CE|e2bcd781-5145-401f-93a6-967394fa863d|2|[?]|[?]|MILD|1|SCREENING|2022-04-28|2021-11-13|2022-05-22|239|73|263|COINCIDENT|2021-12-23|BEFORE|2022-01-31
Study ID|CE|e6abc3f9-be68-415a-8eb6-868f74c2f238|1|[?]|[?]|MODERATE|5|WASHOUT|2022-04-25|2021-09-23|2022-04-28|251|37|254|UNKNOWN|2021-08-20|COINCIDENT|2021-08-20
Study ID|CE|e6abc3f9-be68-415a-8eb6-868f74c2f238|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-10-14|2021-09-07|2021-11-04|58|21|79|UNKNOWN|2021-11-12|COINCIDENT|2021-11-13
Study ID|CE|e977fe2e-6626-4c88-8a05-d37f88c10df4|1|[?]|[?]|SEVERE|4|TREATMENT|2022-01-08|2021-11-10|2022-03-08|78|19|137|UNKNOWN|2022-02-08|AFTER|2022-02-09
Study ID|CE|e977fe2e-6626-4c88-8a05-d37f88c10df4|2|[?]|[?]|MODERATE|3|WASHOUT|2022-05-18|2022-01-06|2022-08-14|208|76|296|COINCIDENT|2022-05-26|AFTER|2022-07-05
Study ID|CE|c403ce49-1286-4be1-b906-8ec089e4fffe|1|[?]|[?]|MODERATE|1|SCREENING|2022-07-16|2021-11-03|2022-07-18|297|42|299|UNKNOWN|2022-05-15|BEFORE|2022-06-02
Study ID|CE|c403ce49-1286-4be1-b906-8ec089e4fffe|2|[?]|[?]|SEVERE|2|TREATMENT|2022-05-30|2021-11-14|2022-07-09|250|53|290|COINCIDENT|2022-02-21|AFTER|2022-03-31
Study ID|CE|7d519538-945d-49c6-be2d-a8b61f42b962|1|[?]|[?]|SEVERE|2|TREATMENT|2021-10-21|2021-10-20|2021-12-29|49|48|118|AFTER|2022-02-26|AFTER|2022-03-18
Study ID|CE|7d519538-945d-49c6-be2d-a8b61f42b962|2|[?]|[?]|SEVERE|2|TREATMENT|2021-09-14|2021-09-09|2022-01-02|12|7|122|BEFORE|2022-01-13|AFTER|2022-03-10
Study ID|CE|0a2112c2-242b-40c1-bfc1-1db362eee1d6|1|[?]|[?]|MILD|4|TREATMENT|2021-09-16|2021-08-21|2022-05-29|34|8|289|UNKNOWN|2021-11-14|AFTER|2021-11-15
Study ID|CE|0a2112c2-242b-40c1-bfc1-1db362eee1d6|2|[?]|[?]|MILD|7|FOLLOW-UP|2021-12-12|2021-10-24|2022-03-23|121|72|222|UNKNOWN|2022-03-21|AFTER|2022-03-29
Study ID|CE|1323f04e-64a4-4fca-ad08-ce9f8877ad19|1|[?]|[?]|MODERATE|4|TREATMENT|2022-06-25|2022-03-18|2022-08-18|240|141|294|COINCIDENT|2021-12-13|COINCIDENT|2022-01-03
Study ID|CE|1323f04e-64a4-4fca-ad08-ce9f8877ad19|2|[?]|[?]|MODERATE|4|TREATMENT|2021-12-12|2021-12-06|2022-08-20|45|39|296|COINCIDENT|2021-11-17|ONGOING|2021-11-18
Study ID|CE|debd39bf-afd2-4181-8dba-15969de2e52e|1|[?]|[?]|MILD|5|WASHOUT|2022-03-31|2021-12-09|2022-05-12|171|59|213|COINCIDENT|2022-06-30|BEFORE|2022-07-05
Study ID|CE|debd39bf-afd2-4181-8dba-15969de2e52e|2|[?]|[?]|MODERATE|3|WASHOUT|2022-05-09|2022-04-02|2022-05-16|210|173|217|AFTER|2021-11-28|ONGOING|2021-11-30
Study ID|CE|fe53160f-1cf3-4e3d-86e9-f579dfe7c3e1|1|[?]|[?]|SEVERE|3|WASHOUT|2021-10-04|2021-09-29|2022-05-29|9|4|246|UNKNOWN|2022-01-21|AFTER|2022-01-22
Study ID|CE|fe53160f-1cf3-4e3d-86e9-f579dfe7c3e1|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-28|2022-03-02|2022-07-16|276|158|294|COINCIDENT|2022-04-09|BEFORE|2022-04-10
Study ID|CE|1a37144b-9674-456f-9921-1cbad458c388|1|[?]|[?]|MODERATE|6|TREATMENT|2022-07-17|2021-10-23|2022-07-19|270|3|272|AFTER|2021-11-02|BEFORE|2021-11-03
Study ID|CE|1a37144b-9674-456f-9921-1cbad458c388|2|[?]|[?]|MODERATE|1|SCREENING|2022-05-30|2021-12-22|2022-08-13|222|63|297|AFTER|2021-12-05|BEFORE|2021-12-06
Study ID|CE|ecb9c7f9-d76a-49fb-9ee9-087f7442349a|1|[?]|[?]|MODERATE|3|WASHOUT|2022-01-24|2021-10-13|2022-06-01|132|29|260|BEFORE|2021-09-20|COINCIDENT|2021-09-21
Study ID|CE|ecb9c7f9-d76a-49fb-9ee9-087f7442349a|2|[?]|[?]|MILD|4|TREATMENT|2021-11-25|2021-09-25|2022-03-21|72|11|188|BEFORE|2022-01-05|AFTER|2022-03-19
Study ID|CE|8c57e3bc-53d5-4804-91a6-ad9cdb66f82b|1|[?]|[?]|MILD|1|SCREENING|2022-04-03|2021-11-26|2022-07-03|181|53|272|COINCIDENT|2022-05-13|ONGOING|2022-05-14
Study ID|CE|8c57e3bc-53d5-4804-91a6-ad9cdb66f82b|2|[?]|[?]|MODERATE|4|TREATMENT|2022-06-22|2022-05-10|2022-06-28|261|218|267|UNKNOWN|2021-11-16|AFTER|2021-12-05
Study ID|CE|e5973012-f101-497e-97ac-31dca1010976|1|[?]|[?]|MODERATE|3|WASHOUT|2022-05-27|2021-11-15|2022-06-30|226|33|260|BEFORE|2021-11-25|BEFORE|2021-11-26
Study ID|CE|e5973012-f101-497e-97ac-31dca1010976|2|[?]|[?]|SEVERE|2|TREATMENT|2021-10-30|2021-10-18|2022-04-10|17|5|179|COINCIDENT|2021-11-22|ONGOING|2021-12-01
Study ID|CE|69d3fc98-8093-4347-8d58-e32d75b8821d|1|[?]|[?]|MODERATE|4|TREATMENT|2022-05-15|2022-05-06|2022-06-27|225|216|268|UNKNOWN|2022-01-10|BEFORE|2022-03-27
Study ID|CE|69d3fc98-8093-4347-8d58-e32d75b8821d|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-01-03|2021-10-28|2022-06-08|93|26|249|AFTER|2022-01-25|AFTER|2022-05-28
Study ID|CE|8bdbec73-69a4-48b9-8663-13ef32c9a40d|1|[?]|[?]|MILD|1|SCREENING|2021-12-08|2021-10-07|2022-06-14|88|26|276|COINCIDENT|2022-03-24|ONGOING|2022-04-15
Study ID|CE|8bdbec73-69a4-48b9-8663-13ef32c9a40d|2|[?]|[?]|SEVERE|2|TREATMENT|2022-04-28|2021-10-31|2022-06-03|229|50|265|UNKNOWN|2022-01-15|BEFORE|2022-01-26
Study ID|CE|3e9d07b3-f91b-4c6c-a9c7-7b97fdb9b0d2|1|[?]|[?]|SEVERE|4|TREATMENT|2022-03-05|2022-01-12|2022-05-30|157|105|243|BEFORE|2022-02-09|COINCIDENT|2022-02-10
Study ID|CE|3e9d07b3-f91b-4c6c-a9c7-7b97fdb9b0d2|2|[?]|[?]|MODERATE|1|SCREENING|2021-12-08|2021-10-10|2022-01-11|70|11|104|BEFORE|2021-12-15|BEFORE|2021-12-16
Study ID|CE|ef3d99d3-a644-4dd0-b0c6-8921899aa59e|1|[?]|[?]|MODERATE|1|SCREENING|2022-01-17|2021-12-30|2022-01-28|103|85|114|COINCIDENT|2022-01-10|COINCIDENT|2022-01-19
Study ID|CE|ef3d99d3-a644-4dd0-b0c6-8921899aa59e|2|[?]|[?]|MODERATE|1|SCREENING|2021-11-07|2021-10-27|2022-02-19|32|21|136|BEFORE|2022-01-06|COINCIDENT|2022-01-20
Study ID|CE|6c70f183-90ac-436e-b1b4-6c9d23b2dbc4|1|[?]|[?]|SEVERE|2|TREATMENT|2022-04-25|2021-11-03|2022-06-01|228|55|265|UNKNOWN|2022-03-26|BEFORE|2022-03-26
Study ID|CE|6c70f183-90ac-436e-b1b4-6c9d23b2dbc4|2|[?]|[?]|SEVERE|6|TREATMENT|2021-12-11|2021-11-20|2022-01-30|93|72|143|UNKNOWN|2022-01-30|AFTER|2022-02-04
Study ID|CE|85cf4495-2bfc-41e5-88f7-fccea156c124|1|[?]|[?]|MODERATE|3|WASHOUT|2022-04-11|2022-03-11|2022-06-01|218|187|269|COINCIDENT|2022-03-20|ONGOING|2022-03-30
Study ID|CE|85cf4495-2bfc-41e5-88f7-fccea156c124|2|[?]|[?]|SEVERE|3|WASHOUT|2021-11-14|2021-10-18|2021-12-21|70|43|107|BEFORE|2021-11-04|BEFORE|2021-11-11
Study ID|CE|1330d021-2954-4531-a684-80f55b5a9644|1|[?]|[?]|SEVERE|6|TREATMENT|2021-08-27|2021-08-25|2022-03-03|7|5|195|AFTER|2021-12-17|AFTER|2022-01-07
Study ID|CE|1330d021-2954-4531-a684-80f55b5a9644|2|[?]|[?]|SEVERE|4|TREATMENT|2021-10-08|2021-09-25|2022-04-07|49|36|230|BEFORE|2022-04-03|BEFORE|2022-04-18
Study ID|CE|94f2f9da-dd24-4135-b61d-ee48c9dd801a|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-09-28|2021-09-27|2022-06-27|3|2|275|BEFORE|2021-10-09|ONGOING|2021-10-10
Study ID|CE|94f2f9da-dd24-4135-b61d-ee48c9dd801a|2|[?]|[?]|MILD|5|WASHOUT|2021-11-07|2021-11-01|2022-06-16|43|37|264|AFTER|2021-12-14|COINCIDENT|2022-01-22
Study ID|CE|cefcf4a6-bda8-4f39-8429-ccfaf2b815f2|1|[?]|[?]|MILD|3|WASHOUT|2022-04-10|2022-03-20|2022-04-29|245|224|264|UNKNOWN|2021-08-19|COINCIDENT|2021-08-20
Study ID|CE|cefcf4a6-bda8-4f39-8429-ccfaf2b815f2|2|[?]|[?]|SEVERE|5|WASHOUT|2022-01-23|2021-11-25|2022-01-25|168|109|170|COINCIDENT|2021-11-02|BEFORE|2021-12-05
Study ID|CE|5fd47059-e6ae-4ae2-84df-d5d6b19de07c|1|[?]|[?]|MILD|5|WASHOUT|2021-11-12|2021-09-14|2022-03-23|65|6|196|AFTER|2022-01-18|COINCIDENT|2022-04-03
Study ID|CE|5fd47059-e6ae-4ae2-84df-d5d6b19de07c|2|[?]|[?]|MILD|4|TREATMENT|2022-02-16|2021-10-03|2022-04-28|161|25|232|AFTER|2021-12-15|AFTER|2021-12-16
Study ID|CE|2b7029f5-5da5-4b3c-8b1c-190226b13524|1|[?]|[?]|MODERATE|2|TREATMENT|2021-12-19|2021-10-17|2022-06-15|97|34|275|BEFORE|2021-12-16|AFTER|2022-03-20
Study ID|CE|2b7029f5-5da5-4b3c-8b1c-190226b13524|2|[?]|[?]|MODERATE|1|SCREENING|2021-11-19|2021-10-06|2022-04-19|67|23|218|AFTER|2021-12-08|BEFORE|2021-12-25
Study ID|CE|5d80cf62-78a8-44fc-81a9-044537f0436f|1|[?]|[?]|MILD|5|WASHOUT|2021-09-25|2021-09-22|2021-11-23|7|4|66|AFTER|2022-06-02|COINCIDENT|2022-06-03
Study ID|CE|5d80cf62-78a8-44fc-81a9-044537f0436f|2|[?]|[?]|MODERATE|5|WASHOUT|2022-05-11|2021-11-23|2022-05-31|235|66|255|BEFORE|2022-05-21|ONGOING|2022-06-02
Study ID|CE|6a24825b-2ccc-4905-aad4-4bbaf7d3ffef|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-06-10|2021-11-30|2022-06-27|244|52|261|AFTER|2022-01-09|BEFORE|2022-01-18
Study ID|CE|6a24825b-2ccc-4905-aad4-4bbaf7d3ffef|2|[?]|[?]|MILD|2|TREATMENT|2022-06-08|2022-04-27|2022-07-09|242|200|273|COINCIDENT|2021-11-25|ONGOING|2021-11-30
Study ID|CE|c68b6ff6-fba7-4e68-9e36-3242b1182910|1|[?]|[?]|SEVERE|3|WASHOUT|2022-04-05|2022-01-05|2022-05-14|231|141|270|BEFORE|2021-12-10|COINCIDENT|2021-12-11
Study ID|CE|c68b6ff6-fba7-4e68-9e36-3242b1182910|2|[?]|[?]|SEVERE|5|WASHOUT|2022-02-19|2021-09-05|2022-06-01|186|19|288|UNKNOWN|2022-04-18|ONGOING|2022-04-19
Study ID|CE|8e4a02c9-3671-49aa-99d9-5ff4a86b707d|1|[?]|[?]|SEVERE|3|WASHOUT|2022-01-27|2021-12-26|2022-05-22|151|119|266|AFTER|2022-01-07|ONGOING|2022-02-19
Study ID|CE|8e4a02c9-3671-49aa-99d9-5ff4a86b707d|2|[?]|[?]|SEVERE|3|WASHOUT|2021-12-20|2021-11-19|2021-12-28|113|82|121|COINCIDENT|2022-01-30|ONGOING|2022-04-02
Study ID|CE|3e684a59-b5ac-4730-a2fe-13595dc2c8a6|1|[?]|[?]|SEVERE|3|WASHOUT|2022-02-21|2022-02-20|2022-04-17|120|119|175|UNKNOWN|2022-05-14|AFTER|2022-06-03
Study ID|CE|3e684a59-b5ac-4730-a2fe-13595dc2c8a6|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-03-18|2022-01-21|2022-04-03|145|89|161|AFTER|2022-06-21|COINCIDENT|2022-06-23
Study ID|CE|e38a9fd6-aee5-48b0-a13a-864415fe9728|1|[?]|[?]|SEVERE|6|TREATMENT|2021-10-02|2021-09-29|2021-12-22|46|43|127|COINCIDENT|2021-08-20|ONGOING|2021-08-21
Study ID|CE|e38a9fd6-aee5-48b0-a13a-864415fe9728|2|[?]|[?]|MODERATE|3|WASHOUT|2021-09-18|2021-09-07|2022-05-26|32|21|282|COINCIDENT|2021-11-28|BEFORE|2021-12-04
Study ID|CE|d751eafe-b68d-4494-9109-7f13e6b64234|1|[?]|[?]|SEVERE|2|TREATMENT|2022-05-09|2022-04-09|2022-07-22|215|185|289|AFTER|2021-11-05|BEFORE|2021-11-13
Study ID|CE|d751eafe-b68d-4494-9109-7f13e6b64234|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-10-16|2021-10-09|2022-04-14|10|3|190|UNKNOWN|2022-03-05|BEFORE|2022-03-09
Study ID|CE|bf7ed2f3-70c6-4686-8bff-27fb4fab8c29|1|[?]|[?]|MODERATE|4|TREATMENT|2022-01-31|2021-10-04|2022-02-13|144|25|157|BEFORE|2021-12-10|COINCIDENT|2022-01-07
Study ID|CE|bf7ed2f3-70c6-4686-8bff-27fb4fab8c29|2|[?]|[?]|SEVERE|4|TREATMENT|2022-05-28|2021-10-31|2022-06-10|261|52|274|COINCIDENT|2021-09-20|BEFORE|2021-09-29
Study ID|CE|b01188af-a822-4411-a34c-65922fa92047|1|[?]|[?]|MODERATE|5|WASHOUT|2022-05-13|2021-11-27|2022-06-11|244|77|273|BEFORE|2021-11-07|COINCIDENT|2022-02-17
Study ID|CE|b01188af-a822-4411-a34c-65922fa92047|2|[?]|[?]|SEVERE|3|WASHOUT|2022-04-29|2022-01-11|2022-05-22|230|122|253|AFTER|2022-03-21|BEFORE|2022-05-07
Study ID|CE|9b873e9b-37fa-4e3e-9068-a2b87fea1604|1|[?]|[?]|SEVERE|2|TREATMENT|2021-11-15|2021-10-04|2022-02-19|68|26|164|AFTER|2021-10-12|BEFORE|2021-10-22
Study ID|CE|9b873e9b-37fa-4e3e-9068-a2b87fea1604|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-03-13|2022-01-04|2022-06-06|186|118|271|AFTER|2021-10-09|COINCIDENT|2022-02-13
Study ID|CE|0cf1fa7a-9450-41d2-8bad-790918f3ff0b|1|[?]|[?]|MODERATE|3|WASHOUT|2022-02-21|2021-12-01|2022-07-15|126|44|270|AFTER|2022-04-03|ONGOING|2022-04-04
Study ID|CE|0cf1fa7a-9450-41d2-8bad-790918f3ff0b|2|[?]|[?]|MILD|6|TREATMENT|2022-05-28|2021-11-08|2022-06-07|222|21|232|UNKNOWN|2021-10-24|BEFORE|2021-11-06
Study ID|CE|217a3159-2d8d-40f8-9593-4730883a5f94|1|[?]|[?]|MODERATE|1|SCREENING|2021-10-21|2021-10-18|2022-05-02|6|3|199|COINCIDENT|2022-04-26|BEFORE|2022-04-28
Study ID|CE|217a3159-2d8d-40f8-9593-4730883a5f94|2|[?]|[?]|MILD|4|TREATMENT|2022-05-15|2022-04-07|2022-07-15|212|174|273|AFTER|2022-05-06|BEFORE|2022-06-04
Study ID|CE|0c713211-b021-4d3b-bca5-4a90d0731fa3|1|[?]|[?]|MODERATE|4|TREATMENT|2021-08-26|2021-08-19|2022-04-02|16|9|235|BEFORE|2021-09-28|BEFORE|2021-09-29
Study ID|CE|0c713211-b021-4d3b-bca5-4a90d0731fa3|2|[?]|[?]|SEVERE|1|SCREENING|2021-11-26|2021-09-25|2022-03-07|108|46|209|UNKNOWN|2022-04-04|ONGOING|2022-04-22
Study ID|CE|324b1ffb-952e-40ae-b9d5-de801b0dd515|1|[?]|[?]|MILD|3|WASHOUT|2022-06-24|2021-09-20|2022-06-26|292|15|294|AFTER|2021-09-16|BEFORE|2021-09-17
Study ID|CE|324b1ffb-952e-40ae-b9d5-de801b0dd515|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-10-15|2021-09-15|2022-01-23|40|10|140|AFTER|2021-12-12|ONGOING|2022-01-05
Study ID|CE|229d8b75-df53-4cf4-b163-4338f51354ca|1|[?]|[?]|SEVERE|2|TREATMENT|2022-01-10|2021-10-19|2022-02-02|144|61|167|AFTER|2021-09-17|ONGOING|2021-09-20
Study ID|CE|229d8b75-df53-4cf4-b163-4338f51354ca|2|[?]|[?]|MODERATE|6|TREATMENT|2021-12-06|2021-11-17|2022-05-05|109|90|259|COINCIDENT|2022-03-27|ONGOING|2022-04-15
Study ID|CE|36814c94-db9d-487c-81aa-22c2bfe89fb6|1|[?]|[?]|MILD|5|WASHOUT|2021-11-02|2021-10-27|2022-03-27|11|5|156|COINCIDENT|2022-02-21|BEFORE|2022-05-26
Study ID|CE|36814c94-db9d-487c-81aa-22c2bfe89fb6|2|[?]|[?]|MODERATE|3|WASHOUT|2021-12-05|2021-11-13|2022-05-17|44|22|207|AFTER|2022-06-03|BEFORE|2022-06-18
Study ID|CE|99f42caa-8619-4864-b717-42594d2c1c4d|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-02-14|2021-12-12|2022-08-14|112|48|293|COINCIDENT|2021-11-12|ONGOING|2021-11-13
Study ID|CE|99f42caa-8619-4864-b717-42594d2c1c4d|2|[?]|[?]|MILD|1|SCREENING|2022-01-10|2021-11-19|2022-07-21|77|25|269|UNKNOWN|2022-06-04|COINCIDENT|2022-06-16
Study ID|CE|fc9a7c4b-b2df-42d5-bafb-909b518df602|1|[?]|[?]|MODERATE|3|WASHOUT|2021-10-28|2021-09-30|2022-04-22|43|15|219|COINCIDENT|2022-06-10|COINCIDENT|2022-06-12
Study ID|CE|fc9a7c4b-b2df-42d5-bafb-909b518df602|2|[?]|[?]|MILD|5|WASHOUT|2021-11-05|2021-09-25|2021-11-23|51|10|69|UNKNOWN|2021-10-27|COINCIDENT|2021-10-27
Study ID|CE|b72d89cb-cbd0-4a2a-b2b6-73ab91370632|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-11-20|2021-11-16|2022-04-21|38|34|190|AFTER|2021-11-12|AFTER|2021-11-21
Study ID|CE|b72d89cb-cbd0-4a2a-b2b6-73ab91370632|2|[?]|[?]|SEVERE|6|TREATMENT|2021-12-01|2021-11-02|2022-02-05|49|20|115|COINCIDENT|2021-10-27|ONGOING|2021-11-01
Study ID|CE|60991758-1054-4201-9716-4b24ae56beaf|1|[?]|[?]|MODERATE|1|SCREENING|2022-03-16|2021-10-22|2022-06-04|219|74|299|COINCIDENT|2021-12-24|AFTER|2022-01-11
Study ID|CE|60991758-1054-4201-9716-4b24ae56beaf|2|[?]|[?]|MODERATE|2|TREATMENT|2021-10-21|2021-08-11|2022-01-16|73|2|160|UNKNOWN|2021-09-11|BEFORE|2021-09-20
Study ID|CE|3dbd06b5-5838-4494-ac8a-cad254dae8ae|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-09-18|2021-09-17|2022-06-27|5|4|287|UNKNOWN|2022-01-28|ONGOING|2022-01-30
Study ID|CE|3dbd06b5-5838-4494-ac8a-cad254dae8ae|2|[?]|[?]|MILD|7|FOLLOW-UP|2021-12-13|2021-11-10|2021-12-23|91|58|101|COINCIDENT|2022-04-01|BEFORE|2022-04-11
Study ID|CE|85fd26a5-3a3f-4fb7-adc2-000a24ec595b|1|[?]|[?]|MODERATE|6|TREATMENT|2021-12-26|2021-11-16|2022-02-28|116|76|180|UNKNOWN|2021-10-27|COINCIDENT|2021-10-31
Study ID|CE|85fd26a5-3a3f-4fb7-adc2-000a24ec595b|2|[?]|[?]|MILD|3|WASHOUT|2022-06-04|2021-12-07|2022-06-22|276|97|294|UNKNOWN|2022-04-29|COINCIDENT|2022-04-30
Study ID|CE|f6de105a-14b1-49d2-a1ef-273e4f0729b7|1|[?]|[?]|MILD|7|FOLLOW-UP|2021-11-24|2021-10-11|2022-03-29|77|33|202|AFTER|2022-04-20|AFTER|2022-04-21
Study ID|CE|f6de105a-14b1-49d2-a1ef-273e4f0729b7|2|[?]|[?]|MODERATE|1|SCREENING|2022-03-15|2022-03-02|2022-04-29|188|175|233|UNKNOWN|2022-01-17|COINCIDENT|2022-02-27
Study ID|CE|09e91029-8b43-4d2f-a4e3-632be587394f|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-01-28|2021-11-07|2022-04-29|172|90|263|AFTER|2022-04-05|COINCIDENT|2022-04-09
Study ID|CE|09e91029-8b43-4d2f-a4e3-632be587394f|2|[?]|[?]|MODERATE|5|WASHOUT|2021-10-17|2021-10-06|2022-02-01|69|58|176|BEFORE|2022-01-11|BEFORE|2022-02-14
Study ID|CE|5c00668d-44b0-4d1f-8da8-435da5b088f5|1|[?]|[?]|SEVERE|3|WASHOUT|2022-03-29|2021-12-20|2022-06-06|171|72|240|AFTER|2021-12-01|BEFORE|2021-12-04
Study ID|CE|5c00668d-44b0-4d1f-8da8-435da5b088f5|2|[?]|[?]|MODERATE|6|TREATMENT|2022-04-28|2022-04-06|2022-07-06|201|179|270|UNKNOWN|2021-10-13|COINCIDENT|2021-10-13
Study ID|CE|09add726-3b75-472e-b0c3-6006a15380f5|1|[?]|[?]|SEVERE|3|WASHOUT|2022-04-01|2022-03-27|2022-05-06|155|150|190|UNKNOWN|2022-06-09|BEFORE|2022-07-01
Study ID|CE|09add726-3b75-472e-b0c3-6006a15380f5|2|[?]|[?]|MILD|3|WASHOUT|2021-11-23|2021-10-31|2022-08-13|26|3|289|AFTER|2021-12-30|COINCIDENT|2022-01-06
Study ID|CE|b51ef82f-586a-4ac9-a0d6-4f68875f3f82|1|[?]|[?]|MODERATE|2|TREATMENT|2022-03-25|2021-10-29|2022-07-29|156|9|282|BEFORE|2022-03-02|AFTER|2022-03-22
Study ID|CE|b51ef82f-586a-4ac9-a0d6-4f68875f3f82|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-11-11|2021-10-22|2022-02-19|22|2|122|BEFORE|2022-02-08|BEFORE|2022-02-12
Study ID|CE|7bd4f72b-7c16-48f2-bc05-25e91e874731|1|[?]|[?]|SEVERE|5|WASHOUT|2021-11-29|2021-10-13|2022-03-29|50|3|170|AFTER|2021-12-21|BEFORE|2021-12-29
Study ID|CE|7bd4f72b-7c16-48f2-bc05-25e91e874731|2|[?]|[?]|MODERATE|3|WASHOUT|2021-11-22|2021-11-08|2021-12-03|43|29|54|BEFORE|2021-12-30|AFTER|2022-01-18
Study ID|CE|130f73ca-f82c-4811-a177-5f7b00d48419|1|[?]|[?]|MILD|3|WASHOUT|2021-12-11|2021-10-24|2021-12-30|63|15|82|AFTER|2022-01-21|AFTER|2022-01-25
Study ID|CE|130f73ca-f82c-4811-a177-5f7b00d48419|2|[?]|[?]|MODERATE|4|TREATMENT|2022-03-29|2022-03-08|2022-04-06|171|150|179|BEFORE|2021-12-20|AFTER|2021-12-27
Study ID|CE|c54c8670-10d9-4405-9540-ae64c6af702c|1|[?]|[?]|MILD|4|TREATMENT|2021-12-12|2021-10-12|2022-05-13|85|24|237|AFTER|2022-01-11|AFTER|2022-01-12
Study ID|CE|c54c8670-10d9-4405-9540-ae64c6af702c|2|[?]|[?]|MILD|3|WASHOUT|2021-09-25|2021-09-22|2022-05-06|7|4|230|COINCIDENT|2021-11-17|ONGOING|2021-11-19
Study ID|CE|80a63cef-bcfc-4b49-80bc-7f6cf7e77a71|1|[?]|[?]|MILD|3|WASHOUT|2022-05-11|2022-01-01|2022-06-05|268|138|293|BEFORE|2021-12-24|AFTER|2022-04-02
Study ID|CE|80a63cef-bcfc-4b49-80bc-7f6cf7e77a71|2|[?]|[?]|SEVERE|6|TREATMENT|2022-04-19|2021-10-21|2022-05-19|246|66|276|BEFORE|2021-11-02|COINCIDENT|2021-12-01
Study ID|CE|2873c83e-0c3d-40b5-98ed-521ad0559370|1|[?]|[?]|MODERATE|6|TREATMENT|2022-02-14|2021-12-13|2022-03-22|147|84|183|BEFORE|2022-02-09|BEFORE|2022-02-13
Study ID|CE|2873c83e-0c3d-40b5-98ed-521ad0559370|2|[?]|[?]|MODERATE|2|TREATMENT|2022-07-06|2021-11-27|2022-07-16|289|68|299|AFTER|2021-10-03|AFTER|2021-10-12
Study ID|CE|05988326-eade-4aba-bba3-1ae3a95cf672|1|[?]|[?]|MILD|4|TREATMENT|2022-02-11|2022-01-08|2022-05-04|176|142|258|BEFORE|2021-09-29|BEFORE|2022-03-01
Study ID|CE|05988326-eade-4aba-bba3-1ae3a95cf672|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-01-28|2021-11-26|2022-04-25|162|99|249|BEFORE|2021-11-04|AFTER|2021-12-05
Study ID|CE|a2c5ff67-5280-4949-b01e-b6e148bfdf16|1|[?]|[?]|SEVERE|5|WASHOUT|2022-05-07|2022-05-05|2022-05-13|251|249|257|UNKNOWN|2021-10-07|ONGOING|2021-11-15
Study ID|CE|a2c5ff67-5280-4949-b01e-b6e148bfdf16|2|[?]|[?]|MODERATE|5|WASHOUT|2022-01-16|2021-12-13|2022-02-13|140|106|168|BEFORE|2022-03-13|BEFORE|2022-04-03
Study ID|CE|58434e9b-ce78-4bb8-8c19-3edaffd41442|1|[?]|[?]|MODERATE|6|TREATMENT|2021-12-22|2021-11-28|2022-02-05|74|50|119|BEFORE|2022-01-01|COINCIDENT|2022-01-10
Study ID|CE|58434e9b-ce78-4bb8-8c19-3edaffd41442|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-10-18|2021-10-11|2022-04-15|9|2|188|AFTER|2021-12-01|ONGOING|2022-01-29
Study ID|CE|29e2110f-69f6-47e7-b412-f1490d15855e|1|[?]|[?]|MODERATE|3|WASHOUT|2021-12-05|2021-11-12|2022-03-28|60|37|173|BEFORE|2021-12-06|BEFORE|2021-12-07
Study ID|CE|29e2110f-69f6-47e7-b412-f1490d15855e|2|[?]|[?]|MODERATE|2|TREATMENT|2022-05-28|2021-10-26|2022-07-08|234|20|275|AFTER|2022-04-04|COINCIDENT|2022-05-03
Study ID|CE|60fcbb9e-b305-4e8f-8f51-ec65bccba7c0|1|[?]|[?]|MILD|7|FOLLOW-UP|2021-09-15|2021-09-15|2021-11-26|2|2|74|BEFORE|2021-10-18|AFTER|2021-10-23
Study ID|CE|60fcbb9e-b305-4e8f-8f51-ec65bccba7c0|2|[?]|[?]|MODERATE|4|TREATMENT|2022-04-19|2021-09-17|2022-04-21|218|4|220|AFTER|2021-09-27|AFTER|2021-10-08
Study ID|CE|d54966ca-f53b-4ebe-80eb-43184a62a26c|1|[?]|[?]|MILD|3|WASHOUT|2021-10-26|2021-10-17|2022-07-13|15|6|275|BEFORE|2022-03-16|AFTER|2022-04-27
Study ID|CE|d54966ca-f53b-4ebe-80eb-43184a62a26c|2|[?]|[?]|MODERATE|5|WASHOUT|2022-07-31|2022-05-24|2022-08-06|293|225|299|COINCIDENT|2021-12-26|COINCIDENT|2021-12-28
Study ID|CE|85e86c83-ac59-4eff-9919-bc373b99ec0a|1|[?]|[?]|SEVERE|2|TREATMENT|2022-02-15|2022-01-19|2022-05-18|157|130|249|COINCIDENT|2021-12-23|AFTER|2021-12-24
Study ID|CE|85e86c83-ac59-4eff-9919-bc373b99ec0a|2|[?]|[?]|SEVERE|5|WASHOUT|2022-07-04|2022-06-04|2022-07-05|296|266|297|AFTER|2022-03-19|AFTER|2022-03-27
Study ID|CE|c5c66bf5-c3d4-4970-9aa8-aede675abbd1|1|[?]|[?]|SEVERE|5|WASHOUT|2022-01-29|2022-01-04|2022-07-29|107|82|288|UNKNOWN|2021-11-08|AFTER|2021-11-10
Study ID|CE|c5c66bf5-c3d4-4970-9aa8-aede675abbd1|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-07-26|2022-01-12|2022-07-30|285|90|289|COINCIDENT|2022-04-01|BEFORE|2022-04-11
Study ID|CE|c8869166-757e-47e0-ab64-263a9d7656b6|1|[?]|[?]|MILD|1|SCREENING|2022-05-22|2021-12-10|2022-06-28|221|58|258|AFTER|2022-03-03|COINCIDENT|2022-03-06
Study ID|CE|c8869166-757e-47e0-ab64-263a9d7656b6|2|[?]|[?]|SEVERE|5|WASHOUT|2022-07-13|2022-04-27|2022-07-27|273|196|287|AFTER|2022-03-16|COINCIDENT|2022-03-18
Study ID|CE|f86d76f1-768e-4e57-89b6-7aedc9354f06|1|[?]|[?]|MODERATE|2|TREATMENT|2021-09-11|2021-09-07|2022-01-07|16|12|134|AFTER|2021-09-10|BEFORE|2021-10-03
Study ID|CE|f86d76f1-768e-4e57-89b6-7aedc9354f06|2|[?]|[?]|MODERATE|6|TREATMENT|2022-03-13|2022-01-03|2022-05-09|199|130|256|BEFORE|2021-08-28|BEFORE|2021-08-28
Study ID|CE|fce3efcc-0df4-45c3-8923-68a138d27d73|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-03-23|2022-01-19|2022-07-18|167|104|284|COINCIDENT|2022-05-26|ONGOING|2022-06-13
Study ID|CE|fce3efcc-0df4-45c3-8923-68a138d27d73|2|[?]|[?]|MODERATE|2|TREATMENT|2022-03-31|2021-12-06|2022-06-06|175|60|242|UNKNOWN|2021-10-10|BEFORE|2021-10-10
Study ID|CE|ee0af298-ceb4-4439-8668-328d7b1f0b6a|1|[?]|[?]|MODERATE|4|TREATMENT|2022-06-26|2021-12-12|2022-07-03|282|86|289|UNKNOWN|2022-05-17|COINCIDENT|2022-06-10
Study ID|CE|ee0af298-ceb4-4439-8668-328d7b1f0b6a|2|[?]|[?]|MILD|6|TREATMENT|2021-11-18|2021-10-19|2022-06-07|62|32|263|AFTER|2021-11-29|ONGOING|2021-12-07
Study ID|CE|d06e8baf-1bbc-4d73-b527-34fd1b395292|1|[?]|[?]|MODERATE|5|WASHOUT|2022-07-26|2021-12-02|2022-07-30|288|52|292|AFTER|2021-12-26|COINCIDENT|2022-01-22
Study ID|CE|d06e8baf-1bbc-4d73-b527-34fd1b395292|2|[?]|[?]|SEVERE|3|WASHOUT|2022-01-06|2021-11-09|2022-03-27|87|29|167|COINCIDENT|2021-12-05|AFTER|2021-12-08
Study ID|CE|74717162-82c4-4d83-a77e-4f3078e4a004|1|[?]|[?]|SEVERE|1|SCREENING|2022-06-20|2021-11-23|2022-06-25|242|33|247|AFTER|2022-07-07|AFTER|2022-07-08
Study ID|CE|74717162-82c4-4d83-a77e-4f3078e4a004|2|[?]|[?]|MODERATE|5|WASHOUT|2022-01-25|2021-12-26|2022-07-21|96|66|273|UNKNOWN|2022-02-22|BEFORE|2022-02-28
Study ID|CE|6f3b2913-194d-4844-80d5-70a3701f5cb8|1|[?]|[?]|MILD|7|FOLLOW-UP|2021-11-01|2021-10-31|2022-05-10|44|43|234|AFTER|2021-12-29|COINCIDENT|2022-01-01
Study ID|CE|6f3b2913-194d-4844-80d5-70a3701f5cb8|2|[?]|[?]|MILD|3|WASHOUT|2022-06-26|2021-10-15|2022-07-05|281|27|290|AFTER|2021-11-08|BEFORE|2021-11-25
Study ID|CE|3b6b4fd0-0730-4398-8f67-9d8cbd4e8465|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-04-05|2021-09-08|2022-04-22|231|22|248|AFTER|2021-10-09|AFTER|2021-12-09
Study ID|CE|3b6b4fd0-0730-4398-8f67-9d8cbd4e8465|2|[?]|[?]|SEVERE|4|TREATMENT|2022-05-27|2022-03-29|2022-06-06|283|224|293|COINCIDENT|2021-08-23|COINCIDENT|2021-08-23
Study ID|CE|c208988f-4212-4eb2-b348-24442f85af9b|1|[?]|[?]|SEVERE|4|TREATMENT|2022-04-23|2022-03-07|2022-05-27|239|192|273|BEFORE|2021-11-18|COINCIDENT|2022-01-30
Study ID|CE|c208988f-4212-4eb2-b348-24442f85af9b|2|[?]|[?]|MILD|1|SCREENING|2022-05-26|2022-03-17|2022-06-08|272|202|285|UNKNOWN|2021-09-21|COINCIDENT|2021-09-29
Study ID|CE|3791a6ab-a874-4b57-9611-26d8eb585711|1|[?]|[?]|MILD|3|WASHOUT|2021-08-28|2021-08-25|2022-02-21|18|15|195|COINCIDENT|2022-01-04|AFTER|2022-01-06
Study ID|CE|3791a6ab-a874-4b57-9611-26d8eb585711|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-04-20|2021-10-22|2022-05-05|253|73|268|UNKNOWN|2022-02-12|ONGOING|2022-03-04
Study ID|CE|814f4185-6b93-45b3-a04f-bc65b47af956|1|[?]|[?]|SEVERE|4|TREATMENT|2022-04-08|2021-10-18|2022-07-12|189|17|284|UNKNOWN|2021-11-08|COINCIDENT|2021-11-13
Study ID|CE|814f4185-6b93-45b3-a04f-bc65b47af956|2|[?]|[?]|MODERATE|5|WASHOUT|2021-10-06|2021-10-03|2022-06-19|5|2|261|AFTER|2022-07-22|AFTER|2022-07-24
Study ID|CE|91b47cdc-d93b-415e-ac54-482a23e15c6c|1|[?]|[?]|MILD|5|WASHOUT|2022-03-10|2021-12-26|2022-03-20|206|132|216|COINCIDENT|2021-10-29|AFTER|2021-12-02
Study ID|CE|91b47cdc-d93b-415e-ac54-482a23e15c6c|2|[?]|[?]|MODERATE|3|WASHOUT|2022-03-09|2021-09-04|2022-06-01|205|19|289|AFTER|2022-02-27|AFTER|2022-02-28
Study ID|CE|0a501dd0-6dca-47e4-9d7e-a773a9c5825c|1|[?]|[?]|MILD|2|TREATMENT|2022-06-25|2022-03-02|2022-08-07|250|135|293|AFTER|2021-10-30|ONGOING|2021-10-31
Study ID|CE|0a501dd0-6dca-47e4-9d7e-a773a9c5825c|2|[?]|[?]|MODERATE|1|SCREENING|2022-01-23|2021-12-08|2022-02-08|97|51|113|UNKNOWN|2022-05-06|ONGOING|2022-07-12
Study ID|CE|e929ba72-b74d-4c71-82f9-da766e17fd6f|1|[?]|[?]|MODERATE|3|WASHOUT|2022-04-04|2022-01-11|2022-05-02|239|156|267|COINCIDENT|2022-01-04|COINCIDENT|2022-01-07
Study ID|CE|e929ba72-b74d-4c71-82f9-da766e17fd6f|2|[?]|[?]|MILD|5|WASHOUT|2021-11-25|2021-10-07|2022-04-11|109|60|246|AFTER|2022-03-16|ONGOING|2022-03-22
Study ID|CE|1f125b08-c7fb-4c6b-b64b-38ce4a50a74b|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-11-02|2021-10-30|2022-05-06|6|3|191|UNKNOWN|2022-01-28|ONGOING|2022-01-29
Study ID|CE|1f125b08-c7fb-4c6b-b64b-38ce4a50a74b|2|[?]|[?]|SEVERE|2|TREATMENT|2022-06-12|2021-11-16|2022-06-15|228|20|231|UNKNOWN|2022-02-02|COINCIDENT|2022-02-10
Study ID|CE|f7ff7030-27e7-4d60-b511-2c6c2bd9eb4f|1|[?]|[?]|MILD|1|SCREENING|2021-10-31|2021-09-11|2021-11-25|70|20|95|COINCIDENT|2022-03-25|COINCIDENT|2022-04-26
Study ID|CE|f7ff7030-27e7-4d60-b511-2c6c2bd9eb4f|2|[?]|[?]|MILD|1|SCREENING|2021-11-09|2021-10-02|2022-06-06|79|41|288|UNKNOWN|2022-01-29|BEFORE|2022-02-20
Study ID|CE|3d436511-0dce-4437-b15b-932141264f50|1|[?]|[?]|SEVERE|3|WASHOUT|2022-06-06|2022-03-01|2022-06-12|277|180|283|BEFORE|2022-02-03|AFTER|2022-06-04
Study ID|CE|3d436511-0dce-4437-b15b-932141264f50|2|[?]|[?]|MILD|4|TREATMENT|2022-03-31|2021-09-05|2022-06-24|210|3|295|UNKNOWN|2021-10-27|AFTER|2022-01-25
Study ID|CE|a0b6b2a4-910a-4c3c-87b6-48ee38dfa2f7|1|[?]|[?]|SEVERE|1|SCREENING|2022-03-23|2022-02-16|2022-04-29|216|181|253|BEFORE|2022-01-06|ONGOING|2022-04-18
Study ID|CE|a0b6b2a4-910a-4c3c-87b6-48ee38dfa2f7|2|[?]|[?]|SEVERE|5|WASHOUT|2021-11-19|2021-10-26|2022-02-03|92|68|168|AFTER|2022-01-03|BEFORE|2022-01-07
Study ID|CE|eb0b2151-9ebc-44cb-8667-15fe2bfd4e46|1|[?]|[?]|MODERATE|3|WASHOUT|2021-11-19|2021-10-29|2021-12-09|24|3|44|COINCIDENT|2022-07-07|BEFORE|2022-07-16
Study ID|CE|eb0b2151-9ebc-44cb-8667-15fe2bfd4e46|2|[?]|[?]|MILD|4|TREATMENT|2022-04-11|2021-12-03|2022-05-16|167|38|202|BEFORE|2022-01-13|ONGOING|2022-02-20
Study ID|CE|ab4630d3-b303-4abf-b74a-944ec3fdae75|1|[?]|[?]|SEVERE|5|WASHOUT|2021-10-13|2021-10-13|2022-03-02|2|2|142|BEFORE|2022-02-23|AFTER|2022-04-16
Study ID|CE|ab4630d3-b303-4abf-b74a-944ec3fdae75|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-06-07|2021-12-02|2022-06-28|239|52|260|AFTER|2021-11-15|COINCIDENT|2021-12-03
Study ID|CE|885d9228-b3dd-4c95-90be-6596c61a3b05|1|[?]|[?]|SEVERE|2|TREATMENT|2022-06-11|2021-09-16|2022-06-12|291|23|292|COINCIDENT|2021-09-17|ONGOING|2021-09-19
Study ID|CE|885d9228-b3dd-4c95-90be-6596c61a3b05|2|[?]|[?]|SEVERE|2|TREATMENT|2022-06-06|2021-11-07|2022-06-19|286|75|299|BEFORE|2022-04-19|AFTER|2022-05-08
Study ID|CE|01c22518-040f-41f9-ac4e-622da72ea8bb|1|[?]|[?]|SEVERE|5|WASHOUT|2022-03-08|2022-02-21|2022-04-04|177|162|204|UNKNOWN|2022-01-03|AFTER|2022-01-24
Study ID|CE|01c22518-040f-41f9-ac4e-622da72ea8bb|2|[?]|[?]|MILD|3|WASHOUT|2021-11-09|2021-10-22|2022-01-30|58|40|140|BEFORE|2021-10-22|COINCIDENT|2021-11-14
Study ID|CE|2a190ec9-08e6-4b07-ae4e-da7c896fb02d|1|[?]|[?]|MODERATE|3|WASHOUT|2022-01-26|2021-11-03|2022-03-18|156|72|207|BEFORE|2022-01-22|BEFORE|2022-01-23
Study ID|CE|2a190ec9-08e6-4b07-ae4e-da7c896fb02d|2|[?]|[?]|SEVERE|4|TREATMENT|2021-11-29|2021-10-08|2022-06-07|98|46|288|COINCIDENT|2021-12-16|AFTER|2022-01-02
Study ID|CE|a90c7293-d8b1-4555-8b71-29e5d9707635|1|[?]|[?]|MODERATE|4|TREATMENT|2022-04-07|2022-03-31|2022-05-22|242|235|287|COINCIDENT|2021-11-08|COINCIDENT|2021-11-16
Study ID|CE|a90c7293-d8b1-4555-8b71-29e5d9707635|2|[?]|[?]|MILD|4|TREATMENT|2021-10-20|2021-08-21|2022-03-20|73|13|224|AFTER|2022-02-01|BEFORE|2022-02-02
Study ID|CE|2b963e8c-d7d4-4a5d-8371-3ea9273624bf|1|[?]|[?]|MILD|1|SCREENING|2021-11-20|2021-11-04|2022-04-07|22|6|160|BEFORE|2021-12-22|COINCIDENT|2022-01-21
Study ID|CE|2b963e8c-d7d4-4a5d-8371-3ea9273624bf|2|[?]|[?]|MODERATE|3|WASHOUT|2022-04-12|2022-01-08|2022-05-11|165|71|194|UNKNOWN|2021-11-15|BEFORE|2021-11-16
Study ID|CE|64fdccee-e171-44be-b8a6-2cd692ac2a5d|1|[?]|[?]|MODERATE|3|WASHOUT|2022-07-18|2022-05-10|2022-08-05|280|211|298|BEFORE|2021-12-03|BEFORE|2022-01-05
Study ID|CE|64fdccee-e171-44be-b8a6-2cd692ac2a5d|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-04-08|2021-11-05|2022-05-11|179|25|212|UNKNOWN|2022-04-25|AFTER|2022-04-26
Study ID|CE|273f51b2-e379-40cd-9db2-6dc6b8e27d7c|1|[?]|[?]|MODERATE|6|TREATMENT|2021-10-28|2021-08-28|2022-01-19|81|20|164|UNKNOWN|2021-12-18|ONGOING|2021-12-29
Study ID|CE|273f51b2-e379-40cd-9db2-6dc6b8e27d7c|2|[?]|[?]|SEVERE|5|WASHOUT|2021-10-22|2021-10-02|2021-11-15|75|55|99|COINCIDENT|2021-09-14|ONGOING|2021-09-15
Study ID|CE|d5581a4d-39c5-4632-82e5-ac43f43641e9|1|[?]|[?]|MILD|2|TREATMENT|2022-06-05|2022-02-13|2022-06-24|261|149|280|UNKNOWN|2022-01-01|COINCIDENT|2022-01-08
Study ID|CE|d5581a4d-39c5-4632-82e5-ac43f43641e9|2|[?]|[?]|MODERATE|3|WASHOUT|2021-12-24|2021-11-09|2022-04-05|98|53|200|COINCIDENT|2022-04-05|ONGOING|2022-04-07
Study ID|CE|23e77b5d-4802-42d0-8dba-af4b45303337|1|[?]|[?]|SEVERE|5|WASHOUT|2022-01-19|2021-11-06|2022-01-21|106|32|108|BEFORE|2021-11-08|ONGOING|2022-03-05
Study ID|CE|23e77b5d-4802-42d0-8dba-af4b45303337|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-21|2022-04-28|2022-07-01|259|205|269|UNKNOWN|2022-06-17|BEFORE|2022-06-18
Study ID|CE|316f549c-6079-4363-a85b-e1e253be2f93|1|[?]|[?]|MODERATE|2|TREATMENT|2021-12-24|2021-12-03|2022-02-07|114|93|159|BEFORE|2022-01-25|ONGOING|2022-02-06
Study ID|CE|316f549c-6079-4363-a85b-e1e253be2f93|2|[?]|[?]|MILD|2|TREATMENT|2022-01-11|2021-10-07|2022-04-11|132|36|222|AFTER|2021-11-16|AFTER|2022-02-12
Study ID|CE|a3abeeb6-eaf0-4eab-a899-30705e4d155a|1|[?]|[?]|SEVERE|2|TREATMENT|2021-12-09|2021-11-14|2022-01-19|73|48|114|COINCIDENT|2022-06-03|AFTER|2022-06-05
Study ID|CE|a3abeeb6-eaf0-4eab-a899-30705e4d155a|2|[?]|[?]|MODERATE|1|SCREENING|2021-10-14|2021-09-29|2022-06-20|17|2|266|COINCIDENT|2022-02-05|AFTER|2022-02-06
Study ID|CE|e08079a2-3221-4294-8448-fd50f847079c|1|[?]|[?]|MILD|5|WASHOUT|2022-02-25|2021-11-09|2022-03-08|164|56|175|AFTER|2022-06-21|ONGOING|2022-07-03
Study ID|CE|e08079a2-3221-4294-8448-fd50f847079c|2|[?]|[?]|MODERATE|2|TREATMENT|2022-07-04|2021-10-24|2022-07-08|293|40|297|AFTER|2021-10-08|BEFORE|2021-11-23
Study ID|CE|e19a993a-4c6c-4c81-8623-722d532297ca|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-12-29|2021-12-16|2022-02-27|143|130|203|COINCIDENT|2022-02-21|ONGOING|2022-04-20
Study ID|CE|e19a993a-4c6c-4c81-8623-722d532297ca|2|[?]|[?]|MODERATE|6|TREATMENT|2022-06-01|2021-12-03|2022-06-03|297|117|299|COINCIDENT|2021-10-20|BEFORE|2021-10-24
Study ID|CE|e0936e84-299e-451f-b8fa-ae8b6f9f83dc|1|[?]|[?]|SEVERE|4|TREATMENT|2022-04-26|2022-02-18|2022-07-13|221|154|299|AFTER|2022-01-01|BEFORE|2022-02-22
Study ID|CE|e0936e84-299e-451f-b8fa-ae8b6f9f83dc|2|[?]|[?]|MODERATE|1|SCREENING|2022-06-07|2022-04-25|2022-07-13|263|220|299|AFTER|2022-01-23|BEFORE|2022-01-25
Study ID|CE|825caa22-c4b4-4d79-9ee7-86d8bb490e7a|1|[?]|[?]|MODERATE|6|TREATMENT|2022-01-18|2021-11-17|2022-05-30|144|82|276|BEFORE|2021-09-10|ONGOING|2021-09-11
Study ID|CE|825caa22-c4b4-4d79-9ee7-86d8bb490e7a|2|[?]|[?]|MODERATE|6|TREATMENT|2021-08-30|2021-08-29|2022-05-22|3|2|268|AFTER|2022-01-01|AFTER|2022-01-17
Study ID|CE|8fe536c8-85cf-4f2a-87d4-05764a9bc9ec|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-04-10|2022-01-29|2022-04-15|238|167|243|AFTER|2021-08-22|BEFORE|2021-08-23
Study ID|CE|8fe536c8-85cf-4f2a-87d4-05764a9bc9ec|2|[?]|[?]|MILD|6|TREATMENT|2021-10-19|2021-08-27|2021-12-25|65|12|132|AFTER|2022-02-10|COINCIDENT|2022-03-25
Study ID|CE|1951f531-f305-4020-b2f5-1763a5caf825|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-25|2022-03-09|2022-07-05|282|174|292|COINCIDENT|2022-04-16|COINCIDENT|2022-05-02
Study ID|CE|1951f531-f305-4020-b2f5-1763a5caf825|2|[?]|[?]|MODERATE|5|WASHOUT|2022-06-11|2022-03-23|2022-07-10|268|188|297|UNKNOWN|2022-01-05|ONGOING|2022-06-21
Study ID|CE|530b8498-6e55-433d-b9b8-0e439fbc2a76|1|[?]|[?]|MILD|1|SCREENING|2021-10-23|2021-10-17|2022-04-22|66|60|247|UNKNOWN|2021-10-02|BEFORE|2021-10-03
Study ID|CE|530b8498-6e55-433d-b9b8-0e439fbc2a76|2|[?]|[?]|SEVERE|6|TREATMENT|2022-04-18|2021-10-04|2022-05-29|243|47|284|BEFORE|2021-09-08|ONGOING|2021-09-22
Study ID|CE|9e950611-579d-4c71-afff-2cd2d5dc37a5|1|[?]|[?]|SEVERE|5|WASHOUT|2022-05-21|2022-04-17|2022-06-18|257|223|285|BEFORE|2022-06-25|AFTER|2022-06-27
Study ID|CE|9e950611-579d-4c71-afff-2cd2d5dc37a5|2|[?]|[?]|MILD|1|SCREENING|2021-09-08|2021-09-08|2021-12-07|2|2|92|UNKNOWN|2021-09-27|BEFORE|2021-09-28
Study ID|CE|b44bf72e-cf3c-43ff-a9c0-68a7115fc254|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-02-09|2022-01-31|2022-07-23|112|103|276|COINCIDENT|2022-05-26|ONGOING|2022-07-02
Study ID|CE|b44bf72e-cf3c-43ff-a9c0-68a7115fc254|2|[?]|[?]|MILD|2|TREATMENT|2022-04-05|2021-12-16|2022-06-04|167|57|227|BEFORE|2022-02-17|AFTER|2022-03-29
Study ID|CE|e1409bdb-3da1-43e3-bfd5-910e263b4451|1|[?]|[?]|MODERATE|6|TREATMENT|2021-11-15|2021-10-16|2021-12-15|46|16|76|COINCIDENT|2021-12-15|COINCIDENT|2021-12-28
Study ID|CE|e1409bdb-3da1-43e3-bfd5-910e263b4451|2|[?]|[?]|MODERATE|6|TREATMENT|2022-05-03|2022-01-02|2022-05-22|215|94|234|BEFORE|2022-01-16|BEFORE|2022-02-05
Study ID|CE|c814d769-4ae9-4330-9aa3-27726bcf47b1|1|[?]|[?]|MILD|4|TREATMENT|2022-04-17|2022-03-17|2022-07-30|185|154|289|UNKNOWN|2022-05-12|ONGOING|2022-06-06
Study ID|CE|c814d769-4ae9-4330-9aa3-27726bcf47b1|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-01-16|2021-10-28|2022-04-19|94|14|187|UNKNOWN|2022-02-16|AFTER|2022-04-30
Study ID|CE|344de0e1-fade-42e7-a779-074a00dfafa0|1|[?]|[?]|MILD|1|SCREENING|2022-04-20|2022-03-07|2022-05-01|245|201|256|UNKNOWN|2022-05-02|BEFORE|2022-05-09
Study ID|CE|344de0e1-fade-42e7-a779-074a00dfafa0|2|[?]|[?]|SEVERE|3|WASHOUT|2022-05-22|2022-03-12|2022-05-31|277|206|286|COINCIDENT|2021-09-30|COINCIDENT|2021-10-07
Study ID|CE|91e53c15-99c3-40da-82f6-cd2ee96ecee6|1|[?]|[?]|MILD|1|SCREENING|2022-03-25|2021-09-09|2022-04-03|212|15|221|UNKNOWN|2022-03-14|AFTER|2022-03-29
Study ID|CE|91e53c15-99c3-40da-82f6-cd2ee96ecee6|2|[?]|[?]|MILD|7|FOLLOW-UP|2021-11-13|2021-09-04|2022-05-09|80|10|257|COINCIDENT|2021-10-18|COINCIDENT|2021-10-19
Study ID|CE|cae377f3-e022-4abe-82a0-2ef6cb6c6b82|1|[?]|[?]|SEVERE|4|TREATMENT|2022-03-12|2022-03-09|2022-08-03|148|145|292|UNKNOWN|2022-02-17|COINCIDENT|2022-03-07
Study ID|CE|cae377f3-e022-4abe-82a0-2ef6cb6c6b82|2|[?]|[?]|MILD|6|TREATMENT|2022-06-12|2022-06-11|2022-07-21|240|239|279|COINCIDENT|2022-02-24|ONGOING|2022-02-28
Study ID|CE|a945ed2b-40ca-4142-a6d8-6e14451d8a4e|1|[?]|[?]|SEVERE|5|WASHOUT|2022-02-18|2022-01-07|2022-06-11|163|121|276|COINCIDENT|2021-11-27|BEFORE|2022-01-15
Study ID|CE|a945ed2b-40ca-4142-a6d8-6e14451d8a4e|2|[?]|[?]|MODERATE|4|TREATMENT|2022-07-02|2021-10-31|2022-07-03|297|53|298|BEFORE|2022-05-24|AFTER|2022-05-29
Study ID|CE|d18fdc52-3a8c-4c0c-8839-0dbd23663dc9|1|[?]|[?]|SEVERE|6|TREATMENT|2022-07-15|2022-03-06|2022-07-16|296|165|297|UNKNOWN|2022-04-25|COINCIDENT|2022-04-30
Study ID|CE|d18fdc52-3a8c-4c0c-8839-0dbd23663dc9|2|[?]|[?]|SEVERE|6|TREATMENT|2021-12-20|2021-12-03|2022-01-22|89|72|122|BEFORE|2022-02-12|ONGOING|2022-02-15
Study ID|CE|f97bb27a-15d6-4dea-b575-38574128e3e0|1|[?]|[?]|SEVERE|3|WASHOUT|2022-06-25|2022-04-08|2022-07-03|290|212|298|AFTER|2021-10-12|BEFORE|2022-03-11
Study ID|CE|f97bb27a-15d6-4dea-b575-38574128e3e0|2|[?]|[?]|MODERATE|1|SCREENING|2022-06-25|2022-05-23|2022-07-04|290|257|299|BEFORE|2021-11-10|BEFORE|2022-01-01
Study ID|CE|7842c627-54d1-4afb-b863-3ef84d7b335a|1|[?]|[?]|MILD|5|WASHOUT|2022-04-14|2021-11-28|2022-05-19|177|40|212|UNKNOWN|2021-11-22|COINCIDENT|2022-04-19
Study ID|CE|7842c627-54d1-4afb-b863-3ef84d7b335a|2|[?]|[?]|SEVERE|5|WASHOUT|2021-11-11|2021-11-02|2022-06-02|23|14|226|COINCIDENT|2022-01-03|ONGOING|2022-01-13
Study ID|CE|d1fe1ae9-17b7-40dc-8250-67515f6659b8|1|[?]|[?]|MILD|5|WASHOUT|2022-02-11|2022-01-11|2022-03-28|128|97|173|UNKNOWN|2022-06-01|ONGOING|2022-06-13
Study ID|CE|d1fe1ae9-17b7-40dc-8250-67515f6659b8|2|[?]|[?]|SEVERE|1|SCREENING|2021-11-07|2021-10-14|2022-01-01|32|8|87|UNKNOWN|2021-11-01|BEFORE|2022-01-28
Study ID|CE|1f438f27-e049-4f32-b59d-2acda0e39316|1|[?]|[?]|MILD|3|WASHOUT|2022-01-10|2021-12-04|2022-07-05|84|47|260|COINCIDENT|2022-02-14|ONGOING|2022-02-28
Study ID|CE|1f438f27-e049-4f32-b59d-2acda0e39316|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-12-19|2021-11-10|2022-05-23|62|23|217|BEFORE|2022-02-17|AFTER|2022-03-14
Study ID|CE|20e1ef99-3101-4fc3-b6c6-f7b7d87f5585|1|[?]|[?]|MODERATE|4|TREATMENT|2022-05-15|2021-11-08|2022-06-06|260|72|282|BEFORE|2021-11-20|AFTER|2022-01-04
Study ID|CE|20e1ef99-3101-4fc3-b6c6-f7b7d87f5585|2|[?]|[?]|SEVERE|6|TREATMENT|2021-11-14|2021-10-30|2021-12-26|78|63|120|AFTER|2022-05-09|BEFORE|2022-05-29
Study ID|CE|030ef2b4-fbd8-4b11-a8af-8d16f2b16007|1|[?]|[?]|SEVERE|3|WASHOUT|2022-05-09|2021-12-28|2022-05-19|195|63|205|AFTER|2021-11-27|AFTER|2021-11-28
Study ID|CE|030ef2b4-fbd8-4b11-a8af-8d16f2b16007|2|[?]|[?]|SEVERE|1|SCREENING|2022-05-26|2022-01-29|2022-06-17|212|95|234|UNKNOWN|2022-01-12|ONGOING|2022-01-14
Study ID|CE|63336123-e50a-4ab9-b5e6-3cabc3743244|1|[?]|[?]|MILD|2|TREATMENT|2022-02-20|2021-09-26|2022-05-10|178|31|257|AFTER|2022-02-12|BEFORE|2022-03-15
Study ID|CE|63336123-e50a-4ab9-b5e6-3cabc3743244|2|[?]|[?]|MILD|3|WASHOUT|2022-05-06|2021-10-14|2022-05-27|253|49|274|BEFORE|2022-01-17|COINCIDENT|2022-01-24
Study ID|CE|34a1462e-fa46-4fe0-bcf8-9aec157ecc7e|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-01-11|2021-09-09|2022-06-14|138|14|292|COINCIDENT|2022-01-29|BEFORE|2022-03-26
Study ID|CE|34a1462e-fa46-4fe0-bcf8-9aec157ecc7e|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-03-21|2021-09-21|2022-04-23|207|26|240|COINCIDENT|2021-09-21|BEFORE|2021-09-21
Study ID|CE|59ffc393-9862-4a7c-af96-c7c27375bc0c|1|[?]|[?]|MILD|4|TREATMENT|2022-01-23|2021-12-05|2022-05-02|151|102|250|COINCIDENT|2021-11-23|BEFORE|2021-11-24
Study ID|CE|59ffc393-9862-4a7c-af96-c7c27375bc0c|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-04-06|2021-09-18|2022-04-22|224|24|240|BEFORE|2021-10-14|ONGOING|2021-10-15
Study ID|CE|2784bbb9-6f8b-450c-97ee-0f05afc7a497|1|[?]|[?]|MODERATE|4|TREATMENT|2022-05-16|2021-11-23|2022-06-02|231|57|248|COINCIDENT|2022-03-06|COINCIDENT|2022-05-04
Study ID|CE|2784bbb9-6f8b-450c-97ee-0f05afc7a497|2|[?]|[?]|MODERATE|3|WASHOUT|2022-07-17|2021-10-24|2022-07-21|293|27|297|AFTER|2021-11-11|COINCIDENT|2021-11-12
Study ID|CE|e0f7f8f4-bc53-457a-b1e7-334d80be8ce5|1|[?]|[?]|MILD|6|TREATMENT|2022-02-21|2021-10-08|2022-06-14|164|28|277|BEFORE|2021-09-17|COINCIDENT|2021-09-19
Study ID|CE|e0f7f8f4-bc53-457a-b1e7-334d80be8ce5|2|[?]|[?]|MILD|3|WASHOUT|2022-05-30|2022-02-17|2022-06-03|262|160|266|BEFORE|2021-12-13|ONGOING|2022-01-07
Study ID|CE|2e012a0a-8b8d-4c4b-93bc-9c4856d84648|1|[?]|[?]|MILD|2|TREATMENT|2021-10-13|2021-10-09|2022-04-27|35|31|231|AFTER|2022-01-23|BEFORE|2022-01-25
Study ID|CE|2e012a0a-8b8d-4c4b-93bc-9c4856d84648|2|[?]|[?]|MODERATE|4|TREATMENT|2022-05-27|2022-01-06|2022-06-09|261|120|274|COINCIDENT|2021-10-19|ONGOING|2021-12-19
Study ID|CE|9c7788ce-b9c4-4410-8cd1-e3acb135fe30|1|[?]|[?]|MODERATE|6|TREATMENT|2022-07-29|2022-04-26|2022-07-30|298|204|299|BEFORE|2022-05-09|BEFORE|2022-05-10
Study ID|CE|9c7788ce-b9c4-4410-8cd1-e3acb135fe30|2|[?]|[?]|MILD|4|TREATMENT|2021-10-25|2021-10-24|2021-11-01|21|20|28|UNKNOWN|2022-01-09|ONGOING|2022-01-22
Study ID|CE|08a80286-6add-4dce-bbe6-b82cc0acc896|1|[?]|[?]|SEVERE|6|TREATMENT|2022-05-17|2021-10-29|2022-05-29|213|13|225|UNKNOWN|2021-11-04|COINCIDENT|2022-01-29
Study ID|CE|08a80286-6add-4dce-bbe6-b82cc0acc896|2|[?]|[?]|MODERATE|6|TREATMENT|2022-06-13|2021-11-02|2022-07-30|240|17|287|AFTER|2021-12-28|AFTER|2022-01-08
Study ID|CE|6fbbc5b9-1a74-40d0-9448-41e909dd41a4|1|[?]|[?]|MODERATE|4|TREATMENT|2022-06-14|2022-01-29|2022-07-22|237|101|275|UNKNOWN|2022-03-03|ONGOING|2022-03-05
Study ID|CE|6fbbc5b9-1a74-40d0-9448-41e909dd41a4|2|[?]|[?]|SEVERE|6|TREATMENT|2022-06-18|2022-01-16|2022-06-20|241|88|243|BEFORE|2022-02-14|COINCIDENT|2022-02-16
Study ID|CE|ad425a12-3cf4-4946-8f9b-daae4296fa21|1|[?]|[?]|SEVERE|2|TREATMENT|2022-05-19|2021-11-27|2022-05-23|207|34|211|BEFORE|2022-02-23|ONGOING|2022-03-08
Study ID|CE|ad425a12-3cf4-4946-8f9b-daae4296fa21|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-02-16|2021-11-20|2022-07-21|115|27|270|COINCIDENT|2022-05-10|ONGOING|2022-05-12
Study ID|CE|bf793505-2348-407b-bcf6-813e5bcb71f3|1|[?]|[?]|MILD|5|WASHOUT|2022-04-10|2022-03-28|2022-05-28|231|218|279|UNKNOWN|2021-09-30|ONGOING|2021-10-24
Study ID|CE|bf793505-2348-407b-bcf6-813e5bcb71f3|2|[?]|[?]|MILD|3|WASHOUT|2021-12-30|2021-09-20|2022-05-03|130|29|254|BEFORE|2021-11-29|ONGOING|2021-12-10
Study ID|CE|b2fc787c-4951-4884-b680-e7c57416c68d|1|[?]|[?]|MODERATE|6|TREATMENT|2022-04-10|2021-12-08|2022-06-13|234|111|298|COINCIDENT|2021-10-16|AFTER|2021-10-18
Study ID|CE|b2fc787c-4951-4884-b680-e7c57416c68d|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-09-14|2021-08-31|2022-03-30|26|12|223|AFTER|2021-12-11|AFTER|2022-03-13
Study ID|CE|7587dc09-07b9-4d28-a07c-c173ee7f785f|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-01-29|2021-10-11|2022-04-10|170|60|241|BEFORE|2022-05-26|ONGOING|2022-06-01
Study ID|CE|7587dc09-07b9-4d28-a07c-c173ee7f785f|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-04-03|2022-03-27|2022-04-27|234|227|258|UNKNOWN|2021-11-18|COINCIDENT|2021-12-15
Study ID|CE|9bfee219-aaa1-48c3-a971-5cb6fe2f930e|1|[?]|[?]|SEVERE|1|SCREENING|2022-04-06|2021-12-18|2022-04-18|211|102|223|AFTER|2022-01-21|COINCIDENT|2022-01-25
Study ID|CE|9bfee219-aaa1-48c3-a971-5cb6fe2f930e|2|[?]|[?]|MODERATE|6|TREATMENT|2021-10-01|2021-09-09|2022-06-25|24|2|291|BEFORE|2022-02-21|ONGOING|2022-04-03
Study ID|CE|657a8fa7-8788-4993-bd8d-d2e86a4572b7|1|[?]|[?]|MILD|6|TREATMENT|2021-12-14|2021-10-31|2022-05-31|99|55|267|BEFORE|2021-11-21|AFTER|2021-11-28
Study ID|CE|657a8fa7-8788-4993-bd8d-d2e86a4572b7|2|[?]|[?]|MILD|6|TREATMENT|2022-02-11|2022-01-29|2022-04-26|158|145|232|COINCIDENT|2021-10-23|COINCIDENT|2021-10-24
Study ID|CE|f25b0eae-0a80-472f-94b8-c5d4f35ea9ee|1|[?]|[?]|MODERATE|5|WASHOUT|2022-03-26|2021-08-25|2022-05-07|215|2|257|UNKNOWN|2022-04-21|COINCIDENT|2022-04-23
Study ID|CE|f25b0eae-0a80-472f-94b8-c5d4f35ea9ee|2|[?]|[?]|SEVERE|5|WASHOUT|2022-02-07|2021-09-18|2022-04-28|168|26|248|AFTER|2022-03-21|AFTER|2022-03-28
Study ID|CE|3b1ec433-5317-4320-a601-36e1c72db8c7|1|[?]|[?]|MODERATE|1|SCREENING|2022-07-11|2022-02-18|2022-07-23|278|135|290|BEFORE|2021-10-16|COINCIDENT|2021-11-19
Study ID|CE|3b1ec433-5317-4320-a601-36e1c72db8c7|2|[?]|[?]|MODERATE|2|TREATMENT|2022-06-22|2022-01-20|2022-07-21|259|106|288|BEFORE|2022-05-31|BEFORE|2022-06-08
Study ID|CE|fbadb011-97b4-4423-bf72-8bb4774381e4|1|[?]|[?]|MODERATE|2|TREATMENT|2022-03-15|2021-10-31|2022-04-05|182|47|203|BEFORE|2021-11-19|ONGOING|2021-11-20
Study ID|CE|fbadb011-97b4-4423-bf72-8bb4774381e4|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-06-19|2022-03-30|2022-06-23|278|197|282|COINCIDENT|2021-10-15|BEFORE|2021-10-17
Study ID|CE|3ae6412f-08b1-4d32-97da-58e3176856b5|1|[?]|[?]|SEVERE|4|TREATMENT|2022-06-03|2022-02-05|2022-06-04|299|181|300|BEFORE|2022-03-22|AFTER|2022-03-30
Study ID|CE|3ae6412f-08b1-4d32-97da-58e3176856b5|2|[?]|[?]|MODERATE|6|TREATMENT|2021-08-12|2021-08-11|2022-05-11|4|3|276|AFTER|2021-08-29|COINCIDENT|2021-08-30
Study ID|CE|c11083b3-523d-451c-9e98-4f4738c45b7a|1|[?]|[?]|SEVERE|2|TREATMENT|2022-05-11|2022-04-08|2022-06-14|242|209|276|BEFORE|2022-05-17|ONGOING|2022-06-11
Study ID|CE|c11083b3-523d-451c-9e98-4f4738c45b7a|2|[?]|[?]|MILD|3|WASHOUT|2022-03-06|2021-09-16|2022-06-19|176|5|281|AFTER|2022-02-08|AFTER|2022-02-19
Study ID|CE|8c41ca81-05e8-42a1-86aa-fdf787ba5ba9|1|[?]|[?]|MILD|2|TREATMENT|2022-02-03|2022-01-20|2022-06-13|144|130|274|BEFORE|2022-03-19|ONGOING|2022-03-30
Study ID|CE|8c41ca81-05e8-42a1-86aa-fdf787ba5ba9|2|[?]|[?]|MILD|4|TREATMENT|2022-01-08|2021-11-09|2022-06-12|118|58|273|BEFORE|2021-10-05|BEFORE|2021-10-06
Study ID|CE|409a8a8f-13e0-4929-a97e-14daef23bef6|1|[?]|[?]|MILD|5|WASHOUT|2021-12-24|2021-09-30|2022-01-24|108|23|139|COINCIDENT|2021-11-12|ONGOING|2021-11-13
Study ID|CE|409a8a8f-13e0-4929-a97e-14daef23bef6|2|[?]|[?]|MODERATE|5|WASHOUT|2021-12-01|2021-09-12|2022-04-15|85|5|220|BEFORE|2021-09-30|COINCIDENT|2021-10-01
Study ID|CE|da4ebea3-ae83-4370-b62a-a96db1b12b94|1|[?]|[?]|MODERATE|1|SCREENING|2021-10-30|2021-10-26|2022-06-30|10|6|253|COINCIDENT|2022-04-09|BEFORE|2022-04-12
Study ID|CE|da4ebea3-ae83-4370-b62a-a96db1b12b94|2|[?]|[?]|MILD|1|SCREENING|2022-01-23|2021-11-06|2022-05-24|95|17|216|BEFORE|2021-12-04|AFTER|2021-12-25
Study ID|CE|cf675c93-71a6-4e6d-bb9e-4cb880f39d0c|1|[?]|[?]|MILD|2|TREATMENT|2022-04-19|2021-12-16|2022-05-02|246|122|259|COINCIDENT|2021-09-05|ONGOING|2021-09-15
Study ID|CE|cf675c93-71a6-4e6d-bb9e-4cb880f39d0c|2|[?]|[?]|SEVERE|4|TREATMENT|2022-02-10|2021-09-02|2022-03-18|178|17|214|UNKNOWN|2021-12-20|COINCIDENT|2022-04-20
Study ID|CE|2c2d051b-9dd9-4899-8ddb-b2f00f97c046|1|[?]|[?]|MODERATE|3|WASHOUT|2022-05-28|2022-05-17|2022-08-18|216|205|298|AFTER|2022-02-20|AFTER|2022-03-08
Study ID|CE|2c2d051b-9dd9-4899-8ddb-b2f00f97c046|2|[?]|[?]|MODERATE|3|WASHOUT|2022-02-13|2021-11-25|2022-06-11|112|32|230|AFTER|2021-11-27|AFTER|2022-01-24
Study ID|CE|fcac6ec4-f62f-48ef-9f90-5342ea4bcd5c|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-01-10|2021-09-23|2022-02-21|114|5|156|COINCIDENT|2022-06-06|BEFORE|2022-06-08
Study ID|CE|fcac6ec4-f62f-48ef-9f90-5342ea4bcd5c|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-07-03|2022-06-24|2022-07-11|288|279|296|UNKNOWN|2021-11-10|ONGOING|2021-11-15
Study ID|CE|4d8033a3-b04e-4f93-b644-75caca7d00bc|1|[?]|[?]|SEVERE|1|SCREENING|2021-09-25|2021-08-27|2021-11-10|38|9|84|UNKNOWN|2021-11-08|AFTER|2022-01-04
Study ID|CE|4d8033a3-b04e-4f93-b644-75caca7d00bc|2|[?]|[?]|MODERATE|1|SCREENING|2022-03-07|2021-09-01|2022-04-29|201|14|254|BEFORE|2022-01-21|COINCIDENT|2022-01-22
Study ID|CE|febce16b-a7bd-4d15-8686-5d9c021c8062|1|[?]|[?]|MILD|1|SCREENING|2022-04-13|2022-02-15|2022-07-11|170|113|259|BEFORE|2022-05-02|COINCIDENT|2022-05-28
Study ID|CE|febce16b-a7bd-4d15-8686-5d9c021c8062|2|[?]|[?]|MILD|4|TREATMENT|2022-07-15|2022-05-26|2022-08-18|263|213|297|COINCIDENT|2022-01-15|AFTER|2022-02-15
Study ID|CE|88704a8c-b2f9-4b83-ac37-be443121d27f|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-11-29|2021-11-13|2022-04-29|84|68|235|BEFORE|2022-06-17|AFTER|2022-06-18
Study ID|CE|88704a8c-b2f9-4b83-ac37-be443121d27f|2|[?]|[?]|SEVERE|2|TREATMENT|2022-03-09|2021-12-13|2022-04-04|184|98|210|BEFORE|2021-12-06|ONGOING|2021-12-15
Study ID|CE|ef5270fe-24e3-4df8-9e0a-b64a033828fe|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-12-06|2021-11-14|2021-12-28|97|75|119|AFTER|2022-04-20|AFTER|2022-05-11
Study ID|CE|ef5270fe-24e3-4df8-9e0a-b64a033828fe|2|[?]|[?]|MODERATE|1|SCREENING|2021-12-26|2021-09-15|2022-04-02|117|15|214|BEFORE|2022-03-25|BEFORE|2022-03-26
Study ID|CE|f9aa875f-6ddd-4fe9-80ca-e12ab3d12f45|1|[?]|[?]|MODERATE|5|WASHOUT|2022-03-09|2021-12-18|2022-04-08|209|128|239|UNKNOWN|2022-04-05|ONGOING|2022-04-16
Study ID|CE|f9aa875f-6ddd-4fe9-80ca-e12ab3d12f45|2|[?]|[?]|MILD|3|WASHOUT|2021-09-28|2021-09-25|2022-02-27|47|44|199|UNKNOWN|2021-10-30|ONGOING|2022-01-25
Study ID|CE|ffe35386-c166-44f6-8fdb-f1feae2b078e|1|[?]|[?]|SEVERE|6|TREATMENT|2021-10-18|2021-10-04|2022-04-02|72|58|238|AFTER|2021-12-26|COINCIDENT|2022-01-07
Study ID|CE|ffe35386-c166-44f6-8fdb-f1feae2b078e|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-03-04|2021-12-09|2022-03-29|209|124|234|AFTER|2021-10-24|COINCIDENT|2021-11-01
Study ID|CE|df12b0b6-0854-4fb9-8b90-f87021c31013|1|[?]|[?]|SEVERE|5|WASHOUT|2022-05-06|2021-11-23|2022-07-15|206|42|276|COINCIDENT|2021-11-18|COINCIDENT|2021-11-19
Study ID|CE|df12b0b6-0854-4fb9-8b90-f87021c31013|2|[?]|[?]|MODERATE|4|TREATMENT|2021-12-06|2021-11-24|2022-03-04|55|43|143|UNKNOWN|2021-12-31|ONGOING|2022-01-01
Study ID|CE|1baa76bc-cc44-42cf-9585-0fda2afe6740|1|[?]|[?]|SEVERE|4|TREATMENT|2022-06-27|2022-04-07|2022-06-29|284|203|286|AFTER|2021-12-05|BEFORE|2022-02-27
Study ID|CE|1baa76bc-cc44-42cf-9585-0fda2afe6740|2|[?]|[?]|MILD|2|TREATMENT|2022-05-17|2021-12-20|2022-06-11|243|95|268|BEFORE|2022-02-13|ONGOING|2022-02-23
Study ID|CE|46265849-9afc-4952-b01d-aa593948576f|1|[?]|[?]|MILD|2|TREATMENT|2021-12-09|2021-10-11|2021-12-25|80|21|96|BEFORE|2022-03-09|COINCIDENT|2022-03-21
Study ID|CE|46265849-9afc-4952-b01d-aa593948576f|2|[?]|[?]|MODERATE|2|TREATMENT|2022-05-19|2021-12-08|2022-06-20|241|79|273|UNKNOWN|2022-02-21|ONGOING|2022-05-07
Study ID|CE|ed5681ef-04ae-4c9c-8af0-998801808ec0|1|[?]|[?]|SEVERE|3|WASHOUT|2022-05-26|2022-02-14|2022-05-31|267|166|272|UNKNOWN|2022-03-24|ONGOING|2022-03-25
Study ID|CE|ed5681ef-04ae-4c9c-8af0-998801808ec0|2|[?]|[?]|MODERATE|3|WASHOUT|2022-04-23|2021-12-24|2022-04-25|234|114|236|UNKNOWN|2022-01-27|COINCIDENT|2022-01-29
Study ID|CE|dc5e28e0-8e0f-4fea-9c63-170cb52a5514|1|[?]|[?]|MILD|1|SCREENING|2022-03-12|2021-12-24|2022-04-25|154|76|198|COINCIDENT|2022-06-17|AFTER|2022-07-26
Study ID|CE|dc5e28e0-8e0f-4fea-9c63-170cb52a5514|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-03-13|2021-10-11|2022-07-10|155|2|274|UNKNOWN|2021-11-12|AFTER|2021-12-22
Study ID|CE|eeb49ee5-dca4-49c0-bc17-899504023412|1|[?]|[?]|SEVERE|2|TREATMENT|2022-06-29|2021-12-28|2022-07-01|285|102|287|BEFORE|2021-11-23|BEFORE|2021-11-27
Study ID|CE|eeb49ee5-dca4-49c0-bc17-899504023412|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-07-13|2022-04-02|2022-07-14|299|197|300|COINCIDENT|2021-10-30|AFTER|2022-01-21
Study ID|CE|bdbcca7f-96e4-4ab3-a10c-433fb2f1b647|1|[?]|[?]|SEVERE|3|WASHOUT|2022-06-01|2021-10-03|2022-06-27|262|21|288|AFTER|2022-03-09|ONGOING|2022-05-22
Study ID|CE|bdbcca7f-96e4-4ab3-a10c-433fb2f1b647|2|[?]|[?]|MODERATE|3|WASHOUT|2022-03-29|2022-01-16|2022-06-09|198|126|270|UNKNOWN|2021-10-21|AFTER|2021-10-23
Study ID|CE|b9309a9f-6f69-4d99-aab1-aed10a722e77|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-01-05|2021-11-26|2022-04-23|118|78|226|BEFORE|2022-04-22|ONGOING|2022-04-24
Study ID|CE|b9309a9f-6f69-4d99-aab1-aed10a722e77|2|[?]|[?]|MODERATE|5|WASHOUT|2021-09-11|2021-09-11|2022-04-02|2|2|205|AFTER|2022-03-18|COINCIDENT|2022-03-30
Study ID|CE|3ca9e210-6f76-4881-b538-f8ce79ccfc57|1|[?]|[?]|MODERATE|2|TREATMENT|2022-01-02|2021-11-01|2022-06-04|110|48|263|UNKNOWN|2021-11-16|AFTER|2022-04-25
Study ID|CE|3ca9e210-6f76-4881-b538-f8ce79ccfc57|2|[?]|[?]|SEVERE|6|TREATMENT|2022-05-17|2022-02-14|2022-06-15|245|153|274|COINCIDENT|2022-01-17|COINCIDENT|2022-01-24
Study ID|CE|2821bf2d-e4d8-483c-8f7d-37d44889728d|1|[?]|[?]|MODERATE|3|WASHOUT|2022-03-31|2022-03-27|2022-06-05|233|229|299|AFTER|2021-10-10|ONGOING|2021-10-11
Study ID|CE|2821bf2d-e4d8-483c-8f7d-37d44889728d|2|[?]|[?]|MODERATE|5|WASHOUT|2022-04-23|2021-11-20|2022-06-02|256|102|296|AFTER|2021-08-23|ONGOING|2021-09-03
Study ID|CE|6d516ba5-96b3-4cfe-91a1-a350569866c6|1|[?]|[?]|MODERATE|1|SCREENING|2022-03-02|2022-02-12|2022-08-02|124|106|277|COINCIDENT|2021-11-01|COINCIDENT|2021-11-02
Study ID|CE|6d516ba5-96b3-4cfe-91a1-a350569866c6|2|[?]|[?]|MODERATE|1|SCREENING|2022-02-06|2021-11-06|2022-05-16|100|8|199|UNKNOWN|2022-04-24|BEFORE|2022-05-20
Study ID|CE|c217b3ca-addb-4c12-95f2-b58583bedcd8|1|[?]|[?]|SEVERE|4|TREATMENT|2022-03-24|2022-01-04|2022-03-29|199|120|204|BEFORE|2021-11-16|AFTER|2021-11-18
Study ID|CE|c217b3ca-addb-4c12-95f2-b58583bedcd8|2|[?]|[?]|SEVERE|4|TREATMENT|2022-05-08|2022-01-31|2022-06-26|244|147|293|BEFORE|2022-01-11|BEFORE|2022-01-31
Study ID|CE|abb79778-ee30-4e6e-8da6-315ed44f1e86|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-12-01|2021-11-12|2021-12-18|33|14|50|UNKNOWN|2022-04-30|AFTER|2022-05-19
Study ID|CE|abb79778-ee30-4e6e-8da6-315ed44f1e86|2|[?]|[?]|MILD|2|TREATMENT|2021-12-24|2021-12-07|2022-08-13|56|39|288|BEFORE|2022-05-01|COINCIDENT|2022-05-07
Study ID|CE|9e2c3174-5021-49a6-86c1-4a95ca7ea2dc|1|[?]|[?]|MODERATE|1|SCREENING|2022-03-25|2021-12-29|2022-03-28|201|115|204|BEFORE|2022-02-28|BEFORE|2022-03-01
Study ID|CE|9e2c3174-5021-49a6-86c1-4a95ca7ea2dc|2|[?]|[?]|MILD|3|WASHOUT|2021-12-26|2021-12-22|2022-06-12|112|108|280|AFTER|2021-11-07|BEFORE|2021-11-08
Study ID|CE|8c1c8309-1e5d-4293-9657-3a1f4f1d4e4f|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-02-18|2021-10-12|2022-04-11|139|10|191|COINCIDENT|2021-12-09|AFTER|2021-12-22
Study ID|CE|8c1c8309-1e5d-4293-9657-3a1f4f1d4e4f|2|[?]|[?]|MODERATE|3|WASHOUT|2021-12-19|2021-12-08|2022-03-21|78|67|170|COINCIDENT|2022-02-24|BEFORE|2022-05-15
Study ID|CE|c0e615c3-b9cb-469c-83e0-6e2e96b96e82|1|[?]|[?]|MODERATE|6|TREATMENT|2022-05-23|2022-04-16|2022-06-13|217|180|238|UNKNOWN|2022-02-04|ONGOING|2022-02-27
Study ID|CE|c0e615c3-b9cb-469c-83e0-6e2e96b96e82|2|[?]|[?]|MODERATE|2|TREATMENT|2022-03-02|2021-11-19|2022-03-14|135|32|147|AFTER|2022-03-19|COINCIDENT|2022-04-05
Study ID|CE|980b659c-8a12-4dd9-b589-f3492331fc70|1|[?]|[?]|MILD|5|WASHOUT|2022-05-03|2021-12-17|2022-05-19|268|131|284|BEFORE|2021-09-03|AFTER|2021-09-08
Study ID|CE|980b659c-8a12-4dd9-b589-f3492331fc70|2|[?]|[?]|SEVERE|4|TREATMENT|2021-10-05|2021-08-24|2021-12-24|58|16|138|UNKNOWN|2021-11-30|BEFORE|2021-12-03
Study ID|CE|c2f0ff14-ddad-46d2-a2cd-30ff2c6b6481|1|[?]|[?]|SEVERE|5|WASHOUT|2021-08-15|2021-08-15|2021-08-31|2|2|18|BEFORE|2021-12-11|BEFORE|2021-12-12
Study ID|CE|c2f0ff14-ddad-46d2-a2cd-30ff2c6b6481|2|[?]|[?]|MILD|4|TREATMENT|2022-03-10|2021-11-25|2022-03-15|209|104|214|UNKNOWN|2021-11-18|COINCIDENT|2021-11-21
Study ID|CE|0c97f3b3-9c2c-40a9-b101-c692977ceaef|1|[?]|[?]|MODERATE|5|WASHOUT|2021-12-03|2021-10-30|2022-05-18|67|33|233|AFTER|2022-01-09|BEFORE|2022-01-17
Study ID|CE|0c97f3b3-9c2c-40a9-b101-c692977ceaef|2|[?]|[?]|MODERATE|4|TREATMENT|2022-05-01|2022-04-27|2022-05-25|216|212|240|AFTER|2022-02-07|AFTER|2022-03-22
Study ID|CE|b02ce526-b4bb-49e3-ad64-7c3ccc43f4a5|1|[?]|[?]|MODERATE|1|SCREENING|2022-02-14|2022-01-23|2022-06-25|117|95|248|BEFORE|2021-11-17|COINCIDENT|2022-04-07
Study ID|CE|b02ce526-b4bb-49e3-ad64-7c3ccc43f4a5|2|[?]|[?]|MODERATE|3|WASHOUT|2022-04-16|2021-12-28|2022-05-09|178|69|201|COINCIDENT|2022-02-25|COINCIDENT|2022-07-06
Study ID|CE|44d7d97c-25b9-4c6b-991b-2fed8b476263|1|[?]|[?]|SEVERE|5|WASHOUT|2021-11-26|2021-10-25|2021-12-07|42|10|53|BEFORE|2022-01-06|AFTER|2022-01-16
Study ID|CE|44d7d97c-25b9-4c6b-991b-2fed8b476263|2|[?]|[?]|SEVERE|2|TREATMENT|2022-02-17|2021-11-13|2022-05-03|125|29|200|BEFORE|2022-05-20|ONGOING|2022-05-25
Study ID|CE|a81fca99-3517-4b04-ad22-6bfee2a1cc49|1|[?]|[?]|SEVERE|5|WASHOUT|2021-09-18|2021-09-02|2021-12-31|23|7|127|BEFORE|2021-09-29|AFTER|2021-10-01
Study ID|CE|a81fca99-3517-4b04-ad22-6bfee2a1cc49|2|[?]|[?]|MODERATE|3|WASHOUT|2021-12-14|2021-10-16|2022-02-14|110|51|172|BEFORE|2022-05-06|ONGOING|2022-06-14
Study ID|CE|cf2dc23d-bb37-49c1-9cab-a1b06cbda411|1|[?]|[?]|MILD|1|SCREENING|2021-11-15|2021-11-04|2022-05-01|32|21|199|UNKNOWN|2022-07-09|AFTER|2022-08-01
Study ID|CE|cf2dc23d-bb37-49c1-9cab-a1b06cbda411|2|[?]|[?]|SEVERE|1|SCREENING|2022-08-09|2022-06-08|2022-08-10|299|237|300|BEFORE|2022-02-25|BEFORE|2022-05-03
Study ID|CE|8e034ca3-fc19-427a-82ff-f12581d19619|1|[?]|[?]|MILD|5|WASHOUT|2022-05-29|2021-11-03|2022-06-08|243|36|253|BEFORE|2022-06-19|ONGOING|2022-06-27
Study ID|CE|8e034ca3-fc19-427a-82ff-f12581d19619|2|[?]|[?]|MODERATE|4|TREATMENT|2021-12-19|2021-11-01|2022-05-13|82|34|227|COINCIDENT|2022-03-13|AFTER|2022-03-23
Study ID|CE|9a0f0a03-746a-49bc-8ef6-a2b206506aa1|1|[?]|[?]|MODERATE|6|TREATMENT|2022-03-11|2021-11-12|2022-04-15|196|77|231|COINCIDENT|2021-10-27|BEFORE|2021-10-29
Study ID|CE|9a0f0a03-746a-49bc-8ef6-a2b206506aa1|2|[?]|[?]|MODERATE|1|SCREENING|2022-05-22|2021-10-10|2022-06-07|268|44|284|AFTER|2022-02-04|COINCIDENT|2022-04-30
Study ID|CE|2e11edef-2791-410b-8089-96bdfc9b73d7|1|[?]|[?]|MODERATE|6|TREATMENT|2021-10-19|2021-10-13|2022-03-17|28|22|177|COINCIDENT|2022-04-26|AFTER|2022-07-08
Study ID|CE|2e11edef-2791-410b-8089-96bdfc9b73d7|2|[?]|[?]|MODERATE|4|TREATMENT|2021-10-06|2021-09-27|2022-06-11|15|6|263|BEFORE|2022-05-05|COINCIDENT|2022-05-14
Study ID|CE|d232c4af-8771-45b6-8727-a5a00e2085d4|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-01-29|2021-11-25|2022-07-03|131|66|286|UNKNOWN|2022-01-12|AFTER|2022-02-07
Study ID|CE|d232c4af-8771-45b6-8727-a5a00e2085d4|2|[?]|[?]|SEVERE|2|TREATMENT|2022-07-09|2022-07-06|2022-07-13|292|289|296|BEFORE|2022-02-21|ONGOING|2022-02-25
Study ID|CE|4910eeaa-f945-4c7a-94ac-c7f1d9456ff8|1|[?]|[?]|SEVERE|2|TREATMENT|2021-10-31|2021-10-28|2021-12-03|5|2|38|UNKNOWN|2022-01-30|AFTER|2022-06-07
Study ID|CE|4910eeaa-f945-4c7a-94ac-c7f1d9456ff8|2|[?]|[?]|MILD|3|WASHOUT|2022-06-11|2021-11-14|2022-07-02|228|19|249|UNKNOWN|2022-06-12|BEFORE|2022-07-16
Study ID|CE|eaf2a5bb-519b-4d63-be7c-a33be121f5c7|1|[?]|[?]|MILD|3|WASHOUT|2021-10-09|2021-09-28|2022-01-09|57|46|149|COINCIDENT|2021-12-23|BEFORE|2022-01-16
Study ID|CE|eaf2a5bb-519b-4d63-be7c-a33be121f5c7|2|[?]|[?]|MILD|5|WASHOUT|2022-03-31|2021-09-19|2022-05-18|230|37|278|AFTER|2021-08-27|COINCIDENT|2021-09-11
Study ID|CE|d131691d-6cc7-4fb9-92b8-e82d6c286389|1|[?]|[?]|MILD|7|FOLLOW-UP|2021-11-10|2021-10-27|2022-04-18|34|20|193|COINCIDENT|2022-01-12|COINCIDENT|2022-01-19
Study ID|CE|d131691d-6cc7-4fb9-92b8-e82d6c286389|2|[?]|[?]|MILD|6|TREATMENT|2022-02-15|2022-01-04|2022-03-03|131|89|147|UNKNOWN|2021-10-31|ONGOING|2021-11-04
Study ID|CE|a2284a75-da2f-4157-bcc3-8c19d8aa91a2|1|[?]|[?]|SEVERE|5|WASHOUT|2022-02-03|2021-12-15|2022-02-12|152|102|161|COINCIDENT|2022-02-16|BEFORE|2022-02-17
Study ID|CE|a2284a75-da2f-4157-bcc3-8c19d8aa91a2|2|[?]|[?]|MILD|7|FOLLOW-UP|2021-12-30|2021-09-28|2022-02-24|117|24|173|COINCIDENT|2022-02-17|ONGOING|2022-02-18
Study ID|CE|96690d2c-8ee6-4217-b728-4f3963e78c0f|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-12-14|2021-10-10|2022-03-25|86|21|187|UNKNOWN|2022-06-16|ONGOING|2022-06-17
Study ID|CE|96690d2c-8ee6-4217-b728-4f3963e78c0f|2|[?]|[?]|MODERATE|3|WASHOUT|2022-06-25|2021-10-14|2022-07-04|279|25|288|BEFORE|2022-04-05|ONGOING|2022-04-09
Study ID|CE|dc2d731e-5302-4b55-a0fd-126cac25413e|1|[?]|[?]|SEVERE|5|WASHOUT|2022-01-23|2021-11-08|2022-03-18|117|41|171|AFTER|2022-02-13|BEFORE|2022-05-02
Study ID|CE|dc2d731e-5302-4b55-a0fd-126cac25413e|2|[?]|[?]|MODERATE|5|WASHOUT|2022-05-14|2022-02-01|2022-06-12|228|126|257|AFTER|2021-12-24|COINCIDENT|2021-12-31
Study ID|CE|baf33df4-7387-411e-8239-ecd5bc2aa3dc|1|[?]|[?]|MILD|2|TREATMENT|2022-06-22|2022-06-15|2022-07-20|242|235|270|COINCIDENT|2022-01-01|ONGOING|2022-01-22
Study ID|CE|baf33df4-7387-411e-8239-ecd5bc2aa3dc|2|[?]|[?]|MILD|1|SCREENING|2022-06-30|2022-02-18|2022-07-31|250|118|281|COINCIDENT|2022-01-09|ONGOING|2022-02-26
Study ID|CE|7d45c9cd-ad39-4c9a-8dcc-bc6087e0cf98|1|[?]|[?]|MODERATE|4|TREATMENT|2022-01-23|2021-11-02|2022-02-05|96|14|109|BEFORE|2022-01-22|AFTER|2022-02-06
Study ID|CE|7d45c9cd-ad39-4c9a-8dcc-bc6087e0cf98|2|[?]|[?]|MODERATE|5|WASHOUT|2021-11-30|2021-11-29|2022-04-07|42|41|170|AFTER|2022-05-06|AFTER|2022-05-25
Study ID|CE|f2742b1c-53d1-454b-ada5-bff2c2e7c755|1|[?]|[?]|MODERATE|6|TREATMENT|2021-10-10|2021-10-05|2021-11-19|42|37|82|AFTER|2021-12-15|BEFORE|2021-12-16
Study ID|CE|f2742b1c-53d1-454b-ada5-bff2c2e7c755|2|[?]|[?]|MODERATE|4|TREATMENT|2021-11-24|2021-09-25|2021-12-03|87|27|96|BEFORE|2022-02-20|COINCIDENT|2022-03-03
Study ID|CE|d8208864-fa0f-471a-a822-8cb606703cc2|1|[?]|[?]|MODERATE|5|WASHOUT|2022-07-06|2022-07-01|2022-07-29|258|253|281|BEFORE|2021-11-08|BEFORE|2021-11-17
Study ID|CE|d8208864-fa0f-471a-a822-8cb606703cc2|2|[?]|[?]|MODERATE|4|TREATMENT|2022-08-08|2021-10-29|2022-08-14|291|8|297|COINCIDENT|2022-07-30|AFTER|2022-07-31
Study ID|CE|d4237095-7463-4f02-b85a-a073e859ddef|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-02-11|2021-12-03|2022-07-16|132|62|287|UNKNOWN|2022-03-03|BEFORE|2022-04-22
Study ID|CE|d4237095-7463-4f02-b85a-a073e859ddef|2|[?]|[?]|MODERATE|6|TREATMENT|2022-07-23|2022-03-06|2022-07-28|294|155|299|AFTER|2022-03-13|AFTER|2022-03-16
Study ID|CE|3e507d13-a5be-4959-8f44-d057ead8d683|1|[?]|[?]|MODERATE|3|WASHOUT|2022-02-23|2021-11-08|2022-03-28|194|87|227|BEFORE|2021-09-01|COINCIDENT|2021-09-01
Study ID|CE|3e507d13-a5be-4959-8f44-d057ead8d683|2|[?]|[?]|SEVERE|6|TREATMENT|2021-08-27|2021-08-25|2021-10-13|14|12|61|COINCIDENT|2022-01-31|COINCIDENT|2022-03-19
Study ID|CE|15432e91-6157-450f-bb5c-024aeea0ea8a|1|[?]|[?]|MODERATE|1|SCREENING|2022-04-08|2021-11-04|2022-07-14|178|23|275|COINCIDENT|2022-01-12|BEFORE|2022-01-13
Study ID|CE|15432e91-6157-450f-bb5c-024aeea0ea8a|2|[?]|[?]|SEVERE|1|SCREENING|2022-03-16|2021-11-29|2022-05-23|155|48|223|COINCIDENT|2021-12-10|COINCIDENT|2021-12-15
Study ID|CE|773a540c-2192-4d70-b1f4-c87a425ca0f5|1|[?]|[?]|MODERATE|1|SCREENING|2021-09-09|2021-09-07|2022-06-08|4|2|276|BEFORE|2021-10-11|BEFORE|2021-10-12
Study ID|CE|773a540c-2192-4d70-b1f4-c87a425ca0f5|2|[?]|[?]|MODERATE|2|TREATMENT|2022-04-14|2021-11-02|2022-04-30|221|58|237|UNKNOWN|2022-04-15|AFTER|2022-05-03
Study ID|CE|bfd02605-982e-4d42-8bbd-817e736cd501|1|[?]|[?]|MILD|5|WASHOUT|2022-03-13|2022-02-02|2022-03-17|140|101|144|AFTER|2022-07-10|BEFORE|2022-08-04
Study ID|CE|bfd02605-982e-4d42-8bbd-817e736cd501|2|[?]|[?]|MODERATE|3|WASHOUT|2022-06-19|2022-06-12|2022-07-05|238|231|254|BEFORE|2021-12-17|AFTER|2021-12-18
Study ID|CE|6bb46b4f-3727-41d0-91cc-fb7b4540b3af|1|[?]|[?]|SEVERE|3|WASHOUT|2022-06-08|2021-12-12|2022-06-20|252|74|264|BEFORE|2021-12-30|BEFORE|2022-01-24
Study ID|CE|6bb46b4f-3727-41d0-91cc-fb7b4540b3af|2|[?]|[?]|SEVERE|6|TREATMENT|2022-01-31|2022-01-30|2022-02-14|124|123|138|AFTER|2021-11-18|BEFORE|2021-11-28
Study ID|CE|91250cab-9762-4c18-81b2-8d8d5fc8b193|1|[?]|[?]|SEVERE|1|SCREENING|2022-01-19|2021-11-22|2022-07-03|109|51|274|COINCIDENT|2022-05-13|BEFORE|2022-05-31
Study ID|CE|91250cab-9762-4c18-81b2-8d8d5fc8b193|2|[?]|[?]|MODERATE|3|WASHOUT|2022-01-07|2021-11-09|2022-04-10|97|38|190|AFTER|2022-02-24|COINCIDENT|2022-03-03
Study ID|CE|d80c7117-562a-4233-add0-d216c6d8ae62|1|[?]|[?]|MODERATE|4|TREATMENT|2021-12-12|2021-09-29|2022-04-17|128|54|254|BEFORE|2021-11-27|COINCIDENT|2022-03-30
Study ID|CE|d80c7117-562a-4233-add0-d216c6d8ae62|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-01-16|2021-09-24|2022-05-20|163|49|287|BEFORE|2022-04-27|COINCIDENT|2022-05-04
Study ID|CE|10b3ab23-8eea-409f-8b9a-22fc1a6b7e94|1|[?]|[?]|MILD|2|TREATMENT|2022-01-24|2021-10-26|2022-05-28|118|28|242|AFTER|2022-02-14|AFTER|2022-02-23
Study ID|CE|10b3ab23-8eea-409f-8b9a-22fc1a6b7e94|2|[?]|[?]|MODERATE|1|SCREENING|2021-11-09|2021-11-06|2021-12-04|42|39|67|AFTER|2021-10-03|BEFORE|2021-10-04
Study ID|CE|848dd063-1b33-4487-8aaa-01757cb77046|1|[?]|[?]|SEVERE|5|WASHOUT|2022-06-03|2021-09-30|2022-06-06|292|46|295|UNKNOWN|2022-02-03|ONGOING|2022-02-04
Study ID|CE|848dd063-1b33-4487-8aaa-01757cb77046|2|[?]|[?]|SEVERE|5|WASHOUT|2021-11-12|2021-10-17|2022-05-27|89|63|285|BEFORE|2021-09-04|AFTER|2021-09-05
Study ID|CE|63a3bf0f-18a8-402b-bb40-d68bc96adc98|1|[?]|[?]|MILD|6|TREATMENT|2021-12-23|2021-12-01|2021-12-26|56|34|59|AFTER|2022-04-22|AFTER|2022-05-14
Study ID|CE|63a3bf0f-18a8-402b-bb40-d68bc96adc98|2|[?]|[?]|SEVERE|3|WASHOUT|2022-08-08|2021-11-19|2022-08-10|284|22|286|AFTER|2022-05-08|COINCIDENT|2022-06-01
Study ID|CE|06a270fe-45b6-406f-a543-4cb7240ebad5|1|[?]|[?]|MODERATE|6|TREATMENT|2021-10-22|2021-10-12|2022-07-02|23|13|276|UNKNOWN|2021-11-12|AFTER|2021-11-24
Study ID|CE|06a270fe-45b6-406f-a543-4cb7240ebad5|2|[?]|[?]|MODERATE|1|SCREENING|2022-01-09|2021-12-21|2022-03-08|102|83|160|BEFORE|2021-10-12|BEFORE|2021-10-15
Study ID|CE|8ccf883c-fec1-41d8-87f4-3c8acea6dad4|1|[?]|[?]|SEVERE|6|TREATMENT|2022-04-12|2021-12-09|2022-04-25|221|97|234|BEFORE|2022-04-04|COINCIDENT|2022-04-16
Study ID|CE|8ccf883c-fec1-41d8-87f4-3c8acea6dad4|2|[?]|[?]|SEVERE|3|WASHOUT|2021-12-24|2021-12-02|2022-03-09|112|90|187|UNKNOWN|2021-12-14|ONGOING|2022-03-18
Study ID|CE|c4cd72ee-a69e-4918-b4ee-749907a13b09|1|[?]|[?]|SEVERE|5|WASHOUT|2021-12-20|2021-11-14|2022-04-17|52|16|170|COINCIDENT|2022-02-20|ONGOING|2022-02-21
Study ID|CE|c4cd72ee-a69e-4918-b4ee-749907a13b09|2|[?]|[?]|SEVERE|1|SCREENING|2021-11-02|2021-11-01|2022-07-22|4|3|266|BEFORE|2022-05-25|COINCIDENT|2022-07-08
Study ID|CE|24d359a0-1b45-42df-bd8b-65856237b539|1|[?]|[?]|MILD|3|WASHOUT|2022-02-24|2021-12-28|2022-03-15|164|106|183|AFTER|2022-06-11|BEFORE|2022-06-15
Study ID|CE|24d359a0-1b45-42df-bd8b-65856237b539|2|[?]|[?]|SEVERE|1|SCREENING|2022-03-23|2021-12-27|2022-06-15|191|105|275|COINCIDENT|2022-04-10|ONGOING|2022-04-18
Study ID|CE|6cc10a89-4636-45dc-a2b5-4722fe7b4f70|1|[?]|[?]|MILD|3|WASHOUT|2022-06-21|2021-11-09|2022-07-01|269|45|279|COINCIDENT|2021-11-03|COINCIDENT|2021-11-04
Study ID|CE|6cc10a89-4636-45dc-a2b5-4722fe7b4f70|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-05-08|2021-11-21|2022-06-07|225|57|255|COINCIDENT|2022-02-15|COINCIDENT|2022-02-20
Study ID|CE|136b774c-27d5-4513-ab9b-e359df78dc12|1|[?]|[?]|MILD|4|TREATMENT|2022-02-02|2021-10-22|2022-06-01|119|16|238|AFTER|2022-03-10|BEFORE|2022-04-07
Study ID|CE|136b774c-27d5-4513-ab9b-e359df78dc12|2|[?]|[?]|MILD|6|TREATMENT|2022-04-16|2021-11-30|2022-06-20|192|55|257|AFTER|2021-10-31|AFTER|2021-12-29
Study ID|CE|0cd176fd-cf7d-4be6-ba63-d4e363bf3b40|1|[?]|[?]|MODERATE|6|TREATMENT|2022-02-28|2021-09-12|2022-04-10|180|11|221|COINCIDENT|2022-01-14|COINCIDENT|2022-01-15
Study ID|CE|0cd176fd-cf7d-4be6-ba63-d4e363bf3b40|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-03-31|2021-09-23|2022-04-30|211|22|241|AFTER|2021-10-01|AFTER|2021-11-01
Study ID|CE|5fcad72b-cd2e-40ce-b2a4-f50768708c77|1|[?]|[?]|MILD|6|TREATMENT|2021-10-03|2021-09-10|2022-01-13|29|6|131|AFTER|2022-05-27|BEFORE|2022-05-31
Study ID|CE|5fcad72b-cd2e-40ce-b2a4-f50768708c77|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-06-09|2022-04-28|2022-06-24|278|236|293|COINCIDENT|2021-11-24|ONGOING|2021-11-25
Study ID|CE|133aa3a3-b051-4faa-b737-1851d7935fee|1|[?]|[?]|SEVERE|1|SCREENING|2021-10-25|2021-10-02|2022-01-19|49|26|135|AFTER|2021-09-28|AFTER|2021-10-02
Study ID|CE|133aa3a3-b051-4faa-b737-1851d7935fee|2|[?]|[?]|SEVERE|5|WASHOUT|2022-04-04|2021-10-19|2022-04-26|210|43|232|BEFORE|2021-09-21|BEFORE|2021-09-23
Study ID|CE|a0293fb2-4ec2-48a8-be40-5936bc7cdde3|1|[?]|[?]|MILD|6|TREATMENT|2022-04-07|2021-12-18|2022-08-02|172|62|289|BEFORE|2022-06-16|AFTER|2022-07-17
Study ID|CE|a0293fb2-4ec2-48a8-be40-5936bc7cdde3|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-07-04|2021-11-12|2022-07-24|260|26|280|UNKNOWN|2022-01-24|AFTER|2022-01-27
Study ID|CE|1e612989-bd41-43fe-82bd-18b651c6c5ca|1|[?]|[?]|MILD|6|TREATMENT|2022-02-02|2021-11-26|2022-06-18|136|68|272|COINCIDENT|2021-12-13|AFTER|2021-12-20
Study ID|CE|1e612989-bd41-43fe-82bd-18b651c6c5ca|2|[?]|[?]|MODERATE|5|WASHOUT|2022-04-28|2022-04-24|2022-06-01|221|217|255|UNKNOWN|2022-01-11|BEFORE|2022-03-13
Study ID|CE|91cbb9a1-c45e-471c-b09d-98de638b7a30|1|[?]|[?]|SEVERE|5|WASHOUT|2021-10-26|2021-09-27|2022-06-28|33|4|278|UNKNOWN|2022-02-10|COINCIDENT|2022-03-30
Study ID|CE|91cbb9a1-c45e-471c-b09d-98de638b7a30|2|[?]|[?]|SEVERE|6|TREATMENT|2022-05-28|2022-05-26|2022-06-17|247|245|267|COINCIDENT|2022-04-20|COINCIDENT|2022-05-15
Study ID|CE|fb2835ae-39a6-48dd-93f4-006b40dc947d|1|[?]|[?]|MODERATE|5|WASHOUT|2022-07-05|2021-11-09|2022-07-07|286|48|288|UNKNOWN|2021-11-13|COINCIDENT|2021-11-30
Study ID|CE|fb2835ae-39a6-48dd-93f4-006b40dc947d|2|[?]|[?]|MILD|5|WASHOUT|2022-06-23|2022-03-21|2022-07-08|274|180|289|AFTER|2021-10-07|ONGOING|2021-10-08
Study ID|CE|fcc5702d-44d6-4ffc-b81c-b121c1b058a9|1|[?]|[?]|SEVERE|2|TREATMENT|2021-12-13|2021-11-13|2022-06-12|81|51|262|COINCIDENT|2021-10-15|BEFORE|2021-10-16
Study ID|CE|fcc5702d-44d6-4ffc-b81c-b121c1b058a9|2|[?]|[?]|MILD|6|TREATMENT|2022-06-10|2022-03-06|2022-07-18|260|164|298|BEFORE|2022-05-16|BEFORE|2022-05-20
Study ID|CE|df209108-bad2-4312-a372-1ca91d659760|1|[?]|[?]|MILD|4|TREATMENT|2022-05-28|2022-04-23|2022-07-02|231|196|266|COINCIDENT|2022-04-04|BEFORE|2022-04-05
Study ID|CE|df209108-bad2-4312-a372-1ca91d659760|2|[?]|[?]|MILD|3|WASHOUT|2021-11-20|2021-10-18|2022-03-08|42|9|150|AFTER|2021-12-14|ONGOING|2022-02-09
Study ID|CE|abca5aba-8fa2-4ecd-9416-42ea63ef1d63|1|[?]|[?]|MILD|6|TREATMENT|2022-04-25|2022-01-17|2022-05-16|209|111|230|COINCIDENT|2021-10-08|BEFORE|2021-10-11
Study ID|CE|abca5aba-8fa2-4ecd-9416-42ea63ef1d63|2|[?]|[?]|MILD|3|WASHOUT|2022-07-20|2022-03-22|2022-07-23|295|175|298|UNKNOWN|2022-04-06|ONGOING|2022-04-22
Study ID|CE|32683fbe-91aa-4e78-9cba-b9f507008b73|1|[?]|[?]|SEVERE|3|WASHOUT|2022-03-24|2022-02-06|2022-03-26|171|125|173|COINCIDENT|2021-12-15|BEFORE|2022-04-18
Study ID|CE|32683fbe-91aa-4e78-9cba-b9f507008b73|2|[?]|[?]|MODERATE|2|TREATMENT|2022-02-08|2022-01-05|2022-03-10|127|93|157|COINCIDENT|2022-05-31|AFTER|2022-07-02
Study ID|CE|118261a7-9740-4085-bfee-32fcdf7e2e73|1|[?]|[?]|SEVERE|5|WASHOUT|2022-01-12|2021-10-06|2022-04-28|139|41|245|COINCIDENT|2021-09-15|ONGOING|2021-10-02
Study ID|CE|118261a7-9740-4085-bfee-32fcdf7e2e73|2|[?]|[?]|MODERATE|2|TREATMENT|2022-06-03|2022-01-13|2022-06-15|281|140|293|UNKNOWN|2021-11-17|AFTER|2021-11-25
Study ID|CE|af31738e-c84d-4a27-b641-01ebc124fea2|1|[?]|[?]|SEVERE|3|WASHOUT|2022-04-23|2022-02-16|2022-07-03|196|130|267|UNKNOWN|2021-12-12|ONGOING|2021-12-23
Study ID|CE|af31738e-c84d-4a27-b641-01ebc124fea2|2|[?]|[?]|SEVERE|2|TREATMENT|2022-01-14|2021-11-17|2022-02-02|97|39|116|BEFORE|2022-04-01|AFTER|2022-04-02
Study ID|CE|a92e4637-f1eb-4a92-8ebf-9cd094ac7e6e|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-05-23|2021-11-23|2022-07-03|247|66|288|BEFORE|2022-01-11|COINCIDENT|2022-01-16
Study ID|CE|a92e4637-f1eb-4a92-8ebf-9cd094ac7e6e|2|[?]|[?]|MILD|6|TREATMENT|2022-04-16|2022-01-10|2022-05-11|210|114|235|COINCIDENT|2022-01-01|ONGOING|2022-01-15
Study ID|CE|1347b170-a767-45a1-afd9-429d63fb750e|1|[?]|[?]|MODERATE|4|TREATMENT|2022-01-24|2022-01-18|2022-06-14|102|96|243|UNKNOWN|2021-11-29|ONGOING|2021-12-06
Study ID|CE|1347b170-a767-45a1-afd9-429d63fb750e|2|[?]|[?]|MODERATE|5|WASHOUT|2022-05-25|2021-12-14|2022-06-16|223|61|245|UNKNOWN|2021-10-27|COINCIDENT|2021-11-01
Study ID|CE|8ece4da9-30d6-4c7a-8ad1-09234b4004cb|1|[?]|[?]|MILD|2|TREATMENT|2022-05-22|2022-03-08|2022-06-14|206|131|229|BEFORE|2021-11-04|COINCIDENT|2021-11-05
Study ID|CE|8ece4da9-30d6-4c7a-8ad1-09234b4004cb|2|[?]|[?]|MODERATE|1|SCREENING|2022-04-25|2022-04-19|2022-08-23|179|173|299|AFTER|2022-01-18|AFTER|2022-02-09
Study ID|CE|5812af5b-fea6-408b-a4ec-5bcaf5664495|1|[?]|[?]|SEVERE|6|TREATMENT|2022-03-04|2022-02-26|2022-05-24|185|179|266|UNKNOWN|2021-11-30|ONGOING|2022-01-05
Study ID|CE|5812af5b-fea6-408b-a4ec-5bcaf5664495|2|[?]|[?]|MODERATE|1|SCREENING|2022-04-11|2021-12-04|2022-06-04|223|95|277|AFTER|2021-12-23|COINCIDENT|2022-02-02
Study ID|CE|c87f8dfc-095a-41d3-8cc6-69ac5c214f45|1|[?]|[?]|MILD|6|TREATMENT|2022-05-07|2022-02-02|2022-07-10|208|114|272|COINCIDENT|2021-11-25|AFTER|2022-01-24
Study ID|CE|c87f8dfc-095a-41d3-8cc6-69ac5c214f45|2|[?]|[?]|MODERATE|5|WASHOUT|2022-01-02|2022-01-01|2022-03-20|83|82|160|UNKNOWN|2021-12-20|AFTER|2021-12-23
Study ID|CE|fcecb8f0-b1c9-421f-b3e9-a29c4292ce89|1|[?]|[?]|MODERATE|4|TREATMENT|2021-09-11|2021-08-23|2021-09-22|29|10|40|BEFORE|2021-10-02|COINCIDENT|2021-10-21
Study ID|CE|fcecb8f0-b1c9-421f-b3e9-a29c4292ce89|2|[?]|[?]|MILD|5|WASHOUT|2021-09-29|2021-09-13|2022-06-06|47|31|297|UNKNOWN|2021-12-03|ONGOING|2021-12-08
Study ID|CE|5601d848-0311-4526-8522-4b3028a88651|1|[?]|[?]|SEVERE|4|TREATMENT|2021-09-04|2021-09-02|2021-12-11|7|5|105|BEFORE|2021-10-04|BEFORE|2021-10-19
Study ID|CE|5601d848-0311-4526-8522-4b3028a88651|2|[?]|[?]|MILD|3|WASHOUT|2021-12-09|2021-11-28|2022-04-03|103|92|218|COINCIDENT|2021-11-30|COINCIDENT|2021-12-02
Study ID|CE|cdcd8764-b9d7-4329-bf91-ea2571753b41|1|[?]|[?]|SEVERE|6|TREATMENT|2022-03-16|2022-02-17|2022-03-26|217|190|227|COINCIDENT|2021-08-17|BEFORE|2021-08-22
Study ID|CE|cdcd8764-b9d7-4329-bf91-ea2571753b41|2|[?]|[?]|MILD|1|SCREENING|2021-09-28|2021-09-18|2022-05-03|48|38|265|BEFORE|2021-11-14|ONGOING|2021-11-15
Study ID|CE|69b001c0-9041-4e54-bfb2-fcfae2f12293|1|[?]|[?]|SEVERE|3|WASHOUT|2022-07-10|2022-04-15|2022-07-25|276|190|291|AFTER|2022-03-10|COINCIDENT|2022-03-12
Study ID|CE|69b001c0-9041-4e54-bfb2-fcfae2f12293|2|[?]|[?]|MILD|3|WASHOUT|2022-03-21|2022-01-20|2022-05-15|165|105|220|AFTER|2021-11-03|BEFORE|2021-12-31
Study ID|CE|4c9431ac-bd26-48a5-8303-86bf54f91e22|1|[?]|[?]|SEVERE|2|TREATMENT|2021-08-23|2021-08-22|2021-11-28|7|6|104|COINCIDENT|2021-12-03|AFTER|2021-12-05
Study ID|CE|4c9431ac-bd26-48a5-8303-86bf54f91e22|2|[?]|[?]|MILD|3|WASHOUT|2021-09-21|2021-09-15|2022-04-20|36|30|247|BEFORE|2021-12-26|AFTER|2022-01-05
Study ID|CE|364dde94-41af-4b6f-b984-192ee3ad71e1|1|[?]|[?]|MODERATE|4|TREATMENT|2022-02-21|2022-02-10|2022-05-02|186|175|256|BEFORE|2022-04-30|AFTER|2022-05-04
Study ID|CE|364dde94-41af-4b6f-b984-192ee3ad71e1|2|[?]|[?]|MODERATE|6|TREATMENT|2021-10-14|2021-09-04|2022-02-11|56|16|176|AFTER|2021-09-17|AFTER|2021-09-19
Study ID|CE|ddb801ce-53aa-4f8c-8ba1-c144c6c85d90|1|[?]|[?]|MODERATE|6|TREATMENT|2022-02-02|2021-09-13|2022-04-10|169|27|236|COINCIDENT|2021-09-21|ONGOING|2022-01-12
Study ID|CE|ddb801ce-53aa-4f8c-8ba1-c144c6c85d90|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-12-23|2021-09-30|2022-04-14|128|44|240|COINCIDENT|2021-10-16|COINCIDENT|2021-11-23
Study ID|CE|1a584105-d14a-4717-9454-e2c3820381f8|1|[?]|[?]|MODERATE|4|TREATMENT|2022-04-26|2022-01-28|2022-06-11|240|152|286|COINCIDENT|2022-05-13|AFTER|2022-06-03
Study ID|CE|1a584105-d14a-4717-9454-e2c3820381f8|2|[?]|[?]|MILD|3|WASHOUT|2021-11-01|2021-09-04|2022-01-07|64|6|131|AFTER|2021-09-02|ONGOING|2021-09-08
Study ID|CE|e43cdc5b-98d1-44d8-8d04-04711fad7f74|1|[?]|[?]|MODERATE|1|SCREENING|2022-04-21|2022-03-26|2022-05-28|209|183|246|UNKNOWN|2022-02-26|COINCIDENT|2022-04-23
Study ID|CE|e43cdc5b-98d1-44d8-8d04-04711fad7f74|2|[?]|[?]|MODERATE|3|WASHOUT|2022-06-05|2022-04-05|2022-06-30|254|193|279|AFTER|2022-01-08|COINCIDENT|2022-02-19
Study ID|CE|046e07bb-a83a-4162-ae06-6a99ebf1b89e|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-07-23|2022-01-05|2022-08-01|271|72|280|AFTER|2022-01-18|COINCIDENT|2022-02-17
Study ID|CE|046e07bb-a83a-4162-ae06-6a99ebf1b89e|2|[?]|[?]|MODERATE|3|WASHOUT|2022-05-23|2022-01-23|2022-08-12|210|90|291|BEFORE|2022-03-24|BEFORE|2022-03-25
Study ID|CE|da8dfa1f-96a2-4d04-9d7d-3d38c38553fd|1|[?]|[?]|SEVERE|5|WASHOUT|2022-03-05|2022-01-07|2022-03-14|181|124|190|UNKNOWN|2022-03-20|BEFORE|2022-03-21
Study ID|CE|da8dfa1f-96a2-4d04-9d7d-3d38c38553fd|2|[?]|[?]|MODERATE|1|SCREENING|2022-03-20|2021-11-26|2022-06-19|196|82|287|AFTER|2022-03-15|BEFORE|2022-03-27
Study ID|CE|83875d10-6b8d-4ee7-b603-b8def51a7461|1|[?]|[?]|MODERATE|2|TREATMENT|2022-04-02|2022-03-16|2022-06-10|163|146|232|BEFORE|2022-02-12|AFTER|2022-04-14
Study ID|CE|83875d10-6b8d-4ee7-b603-b8def51a7461|2|[?]|[?]|MODERATE|1|SCREENING|2022-06-22|2022-04-21|2022-08-03|244|182|286|COINCIDENT|2022-02-11|BEFORE|2022-02-12
Study ID|CE|33e4bc92-e0fb-4067-bec6-91cb7a6a74f3|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-11-03|2021-10-29|2022-06-22|21|16|252|UNKNOWN|2022-03-28|COINCIDENT|2022-06-15
Study ID|CE|33e4bc92-e0fb-4067-bec6-91cb7a6a74f3|2|[?]|[?]|MILD|2|TREATMENT|2021-11-18|2021-11-01|2021-12-21|36|19|69|AFTER|2022-01-24|ONGOING|2022-01-27
Study ID|CE|32af130e-ded7-42b0-80d2-ef2ab8cb3716|1|[?]|[?]|MILD|1|SCREENING|2022-05-23|2022-04-02|2022-07-09|249|198|296|COINCIDENT|2021-11-12|AFTER|2022-02-13
Study ID|CE|32af130e-ded7-42b0-80d2-ef2ab8cb3716|2|[?]|[?]|MODERATE|2|TREATMENT|2022-04-26|2022-04-12|2022-07-07|222|208|294|UNKNOWN|2021-12-07|BEFORE|2021-12-08
Study ID|CE|c5fb53bb-44b4-4b5c-b761-4162d98ebc17|1|[?]|[?]|SEVERE|5|WASHOUT|2022-01-20|2022-01-19|2022-03-06|142|141|187|UNKNOWN|2021-10-11|BEFORE|2021-10-12
Study ID|CE|c5fb53bb-44b4-4b5c-b761-4162d98ebc17|2|[?]|[?]|MILD|4|TREATMENT|2022-02-21|2021-10-10|2022-04-12|174|40|224|BEFORE|2022-04-20|COINCIDENT|2022-04-20
Study ID|CE|2a1a2992-8396-4304-8a92-9cd66a7369a1|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-04-13|2021-11-17|2022-05-12|225|78|254|COINCIDENT|2022-01-02|ONGOING|2022-01-13
Study ID|CE|2a1a2992-8396-4304-8a92-9cd66a7369a1|2|[?]|[?]|MODERATE|1|SCREENING|2021-11-26|2021-11-10|2022-03-14|87|71|195|UNKNOWN|2021-09-25|AFTER|2021-10-09
Study ID|CE|6ba2f713-f79c-4a47-bbd7-92621654749f|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-01|2022-01-11|2022-06-20|223|82|242|COINCIDENT|2022-02-07|AFTER|2022-02-16
Study ID|CE|6ba2f713-f79c-4a47-bbd7-92621654749f|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-11-02|2021-10-30|2022-02-27|12|9|129|UNKNOWN|2022-06-19|COINCIDENT|2022-06-27
Study ID|CE|0eda1b06-4864-40c9-9c20-9c925e1f783f|1|[?]|[?]|MILD|1|SCREENING|2022-07-03|2021-10-22|2022-07-05|296|42|298|COINCIDENT|2021-12-02|ONGOING|2021-12-07
Study ID|CE|0eda1b06-4864-40c9-9c20-9c925e1f783f|2|[?]|[?]|SEVERE|1|SCREENING|2022-02-13|2022-01-08|2022-04-26|156|120|228|COINCIDENT|2021-09-26|ONGOING|2021-11-01
Study ID|CE|03869e30-d967-4f76-9c9c-a36a7ac7d42a|1|[?]|[?]|SEVERE|6|TREATMENT|2022-03-28|2022-02-06|2022-04-08|183|133|194|COINCIDENT|2021-11-15|BEFORE|2021-12-07
Study ID|CE|03869e30-d967-4f76-9c9c-a36a7ac7d42a|2|[?]|[?]|SEVERE|5|WASHOUT|2022-02-11|2021-12-29|2022-02-25|138|94|152|AFTER|2022-04-26|BEFORE|2022-05-01
Study ID|CE|ad5bfc99-cd61-4bea-8df0-2755b2245233|1|[?]|[?]|SEVERE|6|TREATMENT|2022-05-25|2022-01-03|2022-06-15|268|126|289|UNKNOWN|2021-11-08|COINCIDENT|2021-12-05
Study ID|CE|ad5bfc99-cd61-4bea-8df0-2755b2245233|2|[?]|[?]|MODERATE|5|WASHOUT|2021-09-10|2021-09-01|2022-01-22|11|2|145|UNKNOWN|2021-12-30|ONGOING|2022-01-25
Study ID|CE|414d02ae-7812-4727-acb3-de9d06ea42b2|1|[?]|[?]|SEVERE|2|TREATMENT|2021-10-15|2021-10-09|2021-12-31|41|35|118|UNKNOWN|2021-10-06|AFTER|2021-10-08
Study ID|CE|414d02ae-7812-4727-acb3-de9d06ea42b2|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-02-25|2021-11-18|2022-05-06|174|75|244|UNKNOWN|2022-05-28|ONGOING|2022-06-13
Study ID|CE|d0ae8848-985b-4359-9bd1-ea5be3ccc25b|1|[?]|[?]|SEVERE|3|WASHOUT|2022-03-13|2021-12-03|2022-06-03|184|84|266|BEFORE|2021-11-14|AFTER|2022-02-16
Study ID|CE|d0ae8848-985b-4359-9bd1-ea5be3ccc25b|2|[?]|[?]|MILD|1|SCREENING|2021-09-26|2021-09-19|2022-04-22|16|9|224|UNKNOWN|2021-11-21|ONGOING|2022-05-28
Study ID|CE|b62294f9-8b23-4dec-90c8-a24950aa7d7a|1|[?]|[?]|SEVERE|3|WASHOUT|2022-01-19|2021-12-25|2022-07-08|121|96|291|BEFORE|2022-03-01|BEFORE|2022-06-15
Study ID|CE|b62294f9-8b23-4dec-90c8-a24950aa7d7a|2|[?]|[?]|MILD|5|WASHOUT|2022-05-07|2021-10-27|2022-06-19|229|37|272|AFTER|2022-03-27|AFTER|2022-04-26
Study ID|CE|f17d2239-8ee6-4877-8505-755188fd7d8e|1|[?]|[?]|MODERATE|5|WASHOUT|2021-10-23|2021-09-18|2022-01-03|63|28|135|COINCIDENT|2022-01-11|ONGOING|2022-01-18
Study ID|CE|f17d2239-8ee6-4877-8505-755188fd7d8e|2|[?]|[?]|MILD|5|WASHOUT|2021-11-13|2021-08-27|2022-05-11|84|6|263|UNKNOWN|2021-12-27|BEFORE|2022-03-12
Study ID|CE|a5012fe4-fb41-4745-9c68-35255d3fef81|1|[?]|[?]|MODERATE|6|TREATMENT|2022-02-15|2021-11-16|2022-02-21|175|84|181|UNKNOWN|2021-12-12|COINCIDENT|2022-01-27
Study ID|CE|a5012fe4-fb41-4745-9c68-35255d3fef81|2|[?]|[?]|MILD|1|SCREENING|2021-09-05|2021-09-04|2022-05-19|12|11|268|BEFORE|2022-05-10|COINCIDENT|2022-05-16
Study ID|CE|30957f3e-2568-43f7-988b-d7e8b8567bef|1|[?]|[?]|SEVERE|4|TREATMENT|2022-01-20|2021-11-19|2022-03-06|99|37|144|BEFORE|2021-11-22|COINCIDENT|2021-12-01
Study ID|CE|30957f3e-2568-43f7-988b-d7e8b8567bef|2|[?]|[?]|MILD|1|SCREENING|2022-02-28|2022-02-18|2022-04-27|138|128|196|BEFORE|2022-03-24|ONGOING|2022-03-26
Study ID|CE|6cff0c5a-e346-401c-b190-4357112f0917|1|[?]|[?]|MILD|5|WASHOUT|2022-01-25|2021-11-03|2022-05-08|153|70|256|BEFORE|2021-12-19|ONGOING|2022-02-12
Study ID|CE|6cff0c5a-e346-401c-b190-4357112f0917|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-01-13|2022-01-12|2022-02-04|141|140|163|UNKNOWN|2022-02-03|COINCIDENT|2022-04-11
Study ID|CE|e1a36c62-1c14-42a2-bb96-4ab3c8b2649b|1|[?]|[?]|MILD|1|SCREENING|2021-11-22|2021-10-22|2022-01-12|62|31|113|BEFORE|2022-04-06|COINCIDENT|2022-05-08
Study ID|CE|e1a36c62-1c14-42a2-bb96-4ab3c8b2649b|2|[?]|[?]|SEVERE|3|WASHOUT|2021-10-17|2021-09-24|2022-06-10|26|3|262|BEFORE|2022-01-14|COINCIDENT|2022-05-08
Study ID|CE|10abfe98-d242-4549-8099-3c8d50bdbb31|1|[?]|[?]|MILD|2|TREATMENT|2022-03-28|2022-01-05|2022-04-18|200|118|221|UNKNOWN|2022-04-24|COINCIDENT|2022-04-26
Study ID|CE|10abfe98-d242-4549-8099-3c8d50bdbb31|2|[?]|[?]|SEVERE|4|TREATMENT|2022-05-15|2021-09-24|2022-07-04|248|15|298|UNKNOWN|2021-11-30|BEFORE|2022-01-03
Study ID|CE|b85fe6ec-d44e-431a-ae48-22631d3da657|1|[?]|[?]|SEVERE|2|TREATMENT|2022-05-13|2022-04-19|2022-07-06|207|183|261|AFTER|2022-01-26|ONGOING|2022-02-21
Study ID|CE|b85fe6ec-d44e-431a-ae48-22631d3da657|2|[?]|[?]|MODERATE|4|TREATMENT|2022-03-10|2022-01-03|2022-07-25|143|77|280|BEFORE|2022-02-21|BEFORE|2022-02-23
Study ID|CE|5e715398-874e-49ab-b056-faad57de02ee|1|[?]|[?]|MODERATE|4|TREATMENT|2022-02-20|2022-01-23|2022-04-11|169|141|219|UNKNOWN|2021-12-09|ONGOING|2021-12-17
Study ID|CE|5e715398-874e-49ab-b056-faad57de02ee|2|[?]|[?]|MILD|2|TREATMENT|2022-03-16|2021-10-09|2022-05-15|193|35|253|AFTER|2021-09-17|BEFORE|2021-09-18
Study ID|CE|20d29b93-4a30-4914-811a-84386d3e4f2d|1|[?]|[?]|MODERATE|1|SCREENING|2022-03-08|2021-11-03|2022-04-06|170|45|199|BEFORE|2021-12-13|COINCIDENT|2021-12-18
Study ID|CE|20d29b93-4a30-4914-811a-84386d3e4f2d|2|[?]|[?]|MODERATE|2|TREATMENT|2022-05-25|2022-04-20|2022-06-21|248|213|275|UNKNOWN|2022-01-04|ONGOING|2022-03-01
Study ID|CE|abf73edd-8476-43ac-8c86-b12ec46cc06f|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-11-14|2021-11-05|2021-11-18|36|27|40|AFTER|2022-05-15|BEFORE|2022-05-16
Study ID|CE|abf73edd-8476-43ac-8c86-b12ec46cc06f|2|[?]|[?]|SEVERE|1|SCREENING|2022-05-12|2022-01-21|2022-06-27|215|104|261|COINCIDENT|2022-01-10|AFTER|2022-05-08
Study ID|CE|ed9b9e4e-49a2-47bc-bccb-2ae541395917|1|[?]|[?]|MODERATE|4|TREATMENT|2021-09-11|2021-09-02|2022-04-23|17|8|241|AFTER|2021-10-27|AFTER|2021-11-13
Study ID|CE|ed9b9e4e-49a2-47bc-bccb-2ae541395917|2|[?]|[?]|SEVERE|5|WASHOUT|2022-02-20|2022-01-26|2022-04-19|179|154|237|UNKNOWN|2021-10-21|COINCIDENT|2021-10-22
Study ID|CE|14714bb0-b3c3-47c5-a26d-45a0c29a6b75|1|[?]|[?]|SEVERE|2|TREATMENT|2022-08-03|2022-03-23|2022-08-08|278|145|283|COINCIDENT|2022-07-08|COINCIDENT|2022-07-30
Study ID|CE|14714bb0-b3c3-47c5-a26d-45a0c29a6b75|2|[?]|[?]|SEVERE|4|TREATMENT|2022-07-14|2021-11-16|2022-08-07|258|18|282|BEFORE|2022-01-19|ONGOING|2022-03-30
Study ID|CE|8d12b4a9-3b4f-4bf8-9e44-1306a8fd2daa|1|[?]|[?]|SEVERE|5|WASHOUT|2021-09-30|2021-09-25|2022-05-01|55|50|268|AFTER|2021-11-13|BEFORE|2021-12-07
Study ID|CE|8d12b4a9-3b4f-4bf8-9e44-1306a8fd2daa|2|[?]|[?]|SEVERE|1|SCREENING|2022-01-04|2021-08-16|2022-04-28|151|10|265|COINCIDENT|2021-11-29|ONGOING|2021-12-02
Study ID|CE|c8e04db6-28fa-4c0b-8611-8df28ec93013|1|[?]|[?]|MILD|2|TREATMENT|2022-04-11|2022-03-14|2022-05-07|241|213|267|UNKNOWN|2021-09-05|COINCIDENT|2021-09-05
Study ID|CE|c8e04db6-28fa-4c0b-8611-8df28ec93013|2|[?]|[?]|SEVERE|5|WASHOUT|2022-04-01|2021-09-04|2022-05-17|231|22|277|COINCIDENT|2021-11-06|BEFORE|2021-11-27
Study ID|CE|0e35ed14-e076-48cb-9f90-d559a4052575|1|[?]|[?]|MILD|2|TREATMENT|2022-07-14|2021-10-17|2022-07-15|297|27|298|BEFORE|2022-04-18|BEFORE|2022-04-20
Study ID|CE|0e35ed14-e076-48cb-9f90-d559a4052575|2|[?]|[?]|MODERATE|4|TREATMENT|2022-04-03|2021-12-28|2022-07-06|195|99|289|BEFORE|2021-10-30|ONGOING|2021-11-08
Study ID|CE|70433e05-ff36-402f-a3f4-b0427084c7d6|1|[?]|[?]|SEVERE|2|TREATMENT|2022-06-17|2021-11-04|2022-06-20|271|46|274|UNKNOWN|2022-04-13|AFTER|2022-04-21
Study ID|CE|70433e05-ff36-402f-a3f4-b0427084c7d6|2|[?]|[?]|MODERATE|5|WASHOUT|2022-02-15|2021-12-30|2022-07-12|149|102|296|UNKNOWN|2022-05-14|BEFORE|2022-05-19
Study ID|CE|07889b4d-b5c0-4609-b934-984dca657ea9|1|[?]|[?]|MILD|6|TREATMENT|2022-01-29|2022-01-20|2022-02-24|128|119|154|UNKNOWN|2021-11-09|BEFORE|2021-11-14
Study ID|CE|07889b4d-b5c0-4609-b934-984dca657ea9|2|[?]|[?]|MILD|6|TREATMENT|2021-11-15|2021-10-17|2022-04-17|53|24|206|UNKNOWN|2021-10-26|COINCIDENT|2022-02-13
Study ID|CE|89e46790-b0d5-4441-b36c-6a902e0cb5d5|1|[?]|[?]|SEVERE|1|SCREENING|2022-01-03|2021-11-24|2022-08-09|78|38|296|BEFORE|2021-12-20|BEFORE|2021-12-31
Study ID|CE|89e46790-b0d5-4441-b36c-6a902e0cb5d5|2|[?]|[?]|MODERATE|2|TREATMENT|2021-11-11|2021-11-04|2021-12-28|25|18|72|UNKNOWN|2022-03-28|ONGOING|2022-05-06
Study ID|CE|f3658539-a9d4-43c3-aac3-80276a70dfd6|1|[?]|[?]|SEVERE|1|SCREENING|2022-07-07|2022-03-30|2022-07-29|271|172|293|UNKNOWN|2021-11-15|ONGOING|2021-11-18
Study ID|CE|f3658539-a9d4-43c3-aac3-80276a70dfd6|2|[?]|[?]|MODERATE|4|TREATMENT|2022-05-29|2021-12-16|2022-07-02|232|68|266|BEFORE|2021-12-30|COINCIDENT|2022-01-02
Study ID|CE|8d18e5f1-661a-4970-991b-6c80e12d2058|1|[?]|[?]|SEVERE|3|WASHOUT|2022-03-04|2021-12-20|2022-06-19|151|77|258|BEFORE|2022-02-22|BEFORE|2022-03-02
Study ID|CE|8d18e5f1-661a-4970-991b-6c80e12d2058|2|[?]|[?]|SEVERE|4|TREATMENT|2021-11-19|2021-10-13|2022-03-23|46|9|170|UNKNOWN|2022-01-27|ONGOING|2022-02-09
Study ID|CE|58aeb7ff-d7ed-4c85-a6a6-69dcb56398e2|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-09-11|2021-09-11|2021-09-23|2|2|14|BEFORE|2022-05-01|ONGOING|2022-05-02
Study ID|CE|58aeb7ff-d7ed-4c85-a6a6-69dcb56398e2|2|[?]|[?]|MILD|2|TREATMENT|2021-12-01|2021-09-21|2022-06-13|83|12|277|BEFORE|2022-03-30|COINCIDENT|2022-04-01
Study ID|CE|232ddf92-f565-4f3e-9a4d-e114cea61631|1|[?]|[?]|SEVERE|5|WASHOUT|2021-12-15|2021-12-04|2022-05-05|50|39|191|AFTER|2022-06-26|ONGOING|2022-07-16
Study ID|CE|232ddf92-f565-4f3e-9a4d-e114cea61631|2|[?]|[?]|SEVERE|4|TREATMENT|2021-11-14|2021-10-28|2022-04-13|19|2|169|UNKNOWN|2022-05-17|ONGOING|2022-05-20
Study ID|CE|5007d0c9-4a11-4731-a110-f1864faf6854|1|[?]|[?]|MODERATE|1|SCREENING|2022-04-10|2022-03-19|2022-04-30|246|224|266|BEFORE|2021-11-19|AFTER|2021-11-21
Study ID|CE|5007d0c9-4a11-4731-a110-f1864faf6854|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-02-19|2021-11-14|2022-03-31|196|99|236|AFTER|2021-10-01|AFTER|2022-01-26
Study ID|CE|85b48279-6cdd-48c7-b7eb-bd6e595e0f8f|1|[?]|[?]|SEVERE|1|SCREENING|2021-10-20|2021-10-20|2022-04-11|2|2|175|AFTER|2022-03-14|COINCIDENT|2022-03-21
Study ID|CE|85b48279-6cdd-48c7-b7eb-bd6e595e0f8f|2|[?]|[?]|MILD|3|WASHOUT|2022-05-19|2022-03-16|2022-06-29|213|149|254|AFTER|2021-12-06|BEFORE|2022-02-07
Study ID|CE|581601c0-37e2-4ccf-9d24-55c599e44d84|1|[?]|[?]|SEVERE|2|TREATMENT|2022-06-01|2022-02-27|2022-07-06|260|166|295|AFTER|2022-01-19|AFTER|2022-03-13
Study ID|CE|581601c0-37e2-4ccf-9d24-55c599e44d84|2|[?]|[?]|MILD|2|TREATMENT|2022-02-13|2021-10-09|2022-05-31|152|25|259|AFTER|2022-05-28|ONGOING|2022-06-27
Study ID|CE|83f371a4-b017-4ccd-ae39-3ec0222a5ea2|1|[?]|[?]|MILD|6|TREATMENT|2022-05-11|2021-11-06|2022-06-12|221|35|253|COINCIDENT|2021-11-18|COINCIDENT|2021-11-22
Study ID|CE|83f371a4-b017-4ccd-ae39-3ec0222a5ea2|2|[?]|[?]|SEVERE|1|SCREENING|2021-11-10|2021-11-06|2022-02-26|39|35|147|UNKNOWN|2022-01-09|BEFORE|2022-04-16
Study ID|CE|eb29f19c-b1ea-4618-bae9-a361b44ff63d|1|[?]|[?]|SEVERE|4|TREATMENT|2022-01-24|2021-12-18|2022-05-01|105|68|202|AFTER|2021-11-23|ONGOING|2021-12-03
Study ID|CE|eb29f19c-b1ea-4618-bae9-a361b44ff63d|2|[?]|[?]|SEVERE|4|TREATMENT|2021-12-11|2021-10-16|2022-07-21|61|5|283|COINCIDENT|2022-01-24|COINCIDENT|2022-02-01
Study ID|CE|6e271652-436d-49c6-b3a7-d66728d83df2|1|[?]|[?]|MODERATE|4|TREATMENT|2022-05-05|2022-04-23|2022-05-21|221|209|237|AFTER|2021-10-26|BEFORE|2021-10-27
Study ID|CE|6e271652-436d-49c6-b3a7-d66728d83df2|2|[?]|[?]|MILD|3|WASHOUT|2021-11-16|2021-10-25|2022-01-11|51|29|107|UNKNOWN|2021-11-17|BEFORE|2021-11-26
Study ID|CE|d604ff11-f208-4ed0-8aaa-d9f2e6801a80|1|[?]|[?]|SEVERE|6|TREATMENT|2021-12-04|2021-11-18|2022-03-18|52|36|156|BEFORE|2022-03-12|AFTER|2022-03-25
Study ID|CE|d604ff11-f208-4ed0-8aaa-d9f2e6801a80|2|[?]|[?]|SEVERE|6|TREATMENT|2022-05-03|2022-01-30|2022-06-29|202|109|259|AFTER|2022-01-11|AFTER|2022-01-15
Study ID|CE|49817fe6-5663-49b8-861e-79099a5c9798|1|[?]|[?]|MILD|4|TREATMENT|2022-03-02|2021-12-03|2022-08-14|131|42|296|COINCIDENT|2022-05-05|ONGOING|2022-05-25
Study ID|CE|49817fe6-5663-49b8-861e-79099a5c9798|2|[?]|[?]|MODERATE|1|SCREENING|2022-03-20|2021-12-30|2022-07-25|149|69|276|AFTER|2021-12-15|ONGOING|2022-01-25
Study ID|CE|f0f58cb2-e314-4869-b28f-a143a705a667|1|[?]|[?]|MILD|2|TREATMENT|2022-02-03|2021-10-22|2022-03-24|177|73|226|UNKNOWN|2021-08-27|COINCIDENT|2021-08-27
Study ID|CE|f0f58cb2-e314-4869-b28f-a143a705a667|2|[?]|[?]|MODERATE|4|TREATMENT|2021-12-18|2021-10-28|2022-02-09|130|79|183|COINCIDENT|2022-03-29|BEFORE|2022-04-07
Study ID|CE|6b24c2d9-7aa1-4b21-b13b-11162e1bf375|1|[?]|[?]|SEVERE|4|TREATMENT|2021-10-15|2021-10-11|2021-12-14|39|35|99|BEFORE|2021-12-16|ONGOING|2021-12-18
Study ID|CE|6b24c2d9-7aa1-4b21-b13b-11162e1bf375|2|[?]|[?]|MILD|5|WASHOUT|2021-12-18|2021-11-29|2022-05-19|103|84|255|UNKNOWN|2021-10-25|COINCIDENT|2021-10-26
Study ID|CE|5a60ad4c-9966-47d1-9418-9f9cb058d026|1|[?]|[?]|MILD|5|WASHOUT|2022-02-25|2021-12-13|2022-05-07|178|104|249|COINCIDENT|2021-11-27|BEFORE|2021-11-30
Study ID|CE|5a60ad4c-9966-47d1-9418-9f9cb058d026|2|[?]|[?]|MILD|4|TREATMENT|2022-04-30|2022-04-26|2022-05-08|242|238|250|UNKNOWN|2022-01-27|COINCIDENT|2022-03-08
Study ID|CE|2f385096-51a8-4c83-8805-8bb8888a6b0e|1|[?]|[?]|MILD|5|WASHOUT|2021-11-07|2021-10-31|2022-05-20|52|45|246|BEFORE|2022-01-10|COINCIDENT|2022-05-12
Study ID|CE|2f385096-51a8-4c83-8805-8bb8888a6b0e|2|[?]|[?]|SEVERE|6|TREATMENT|2021-11-06|2021-10-06|2021-12-26|51|20|101|BEFORE|2021-11-03|COINCIDENT|2021-11-06
Study ID|CE|549a4864-34d9-4852-b90a-a4676ba46189|1|[?]|[?]|SEVERE|3|WASHOUT|2022-05-04|2021-12-17|2022-05-28|202|64|226|UNKNOWN|2022-03-08|BEFORE|2022-03-31
Study ID|CE|549a4864-34d9-4852-b90a-a4676ba46189|2|[?]|[?]|MILD|4|TREATMENT|2021-10-27|2021-10-16|2022-06-01|13|2|230|COINCIDENT|2022-03-18|BEFORE|2022-06-01
Study ID|CE|ed891416-d5de-4985-9858-1ddeba0fb3de|1|[?]|[?]|MODERATE|2|TREATMENT|2022-02-24|2022-02-16|2022-04-14|140|132|189|BEFORE|2022-05-28|COINCIDENT|2022-05-29
Study ID|CE|ed891416-d5de-4985-9858-1ddeba0fb3de|2|[?]|[?]|SEVERE|4|TREATMENT|2021-11-28|2021-11-27|2022-05-09|52|51|214|UNKNOWN|2021-10-23|COINCIDENT|2022-01-11
Study ID|CE|c594a6bc-d680-4e20-aff5-88a5ba520340|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-02-10|2021-12-18|2022-07-17|116|62|273|AFTER|2021-12-27|COINCIDENT|2021-12-30
Study ID|CE|c594a6bc-d680-4e20-aff5-88a5ba520340|2|[?]|[?]|MODERATE|6|TREATMENT|2022-02-17|2022-02-03|2022-05-23|123|109|218|UNKNOWN|2021-10-19|ONGOING|2021-10-19
Study ID|CE|89e24da4-3b14-4bb5-aad1-93988184ba42|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-11-28|2021-11-26|2022-01-19|101|99|153|AFTER|2021-09-18|ONGOING|2021-09-26
Study ID|CE|89e24da4-3b14-4bb5-aad1-93988184ba42|2|[?]|[?]|MODERATE|1|SCREENING|2022-01-15|2022-01-05|2022-05-18|149|139|272|UNKNOWN|2022-02-22|COINCIDENT|2022-02-25
Study ID|CE|f7662580-466d-4a62-bb12-7074c0b93927|1|[?]|[?]|SEVERE|4|TREATMENT|2021-10-14|2021-10-11|2021-11-17|5|2|39|BEFORE|2022-06-28|ONGOING|2022-07-16
Study ID|CE|f7662580-466d-4a62-bb12-7074c0b93927|2|[?]|[?]|MODERATE|3|WASHOUT|2021-11-23|2021-10-12|2022-07-11|45|3|275|COINCIDENT|2022-02-27|COINCIDENT|2022-03-21
Study ID|CE|7f931cc2-b6e7-4a31-a510-d7832b76b94a|1|[?]|[?]|MILD|6|TREATMENT|2022-01-14|2021-12-21|2022-05-25|114|90|245|UNKNOWN|2022-02-04|AFTER|2022-03-26
Study ID|CE|7f931cc2-b6e7-4a31-a510-d7832b76b94a|2|[?]|[?]|MILD|1|SCREENING|2022-03-28|2022-02-08|2022-06-08|187|139|259|UNKNOWN|2022-04-23|AFTER|2022-05-14
Study ID|CE|768fd6ff-701e-4fde-82e9-432fff3bc729|1|[?]|[?]|SEVERE|5|WASHOUT|2022-04-18|2021-09-13|2022-04-19|243|26|244|UNKNOWN|2021-12-20|ONGOING|2021-12-23
Study ID|CE|768fd6ff-701e-4fde-82e9-432fff3bc729|2|[?]|[?]|SEVERE|4|TREATMENT|2022-04-10|2021-10-01|2022-05-07|235|44|262|COINCIDENT|2022-01-18|ONGOING|2022-02-09
Study ID|CE|cb48c1d0-24f7-4803-9a1a-d5a35e4b06cc|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-02-06|2021-10-30|2022-04-15|134|35|202|COINCIDENT|2022-02-04|BEFORE|2022-04-11
Study ID|CE|cb48c1d0-24f7-4803-9a1a-d5a35e4b06cc|2|[?]|[?]|MILD|1|SCREENING|2022-05-30|2021-10-25|2022-06-15|247|30|263|BEFORE|2022-06-12|AFTER|2022-06-21
Study ID|CE|060ee7f9-a05e-48df-ae4b-6ac2b8aea91c|1|[?]|[?]|SEVERE|3|WASHOUT|2021-10-04|2021-09-12|2022-05-29|56|34|293|BEFORE|2021-10-23|BEFORE|2021-10-27
Study ID|CE|060ee7f9-a05e-48df-ae4b-6ac2b8aea91c|2|[?]|[?]|MILD|4|TREATMENT|2022-04-10|2021-12-01|2022-04-20|244|114|254|BEFORE|2021-10-17|BEFORE|2021-10-19
Study ID|CE|510a8ff9-0d06-412d-8de6-f88cf734d3f4|1|[?]|[?]|SEVERE|3|WASHOUT|2021-09-11|2021-09-04|2021-12-26|12|5|118|BEFORE|2021-11-11|BEFORE|2021-11-12
Study ID|CE|510a8ff9-0d06-412d-8de6-f88cf734d3f4|2|[?]|[?]|MILD|2|TREATMENT|2021-09-20|2021-09-07|2021-10-18|21|8|49|UNKNOWN|2022-04-25|BEFORE|2022-05-06
Study ID|CE|c930bfa0-66b8-490b-a9fb-c6d0d98c79a7|1|[?]|[?]|MILD|3|WASHOUT|2022-01-28|2021-12-06|2022-03-02|138|85|171|AFTER|2021-12-14|BEFORE|2021-12-20
Study ID|CE|c930bfa0-66b8-490b-a9fb-c6d0d98c79a7|2|[?]|[?]|MILD|3|WASHOUT|2022-03-25|2022-01-07|2022-06-18|194|117|279|BEFORE|2022-03-27|BEFORE|2022-03-28
Study ID|CE|212370d6-958a-4f10-99fa-52a82dd9642f|1|[?]|[?]|MODERATE|2|TREATMENT|2022-01-09|2021-10-15|2022-05-24|94|8|229|UNKNOWN|2022-06-17|ONGOING|2022-07-05
Study ID|CE|212370d6-958a-4f10-99fa-52a82dd9642f|2|[?]|[?]|MILD|1|SCREENING|2022-02-10|2022-01-24|2022-05-27|126|109|232|AFTER|2021-12-29|BEFORE|2022-01-04
Study ID|CE|5b4d1030-da3a-4935-bad9-66f7f06a9011|1|[?]|[?]|MODERATE|5|WASHOUT|2022-02-21|2022-02-05|2022-02-24|140|124|143|AFTER|2021-10-14|COINCIDENT|2021-10-18
Study ID|CE|5b4d1030-da3a-4935-bad9-66f7f06a9011|2|[?]|[?]|MODERATE|6|TREATMENT|2022-02-26|2021-10-12|2022-03-20|145|8|167|COINCIDENT|2021-11-04|ONGOING|2021-11-17
Study ID|CE|b57c8ca5-e2cf-43a9-945b-69356c428ea2|1|[?]|[?]|MILD|2|TREATMENT|2022-05-06|2021-11-12|2022-07-06|238|63|299|BEFORE|2022-04-22|BEFORE|2022-04-24
Study ID|CE|b57c8ca5-e2cf-43a9-945b-69356c428ea2|2|[?]|[?]|MODERATE|4|TREATMENT|2022-01-10|2021-10-04|2022-02-10|122|24|153|UNKNOWN|2022-03-01|BEFORE|2022-04-25
Study ID|CE|ae30d67b-08bc-434f-a478-217b2c337bf1|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-01-21|2021-12-09|2022-03-10|114|71|162|AFTER|2022-01-24|COINCIDENT|2022-01-31
Study ID|CE|ae30d67b-08bc-434f-a478-217b2c337bf1|2|[?]|[?]|MODERATE|2|TREATMENT|2022-03-17|2021-10-08|2022-07-01|169|9|275|UNKNOWN|2021-11-20|BEFORE|2021-11-21
Study ID|CE|80e0a3ad-4614-45fa-b7da-4e3a75948dd8|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-01-31|2021-11-02|2022-06-25|147|57|292|AFTER|2021-11-10|BEFORE|2021-11-17
Study ID|CE|80e0a3ad-4614-45fa-b7da-4e3a75948dd8|2|[?]|[?]|MILD|6|TREATMENT|2021-10-09|2021-09-08|2022-02-19|33|2|166|COINCIDENT|2022-02-02|AFTER|2022-02-06
Study ID|CE|d2d84e70-17a5-426b-9950-eeb8400f3799|1|[?]|[?]|SEVERE|6|TREATMENT|2022-01-18|2021-09-09|2022-04-12|156|25|240|AFTER|2021-11-29|BEFORE|2021-12-06
Study ID|CE|d2d84e70-17a5-426b-9950-eeb8400f3799|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-02-02|2021-12-03|2022-02-27|171|110|196|COINCIDENT|2022-04-02|ONGOING|2022-04-23
Study ID|CE|ab29520f-676b-4f65-ac81-82304aef6428|1|[?]|[?]|MODERATE|5|WASHOUT|2022-01-15|2021-12-17|2022-03-31|160|131|235|COINCIDENT|2022-01-11|BEFORE|2022-01-18
Study ID|CE|ab29520f-676b-4f65-ac81-82304aef6428|2|[?]|[?]|SEVERE|4|TREATMENT|2022-01-17|2021-09-22|2022-06-01|162|45|297|BEFORE|2021-10-19|ONGOING|2022-03-28
Study ID|CE|a2dd2ef8-c42f-4e17-aa79-72a1fcf94596|1|[?]|[?]|SEVERE|1|SCREENING|2022-06-07|2022-03-30|2022-06-22|284|215|299|UNKNOWN|2022-03-17|AFTER|2022-05-16
Study ID|CE|a2dd2ef8-c42f-4e17-aa79-72a1fcf94596|2|[?]|[?]|MODERATE|6|TREATMENT|2021-08-31|2021-08-30|2022-04-04|4|3|220|BEFORE|2021-10-18|AFTER|2021-10-26
Study ID|CE|6d740f8e-f7d4-40ec-b8d9-2ebbdcd7fb65|1|[?]|[?]|MODERATE|2|TREATMENT|2022-04-30|2021-10-14|2022-05-23|257|59|280|UNKNOWN|2022-02-12|ONGOING|2022-02-25
Study ID|CE|6d740f8e-f7d4-40ec-b8d9-2ebbdcd7fb65|2|[?]|[?]|MODERATE|6|TREATMENT|2021-09-24|2021-09-21|2022-03-11|39|36|207|AFTER|2021-11-15|COINCIDENT|2021-12-28
Study ID|CE|55eeb8e7-c997-4f21-aa9a-92cfe57d6ade|1|[?]|[?]|SEVERE|6|TREATMENT|2021-11-01|2021-10-04|2021-11-24|82|54|105|AFTER|2021-11-02|AFTER|2021-12-17
Study ID|CE|55eeb8e7-c997-4f21-aa9a-92cfe57d6ade|2|[?]|[?]|MILD|4|TREATMENT|2022-03-15|2021-10-20|2022-03-17|216|70|218|BEFORE|2021-09-16|ONGOING|2021-09-18
Study ID|CE|f02d68f6-149f-44f8-ae15-004b13f2447d|1|[?]|[?]|MILD|6|TREATMENT|2022-07-21|2021-11-19|2022-07-28|292|48|299|AFTER|2021-11-22|AFTER|2021-11-29
Study ID|CE|f02d68f6-149f-44f8-ae15-004b13f2447d|2|[?]|[?]|MODERATE|3|WASHOUT|2021-12-26|2021-11-02|2022-06-22|85|31|263|BEFORE|2021-11-27|COINCIDENT|2021-12-05
Study ID|CE|0dc1253a-6f7b-4fb2-a008-832188c2baaf|1|[?]|[?]|MODERATE|4|TREATMENT|2022-07-11|2022-01-02|2022-07-15|291|101|295|AFTER|2021-12-25|BEFORE|2021-12-29
Study ID|CE|0dc1253a-6f7b-4fb2-a008-832188c2baaf|2|[?]|[?]|MILD|7|FOLLOW-UP|2021-12-30|2021-11-14|2022-01-22|98|52|121|AFTER|2022-05-11|AFTER|2022-05-13
Study ID|CE|4335a7d8-78a7-43a5-891c-b9db8066e4b7|1|[?]|[?]|MODERATE|3|WASHOUT|2022-01-27|2021-12-26|2022-06-16|120|88|260|COINCIDENT|2022-03-27|BEFORE|2022-03-28
Study ID|CE|4335a7d8-78a7-43a5-891c-b9db8066e4b7|2|[?]|[?]|SEVERE|3|WASHOUT|2022-06-09|2022-02-15|2022-06-28|253|139|272|UNKNOWN|2021-11-01|ONGOING|2021-11-11
Study ID|CE|34336761-a918-4570-bbb9-46fcf39cb60f|1|[?]|[?]|SEVERE|5|WASHOUT|2021-10-12|2021-09-13|2022-01-02|53|24|135|AFTER|2022-02-22|ONGOING|2022-02-26
Study ID|CE|34336761-a918-4570-bbb9-46fcf39cb60f|2|[?]|[?]|MODERATE|3|WASHOUT|2021-09-08|2021-09-05|2021-11-19|19|16|91|UNKNOWN|2022-05-05|ONGOING|2022-05-15
Study ID|CE|9b20980a-c8fe-4d09-aa6c-2022eeeafdc1|1|[?]|[?]|SEVERE|5|WASHOUT|2021-12-06|2021-12-05|2022-01-26|120|119|171|AFTER|2021-09-29|AFTER|2021-09-30
Study ID|CE|9b20980a-c8fe-4d09-aa6c-2022eeeafdc1|2|[?]|[?]|SEVERE|3|WASHOUT|2022-01-08|2021-10-31|2022-04-06|153|84|241|AFTER|2022-01-15|BEFORE|2022-02-04
Study ID|CE|b8f38aeb-6f0c-42a9-b7ef-d054e379a0e2|1|[?]|[?]|SEVERE|4|TREATMENT|2021-09-20|2021-09-18|2022-01-23|8|6|133|UNKNOWN|2021-09-25|ONGOING|2021-09-27
Study ID|CE|b8f38aeb-6f0c-42a9-b7ef-d054e379a0e2|2|[?]|[?]|SEVERE|4|TREATMENT|2022-01-19|2021-12-02|2022-04-06|129|81|206|AFTER|2022-02-01|AFTER|2022-02-10
Study ID|CE|2288a9c2-c5cb-4517-91a9-6f329b6c074c|1|[?]|[?]|MODERATE|3|WASHOUT|2022-02-21|2022-01-10|2022-03-24|156|114|187|UNKNOWN|2022-04-03|COINCIDENT|2022-05-17
Study ID|CE|2288a9c2-c5cb-4517-91a9-6f329b6c074c|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-02-20|2022-01-02|2022-06-15|155|106|270|AFTER|2021-09-27|ONGOING|2021-09-28
Study ID|CE|a10ca8a1-71ac-4648-966c-a4fbe0ea9f6a|1|[?]|[?]|MILD|3|WASHOUT|2022-03-30|2022-03-24|2022-05-13|185|179|229|UNKNOWN|2022-01-31|COINCIDENT|2022-02-04
Study ID|CE|a10ca8a1-71ac-4648-966c-a4fbe0ea9f6a|2|[?]|[?]|MODERATE|5|WASHOUT|2022-03-17|2022-02-20|2022-05-04|172|147|220|UNKNOWN|2022-04-09|ONGOING|2022-04-27
Study ID|CE|10173319-d6ab-4249-a3a5-4e60f68cf5db|1|[?]|[?]|MODERATE|1|SCREENING|2022-02-16|2021-08-25|2022-05-10|177|2|260|AFTER|2021-12-03|ONGOING|2021-12-08
Study ID|CE|10173319-d6ab-4249-a3a5-4e60f68cf5db|2|[?]|[?]|MILD|4|TREATMENT|2021-12-17|2021-11-29|2022-05-12|116|98|262|COINCIDENT|2022-03-17|BEFORE|2022-03-18
Study ID|CE|9a049fca-bafc-4153-83b4-4dc70c68304c|1|[?]|[?]|MODERATE|6|TREATMENT|2022-05-19|2022-02-18|2022-06-06|281|191|299|BEFORE|2022-02-15|ONGOING|2022-02-17
Study ID|CE|9a049fca-bafc-4153-83b4-4dc70c68304c|2|[?]|[?]|SEVERE|4|TREATMENT|2022-03-02|2022-02-27|2022-03-30|203|200|231|COINCIDENT|2022-01-21|ONGOING|2022-02-09
Study ID|CE|285df392-2e9c-494e-852f-54950a3dad0f|1|[?]|[?]|MILD|5|WASHOUT|2021-12-03|2021-11-27|2022-03-24|54|48|165|COINCIDENT|2022-04-30|ONGOING|2022-05-07
Study ID|CE|285df392-2e9c-494e-852f-54950a3dad0f|2|[?]|[?]|MILD|3|WASHOUT|2021-11-08|2021-10-20|2021-12-29|29|10|80|AFTER|2022-03-09|AFTER|2022-03-18
Study ID|CE|b9c37acb-5ca8-40fd-8602-d0ad4482f2eb|1|[?]|[?]|MILD|1|SCREENING|2022-02-08|2022-01-22|2022-07-24|123|106|289|COINCIDENT|2021-12-07|ONGOING|2021-12-08
Study ID|CE|b9c37acb-5ca8-40fd-8602-d0ad4482f2eb|2|[?]|[?]|MODERATE|6|TREATMENT|2022-08-03|2022-04-30|2022-08-04|299|204|300|BEFORE|2022-01-23|ONGOING|2022-02-19
Study ID|CE|e7ce576e-012e-4632-ada0-59e2a592d408|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-10-14|2021-10-13|2022-01-25|33|32|136|AFTER|2021-11-11|BEFORE|2021-11-20
Study ID|CE|e7ce576e-012e-4632-ada0-59e2a592d408|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-01-06|2021-12-08|2022-04-22|117|88|223|BEFORE|2022-01-03|BEFORE|2022-01-06
Study ID|CE|d8a4a180-a82d-4ddb-9274-5d83c70112a3|1|[?]|[?]|MILD|4|TREATMENT|2021-12-08|2021-10-13|2022-02-26|92|36|172|BEFORE|2022-03-20|COINCIDENT|2022-03-31
Study ID|CE|d8a4a180-a82d-4ddb-9274-5d83c70112a3|2|[?]|[?]|MODERATE|1|SCREENING|2022-04-06|2021-12-05|2022-04-08|211|89|213|BEFORE|2021-12-03|BEFORE|2021-12-03
Study ID|CE|63706db7-5cac-4126-a1ab-dca325988bf6|1|[?]|[?]|MILD|3|WASHOUT|2022-08-18|2022-08-05|2022-08-20|296|283|298|COINCIDENT|2022-03-10|ONGOING|2022-03-21
Study ID|CE|63706db7-5cac-4126-a1ab-dca325988bf6|2|[?]|[?]|SEVERE|1|SCREENING|2022-05-08|2022-01-23|2022-05-19|194|89|205|AFTER|2021-11-20|AFTER|2021-12-30
Study ID|CE|9eed1701-6dbc-45c7-8ea7-4d5b686fb6ff|1|[?]|[?]|MODERATE|1|SCREENING|2021-11-15|2021-11-08|2022-02-25|88|81|190|UNKNOWN|2021-08-26|BEFORE|2021-08-26
Study ID|CE|9eed1701-6dbc-45c7-8ea7-4d5b686fb6ff|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-03-18|2021-08-25|2022-05-30|211|6|284|COINCIDENT|2022-01-30|BEFORE|2022-02-03
Study ID|CE|74d84f4c-4566-4249-96a1-533de932dd89|1|[?]|[?]|SEVERE|1|SCREENING|2022-08-08|2022-03-28|2022-08-10|295|162|297|BEFORE|2022-01-25|BEFORE|2022-01-27
Study ID|CE|74d84f4c-4566-4249-96a1-533de932dd89|2|[?]|[?]|SEVERE|6|TREATMENT|2022-03-18|2021-10-29|2022-04-13|152|12|178|UNKNOWN|2021-12-28|COINCIDENT|2021-12-30
Study ID|CE|fe2e55ec-2e4c-4baa-9c92-60e7ed17c458|1|[?]|[?]|SEVERE|5|WASHOUT|2022-02-16|2021-12-18|2022-03-30|182|122|224|BEFORE|2021-10-19|ONGOING|2022-02-26
Study ID|CE|fe2e55ec-2e4c-4baa-9c92-60e7ed17c458|2|[?]|[?]|MILD|6|TREATMENT|2022-01-31|2021-08-28|2022-04-13|166|10|238|COINCIDENT|2022-06-04|BEFORE|2022-06-07
Study ID|CE|86bb2bc8-a4ec-4965-af26-11f4979f99bb|1|[?]|[?]|SEVERE|1|SCREENING|2021-09-28|2021-09-09|2022-03-17|43|24|213|COINCIDENT|2022-01-18|ONGOING|2022-01-19
Study ID|CE|86bb2bc8-a4ec-4965-af26-11f4979f99bb|2|[?]|[?]|SEVERE|2|TREATMENT|2022-04-30|2022-01-19|2022-06-08|257|156|296|UNKNOWN|2022-04-17|BEFORE|2022-05-12
Study ID|CE|974ff09c-caf2-414a-ba3a-9b9471fbd620|1|[?]|[?]|MODERATE|4|TREATMENT|2021-11-25|2021-09-28|2022-01-18|88|30|142|BEFORE|2021-10-31|COINCIDENT|2021-12-24
Study ID|CE|974ff09c-caf2-414a-ba3a-9b9471fbd620|2|[?]|[?]|MILD|1|SCREENING|2022-05-03|2022-03-02|2022-05-15|247|185|259|BEFORE|2022-04-04|AFTER|2022-05-04
Study ID|CE|c9ec4c3f-144a-44b6-b5a8-83bb25599c0e|1|[?]|[?]|MODERATE|4|TREATMENT|2021-12-15|2021-10-17|2022-03-10|126|67|211|COINCIDENT|2021-11-07|AFTER|2021-11-11
Study ID|CE|c9ec4c3f-144a-44b6-b5a8-83bb25599c0e|2|[?]|[?]|MILD|6|TREATMENT|2021-11-08|2021-10-20|2021-12-21|89|70|132|AFTER|2021-11-01|BEFORE|2021-11-05
Study ID|CE|713e69bd-2de6-434b-94ba-20b55da40e62|1|[?]|[?]|SEVERE|2|TREATMENT|2022-03-05|2022-01-16|2022-05-31|206|158|293|AFTER|2021-12-04|ONGOING|2021-12-05
Study ID|CE|713e69bd-2de6-434b-94ba-20b55da40e62|2|[?]|[?]|SEVERE|1|SCREENING|2022-02-13|2022-01-10|2022-02-15|186|152|188|UNKNOWN|2021-10-21|COINCIDENT|2021-10-22
Study ID|CE|7ab6fabe-0ef9-4661-9eec-f16834285435|1|[?]|[?]|MILD|4|TREATMENT|2021-11-30|2021-10-08|2022-02-22|81|28|165|BEFORE|2021-10-15|ONGOING|2021-11-21
Study ID|CE|7ab6fabe-0ef9-4661-9eec-f16834285435|2|[?]|[?]|SEVERE|4|TREATMENT|2022-05-04|2021-09-28|2022-05-13|236|18|245|BEFORE|2022-02-01|BEFORE|2022-02-08
Study ID|CE|2d16c162-8f9f-4753-a06f-406c60f8bd9a|1|[?]|[?]|MODERATE|3|WASHOUT|2022-03-13|2022-02-26|2022-06-07|148|133|234|UNKNOWN|2022-01-11|ONGOING|2022-02-18
Study ID|CE|2d16c162-8f9f-4753-a06f-406c60f8bd9a|2|[?]|[?]|MODERATE|3|WASHOUT|2022-07-06|2021-12-29|2022-08-09|263|74|297|AFTER|2022-04-22|ONGOING|2022-05-28
Study ID|CE|4fc2b201-daad-42fb-b99c-63629135b9ce|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-01-16|2022-01-14|2022-03-14|92|90|149|AFTER|2021-11-30|AFTER|2021-12-11
Study ID|CE|4fc2b201-daad-42fb-b99c-63629135b9ce|2|[?]|[?]|MODERATE|1|SCREENING|2021-11-13|2021-11-08|2022-06-13|28|23|240|COINCIDENT|2022-01-15|AFTER|2022-01-16
Study ID|CE|aaac8972-4d1a-45b2-ae50-57b398adf837|1|[?]|[?]|SEVERE|5|WASHOUT|2022-02-14|2021-12-02|2022-05-03|142|68|220|COINCIDENT|2021-12-04|COINCIDENT|2021-12-09
Study ID|CE|aaac8972-4d1a-45b2-ae50-57b398adf837|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-11-29|2021-11-17|2022-05-17|65|53|234|COINCIDENT|2022-02-07|BEFORE|2022-02-22
Study ID|CE|5921f5c3-9900-4dba-a835-77dfc8c43637|1|[?]|[?]|SEVERE|3|WASHOUT|2022-06-23|2021-12-29|2022-07-28|254|78|289|UNKNOWN|2021-10-19|BEFORE|2021-10-19
Study ID|CE|5921f5c3-9900-4dba-a835-77dfc8c43637|2|[?]|[?]|SEVERE|6|TREATMENT|2021-11-20|2021-11-13|2022-02-05|39|32|116|UNKNOWN|2022-06-07|BEFORE|2022-07-03
Study ID|CE|d4377c02-9a8e-4aca-a5b2-2669c963918c|1|[?]|[?]|MODERATE|1|SCREENING|2022-07-01|2021-11-21|2022-07-02|298|76|299|AFTER|2022-04-06|BEFORE|2022-05-07
Study ID|CE|d4377c02-9a8e-4aca-a5b2-2669c963918c|2|[?]|[?]|SEVERE|5|WASHOUT|2021-11-29|2021-10-13|2022-01-11|84|37|127|BEFORE|2021-10-23|AFTER|2021-10-24
Study ID|CE|d84da97a-bd8d-4dba-8eb2-e545c8eac4e4|1|[?]|[?]|MODERATE|6|TREATMENT|2021-11-11|2021-11-01|2022-01-18|34|24|102|UNKNOWN|2021-10-21|COINCIDENT|2021-10-23
Study ID|CE|d84da97a-bd8d-4dba-8eb2-e545c8eac4e4|2|[?]|[?]|MODERATE|6|TREATMENT|2022-05-29|2021-12-24|2022-06-17|233|77|252|AFTER|2021-12-24|AFTER|2022-01-01
Study ID|CE|9fc55af3-7317-40ed-bc56-1a89dd399808|1|[?]|[?]|SEVERE|1|SCREENING|2021-12-28|2021-12-22|2022-03-14|97|91|173|UNKNOWN|2021-12-28|BEFORE|2022-03-24
Study ID|CE|9fc55af3-7317-40ed-bc56-1a89dd399808|2|[?]|[?]|MILD|4|TREATMENT|2022-03-16|2022-01-02|2022-07-15|175|102|296|BEFORE|2022-03-16|ONGOING|2022-03-16
Study ID|CE|a68f4255-fc70-4b26-a0c0-d6de9b7369d0|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-11-16|2021-11-11|2022-05-06|18|13|189|COINCIDENT|2021-12-28|BEFORE|2022-01-14
Study ID|CE|a68f4255-fc70-4b26-a0c0-d6de9b7369d0|2|[?]|[?]|MODERATE|5|WASHOUT|2021-12-10|2021-11-22|2022-08-08|42|24|283|UNKNOWN|2022-07-08|AFTER|2022-07-09
Study ID|CE|deae6b40-62c1-4064-bf0f-ab4f8fb92555|1|[?]|[?]|MILD|3|WASHOUT|2022-05-13|2022-01-01|2022-06-27|250|118|295|UNKNOWN|2022-02-01|AFTER|2022-02-12
Study ID|CE|deae6b40-62c1-4064-bf0f-ab4f8fb92555|2|[?]|[?]|MILD|7|FOLLOW-UP|2021-09-24|2021-09-17|2021-10-11|19|12|36|UNKNOWN|2021-11-16|BEFORE|2021-11-22
Study ID|CE|a564a6ed-ebde-4d1d-a934-b54eb473a48f|1|[?]|[?]|MODERATE|5|WASHOUT|2022-04-17|2022-01-09|2022-07-27|179|81|280|BEFORE|2022-06-25|AFTER|2022-07-12
Study ID|CE|a564a6ed-ebde-4d1d-a934-b54eb473a48f|2|[?]|[?]|SEVERE|6|TREATMENT|2022-05-03|2022-04-25|2022-05-19|195|187|211|AFTER|2021-12-27|ONGOING|2022-06-07
Study ID|CE|326438a0-7ab6-48c3-95d7-43bf8f86b14c|1|[?]|[?]|MILD|2|TREATMENT|2022-01-29|2021-09-10|2022-05-19|167|26|277|UNKNOWN|2021-08-25|COINCIDENT|2021-08-26
Study ID|CE|326438a0-7ab6-48c3-95d7-43bf8f86b14c|2|[?]|[?]|MODERATE|5|WASHOUT|2022-06-02|2021-11-16|2022-06-07|291|93|296|UNKNOWN|2021-11-21|AFTER|2021-11-22
Study ID|CE|85d8f88d-a898-4915-a9c3-caa158d0b213|1|[?]|[?]|MILD|6|TREATMENT|2021-09-13|2021-08-25|2022-04-03|28|9|230|BEFORE|2022-05-23|AFTER|2022-05-30
Study ID|CE|85d8f88d-a898-4915-a9c3-caa158d0b213|2|[?]|[?]|MODERATE|4|TREATMENT|2022-06-05|2021-12-18|2022-06-09|293|124|297|BEFORE|2022-03-30|AFTER|2022-04-18
Study ID|CE|2d55e323-8719-4ffa-ab70-11adf033ce07|1|[?]|[?]|MILD|2|TREATMENT|2022-04-30|2021-12-13|2022-07-15|186|48|262|BEFORE|2022-05-19|ONGOING|2022-05-23
Study ID|CE|2d55e323-8719-4ffa-ab70-11adf033ce07|2|[?]|[?]|MILD|4|TREATMENT|2021-11-30|2021-11-02|2022-05-01|35|7|187|BEFORE|2022-06-21|AFTER|2022-06-30
Study ID|CE|0246f358-ce63-4bd6-a125-594ff357723e|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-25|2022-04-03|2022-07-27|265|182|297|AFTER|2022-01-20|ONGOING|2022-02-22
Study ID|CE|0246f358-ce63-4bd6-a125-594ff357723e|2|[?]|[?]|MODERATE|6|TREATMENT|2022-01-18|2021-11-12|2022-02-02|107|40|122|BEFORE|2021-10-13|BEFORE|2021-10-14
Study ID|CE|149e623e-b430-45e2-924e-46c437f3db59|1|[?]|[?]|MILD|2|TREATMENT|2022-04-22|2021-09-17|2022-07-01|227|10|297|COINCIDENT|2021-12-11|AFTER|2022-01-20
Study ID|CE|149e623e-b430-45e2-924e-46c437f3db59|2|[?]|[?]|MILD|2|TREATMENT|2022-04-29|2021-12-11|2022-05-27|234|95|262|UNKNOWN|2022-02-06|COINCIDENT|2022-03-12
Study ID|CE|fcb09a08-0491-4bc4-a9b1-1fbd89586f71|1|[?]|[?]|MODERATE|6|TREATMENT|2022-01-30|2021-10-06|2022-03-05|160|44|194|COINCIDENT|2022-01-02|ONGOING|2022-02-10
Study ID|CE|fcb09a08-0491-4bc4-a9b1-1fbd89586f71|2|[?]|[?]|MODERATE|4|TREATMENT|2021-12-02|2021-09-13|2022-05-29|101|21|279|UNKNOWN|2022-02-10|AFTER|2022-02-11
Study ID|CE|b5ad47f0-2842-430f-a0d9-aba11223ccfe|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-11-23|2021-11-14|2021-12-23|72|63|102|BEFORE|2021-12-15|BEFORE|2022-02-10
Study ID|CE|b5ad47f0-2842-430f-a0d9-aba11223ccfe|2|[?]|[?]|SEVERE|6|TREATMENT|2021-10-03|2021-09-17|2021-10-29|21|5|47|COINCIDENT|2021-09-14|COINCIDENT|2021-09-14
Study ID|CE|1075bd3e-efcb-419d-8725-fab6f0c13f3a|1|[?]|[?]|MODERATE|6|TREATMENT|2022-04-12|2022-03-10|2022-04-24|233|200|245|BEFORE|2021-12-08|AFTER|2021-12-19
Study ID|CE|1075bd3e-efcb-419d-8725-fab6f0c13f3a|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-11|2022-04-24|2022-06-17|293|245|299|AFTER|2022-04-30|AFTER|2022-05-13
Study ID|CE|55a344d4-09b0-470b-9607-a19be9d5bd8d|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-11-23|2021-11-08|2022-01-23|38|23|99|BEFORE|2022-04-19|BEFORE|2022-04-27
Study ID|CE|55a344d4-09b0-470b-9607-a19be9d5bd8d|2|[?]|[?]|MILD|6|TREATMENT|2022-05-14|2021-12-06|2022-08-03|210|51|291|AFTER|2022-03-10|ONGOING|2022-05-01
Study ID|CE|4fa27209-acde-4b73-852c-9124a6608f5a|1|[?]|[?]|MODERATE|1|SCREENING|2021-10-29|2021-10-24|2022-07-20|7|2|271|COINCIDENT|2022-04-16|COINCIDENT|2022-04-25
Study ID|CE|4fa27209-acde-4b73-852c-9124a6608f5a|2|[?]|[?]|MILD|1|SCREENING|2022-02-20|2022-01-04|2022-08-15|121|74|297|BEFORE|2022-06-25|BEFORE|2022-06-26
Study ID|CE|d692395a-1a30-4960-95f6-7e854c9f7ce4|1|[?]|[?]|SEVERE|4|TREATMENT|2021-12-08|2021-11-10|2022-04-08|79|51|200|UNKNOWN|2021-10-25|AFTER|2021-11-03
Study ID|CE|d692395a-1a30-4960-95f6-7e854c9f7ce4|2|[?]|[?]|SEVERE|2|TREATMENT|2022-04-10|2022-03-27|2022-06-06|202|188|259|COINCIDENT|2022-02-20|BEFORE|2022-04-13
Study ID|CE|ac690278-07ba-4f47-ad36-f90640c4cac1|1|[?]|[?]|SEVERE|2|TREATMENT|2022-01-18|2021-11-04|2022-02-18|116|41|147|UNKNOWN|2021-11-24|ONGOING|2021-11-25
Study ID|CE|ac690278-07ba-4f47-ad36-f90640c4cac1|2|[?]|[?]|MILD|4|TREATMENT|2022-06-19|2021-09-26|2022-07-18|268|2|297|BEFORE|2021-11-27|AFTER|2021-12-07
Study ID|CE|3344cb70-4cee-4871-9e3c-ee86dc8c09b4|1|[?]|[?]|SEVERE|6|TREATMENT|2022-02-06|2021-12-02|2022-02-08|100|34|102|COINCIDENT|2022-02-27|ONGOING|2022-02-28
Study ID|CE|3344cb70-4cee-4871-9e3c-ee86dc8c09b4|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-03-26|2022-03-04|2022-04-23|148|126|176|UNKNOWN|2022-03-31|COINCIDENT|2022-04-01
Study ID|CE|0ed45504-ee29-4f01-9777-b71461c3f915|1|[?]|[?]|MODERATE|6|TREATMENT|2022-06-02|2021-09-16|2022-06-09|270|11|277|BEFORE|2021-11-15|BEFORE|2021-12-04
Study ID|CE|0ed45504-ee29-4f01-9777-b71461c3f915|2|[?]|[?]|MODERATE|5|WASHOUT|2022-02-25|2021-11-05|2022-05-02|173|61|239|COINCIDENT|2022-05-15|AFTER|2022-05-28
Study ID|CE|9d5ab0d2-0ca8-4747-b374-5bc2ec812b53|1|[?]|[?]|MODERATE|5|WASHOUT|2021-11-29|2021-11-20|2022-01-08|72|63|112|BEFORE|2022-02-04|AFTER|2022-02-10
Study ID|CE|9d5ab0d2-0ca8-4747-b374-5bc2ec812b53|2|[?]|[?]|MODERATE|4|TREATMENT|2022-06-17|2022-01-11|2022-06-21|272|115|276|BEFORE|2021-11-12|AFTER|2021-12-02
Study ID|CE|1dc9438c-e39c-4aa6-8d08-3702919ebe2e|1|[?]|[?]|MILD|3|WASHOUT|2021-11-12|2021-10-03|2022-05-18|76|36|263|UNKNOWN|2022-01-10|COINCIDENT|2022-01-12
Study ID|CE|1dc9438c-e39c-4aa6-8d08-3702919ebe2e|2|[?]|[?]|MODERATE|6|TREATMENT|2022-04-16|2022-03-21|2022-05-22|231|205|267|BEFORE|2022-04-12|AFTER|2022-04-22
Study ID|CE|9492e29a-7a6a-46f2-aa3f-c751b4c2f77b|1|[?]|[?]|SEVERE|3|WASHOUT|2021-10-29|2021-10-28|2022-03-12|7|6|141|UNKNOWN|2022-01-24|ONGOING|2022-02-01
Study ID|CE|9492e29a-7a6a-46f2-aa3f-c751b4c2f77b|2|[?]|[?]|MODERATE|2|TREATMENT|2021-11-11|2021-10-27|2022-06-05|20|5|226|BEFORE|2022-03-29|ONGOING|2022-04-27
Study ID|CE|82c7c099-b23e-4658-aca5-f51872352237|1|[?]|[?]|MODERATE|3|WASHOUT|2022-01-21|2021-12-30|2022-03-22|147|125|207|AFTER|2021-11-27|AFTER|2022-01-23
Study ID|CE|82c7c099-b23e-4658-aca5-f51872352237|2|[?]|[?]|SEVERE|5|WASHOUT|2021-10-01|2021-09-16|2022-03-08|35|20|193|UNKNOWN|2021-09-01|COINCIDENT|2021-11-13
Study ID|CE|3c34e10b-33bf-4e47-b2c6-4beaa9855655|1|[?]|[?]|MODERATE|5|WASHOUT|2022-05-04|2022-02-23|2022-06-08|219|149|254|BEFORE|2021-12-07|BEFORE|2021-12-15
Study ID|CE|3c34e10b-33bf-4e47-b2c6-4beaa9855655|2|[?]|[?]|MILD|3|WASHOUT|2022-01-29|2022-01-18|2022-06-28|124|113|274|COINCIDENT|2022-03-26|ONGOING|2022-04-09
Study ID|CE|8bb18393-9df8-4a39-8fcd-46c740b3b0f2|1|[?]|[?]|MODERATE|1|SCREENING|2021-10-10|2021-09-30|2022-04-21|18|8|211|BEFORE|2021-11-05|AFTER|2021-11-07
Study ID|CE|8bb18393-9df8-4a39-8fcd-46c740b3b0f2|2|[?]|[?]|SEVERE|5|WASHOUT|2021-10-03|2021-09-24|2022-06-16|11|2|267|BEFORE|2022-02-13|AFTER|2022-03-14
Study ID|CE|c332cb21-29a0-40a7-903a-cfc7e924cd3e|1|[?]|[?]|SEVERE|1|SCREENING|2021-12-10|2021-11-24|2022-06-17|109|93|298|AFTER|2022-02-14|AFTER|2022-02-28
Study ID|CE|c332cb21-29a0-40a7-903a-cfc7e924cd3e|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-03-31|2021-11-28|2022-04-02|220|97|222|UNKNOWN|2021-11-20|ONGOING|2022-01-25
Study ID|CE|12e20b79-d475-45d0-913b-692c4bd6b77c|1|[?]|[?]|MODERATE|6|TREATMENT|2022-04-16|2021-10-08|2022-05-20|203|13|237|COINCIDENT|2021-12-03|ONGOING|2021-12-04
Study ID|CE|12e20b79-d475-45d0-913b-692c4bd6b77c|2|[?]|[?]|MILD|5|WASHOUT|2022-06-27|2022-02-02|2022-07-17|275|130|295|AFTER|2021-11-23|BEFORE|2021-11-24
Study ID|CE|47ae4992-d9f2-41b8-b2bb-57b79f4d86a5|1|[?]|[?]|MODERATE|1|SCREENING|2021-11-24|2021-09-04|2022-02-13|90|9|171|COINCIDENT|2021-12-02|BEFORE|2021-12-20
Study ID|CE|47ae4992-d9f2-41b8-b2bb-57b79f4d86a5|2|[?]|[?]|SEVERE|6|TREATMENT|2022-02-13|2022-02-12|2022-02-25|171|170|183|UNKNOWN|2021-10-17|BEFORE|2021-10-21
Study ID|CE|b6f61fd5-1cae-4def-8da2-1155777dace4|1|[?]|[?]|SEVERE|4|TREATMENT|2021-11-04|2021-10-25|2021-11-27|31|21|54|COINCIDENT|2021-11-28|BEFORE|2022-01-05
Study ID|CE|b6f61fd5-1cae-4def-8da2-1155777dace4|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-01-30|2022-01-26|2022-07-22|118|114|291|UNKNOWN|2022-07-04|ONGOING|2022-07-06
Study ID|CE|bf1aba67-4c57-4e5b-9c56-bad135c55428|1|[?]|[?]|MILD|5|WASHOUT|2022-01-06|2021-12-17|2022-01-22|137|117|153|AFTER|2021-09-10|BEFORE|2021-09-15
Study ID|CE|bf1aba67-4c57-4e5b-9c56-bad135c55428|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-04-21|2021-11-15|2022-06-17|242|85|299|BEFORE|2021-10-04|COINCIDENT|2021-11-01
Study ID|CE|821b34a1-4785-41de-9af0-cd213b51f70e|1|[?]|[?]|MODERATE|1|SCREENING|2022-06-10|2022-02-13|2022-07-25|253|136|298|COINCIDENT|2021-11-21|AFTER|2022-04-25
Study ID|CE|821b34a1-4785-41de-9af0-cd213b51f70e|2|[?]|[?]|MODERATE|4|TREATMENT|2021-12-08|2021-10-28|2022-01-19|69|28|111|COINCIDENT|2022-03-17|ONGOING|2022-03-18
Study ID|CE|de9a8eef-40d1-46d0-ad17-0139e1ef6da7|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-09-24|2021-09-23|2022-02-24|3|2|156|UNKNOWN|2022-04-05|AFTER|2022-04-07
Study ID|CE|de9a8eef-40d1-46d0-ad17-0139e1ef6da7|2|[?]|[?]|MODERATE|6|TREATMENT|2022-02-04|2021-11-14|2022-03-06|136|54|166|COINCIDENT|2022-03-16|ONGOING|2022-03-17
Study ID|CE|ebbee535-ce64-49fd-89ca-81b022838a8a|1|[?]|[?]|MILD|3|WASHOUT|2022-08-08|2022-01-28|2022-08-21|283|91|296|BEFORE|2022-02-26|ONGOING|2022-04-07
Study ID|CE|ebbee535-ce64-49fd-89ca-81b022838a8a|2|[?]|[?]|MILD|2|TREATMENT|2022-01-18|2021-11-13|2022-05-18|81|15|201|BEFORE|2022-07-22|COINCIDENT|2022-07-30
Study ID|CE|86577261-79c9-40a0-90f6-341cc56dd879|1|[?]|[?]|SEVERE|2|TREATMENT|2022-03-09|2021-10-14|2022-05-12|184|38|248|UNKNOWN|2022-01-28|COINCIDENT|2022-02-04
Study ID|CE|86577261-79c9-40a0-90f6-341cc56dd879|2|[?]|[?]|MODERATE|4|TREATMENT|2021-09-27|2021-09-10|2022-04-30|21|4|236|AFTER|2021-10-22|AFTER|2021-10-23
Study ID|CE|1af42d8c-ea33-447a-bc0e-7a5aef9f58a0|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-04|2021-12-04|2022-07-30|234|52|290|BEFORE|2022-06-18|COINCIDENT|2022-07-21
Study ID|CE|1af42d8c-ea33-447a-bc0e-7a5aef9f58a0|2|[?]|[?]|SEVERE|5|WASHOUT|2022-01-28|2021-12-13|2022-07-18|107|61|278|UNKNOWN|2021-12-19|BEFORE|2022-01-21
Study ID|CE|59e4a43c-093a-47ec-af14-f59735ccce87|1|[?]|[?]|SEVERE|1|SCREENING|2022-01-19|2021-11-24|2022-05-25|112|56|238|AFTER|2022-06-18|AFTER|2022-06-27
Study ID|CE|59e4a43c-093a-47ec-af14-f59735ccce87|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-05-23|2022-01-04|2022-06-03|236|97|247|AFTER|2022-04-28|ONGOING|2022-04-29
Study ID|CE|5cb7a6b6-7e48-415c-a616-3db61858a2b9|1|[?]|[?]|MODERATE|3|WASHOUT|2022-03-06|2022-02-26|2022-04-24|155|147|204|AFTER|2022-05-13|COINCIDENT|2022-05-20
Study ID|CE|5cb7a6b6-7e48-415c-a616-3db61858a2b9|2|[?]|[?]|MILD|6|TREATMENT|2021-10-25|2021-10-23|2022-02-03|23|21|124|AFTER|2022-04-04|AFTER|2022-05-13
Study ID|CE|f3c49594-5c9e-4c45-9e0b-5c07b0f71596|1|[?]|[?]|MODERATE|4|TREATMENT|2021-09-11|2021-09-02|2022-05-04|20|11|255|COINCIDENT|2022-02-25|AFTER|2022-02-28
Study ID|CE|f3c49594-5c9e-4c45-9e0b-5c07b0f71596|2|[?]|[?]|MODERATE|5|WASHOUT|2022-05-20|2021-12-02|2022-06-17|271|102|299|AFTER|2021-10-20|AFTER|2021-10-30
Study ID|CE|566b7b8c-95bf-43c8-b71f-4e3fab6d3fbe|1|[?]|[?]|SEVERE|1|SCREENING|2021-12-30|2021-12-23|2022-06-09|94|87|255|BEFORE|2022-03-11|ONGOING|2022-04-12
Study ID|CE|566b7b8c-95bf-43c8-b71f-4e3fab6d3fbe|2|[?]|[?]|SEVERE|4|TREATMENT|2022-06-02|2022-03-05|2022-06-11|248|159|257|COINCIDENT|2021-10-26|AFTER|2021-11-02
Study ID|CE|6e7b3388-f0fe-4867-9037-202cab925b1d|1|[?]|[?]|SEVERE|5|WASHOUT|2021-11-18|2021-11-02|2022-06-17|33|17|244|COINCIDENT|2021-10-19|ONGOING|2021-10-20
Study ID|CE|6e7b3388-f0fe-4867-9037-202cab925b1d|2|[?]|[?]|MILD|1|SCREENING|2022-08-11|2022-07-11|2022-08-12|299|268|300|COINCIDENT|2022-01-26|AFTER|2022-02-06
Study ID|CE|1e595d68-b74a-499e-801b-5f6a708e39c3|1|[?]|[?]|SEVERE|3|WASHOUT|2021-10-02|2021-09-17|2022-05-20|20|5|250|AFTER|2021-09-24|ONGOING|2021-09-26
Study ID|CE|1e595d68-b74a-499e-801b-5f6a708e39c3|2|[?]|[?]|SEVERE|3|WASHOUT|2022-06-25|2022-01-07|2022-07-06|286|117|297|BEFORE|2021-11-02|BEFORE|2021-11-02
Study ID|CE|0dd22462-a34b-42ab-ad3d-2b4c029b9399|1|[?]|[?]|MODERATE|4|TREATMENT|2022-01-08|2021-12-07|2022-03-29|109|77|189|AFTER|2022-04-30|AFTER|2022-05-01
Study ID|CE|0dd22462-a34b-42ab-ad3d-2b4c029b9399|2|[?]|[?]|SEVERE|3|WASHOUT|2022-02-05|2021-10-28|2022-05-28|137|37|249|COINCIDENT|2021-10-03|COINCIDENT|2021-10-08
Study ID|CE|e653c9e9-26ff-4b4e-80f1-464dc0995a42|1|[?]|[?]|SEVERE|3|WASHOUT|2022-05-08|2022-01-07|2022-05-12|266|145|270|BEFORE|2021-11-26|COINCIDENT|2021-12-17
Study ID|CE|e653c9e9-26ff-4b4e-80f1-464dc0995a42|2|[?]|[?]|SEVERE|3|WASHOUT|2022-02-13|2021-11-07|2022-03-31|182|84|228|UNKNOWN|2022-03-06|COINCIDENT|2022-03-07
Study ID|CE|a3a8b4fb-1d7c-444f-9011-d037bfdec8a7|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-02-10|2021-10-16|2022-05-16|183|66|278|COINCIDENT|2021-09-01|AFTER|2021-10-02
Study ID|CE|a3a8b4fb-1d7c-444f-9011-d037bfdec8a7|2|[?]|[?]|SEVERE|6|TREATMENT|2021-10-17|2021-10-15|2022-05-14|67|65|276|UNKNOWN|2021-12-27|BEFORE|2021-12-30
Study ID|CE|379863fa-bfee-4e4d-befe-b8fd41c364ff|1|[?]|[?]|SEVERE|2|TREATMENT|2021-11-05|2021-09-12|2022-03-07|72|18|194|BEFORE|2021-12-30|ONGOING|2022-01-17
Study ID|CE|379863fa-bfee-4e4d-befe-b8fd41c364ff|2|[?]|[?]|MILD|1|SCREENING|2022-06-08|2022-02-27|2022-06-20|287|186|299|UNKNOWN|2022-01-04|AFTER|2022-01-06
Study ID|CE|b06186b7-1214-430a-bab2-df8236efd19f|1|[?]|[?]|SEVERE|2|TREATMENT|2021-12-06|2021-10-17|2022-06-20|55|5|251|COINCIDENT|2022-02-21|AFTER|2022-02-24
Study ID|CE|b06186b7-1214-430a-bab2-df8236efd19f|2|[?]|[?]|SEVERE|2|TREATMENT|2021-12-24|2021-11-20|2022-03-21|73|39|160|UNKNOWN|2022-02-14|AFTER|2022-02-22
Study ID|CE|55195f1a-0df1-40b2-8c58-835ade2af55f|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-04-06|2021-12-19|2022-05-06|227|119|257|UNKNOWN|2022-02-03|AFTER|2022-03-04
Study ID|CE|55195f1a-0df1-40b2-8c58-835ade2af55f|2|[?]|[?]|MILD|6|TREATMENT|2022-01-10|2021-10-21|2022-05-22|141|60|273|UNKNOWN|2022-05-27|ONGOING|2022-05-28
Study ID|CE|eb79afb1-9c3a-454f-baa5-627758587ac7|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-07-08|2022-03-07|2022-07-25|274|151|291|UNKNOWN|2021-10-12|ONGOING|2021-10-13
Study ID|CE|eb79afb1-9c3a-454f-baa5-627758587ac7|2|[?]|[?]|SEVERE|5|WASHOUT|2021-11-26|2021-11-05|2022-02-08|50|29|124|BEFORE|2022-04-10|BEFORE|2022-05-26
Study ID|CE|781798a9-20dd-4cc9-bb23-5794f2eb7336|1|[?]|[?]|MODERATE|2|TREATMENT|2022-01-13|2021-12-17|2022-07-25|83|56|276|AFTER|2022-06-01|ONGOING|2022-06-18
Study ID|CE|781798a9-20dd-4cc9-bb23-5794f2eb7336|2|[?]|[?]|MILD|4|TREATMENT|2021-11-21|2021-11-04|2022-05-04|30|13|194|UNKNOWN|2021-12-27|ONGOING|2021-12-28
Study ID|CE|ade91982-0b4d-4d0d-b21f-d3abf6dc96f5|1|[?]|[?]|MODERATE|1|SCREENING|2021-12-30|2021-11-30|2022-01-16|115|85|132|UNKNOWN|2022-03-07|BEFORE|2022-03-12
Study ID|CE|ade91982-0b4d-4d0d-b21f-d3abf6dc96f5|2|[?]|[?]|MODERATE|2|TREATMENT|2022-06-28|2022-03-15|2022-06-30|295|190|297|UNKNOWN|2022-01-05|BEFORE|2022-03-11
Study ID|CE|00e59aa5-5211-459e-ac38-bbafb5ff3f24|1|[?]|[?]|MODERATE|6|TREATMENT|2021-10-01|2021-09-28|2022-05-19|20|17|250|UNKNOWN|2021-12-05|AFTER|2022-01-25
Study ID|CE|00e59aa5-5211-459e-ac38-bbafb5ff3f24|2|[?]|[?]|SEVERE|6|TREATMENT|2021-10-19|2021-09-26|2022-03-25|38|15|195|COINCIDENT|2021-12-01|ONGOING|2021-12-06
Study ID|CE|e99cb8c0-6dea-446a-b798-9c83a8d7e7a5|1|[?]|[?]|SEVERE|1|SCREENING|2022-06-12|2022-05-31|2022-06-26|266|254|280|UNKNOWN|2022-01-20|BEFORE|2022-01-24
Study ID|CE|e99cb8c0-6dea-446a-b798-9c83a8d7e7a5|2|[?]|[?]|SEVERE|4|TREATMENT|2021-11-25|2021-10-04|2022-03-21|67|15|183|COINCIDENT|2022-02-04|AFTER|2022-03-07
Study ID|CE|58b27f5f-433c-4663-99f8-b05eaadebcf1|1|[?]|[?]|MODERATE|5|WASHOUT|2022-01-13|2022-01-06|2022-04-03|160|153|240|UNKNOWN|2021-12-01|COINCIDENT|2022-01-15
Study ID|CE|58b27f5f-433c-4663-99f8-b05eaadebcf1|2|[?]|[?]|MILD|2|TREATMENT|2021-09-08|2021-08-26|2021-10-23|33|20|78|COINCIDENT|2022-01-10|ONGOING|2022-01-31
Study ID|CE|05ad2b06-dee9-46de-bd5a-82370ab7619e|1|[?]|[?]|SEVERE|5|WASHOUT|2022-03-02|2021-10-21|2022-04-27|189|57|245|COINCIDENT|2022-03-07|BEFORE|2022-03-30
Study ID|CE|05ad2b06-dee9-46de-bd5a-82370ab7619e|2|[?]|[?]|SEVERE|5|WASHOUT|2022-06-01|2022-05-14|2022-06-09|280|262|288|UNKNOWN|2021-11-06|BEFORE|2021-11-11
Study ID|CE|fae01538-e100-4d2c-98ef-c3713d1d7081|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-10-12|2021-10-10|2021-10-29|23|21|40|COINCIDENT|2022-02-09|BEFORE|2022-02-10
Study ID|CE|fae01538-e100-4d2c-98ef-c3713d1d7081|2|[?]|[?]|MILD|5|WASHOUT|2022-07-12|2021-12-09|2022-07-13|296|81|297|AFTER|2021-09-24|BEFORE|2021-09-25
Study ID|CE|a510ec7d-0345-4e62-b40c-80c8cfa7cd20|1|[?]|[?]|SEVERE|6|TREATMENT|2022-02-11|2021-08-19|2022-04-30|183|7|261|BEFORE|2021-11-24|AFTER|2021-12-06
Study ID|CE|a510ec7d-0345-4e62-b40c-80c8cfa7cd20|2|[?]|[?]|MODERATE|6|TREATMENT|2021-11-14|2021-10-06|2022-05-02|94|55|263|BEFORE|2021-10-30|ONGOING|2021-10-31
Study ID|CE|fea49005-0bfc-484e-98e6-ac47d64fbf56|1|[?]|[?]|MILD|5|WASHOUT|2021-11-05|2021-10-25|2022-06-16|32|21|255|AFTER|2021-10-27|COINCIDENT|2021-11-29
Study ID|CE|fea49005-0bfc-484e-98e6-ac47d64fbf56|2|[?]|[?]|MODERATE|5|WASHOUT|2021-11-09|2021-10-12|2021-11-25|36|8|52|AFTER|2022-04-18|BEFORE|2022-05-29
Study ID|CE|b2c1c740-dabb-4c35-9ec3-89fa8b631104|1|[?]|[?]|SEVERE|4|TREATMENT|2021-12-19|2021-12-06|2022-02-07|86|73|136|UNKNOWN|2022-03-13|ONGOING|2022-03-17
Study ID|CE|b2c1c740-dabb-4c35-9ec3-89fa8b631104|2|[?]|[?]|MILD|4|TREATMENT|2022-05-01|2022-03-08|2022-07-02|219|165|281|AFTER|2022-01-02|COINCIDENT|2022-02-15
Study ID|CE|66ae8b7c-4307-4873-8dc0-37d451513ade|1|[?]|[?]|MODERATE|5|WASHOUT|2022-01-20|2021-12-23|2022-03-06|100|72|145|BEFORE|2022-03-24|AFTER|2022-05-31
Study ID|CE|66ae8b7c-4307-4873-8dc0-37d451513ade|2|[?]|[?]|MILD|1|SCREENING|2021-12-19|2021-10-19|2022-01-17|68|7|97|AFTER|2021-11-05|AFTER|2021-11-14
Study ID|CE|4f522ceb-0594-4d09-a8dc-ae62fc25b236|1|[?]|[?]|MILD|3|WASHOUT|2021-10-01|2021-09-27|2022-07-02|11|7|285|COINCIDENT|2021-11-20|COINCIDENT|2021-11-25
Study ID|CE|4f522ceb-0594-4d09-a8dc-ae62fc25b236|2|[?]|[?]|MODERATE|5|WASHOUT|2022-04-04|2021-11-13|2022-07-02|196|54|285|BEFORE|2022-02-22|BEFORE|2022-02-23
Study ID|CE|38cc70be-90f8-4047-a6c3-202950fd7bf5|1|[?]|[?]|MILD|3|WASHOUT|2022-04-26|2021-11-14|2022-07-23|190|27|278|UNKNOWN|2021-11-14|ONGOING|2021-11-16
Study ID|CE|38cc70be-90f8-4047-a6c3-202950fd7bf5|2|[?]|[?]|SEVERE|2|TREATMENT|2021-12-02|2021-11-09|2022-05-26|45|22|220|COINCIDENT|2022-01-04|COINCIDENT|2022-01-04
Study ID|CE|19f9dd2b-c46c-4629-94dd-d38b92434e2b|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-01-26|2022-01-22|2022-05-07|145|141|246|AFTER|2021-09-25|COINCIDENT|2021-10-10
Study ID|CE|19f9dd2b-c46c-4629-94dd-d38b92434e2b|2|[?]|[?]|MILD|1|SCREENING|2022-02-03|2021-09-08|2022-05-20|153|5|259|BEFORE|2022-05-15|ONGOING|2022-05-17
Study ID|CE|2edbba86-21c3-4d85-a985-b3a6916f9f97|1|[?]|[?]|SEVERE|3|WASHOUT|2022-04-07|2022-01-02|2022-04-26|179|84|198|AFTER|2021-10-30|ONGOING|2021-10-31
Study ID|CE|2edbba86-21c3-4d85-a985-b3a6916f9f97|2|[?]|[?]|MILD|5|WASHOUT|2022-06-15|2022-02-27|2022-07-15|248|140|278|UNKNOWN|2021-10-20|BEFORE|2021-10-28
Study ID|CE|44914c1c-b117-4162-8da2-c1689a94b998|1|[?]|[?]|SEVERE|2|TREATMENT|2021-11-05|2021-09-30|2022-02-07|90|54|184|UNKNOWN|2022-03-16|ONGOING|2022-03-23
Study ID|CE|44914c1c-b117-4162-8da2-c1689a94b998|2|[?]|[?]|MILD|6|TREATMENT|2022-04-07|2021-09-18|2022-04-28|243|42|264|UNKNOWN|2022-03-16|BEFORE|2022-03-30
Study ID|CE|e8e27076-473e-4293-b243-1bb94b3bf269|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-01-20|2022-01-06|2022-03-14|124|110|177|BEFORE|2021-12-05|BEFORE|2022-02-24
Study ID|CE|e8e27076-473e-4293-b243-1bb94b3bf269|2|[?]|[?]|SEVERE|5|WASHOUT|2021-10-20|2021-10-05|2022-03-14|32|17|177|BEFORE|2021-11-26|COINCIDENT|2021-12-11
Study ID|CE|cd33ac34-c57a-49c6-b847-59effff0d1c4|1|[?]|[?]|MODERATE|3|WASHOUT|2021-11-21|2021-10-23|2022-02-14|87|58|172|BEFORE|2022-01-06|COINCIDENT|2022-03-16
Study ID|CE|cd33ac34-c57a-49c6-b847-59effff0d1c4|2|[?]|[?]|MODERATE|6|TREATMENT|2021-12-06|2021-09-29|2022-03-08|102|34|194|COINCIDENT|2021-10-04|COINCIDENT|2021-10-05
Study ID|CE|2d6d1b14-f011-4f9c-810e-ea30fb92a74f|1|[?]|[?]|MILD|3|WASHOUT|2021-11-15|2021-09-29|2021-12-13|65|18|93|COINCIDENT|2021-11-20|AFTER|2021-12-02
Study ID|CE|2d6d1b14-f011-4f9c-810e-ea30fb92a74f|2|[?]|[?]|SEVERE|2|TREATMENT|2021-10-12|2021-10-09|2022-02-14|31|28|156|COINCIDENT|2021-09-22|ONGOING|2021-09-25
Study ID|CE|d22fb880-8b73-4eee-8f7d-7ef0eecd8bd9|1|[?]|[?]|MILD|6|TREATMENT|2022-02-08|2021-11-04|2022-03-03|103|7|126|UNKNOWN|2021-12-09|ONGOING|2021-12-14
Study ID|CE|d22fb880-8b73-4eee-8f7d-7ef0eecd8bd9|2|[?]|[?]|MILD|5|WASHOUT|2022-04-10|2022-03-01|2022-04-26|164|124|180|BEFORE|2022-04-21|COINCIDENT|2022-05-29
Study ID|CE|09ee7713-76e0-4c7e-9b09-ed1e30338692|1|[?]|[?]|MODERATE|3|WASHOUT|2022-03-29|2022-03-14|2022-04-03|176|161|181|AFTER|2022-01-12|ONGOING|2022-01-13
Study ID|CE|09ee7713-76e0-4c7e-9b09-ed1e30338692|2|[?]|[?]|MILD|2|TREATMENT|2022-01-03|2021-12-26|2022-05-15|91|83|223|BEFORE|2022-06-22|AFTER|2022-07-01
Study ID|CE|4ba85b15-78bc-4434-9473-b728a29918e7|1|[?]|[?]|MODERATE|1|SCREENING|2022-06-23|2021-11-15|2022-06-24|249|29|250|COINCIDENT|2022-05-27|BEFORE|2022-05-29
Study ID|CE|4ba85b15-78bc-4434-9473-b728a29918e7|2|[?]|[?]|SEVERE|1|SCREENING|2021-11-21|2021-10-22|2021-12-18|35|5|62|COINCIDENT|2022-01-12|BEFORE|2022-02-17
Study ID|CE|ae3512e5-96ff-4ed1-8756-b279cb283132|1|[?]|[?]|SEVERE|2|TREATMENT|2022-01-06|2021-10-30|2022-04-26|70|2|180|BEFORE|2022-01-13|ONGOING|2022-01-14
Study ID|CE|ae3512e5-96ff-4ed1-8756-b279cb283132|2|[?]|[?]|SEVERE|4|TREATMENT|2022-06-04|2022-05-25|2022-07-27|219|209|272|COINCIDENT|2022-05-31|BEFORE|2022-06-10
Study ID|CE|f6e6bd11-b4ef-4eb5-a21e-9a5406abb936|1|[?]|[?]|SEVERE|2|TREATMENT|2021-12-19|2021-12-15|2022-02-05|104|100|152|UNKNOWN|2021-09-27|COINCIDENT|2021-10-06
Study ID|CE|f6e6bd11-b4ef-4eb5-a21e-9a5406abb936|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-03-09|2021-09-11|2022-06-17|184|5|284|COINCIDENT|2021-09-25|BEFORE|2021-09-30
Study ID|CE|59ed4050-4faa-4336-92bb-949fecdc4b00|1|[?]|[?]|SEVERE|2|TREATMENT|2022-01-29|2021-12-18|2022-05-21|110|68|222|COINCIDENT|2022-03-09|AFTER|2022-04-27
Study ID|CE|59ed4050-4faa-4336-92bb-949fecdc4b00|2|[?]|[?]|MODERATE|3|WASHOUT|2022-04-17|2021-12-03|2022-08-01|188|53|294|AFTER|2022-03-08|BEFORE|2022-03-30
Study ID|CE|3c2d3684-0d5a-4808-be0c-0823d8cb9df8|1|[?]|[?]|MODERATE|3|WASHOUT|2022-03-05|2022-02-13|2022-07-28|143|123|288|AFTER|2021-12-08|BEFORE|2021-12-09
Study ID|CE|3c2d3684-0d5a-4808-be0c-0823d8cb9df8|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-06-12|2022-01-20|2022-07-11|242|99|271|AFTER|2021-12-03|ONGOING|2022-02-12
Study ID|CE|af4a272e-d496-4495-aeb3-385d991445cb|1|[?]|[?]|MILD|6|TREATMENT|2022-05-20|2021-09-13|2022-06-05|281|32|297|COINCIDENT|2022-04-06|BEFORE|2022-04-14
Study ID|CE|af4a272e-d496-4495-aeb3-385d991445cb|2|[?]|[?]|MILD|7|FOLLOW-UP|2022-03-25|2021-11-06|2022-04-23|225|86|254|BEFORE|2022-03-09|ONGOING|2022-03-15
Study ID|CE|3f08021d-f0ce-4ec8-8391-230f3f955f51|1|[?]|[?]|MILD|3|WASHOUT|2022-04-18|2022-04-03|2022-08-20|174|159|298|UNKNOWN|2022-04-12|AFTER|2022-05-20
Study ID|CE|3f08021d-f0ce-4ec8-8391-230f3f955f51|2|[?]|[?]|MILD|3|WASHOUT|2021-12-10|2021-11-26|2022-05-30|45|31|216|COINCIDENT|2022-02-06|AFTER|2022-02-26
Study ID|CE|a2e4b861-b070-4901-83c5-b00c4fd48d89|1|[?]|[?]|MODERATE|5|WASHOUT|2022-03-09|2022-01-14|2022-04-03|212|158|237|AFTER|2021-08-13|BEFORE|2021-08-14
Study ID|CE|a2e4b861-b070-4901-83c5-b00c4fd48d89|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-01-30|2021-11-23|2022-05-08|174|106|272|AFTER|2021-12-23|ONGOING|2021-12-24
Study ID|CE|0bbfbb9e-0acc-45c5-a49e-6172d899c8d7|1|[?]|[?]|MILD|6|TREATMENT|2022-07-21|2022-03-19|2022-07-27|293|169|299|UNKNOWN|2022-05-24|BEFORE|2022-06-03
Study ID|CE|0bbfbb9e-0acc-45c5-a49e-6172d899c8d7|2|[?]|[?]|SEVERE|1|SCREENING|2022-07-24|2022-03-08|2022-07-27|296|158|299|BEFORE|2021-11-30|BEFORE|2022-05-03
Study ID|CE|bd118e24-0744-4d61-8d3b-e39c8925765d|1|[?]|[?]|MODERATE|2|TREATMENT|2021-12-26|2021-09-24|2022-05-29|120|27|274|BEFORE|2021-10-27|ONGOING|2021-12-01
Study ID|CE|bd118e24-0744-4d61-8d3b-e39c8925765d|2|[?]|[?]|SEVERE|5|WASHOUT|2022-01-16|2021-10-25|2022-01-20|141|58|145|BEFORE|2022-02-11|COINCIDENT|2022-03-20
Study ID|CE|90402180-9860-48b5-b39f-2853f61f798c|1|[?]|[?]|SEVERE|4|TREATMENT|2022-05-20|2021-11-18|2022-05-22|285|102|287|COINCIDENT|2022-02-07|ONGOING|2022-02-20
Study ID|CE|90402180-9860-48b5-b39f-2853f61f798c|2|[?]|[?]|MODERATE|5|WASHOUT|2022-06-03|2021-09-12|2022-06-04|299|35|300|AFTER|2021-10-30|COINCIDENT|2021-10-31
Study ID|CE|a12d498c-5df4-49e4-9344-81dc0e85ae95|1|[?]|[?]|SEVERE|3|WASHOUT|2022-05-16|2021-08-31|2022-05-25|283|25|292|UNKNOWN|2021-11-20|ONGOING|2021-11-24
Study ID|CE|a12d498c-5df4-49e4-9344-81dc0e85ae95|2|[?]|[?]|MODERATE|1|SCREENING|2021-08-18|2021-08-09|2021-09-01|12|3|26|AFTER|2021-12-07|ONGOING|2022-01-18
Study ID|CE|02653a1e-e5bc-424d-8d16-878d950e6477|1|[?]|[?]|MODERATE|3|WASHOUT|2022-07-22|2022-06-08|2022-08-08|269|225|286|AFTER|2021-10-31|AFTER|2021-11-01
Study ID|CE|02653a1e-e5bc-424d-8d16-878d950e6477|2|[?]|[?]|SEVERE|3|WASHOUT|2022-03-02|2021-12-14|2022-04-13|127|49|169|BEFORE|2022-03-04|COINCIDENT|2022-03-18
Study ID|CE|1d2862be-1311-4934-8e2a-667a6b588468|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-05-10|2022-02-16|2022-06-12|219|136|252|UNKNOWN|2022-03-10|ONGOING|2022-03-18
Study ID|CE|1d2862be-1311-4934-8e2a-667a6b588468|2|[?]|[?]|SEVERE|3|WASHOUT|2021-12-02|2021-11-02|2021-12-29|60|30|87|AFTER|2021-10-23|COINCIDENT|2021-10-27
Study ID|CE|703313f4-61d3-41fe-acc9-c1167076306b|1|[?]|[?]|MILD|7|FOLLOW-UP|2021-11-07|2021-10-31|2022-03-12|78|71|203|BEFORE|2021-11-07|AFTER|2022-04-17
Study ID|CE|703313f4-61d3-41fe-acc9-c1167076306b|2|[?]|[?]|MILD|3|WASHOUT|2021-10-08|2021-09-04|2022-06-01|48|14|284|AFTER|2021-09-11|BEFORE|2021-10-04
Study ID|CE|9e662145-d0f9-4b10-acd0-8084041a5101|1|[?]|[?]|MODERATE|2|TREATMENT|2022-07-24|2022-03-30|2022-07-27|293|177|296|COINCIDENT|2022-05-03|AFTER|2022-05-29
Study ID|CE|9e662145-d0f9-4b10-acd0-8084041a5101|2|[?]|[?]|SEVERE|5|WASHOUT|2021-12-20|2021-10-31|2022-02-08|77|27|127|BEFORE|2022-01-20|ONGOING|2022-02-07
Study ID|CE|5e99b934-db09-4b04-a001-8bcfd63b161e|1|[?]|[?]|MILD|4|TREATMENT|2022-05-13|2022-01-28|2022-06-09|252|147|279|AFTER|2022-02-04|ONGOING|2022-02-06
Study ID|CE|5e99b934-db09-4b04-a001-8bcfd63b161e|2|[?]|[?]|MODERATE|5|WASHOUT|2021-10-06|2021-09-21|2022-03-13|33|18|191|AFTER|2021-12-03|ONGOING|2021-12-14
Study ID|CE|48356313-8821-4814-b386-1426007dc54c|1|[?]|[?]|MILD|5|WASHOUT|2021-10-09|2021-09-09|2021-10-31|37|7|59|COINCIDENT|2021-11-17|COINCIDENT|2021-11-23
Study ID|CE|48356313-8821-4814-b386-1426007dc54c|2|[?]|[?]|SEVERE|1|SCREENING|2021-10-08|2021-09-14|2022-06-08|36|12|279|BEFORE|2022-01-17|BEFORE|2022-02-04
Study ID|CE|be84317a-930c-4f7c-bd68-c5a321eaabb0|1|[?]|[?]|MILD|5|WASHOUT|2022-05-12|2021-11-14|2022-07-08|219|40|276|AFTER|2022-05-13|ONGOING|2022-06-07
Study ID|CE|be84317a-930c-4f7c-bd68-c5a321eaabb0|2|[?]|[?]|SEVERE|1|SCREENING|2022-06-19|2022-01-30|2022-06-22|257|117|260|UNKNOWN|2022-03-13|COINCIDENT|2022-03-30
Study ID|CE|c42b2179-384c-43f6-a5c2-8cb461303738|1|[?]|[?]|MILD|4|TREATMENT|2022-04-21|2021-12-05|2022-05-11|211|74|231|AFTER|2022-01-06|ONGOING|2022-01-07
Study ID|CE|c42b2179-384c-43f6-a5c2-8cb461303738|2|[?]|[?]|MODERATE|4|TREATMENT|2022-01-18|2021-11-23|2022-02-08|118|62|139|UNKNOWN|2022-04-01|BEFORE|2022-04-07
Study ID|CE|686be7c0-f49b-44ba-ba30-d1d9c00d0f4e|1|[?]|[?]|MILD|3|WASHOUT|2022-01-16|2021-09-01|2022-06-01|162|25|298|COINCIDENT|2021-12-11|BEFORE|2021-12-16
Study ID|CE|686be7c0-f49b-44ba-ba30-d1d9c00d0f4e|2|[?]|[?]|SEVERE|6|TREATMENT|2022-04-07|2021-11-12|2022-05-30|243|97|296|COINCIDENT|2021-08-23|AFTER|2021-09-01
Study ID|CE|8cb48d4c-1f19-4d4d-8604-8116b52e6ced|1|[?]|[?]|MILD|2|TREATMENT|2021-11-25|2021-09-01|2022-03-09|93|8|197|AFTER|2021-08-30|ONGOING|2021-08-31
Study ID|CE|8cb48d4c-1f19-4d4d-8604-8116b52e6ced|2|[?]|[?]|MILD|5|WASHOUT|2022-03-19|2021-09-10|2022-05-28|207|17|277|AFTER|2021-09-25|COINCIDENT|2021-11-07
Study ID|CE|a0123519-cc0c-4792-9644-b586d66cbee3|1|[?]|[?]|MODERATE|4|TREATMENT|2022-05-29|2021-09-13|2022-06-08|285|27|295|BEFORE|2022-03-22|BEFORE|2022-04-24
Study ID|CE|a0123519-cc0c-4792-9644-b586d66cbee3|2|[?]|[?]|MODERATE|2|TREATMENT|2022-04-11|2022-01-09|2022-05-30|237|145|286|BEFORE|2021-12-14|COINCIDENT|2022-01-07
Study ID|CE|5a318a1f-73aa-426d-a74f-51d34974bbdf|1|[?]|[?]|SEVERE|4|TREATMENT|2021-11-03|2021-10-18|2022-03-09|27|11|153|BEFORE|2022-04-14|ONGOING|2022-04-25
Study ID|CE|5a318a1f-73aa-426d-a74f-51d34974bbdf|2|[?]|[?]|MODERATE|6|TREATMENT|2022-06-08|2022-04-18|2022-07-29|244|193|295|AFTER|2021-10-12|ONGOING|2021-10-13
Study ID|CE|fb6cd756-1ebc-46e5-9bf5-72190d6f9e5c|1|[?]|[?]|SEVERE|1|SCREENING|2021-11-06|2021-11-05|2021-11-08|22|21|24|COINCIDENT|2022-06-11|ONGOING|2022-06-20
Study ID|CE|fb6cd756-1ebc-46e5-9bf5-72190d6f9e5c|2|[?]|[?]|MILD|1|SCREENING|2022-05-30|2022-01-17|2022-07-30|227|94|288|BEFORE|2022-03-30|COINCIDENT|2022-04-13
Study ID|CE|251a673b-c882-4808-a1e0-37a01262b58a|1|[?]|[?]|MILD|3|WASHOUT|2022-05-06|2021-08-25|2022-05-10|269|15|273|COINCIDENT|2021-10-18|COINCIDENT|2021-10-24
Study ID|CE|251a673b-c882-4808-a1e0-37a01262b58a|2|[?]|[?]|MILD|5|WASHOUT|2022-03-23|2021-09-27|2022-04-29|225|48|262|BEFORE|2021-12-06|ONGOING|2021-12-22
Study ID|CE|81479285-f19f-44b5-96c3-a23c08894e21|1|[?]|[?]|MODERATE|1|SCREENING|2022-07-03|2021-11-04|2022-07-29|264|23|290|UNKNOWN|2021-11-13|AFTER|2021-11-19
Study ID|CE|81479285-f19f-44b5-96c3-a23c08894e21|2|[?]|[?]|MODERATE|4|TREATMENT|2022-03-15|2021-11-05|2022-05-28|154|24|228|BEFORE|2021-12-31|ONGOING|2022-01-07
Study ID|CE|8b72db84-3214-4393-9344-7b01ffd75a8f|1|[?]|[?]|SEVERE|4|TREATMENT|2021-11-30|2021-11-03|2021-12-05|57|30|62|UNKNOWN|2022-05-07|ONGOING|2022-05-12
Study ID|CE|8b72db84-3214-4393-9344-7b01ffd75a8f|2|[?]|[?]|MILD|6|TREATMENT|2022-01-04|2021-12-28|2022-07-18|92|85|287|BEFORE|2021-10-19|COINCIDENT|2021-10-20
Study ID|CE|e137fe71-a123-4b88-a1b6-b49f510bebeb|1|[?]|[?]|SEVERE|2|TREATMENT|2022-04-07|2021-10-25|2022-05-14|173|9|210|COINCIDENT|2022-06-19|BEFORE|2022-07-16
Study ID|CE|e137fe71-a123-4b88-a1b6-b49f510bebeb|2|[?]|[?]|MILD|2|TREATMENT|2022-04-23|2021-10-28|2022-05-14|189|12|210|COINCIDENT|2021-12-03|BEFORE|2021-12-05
Study ID|CE|84980f4f-a492-4502-9779-5f0eb0a4c6a2|1|[?]|[?]|MILD|5|WASHOUT|2022-01-11|2021-11-05|2022-05-26|114|47|249|BEFORE|2022-03-23|ONGOING|2022-04-03
Study ID|CE|84980f4f-a492-4502-9779-5f0eb0a4c6a2|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-05-06|2022-05-05|2022-06-20|229|228|274|AFTER|2022-01-26|BEFORE|2022-02-06
Study ID|CE|602009f9-f365-4d39-a286-e781386731c8|1|[?]|[?]|MODERATE|6|TREATMENT|2022-05-16|2021-12-06|2022-06-14|217|56|246|COINCIDENT|2021-12-16|ONGOING|2021-12-20
Study ID|CE|602009f9-f365-4d39-a286-e781386731c8|2|[?]|[?]|SEVERE|4|TREATMENT|2022-01-07|2021-12-07|2022-05-10|88|57|211|AFTER|2021-11-24|AFTER|2021-12-22
Study ID|CE|b2c2afea-6336-4b56-80e0-1d22ac07de48|1|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-05-13|2022-02-25|2022-06-13|196|119|227|UNKNOWN|2022-01-18|AFTER|2022-02-01
Study ID|CE|b2c2afea-6336-4b56-80e0-1d22ac07de48|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2022-04-23|2021-11-29|2022-07-20|176|31|264|COINCIDENT|2022-01-05|BEFORE|2022-01-07
Study ID|CE|1044cde5-b270-498a-9e54-af607177b34c|1|[?]|[?]|MILD|4|TREATMENT|2022-08-14|2022-02-26|2022-08-15|297|128|298|UNKNOWN|2022-02-26|COINCIDENT|2022-03-15
Study ID|CE|1044cde5-b270-498a-9e54-af607177b34c|2|[?]|[?]|SEVERE|2|TREATMENT|2022-08-05|2021-10-31|2022-08-09|288|10|292|UNKNOWN|2022-04-30|ONGOING|2022-05-03
Study ID|CE|02eb41cd-6bea-4a56-b021-a3a8bb3930ca|1|[?]|[?]|MILD|7|FOLLOW-UP|2022-01-01|2021-12-14|2022-07-15|75|57|270|UNKNOWN|2021-11-29|COINCIDENT|2021-12-07
Study ID|CE|02eb41cd-6bea-4a56-b021-a3a8bb3930ca|2|[?]|[?]|MODERATE|7|FOLLOW-UP|2021-11-10|2021-10-29|2021-12-14|23|11|57|AFTER|2022-03-28|COINCIDENT|2022-03-31
Study ID|CE|4913919b-0dc2-4fc1-a7ca-f282ce7249d3|1|[?]|[?]|MILD|4|TREATMENT|2022-03-22|2021-12-04|2022-07-16|146|38|262|BEFORE|2021-11-02|ONGOING|2021-11-03
Study ID|CE|4913919b-0dc2-4fc1-a7ca-f282ce7249d3|2|[?]|[?]|MILD|3|WASHOUT|2021-11-26|2021-10-30|2022-06-20|30|3|236|COINCIDENT|2022-07-10|AFTER|2022-08-11
Study ID|CE|736c3d8e-42f5-4c39-89ef-42a7883f33c1|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2021-10-23|2021-10-22|2022-06-01|38|37|259|COINCIDENT|2022-03-12|ONGOING|2022-04-26
Study ID|CE|736c3d8e-42f5-4c39-89ef-42a7883f33c1|2|[?]|[?]|MILD|6|TREATMENT|2021-11-22|2021-10-25|2022-04-16|68|40|213|BEFORE|2021-11-14|ONGOING|2021-11-23
Study ID|CE|9847eca9-c477-4a03-96ab-3ad77da580bf|1|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-07-08|2022-05-13|2022-07-14|281|225|287|COINCIDENT|2022-02-02|BEFORE|2022-05-23
Study ID|CE|9847eca9-c477-4a03-96ab-3ad77da580bf|2|[?]|[?]|MILD|4|TREATMENT|2022-02-26|2022-01-19|2022-05-30|149|111|242|BEFORE|2022-01-02|COINCIDENT|2022-01-03
Study ID|CE|652a6c34-caae-455c-939b-de93c811b8e4|1|[?]|[?]|MODERATE|6|TREATMENT|2022-04-02|2022-02-23|2022-05-28|155|117|211|AFTER|2022-03-10|AFTER|2022-03-11
Study ID|CE|652a6c34-caae-455c-939b-de93c811b8e4|2|[?]|[?]|MODERATE|4|TREATMENT|2021-10-31|2021-10-31|2022-07-06|2|2|250|AFTER|2021-11-08|COINCIDENT|2021-11-09
Study ID|CE|7265965a-9dee-479e-91ff-99e4b3d38be5|1|[?]|[?]|SEVERE|2|TREATMENT|2022-06-01|2022-03-06|2022-06-07|224|137|230|AFTER|2021-11-22|AFTER|2021-11-23
Study ID|CE|7265965a-9dee-479e-91ff-99e4b3d38be5|2|[?]|[?]|SEVERE|7|FOLLOW-UP|2022-05-28|2021-12-02|2022-07-30|220|43|283|AFTER|2022-03-31|AFTER|2022-06-24
